data_2hbp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hbp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.662 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 1.2 p . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 121.3 0.572 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 12.1 ptp180 -136.97 -177.09 4.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.054 -171.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.701 HD11 ' HE2' ' A' ' 16' ' ' LYS . 2.2 tm? -91.24 106.68 18.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.41 -174.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.493 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 35.3 m95 -92.12 149.32 21.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.738 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.1 t -135.75 139.96 45.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.825 ' HA ' HD12 ' A' ' 46' ' ' LEU . 1.2 p-10 -80.8 175.14 10.94 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.619 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.53 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 3.7 tpm_? -54.21 -51.21 65.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.836 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -80.21 -14.85 58.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.616 -172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.68 47.31 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.466 -0.653 . . . . 0.0 111.466 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.2 m -86.62 -36.88 18.56 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.735 0.302 . . . . 0.0 110.189 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.486 ' CE2' ' HE2' ' A' ' 45' ' ' LYS . 39.3 p90 -129.99 141.42 50.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.812 0.815 . . . . 0.0 111.985 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.701 ' HE2' HD11 ' A' ' 7' ' ' LEU . 9.5 ptmm? -128.93 131.81 47.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.895 174.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -134.9 140.92 44.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -172.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 8.6 p-10 -81.22 122.4 27.35 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 169.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.678 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -162.01 155.89 21.51 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.594 -175.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.518 ' HG2' ' N ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -116.33 145.93 42.83 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.415 171.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.566 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 62.7 t80 -80.91 129.55 34.59 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.148 0.499 . . . . 0.0 110.395 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -108.75 -49.55 7.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.091 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.42 140.87 6.43 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.901 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.566 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 30.8 t -111.1 130.41 55.62 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.41 137.98 18.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.613 0.244 . . . . 0.0 110.713 -174.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 61.6 24.62 14.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.481 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.6 2.68 75.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.789 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -115.03 161.83 17.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.549 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.522 HG13 ' HB1' ' A' ' 43' ' ' ALA . 69.6 mt -114.36 120.66 64.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.361 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.417 ' O ' HG13 ' A' ' 22' ' ' ILE . 23.0 m-70 -80.48 123.53 28.15 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 97.7 mt -126.34 139.67 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.152 -174.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -112.66 103.13 11.17 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.205 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.8 mtpt -59.65 152.64 21.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.32 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 5' ' ' SER . . . -72.23 -15.17 61.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.217 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.36 -13.29 60.72 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.437 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.27 9.46 51.1 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.154 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.99 142.77 16.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.759 0.279 . . . . 0.0 110.43 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 38' ' ' LYS . 4.1 tmmm? -105.33 125.21 50.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 pt -127.29 172.44 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.888 0.375 . . . . 0.0 111.123 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.9 110.0 11.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.2 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.15 127.03 71.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.875 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 128.4 36.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.708 0.289 . . . . 0.0 110.486 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.522 ' HB1' HG13 ' A' ' 29' ' ' ILE . . . -70.78 -10.16 58.92 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.522 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 11.7 p-10 -96.23 -19.76 19.07 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -172.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HE2' ' CE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -104.84 19.56 20.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.428 0.632 . . . . 0.0 109.953 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.825 HD12 ' HA ' ' A' ' 10' ' ' ASP . 8.1 tp -101.5 176.44 5.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.076 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.663 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 22.2 t -88.38 147.52 24.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.065 0.936 . . . . 0.0 111.005 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.687 HD21 ' HB3' ' A' ' 66' ' ' LYS . 1.1 m120 -56.87 -35.38 68.84 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.455 -172.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.07 -45.55 73.51 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.095 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.663 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 2.2 m-20 -59.21 -40.8 86.95 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.989 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.792 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -68.05 -42.94 79.75 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.288 178.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.597 ' O ' ' HG2' ' A' ' 56' ' ' LYS . . . -58.81 -35.19 72.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.253 0.549 . . . . 0.0 110.051 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.429 ' CE2' HD12 ' A' ' 57' ' ' ILE . 43.6 t80 -68.79 -50.26 51.77 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.151 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.553 HG11 ' O ' ' A' ' 50' ' ' ASP . 2.4 p -68.89 -31.41 50.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.614 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.792 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.0 mt-10 -51.91 -40.95 61.54 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.604 168.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.689 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -75.54 -33.97 60.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 110.574 -174.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.431 HG22 ' HD2' ' A' ' 21' ' ' PHE . 52.2 mt -66.26 -39.65 84.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.971 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 p -92.13 -46.32 7.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -171.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.51 -5.5 35.38 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -89.75 -178.48 5.52 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.515 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 13.8 t -124.25 125.41 44.35 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.166 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 21.3 mt -104.19 24.16 11.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.771 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -53.83 -46.53 71.21 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.897 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -59.43 -24.79 63.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.504 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.522 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 90.9 m-85 -89.17 -14.07 36.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 0.0 110.739 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.687 ' HB3' HD21 ' A' ' 48' ' ' ASN . 93.4 mttt . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.444 -0.77 0 CA-C-O 121.44 0.638 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 2.8 ptp180 -110.13 174.83 5.68 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.689 -173.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 16' ' ' LYS . 1.7 tm? -94.2 104.72 16.72 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.155 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.775 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 69.3 m95 -91.56 142.73 27.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.825 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.4 t -132.82 142.45 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 O-C-N 123.488 0.492 . . . . 0.0 110.926 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.965 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -90.63 161.2 15.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -68.5 -23.03 64.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.074 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -75.88 -23.37 55.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.132 0.492 . . . . 0.0 110.377 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.11 12.32 60.28 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.941 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -87.66 -48.11 8.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.525 0.679 . . . . 0.0 109.868 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.965 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 2.4 m-85 -79.67 134.33 36.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.034 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.775 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 7.2 ptpp? -159.97 128.96 5.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.493 165.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.45 151.67 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 120.129 -0.629 . . . . 0.0 111.955 -173.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.571 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 8.0 p-10 -84.05 125.48 32.14 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.691 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.41 ' HB2' ' HG ' ' A' ' 31' ' ' LEU . . . -167.93 156.83 9.41 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.183 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.71 149.16 30.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.538 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.731 ' HA ' HD11 ' A' ' 31' ' ' LEU . 58.2 t80 -87.39 131.36 34.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.491 -173.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -107.85 -44.98 7.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.823 0.344 . . . . 0.0 110.58 179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.33 161.81 31.07 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 121.129 -0.557 . . . . 0.0 111.836 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 t -141.78 132.58 25.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.286 0.543 . . . . 0.0 110.96 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.09 149.33 26.0 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.12 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.58 21.43 10.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.095 0.558 . . . . 0.0 111.937 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.17 23.06 50.1 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.336 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.646 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 47.1 mmtm -125.59 146.51 49.66 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 120.872 0.367 . . . . 0.0 110.982 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.555 ' CG2' HD12 ' A' ' 31' ' ' LEU . 1.9 mp -106.92 123.95 62.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.354 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.521 ' O ' HG13 ' A' ' 22' ' ' ILE . 36.6 m170 -89.83 120.32 30.97 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.731 HD11 ' HA ' ' A' ' 21' ' ' PHE . 3.0 tp -121.63 153.35 38.22 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.342 -173.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -128.53 107.2 9.52 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.352 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.501 ' HD3' HD11 ' A' ' 39' ' ' ILE . 12.6 mmmm -58.59 161.35 4.69 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.242 -175.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.62 -25.63 68.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.773 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -79.16 -19.61 50.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.081 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.7 26.92 6.23 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.691 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.497 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 47.3 t -102.42 143.01 15.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -105.52 131.12 53.32 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.079 0.466 . . . . 0.0 110.963 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.501 HD11 ' HD3' ' A' ' 33' ' ' LYS . 24.5 pt -135.36 160.27 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.605 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.81 117.87 29.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.039 0.447 . . . . 0.0 110.135 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.2 t -112.11 134.98 52.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.775 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.646 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . . . -69.8 127.03 31.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.724 0.297 . . . . 0.0 110.907 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.11 -14.15 61.28 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.418 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.406 ' OD1' ' HB3' ' A' ' 42' ' ' ALA . 7.1 p-10 -92.88 -14.72 27.29 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 19.4 ptmt -97.51 -2.1 42.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.474 0.654 . . . . 0.0 110.124 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 46' ' ' LEU . 2.6 tp -84.86 159.63 20.34 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.504 -170.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.582 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 48.1 t -71.65 153.34 42.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.4 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.452 ' HA ' HD23 ' A' ' 51' ' ' LEU . 12.6 m-80 -64.12 -28.65 69.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.211 -176.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -66.11 -47.82 72.93 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.865 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.582 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 4.1 m-20 -62.63 -32.14 73.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.486 177.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.697 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -65.98 -51.6 57.02 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.112 177.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -63.71 -27.2 69.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.123 0.487 . . . . 0.0 111.06 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.467 ' CE1' HD11 ' A' ' 57' ' ' ILE . 22.9 t80 -70.0 -48.3 58.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.866 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 50' ' ' ASP . 78.8 t -62.8 -34.3 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.777 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 44.0 mt-10 -54.84 -32.77 60.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.022 0.439 . . . . 0.0 110.512 174.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.552 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -80.18 -47.15 15.13 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.053 -178.008 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.467 HD11 ' CE1' ' A' ' 53' ' ' TYR . 25.0 mt -62.47 -36.63 75.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 111.727 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 55.8 p -103.12 -46.48 4.62 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.22 -8.01 30.87 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -173.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 92.8 m-85 -90.99 135.42 33.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.11 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.1 m -82.11 130.59 35.13 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.766 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 51' ' ' LEU . 48.6 mt -104.63 30.2 5.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.179 0.514 . . . . 0.0 109.875 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -53.95 -47.48 71.24 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.349 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -67.11 -13.55 62.05 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.8 -14.97 27.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.922 0.391 . . . . 0.0 110.235 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 92.2 mttt . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.599 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 CA--C 1.517 -0.306 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.636 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 9.3 ptp180 -143.39 -179.29 6.32 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.81 -167.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.697 HD13 ' HB3' ' A' ' 16' ' ' LYS . 2.1 tm? -95.24 105.27 17.2 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.856 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.583 ' CE3' ' HB3' ' A' ' 50' ' ' ASP . 37.0 m95 -91.57 139.16 30.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 10' ' ' ASP . 47.6 t -119.31 137.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.846 0.355 . . . . 0.0 110.858 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.558 ' HB3' ' H ' ' A' ' 14' ' ' THR . 9.8 t70 -63.46 158.82 19.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -74.11 -35.03 64.12 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.712 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -95.87 11.97 31.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.137 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.71 28.58 73.5 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.897 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.558 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 6.7 m -67.5 -37.07 82.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.745 -0.228 . . . . 0.0 111.111 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -158.39 157.54 32.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.261 0.553 . . . . 0.0 111.407 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.697 ' HB3' HD13 ' A' ' 7' ' ' LEU . 9.1 mtmp? -125.13 132.29 53.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.514 171.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.433 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -135.27 141.39 42.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 112.548 0.574 . . . . 0.0 112.548 -175.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.7 OUTLIER -95.29 115.11 26.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.312 176.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.826 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . . . -170.24 167.19 8.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.16 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.3 140.33 49.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.898 ' HA ' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -65.72 134.54 53.41 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.993 0.425 . . . . 0.0 109.876 177.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.973 HD11 ' HE3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -110.29 -47.64 6.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.111 177.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.54 139.41 5.78 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.293 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.812 ' HG ' HG12 ' A' ' 29' ' ' ILE . 78.2 m -98.69 126.36 44.27 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.58 136.5 22.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.6 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 tptt 63.8 27.64 14.63 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.643 0.735 . . . . 0.0 110.118 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.56 3.57 88.92 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.211 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.842 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 42.1 mttm -109.95 171.91 7.17 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.812 HG12 ' HG ' ' A' ' 24' ' ' CYS . 57.9 mt -124.67 116.72 48.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.384 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.414 ' O ' HG13 ' A' ' 22' ' ' ILE . 57.3 m-70 -75.88 128.2 34.61 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.898 HD23 ' HA ' ' A' ' 21' ' ' PHE . 77.1 mt -126.82 136.92 53.02 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.363 -172.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.531 ' HB2' HD13 ' A' ' 22' ' ' ILE . 15.1 t-160 -102.31 102.59 12.97 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.345 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.826 ' HD2' ' HB3' ' A' ' 19' ' ' ALA . 1.6 mmmp? -65.13 163.99 13.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.073 -176.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.3 -13.48 62.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.101 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -87.29 -10.49 52.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.592 176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.91 -18.4 52.47 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.922 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.6 p -72.65 147.98 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.945 0.402 . . . . 0.0 110.823 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.973 ' HE3' HD11 ' A' ' 22' ' ' ILE . 84.6 tttt -111.16 132.96 53.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.613 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 pt -126.95 174.69 10.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.484 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.89 103.19 5.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.245 0.545 . . . . 0.0 110.056 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.527 HG12 ' HE3' ' A' ' 45' ' ' LYS . 73.2 t -106.84 118.63 54.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.668 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.842 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -57.85 139.14 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.375 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.14 -9.33 58.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.693 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -84.05 -31.27 25.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.122 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.527 ' HE3' HG12 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -99.24 27.34 5.21 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.362 175.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.535 HD13 HD12 ' A' ' 29' ' ' ILE . 13.9 mt -102.26 163.67 12.11 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 122.338 1.066 . . . . 0.0 112.241 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.551 ' O ' HD23 ' A' ' 51' ' ' LEU . 30.2 t -71.05 135.65 47.87 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.104 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.47 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 3.0 m-20 -48.44 -38.91 21.04 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.842 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.74 -47.07 83.5 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.564 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.583 ' HB3' ' CE3' ' A' ' 8' ' ' TRP . 43.6 m-20 -67.49 -34.97 78.24 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.238 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.781 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -70.95 -41.71 70.76 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.505 176.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.508 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -60.69 -29.44 69.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.515 0.674 . . . . 0.0 110.135 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.454 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 51.1 t80 -71.51 -51.59 22.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.935 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.77 ' HA ' HG12 ' A' ' 57' ' ' ILE . 2.7 p -71.23 -27.66 30.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.607 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.781 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 42.6 mt-10 -51.67 -38.53 55.36 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.165 0.507 . . . . 0.0 109.796 168.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -76.4 -41.11 48.97 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.783 -178.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.77 HG12 ' HA ' ' A' ' 54' ' ' VAL . 7.5 mm -61.69 -36.29 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.8 p -101.88 -49.17 4.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.34 -34.22 4.37 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.989 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -87.98 140.74 29.19 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 117.14 0.47 . . . . 0.0 110.451 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.7 t -79.51 135.73 36.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.424 -171.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 23.8 mt -104.68 22.28 15.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.115 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.587 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 2.2 tp10 -50.69 -38.63 47.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.4 0.619 . . . . 0.0 110.362 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -67.48 -5.92 17.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.843 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -115.94 -12.48 11.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.229 0.537 . . . . 0.0 110.103 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.587 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 45.1 mtpt . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.831 -174.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 1.051 ' H ' ' HG2' ' A' ' 20' ' ' GLU . 60.9 p . . . . . 0 CA--C 1.522 -0.125 0 CA-C-O 122.403 1.097 . . . . 0.0 112.479 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 11.6 ptp180 -118.96 176.52 5.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.798 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 16' ' ' LYS . 1.6 tm? -95.66 105.68 17.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.975 0.417 . . . . 0.0 110.769 -173.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.668 ' HB2' HG23 ' A' ' 17' ' ' VAL . 48.7 m95 -92.4 152.64 19.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.299 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.481 HG23 ' HG2' ' A' ' 16' ' ' LYS . 47.6 t -135.76 142.94 37.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.649 ' HA ' HD12 ' A' ' 46' ' ' LEU . 3.5 p-10 -85.41 178.31 7.49 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.084 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -59.52 -40.48 87.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.83 0.348 . . . . 0.0 111.552 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.8 m -84.5 -18.65 35.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.5 13.93 74.89 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.708 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 m -79.87 -37.02 35.75 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.683 -0.258 . . . . 0.0 111.182 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 47.0 p90 -123.4 125.15 44.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.009 0.909 . . . . 0.0 112.175 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.564 ' HB3' HD12 ' A' ' 7' ' ' LEU . 52.2 mttp -116.61 131.17 57.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.452 174.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.668 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -131.91 136.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.553 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.1 p-10 -90.02 106.11 18.26 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.181 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . . . -161.44 161.79 30.3 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.767 -171.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 1.051 ' HG2' ' H ' ' A' ' 5' ' ' SER . 1.1 mm-40 -107.92 142.79 37.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.563 174.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.623 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 69.4 t80 -73.85 130.32 39.68 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.975 174.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -115.8 -47.62 4.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.408 178.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.83 148.51 14.86 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.86 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.623 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 30.8 t -124.18 126.89 46.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.859 0.329 . . . . 0.0 110.126 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.33 116.69 16.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.112 -173.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.5 tptt 55.2 44.5 27.6 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.201 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.28 2.82 85.19 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.46 175.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -107.06 151.74 24.94 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 117.118 0.459 . . . . 0.0 110.079 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.674 HG13 ' HB1' ' A' ' 43' ' ' ALA . 91.0 mt -119.87 123.76 71.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.286 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.499 ' O ' HG13 ' A' ' 22' ' ' ILE . 34.6 m170 -84.96 124.08 31.27 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 21' ' ' PHE . 96.5 mt -125.63 138.45 53.92 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.83 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -107.37 101.14 10.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.175 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HE3' HG11 ' A' ' 17' ' ' VAL . 38.1 mtpt -64.96 159.06 23.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.471 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.9 -15.68 63.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.54 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.77 -20.07 61.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.566 174.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.57 -20.5 27.37 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.963 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.7 p -79.2 142.12 14.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.293 0.568 . . . . 0.0 111.19 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -99.65 127.8 45.76 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.928 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.1 pt -122.87 162.62 22.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.958 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.91 122.66 38.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.842 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.59 163.55 15.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.42 119.71 32.22 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.411 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.674 ' HB1' HG13 ' A' ' 29' ' ' ILE . . . -64.24 -21.92 66.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.735 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.4 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 27.2 t70 -69.61 -22.41 63.5 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.764 -174.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HE2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -127.22 28.62 5.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.431 0.634 . . . . 0.0 110.377 179.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 10' ' ' ASP . 10.7 tp -95.03 170.58 9.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.592 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.638 ' O ' HD21 ' A' ' 51' ' ' LEU . 33.4 t -72.74 139.73 47.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.422 0.63 . . . . 0.0 110.1 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.475 ' CB ' ' HB3' ' A' ' 66' ' ' LYS . 11.2 p30 -66.06 -24.51 66.74 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.983 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -63.87 -47.77 79.36 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.637 0.732 . . . . 0.0 109.192 174.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.638 ' O ' HG13 ' A' ' 54' ' ' VAL . 3.3 m-20 -58.62 -43.8 89.78 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.712 176.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.776 HD22 ' HA ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -67.57 -42.39 82.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.819 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -61.5 -29.64 70.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.401 0.62 . . . . 0.0 110.134 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.732 ' CE2' HD12 ' A' ' 57' ' ' ILE . 40.9 t80 -74.61 -49.13 22.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.763 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 50' ' ' ASP . 2.2 p -69.48 -27.65 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.119 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.755 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 50.6 mt-10 -51.24 -40.91 59.85 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 167.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 52' ' ' ALA . 9.3 mmpt? -74.14 -38.61 63.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.389 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.732 HD12 ' CE2' ' A' ' 53' ' ' TYR . 31.9 mt -62.84 -39.8 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.976 0.417 . . . . 0.0 111.253 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.595 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 40.3 p -95.22 -43.91 7.85 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -168.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.2 7.46 43.4 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.494 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.595 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 98.1 m-85 -103.7 177.06 4.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -123.69 124.66 43.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.959 0.409 . . . . 0.0 110.034 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 65' ' ' PHE . 62.1 mt -102.89 41.19 1.27 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.45 0.643 . . . . 0.0 110.189 -175.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.702 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 8.5 tp10 -50.62 -59.65 3.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.479 -176.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -70.35 -10.47 59.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.339 0.59 . . . . 0.0 109.917 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.659 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 60.3 m-85 -91.88 -14.2 30.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.566 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.776 ' HA ' HD22 ' A' ' 51' ' ' LEU . 50.8 mtmt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.476 -175.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.6 p . . . . . 0 N--CA 1.441 -0.9 0 CA-C-O 121.041 0.448 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 2.8 ptp180 -136.54 -179.17 5.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.052 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -93.18 115.14 27.77 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.497 -172.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.704 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 62.4 m95 -104.6 149.15 25.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.156 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 59.5 t -136.75 149.92 26.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 123.543 0.527 . . . . 0.0 109.829 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.984 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -96.67 174.09 7.0 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.214 178.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 11' ' ' ARG . 1.6 tmm_? -66.82 -34.29 77.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.705 0.288 . . . . 0.0 110.857 -174.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -75.68 -23.36 56.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.21 2.17 66.3 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.666 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -80.8 -40.48 24.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.349 0.595 . . . . 0.0 109.834 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.984 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 5.7 m-85 -85.93 127.12 34.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.829 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.704 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 8.6 ptmt -153.35 128.57 9.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.917 166.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.412 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -158.36 156.36 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.785 -173.367 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -92.81 118.67 31.35 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.899 174.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -163.86 164.62 23.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.621 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 138.32 51.3 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.815 ' HD2' HG23 ' A' ' 29' ' ' ILE . 6.6 t80 -74.41 117.91 16.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.324 0.583 . . . . 0.0 109.504 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -96.07 -45.37 13.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.136 -177.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.93 143.21 7.55 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.766 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.588 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 22.1 p -100.82 133.93 44.55 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.74 126.91 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.576 -173.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.3 OUTLIER 61.44 34.2 18.27 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.811 176.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.29 7.42 88.48 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.254 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -104.7 165.91 10.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.028 0.442 . . . . 0.0 110.442 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.815 HG23 ' HD2' ' A' ' 21' ' ' PHE . 84.6 mt -125.51 116.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.52 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.484 ' O ' HG13 ' A' ' 22' ' ' ILE . 11.2 m170 -83.61 126.94 33.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.721 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.7 mt -124.72 138.89 54.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.284 0.564 . . . . 0.0 111.021 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -104.72 105.55 15.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.468 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.592 ' HD3' HD13 ' A' ' 39' ' ' ILE . 13.5 mmmm -61.14 162.89 6.75 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.527 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -68.14 -12.47 60.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.265 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -89.26 -13.46 38.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.195 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.82 2.56 56.19 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.468 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.17 148.14 5.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.554 0.216 . . . . 0.0 110.46 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -100.04 126.41 46.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.041 0.448 . . . . 0.0 110.857 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.592 HD13 ' HD3' ' A' ' 33' ' ' LYS . 24.8 pt -124.86 168.45 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.949 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.88 124.36 18.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.258 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 m -114.05 164.71 9.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.499 ' HB1' ' HG3' ' A' ' 45' ' ' LYS . . . -85.86 127.85 34.68 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.183 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.549 ' HB1' HG13 ' A' ' 29' ' ' ILE . . . -63.97 -5.8 5.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.372 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -110.71 -15.72 13.77 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.624 ' HB2' ' HZ3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -96.26 0.88 51.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 6.6 tp -86.27 169.23 13.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.058 -175.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.626 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.5 t -78.9 138.29 38.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.776 0.798 . . . . 0.0 109.923 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.439 ' ND2' ' HB3' ' A' ' 66' ' ' LYS . 1.2 m-20 -53.53 -32.79 52.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.329 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -62.91 -48.13 80.28 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.046 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.652 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.6 m-20 -59.67 -39.26 83.88 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.555 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.725 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -70.21 -38.89 75.39 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.158 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.644 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -60.33 -30.44 69.51 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.566 0.698 . . . . 0.0 110.197 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.658 ' CE2' HD13 ' A' ' 57' ' ' ILE . 80.2 t80 -74.36 -48.41 28.21 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.507 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -65.17 -26.98 41.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.415 -0.803 . . . . 0.0 110.853 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.725 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 37.8 mt-10 -51.47 -43.53 62.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.26 166.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.591 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 1.6 ppmt? -72.87 -31.58 64.82 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.992 0.425 . . . . 0.0 109.983 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.658 HD13 ' CE2' ' A' ' 53' ' ' TYR . 37.7 mt -66.94 -42.84 89.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.735 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.4 p -104.52 -46.38 4.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -171.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.13 -14.57 23.51 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -79.74 137.64 37.08 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.417 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 20.9 t -89.45 112.04 23.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.938 0.399 . . . . 0.0 110.238 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 30.1 mt -91.51 24.86 2.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.638 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -53.48 -47.37 69.85 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.677 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -73.33 -5.35 39.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.502 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -97.41 -16.13 20.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.102 0.477 . . . . 0.0 110.14 176.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 97.9 mttt . . . . . 0 C--O 1.235 0.341 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.877 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.635 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 25.1 t . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.123 0.487 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -148.59 -179.82 7.26 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 110.737 178.064 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.444 HD13 ' HB3' ' A' ' 16' ' ' LYS . 2.6 tm? -103.72 108.18 19.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.507 -175.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.591 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 43.1 m95 -93.22 145.46 24.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.046 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.24 148.5 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.598 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -86.66 177.32 7.39 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.187 176.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.639 ' HD3' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -55.11 -44.87 75.35 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.305 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.639 ' N ' ' HD3' ' A' ' 11' ' ' ARG . 64.6 p -85.4 -28.97 24.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.017 0.437 . . . . 0.0 111.436 -173.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.11 20.3 30.92 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.467 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.6 m -78.24 -37.48 45.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.783 0.325 . . . . 0.0 110.297 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.405 ' HZ ' ' HD3' ' A' ' 45' ' ' LYS . 42.0 p90 -132.87 133.56 43.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.84 0.828 . . . . 0.0 112.376 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.444 ' HB3' HD13 ' A' ' 7' ' ' LEU . 21.7 mtmm -123.11 143.89 49.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.608 175.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.698 HG11 ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -137.66 135.85 46.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.657 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 10.3 p-10 -85.89 105.36 16.32 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.486 173.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.763 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . . . -156.21 162.43 40.18 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.329 -171.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -119.1 139.47 51.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.857 172.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.819 ' HD2' HG21 ' A' ' 29' ' ' ILE . 33.6 t80 -68.56 132.22 46.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -113.76 -48.89 5.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.19 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.08 157.59 29.15 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.0 p -116.87 140.87 48.94 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 28' ' ' LYS . . . -135.02 105.59 6.43 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.172 -174.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? 59.12 41.86 19.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.923 0.868 . . . . 0.0 109.573 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.71 -19.18 52.87 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.978 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 42' ' ' ALA . 3.6 ptpp? -89.18 163.72 15.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.406 0.603 . . . . 0.0 110.423 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.819 HG21 ' HD2' ' A' ' 21' ' ' PHE . 57.8 mt -115.39 126.8 73.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.12 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.451 ' O ' HG13 ' A' ' 22' ' ' ILE . 91.4 m-70 -86.16 127.27 34.69 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 169.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.763 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 95.8 mt -125.63 137.8 53.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.91 -176.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -106.3 110.05 22.17 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.271 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.698 ' HE3' HG11 ' A' ' 17' ' ' VAL . 11.8 mmmm -58.05 151.81 17.91 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 123.696 0.623 . . . . 0.0 109.901 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.65 -16.06 63.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.623 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -89.82 -7.13 55.03 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.153 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.45 -23.41 12.33 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.718 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 t -67.44 145.78 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 117.001 0.4 . . . . 0.0 110.88 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -112.37 130.27 56.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.821 0.343 . . . . 0.0 110.196 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.8 pt -126.1 165.68 23.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.385 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.58 124.46 40.0 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.558 HG11 ' HE3' ' A' ' 45' ' ' LYS . 70.4 t -130.4 120.58 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.402 -175.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . . . -66.06 129.27 39.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.2 -18.27 63.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.626 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.721 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 2.9 p30 -72.72 -25.64 61.3 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.094 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.558 ' HE3' HG11 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.43 29.03 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.751 0.786 . . . . 0.0 110.051 176.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.5 tp -108.77 174.5 5.84 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.197 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.557 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 47.6 t -80.21 138.01 36.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.925 0.869 . . . . 0.0 110.766 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -51.2 -41.23 60.1 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.756 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.7 -45.27 87.32 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.132 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.591 ' OD2' ' HA ' ' A' ' 8' ' ' TRP . 3.9 m-20 -60.24 -36.83 78.63 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.166 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.771 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -67.18 -42.72 83.74 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 120.597 -0.441 . . . . 0.0 109.918 176.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.646 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -60.97 -29.65 69.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.486 0.66 . . . . 0.0 110.237 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -73.85 -51.32 16.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.169 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.815 ' HA ' HG12 ' A' ' 57' ' ' ILE . 3.6 p -69.63 -25.7 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.143 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.771 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.0 mt-10 -50.34 -44.38 54.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.101 0.476 . . . . 0.0 109.733 167.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 52' ' ' ALA . 1.1 mpmm? -72.76 -34.55 67.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.492 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.815 HG12 ' HA ' ' A' ' 54' ' ' VAL . 4.9 mm -68.78 -34.15 63.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.067 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.738 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 37.6 p -99.31 -48.1 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -171.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.56 -0.76 34.5 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -171.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.738 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 87.3 m-85 -102.04 141.13 35.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.42 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 17.7 t -88.2 111.7 21.92 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.684 HD12 HG11 ' A' ' 54' ' ' VAL . 50.9 mt -90.3 24.44 2.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.174 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -57.78 -40.97 81.06 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.002 0.43 . . . . 0.0 110.504 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.6 ' HB2' ' HZ1' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -71.35 -5.79 35.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.254 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.721 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 96.4 m-85 -108.68 -4.33 17.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.307 177.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 98.8 mttt . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.038 -176.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.876 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 12.1 t . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -152.72 174.14 14.39 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.82 -0.55 . . . . 0.0 111.555 -177.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.72 HD12 ' HB3' ' A' ' 16' ' ' LYS . 1.8 tm? -94.75 104.58 16.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.182 -174.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.596 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 63.2 m95 -92.88 143.94 25.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.086 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.489 HG21 ' HG2' ' A' ' 16' ' ' LYS . 45.3 t -128.73 143.35 41.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.525 ' HA ' HD11 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -89.31 160.13 17.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -70.64 -20.76 62.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.586 -170.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 t -82.28 -12.78 57.81 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.245 0.545 . . . . 0.0 109.781 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.4 30.8 61.91 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.915 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.6 m -93.9 -44.4 8.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.413 0.149 . . . . 0.0 110.975 -176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 10' ' ' ASP . 34.8 p90 -127.17 131.74 50.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.912 0.863 . . . . 0.0 112.932 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.72 ' HB3' HD12 ' A' ' 7' ' ' LEU . 86.9 mttt -116.48 130.73 56.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.674 170.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.45 144.66 27.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.626 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 17.9 t70 -94.46 115.07 27.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.196 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.616 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . . . -161.07 162.56 31.67 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.914 -172.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.876 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 5.5 mm-40 -107.94 137.97 45.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.246 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.884 ' HD1' HG23 ' A' ' 29' ' ' ILE . 4.4 t80 -78.95 120.09 23.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.813 HD12 ' HE3' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -105.41 -42.01 6.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.711 -174.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.73 142.15 7.56 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.848 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.518 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 27.5 p -104.73 125.53 50.9 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.24 115.54 20.56 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.117 -172.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 65.67 -76.29 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.112 0.883 . . . . 0.0 111.085 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.49 18.32 1.49 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.949 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -125.77 166.52 16.66 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.472 0.653 . . . . 0.0 111.503 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.884 HG23 ' HD1' ' A' ' 21' ' ' PHE . 67.4 mt -117.24 126.49 74.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.828 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.461 ' O ' HG13 ' A' ' 22' ' ' ILE . 25.2 m170 -91.29 127.42 36.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 2.5 mm? -121.0 140.64 51.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.481 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -104.29 101.33 11.05 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 169.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.6 ' HD2' HD12 ' A' ' 39' ' ' ILE . 44.0 mtpt -68.21 154.67 41.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.165 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.73 -14.05 57.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.551 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.63 ' OD1' HG13 ' A' ' 37' ' ' VAL . 43.2 p30 -80.84 -18.93 45.8 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.935 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.65 -21.11 9.22 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.521 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.63 HG13 ' OD1' ' A' ' 35' ' ' ASN . 9.9 p -85.16 150.75 3.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.276 0.56 . . . . 0.0 111.238 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.813 ' HE3' HD12 ' A' ' 22' ' ' ILE . 85.4 tttt -107.24 125.92 51.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.557 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.6 HD12 ' HD2' ' A' ' 33' ' ' LYS . 16.4 pt -122.07 169.99 12.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.279 -173.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.03 103.68 6.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.607 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.492 HG11 HD12 ' A' ' 46' ' ' LEU . 67.8 t -101.82 122.81 54.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.428 ' HB1' ' OD1' ' A' ' 44' ' ' ASP . . . -60.45 129.57 42.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.259 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 29' ' ' ILE . . . -72.4 -6.38 43.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.01 0.433 . . . . 0.0 111.835 -172.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.428 ' OD1' ' HB1' ' A' ' 42' ' ' ALA . 8.6 p-10 -98.14 -20.23 17.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.823 -173.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.446 ' HE2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -102.82 6.03 39.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.782 0.801 . . . . 0.0 109.78 176.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.525 HD11 ' HA ' ' A' ' 10' ' ' ASP . 13.1 tp -91.62 170.39 9.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.299 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.617 ' O ' HD21 ' A' ' 51' ' ' LEU . 40.7 t -75.65 135.35 40.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.694 0.759 . . . . 0.0 110.444 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.439 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 19.3 m-20 -60.03 -32.15 70.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.949 -174.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.89 -43.78 97.88 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.664 0.745 . . . . 0.0 109.845 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.596 ' OD2' ' HA ' ' A' ' 8' ' ' TRP . 4.0 m-20 -64.75 -37.92 89.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.444 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.76 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -67.73 -39.8 84.25 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.667 177.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.644 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -60.25 -32.13 70.86 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.458 0.647 . . . . 0.0 109.978 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.738 ' CE2' HD13 ' A' ' 57' ' ' ILE . 80.6 t80 -72.21 -48.41 43.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.523 176.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -68.94 -26.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 121.757 -0.589 . . . . 0.0 111.241 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.76 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 48.2 mt-10 -51.3 -38.33 52.33 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.139 0.495 . . . . 0.0 109.764 166.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -73.56 -43.65 59.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.042 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.738 HD13 ' CE2' ' A' ' 53' ' ' TYR . 35.9 mt -57.58 -37.96 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.023 0.44 . . . . 0.0 111.193 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 35.1 p -98.66 -47.1 5.46 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -170.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.76 -3.77 39.2 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -171.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -92.09 172.84 8.17 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.7 t -117.94 128.01 54.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.172 0.51 . . . . 0.0 109.918 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 33.3 mt -106.22 19.76 20.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.941 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -53.17 -42.71 66.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.189 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -59.14 -23.62 62.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.5 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -97.25 -12.78 22.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.668 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 97.3 mttt . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.428 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.783 ' H ' ' HG2' ' A' ' 20' ' ' GLU . 40.1 t . . . . . 0 C--O 1.235 0.291 0 CA-C-O 122.052 0.929 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 13.8 ptp180 -126.12 177.36 6.42 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.447 -171.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 16' ' ' LYS . 1.9 tm? -89.39 119.11 29.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.882 0.372 . . . . 0.0 111.325 -171.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.552 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 41.9 m95 -108.5 148.04 30.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.953 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.516 ' CG1' ' HA2' ' A' ' 13' ' ' GLY . 39.2 t -129.88 143.41 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 123.026 0.204 . . . . 0.0 110.456 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.646 ' HA ' HD11 ' A' ' 46' ' ' LEU . 1.7 p-10 -86.05 -179.47 6.77 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.9 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -52.94 -44.87 67.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.603 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 m -88.1 -20.53 25.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.039 0.447 . . . . 0.0 111.069 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.516 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . 86.81 14.58 64.83 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.629 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 m -74.49 -38.68 62.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.774 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 49.2 p90 -120.21 121.54 38.97 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 122.062 0.934 . . . . 0.0 111.846 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.716 ' HB3' HD13 ' A' ' 7' ' ' LEU . 49.5 mttp -112.41 130.95 55.8 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.005 -1.452 . . . . 0.0 107.611 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.5 146.09 28.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.183 0.516 . . . . 0.0 112.142 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.3 p30 -86.14 124.05 32.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.001 172.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.626 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -169.52 156.81 6.87 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.632 -175.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.783 ' HG2' ' H ' ' A' ' 5' ' ' SER . 0.4 OUTLIER -112.05 139.9 47.18 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.538 172.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.73 ' HE2' ' HB3' ' A' ' 24' ' ' CYS . 28.7 t80 -68.49 133.67 48.95 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.273 176.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -120.94 -48.93 3.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.462 178.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 30' ' ' HIS . . . -148.25 144.41 12.28 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.73 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 30.8 p -123.16 115.18 21.36 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.506 -0.408 . . . . 0.0 109.974 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.78 146.02 22.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 58.24 34.48 24.14 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.625 0.578 . . . . 0.0 111.26 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.89 17.01 64.74 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.401 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 39.4 mmtm -114.74 153.69 29.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.913 0.387 . . . . 0.0 110.039 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.547 HG22 ' HD2' ' A' ' 21' ' ' PHE . 79.0 mt -114.1 113.06 42.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.035 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.523 ' O ' HG13 ' A' ' 22' ' ' ILE . 15.2 m-70 -75.48 119.87 20.14 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.021 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.626 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 91.3 mt -124.57 140.25 53.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.171 0.51 . . . . 0.0 111.498 -172.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.488 ' NE2' ' HA2' ' A' ' 36' ' ' GLY . 17.7 t-80 -108.94 98.58 8.04 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.36 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' HB3' ' HZ1' ' A' ' 33' ' ' LYS . 1.7 mmmp? -57.69 167.09 1.17 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.852 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.19 -28.16 69.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.498 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -86.06 10.35 14.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.488 ' HA2' ' NE2' ' A' ' 32' ' ' HIS . . . 73.89 27.44 66.78 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.465 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.45 137.95 25.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 66.8 mttt -99.47 124.39 44.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.074 0.464 . . . . 0.0 111.383 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.1 pt -126.97 146.4 32.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.126 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.09 103.29 14.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.1 t -103.22 110.99 31.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -56.99 127.48 32.12 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.576 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.36 -8.0 29.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.069 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.442 ' OD2' ' HB1' ' A' ' 42' ' ' ALA . 2.8 p30 -95.59 -10.38 29.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -120.61 17.58 12.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.012 0.911 . . . . 0.0 108.806 171.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.646 HD11 ' HA ' ' A' ' 10' ' ' ASP . 13.7 tp -97.6 166.68 11.39 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.177 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.597 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 47.3 t -74.33 137.31 42.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.636 0.732 . . . . 0.0 110.693 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -58.07 -29.41 65.4 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.744 -177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.49 -50.68 72.6 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.7 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.597 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 3.8 m-20 -61.67 -36.82 81.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.83 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.76 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -68.79 -41.15 79.15 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.55 177.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -64.65 -28.63 69.74 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.544 0.688 . . . . 0.0 109.611 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.765 ' CE2' HD12 ' A' ' 57' ' ' ILE . 16.7 t80 -73.28 -48.02 38.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.49 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.714 HG11 HD22 ' A' ' 62' ' ' LEU . 3.0 p -68.48 -26.68 34.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 121.761 -0.587 . . . . 0.0 110.949 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.76 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.2 mt-10 -52.03 -35.25 46.37 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.11 0.481 . . . . 0.0 110.059 167.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 1.7 tptt -73.2 -50.29 23.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.161 176.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.765 HD12 ' CE2' ' A' ' 53' ' ' TYR . 51.1 mt -49.98 -46.34 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.126 0.489 . . . . 0.0 111.811 -177.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.409 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 34.2 p -105.08 -46.83 4.16 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -170.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.87 -6.7 27.55 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 90.3 m-85 -83.17 141.24 32.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.0 t -90.36 108.74 19.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.043 0.449 . . . . 0.0 110.037 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.714 HD22 HG11 ' A' ' 54' ' ' VAL . 2.6 mm? -87.1 19.41 3.12 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.403 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -53.82 -43.74 69.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.387 0.675 . . . . 0.0 110.756 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -67.44 -12.62 60.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.806 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -108.99 -0.99 19.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.723 0.297 . . . . 0.0 110.776 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 98.9 mttt . . . . . 0 C--N 1.327 -0.381 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.8 t . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.587 0.708 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 18.6 ptp180 -137.0 -179.13 5.52 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.66 -173.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.91 110.82 21.41 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.139 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.524 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 41.1 m95 -91.93 138.07 31.85 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.7 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 10' ' ' ASP . 58.9 t -129.41 142.54 43.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.459 ' HB3' ' H ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -74.48 159.43 32.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.616 0.722 . . . . 0.0 110.699 172.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.422 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -64.22 -21.36 66.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.403 -172.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.4 m -113.72 6.72 16.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.969 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.38 24.51 72.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.468 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 m -68.82 -40.11 79.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.615 0.245 . . . . 0.0 111.572 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.459 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 5.6 p90 -137.29 142.81 41.93 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.163 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 45.4 mttp -137.56 131.03 31.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.586 HG11 ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -148.51 146.31 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-O 120.912 0.386 . . . . 0.0 111.431 177.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.5 m-20 -83.32 121.51 27.22 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.16 171.94 17.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.237 0.542 . . . . 0.0 111.71 -173.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.93 142.59 51.21 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.62 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.589 ' HA ' HD13 ' A' ' 31' ' ' LEU . 64.6 t80 -77.67 132.23 38.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.104 0.478 . . . . 0.0 110.354 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -112.02 -51.1 5.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.52 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.11 145.94 11.14 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.217 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.539 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 27.0 t -123.8 130.8 53.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.828 0.347 . . . . 0.0 110.493 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.15 143.79 21.63 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 -177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 60.02 29.13 18.72 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.783 0.677 . . . . 0.0 111.601 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.06 1.16 89.82 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.498 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -106.73 161.0 15.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.964 0.412 . . . . 0.0 110.47 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.601 HG23 HD11 ' A' ' 31' ' ' LEU . 94.1 mt -123.11 123.49 68.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.531 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.401 ' O ' HG13 ' A' ' 22' ' ' ILE . 90.0 m-70 -87.76 128.09 35.32 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.601 HD11 HG23 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -124.03 148.42 47.04 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.665 -176.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -110.91 100.14 8.92 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.208 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.731 ' HD2' HD11 ' A' ' 39' ' ' ILE . 59.5 mtpt -71.94 152.0 42.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.784 -173.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.25 -12.0 46.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.99 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.42 -20.6 62.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.087 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.14 0.99 44.77 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.122 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.45 141.46 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.831 0.348 . . . . 0.0 111.207 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -98.26 128.03 44.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.967 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.731 HD11 ' HD2' ' A' ' 33' ' ' LYS . 49.0 pt -127.4 169.28 19.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.111 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.3 109.32 8.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.951 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.597 ' HB ' ' HE3' ' A' ' 45' ' ' LYS . 32.8 m -110.19 147.45 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.9 129.12 37.43 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.78 -16.17 47.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.451 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 4.7 p-10 -74.27 -23.2 59.09 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -173.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.597 ' HE3' ' HB ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.54 38.37 1.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.903 0.858 . . . . 0.0 110.163 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.449 HD23 HD13 ' A' ' 29' ' ' ILE . 6.0 mp -115.76 161.63 18.45 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.121 176.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.588 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 43.8 t -74.29 140.46 44.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.754 0.788 . . . . 0.0 110.047 176.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.1 m-20 -49.86 -34.32 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.267 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -59.22 -51.33 70.44 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.599 0.714 . . . . 0.0 109.981 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.626 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.1 m-20 -60.37 -38.24 83.26 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.422 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.796 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.5 OUTLIER -70.3 -43.85 69.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.363 179.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.62 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -58.96 -30.27 67.79 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.551 0.691 . . . . 0.0 110.375 -178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.403 ' O ' HG12 ' A' ' 57' ' ' ILE . 51.6 t80 -73.75 -50.64 19.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.325 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.728 ' HA ' HG12 ' A' ' 57' ' ' ILE . 2.2 p -69.94 -29.1 39.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.401 -176.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.796 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 47.4 mt-10 -51.61 -40.05 59.14 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.193 0.521 . . . . 0.0 109.914 169.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.851 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -78.38 -31.65 48.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.873 -176.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.728 HG12 ' HA ' ' A' ' 54' ' ' VAL . 10.9 mm -66.3 -35.82 75.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.031 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.4 p -107.88 -47.35 3.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -170.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.47 -31.85 4.28 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.389 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.465 ' HZ ' ' HB3' ' A' ' 24' ' ' CYS . 14.9 p90 -87.28 152.64 22.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.177 0.488 . . . . 0.0 110.842 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.432 ' OG ' ' HG2' ' A' ' 63' ' ' GLU . 7.7 t -92.37 140.97 29.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.708 -172.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.6 HD12 HG13 ' A' ' 54' ' ' VAL . 35.3 mt -115.94 31.42 6.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.86 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG2' ' OG ' ' A' ' 61' ' ' SER . 18.5 mm-40 -53.13 -40.69 64.42 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.666 174.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -62.78 -15.2 52.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.971 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.451 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 36.9 m-85 -106.96 -7.32 17.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.245 0.545 . . . . 0.0 110.545 -177.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 48' ' ' ASN . 99.1 mttt . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.221 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 12.0 ptp180 -131.44 -179.9 5.64 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.107 -170.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.807 HD13 ' HB3' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -95.06 106.22 18.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.814 -171.083 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -92.18 141.77 28.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.474 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 10' ' ' ASP . 96.5 t -132.88 136.84 55.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.989 0.423 . . . . 0.0 111.442 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.563 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.14 153.42 41.66 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.601 0.715 . . . . 0.0 110.379 171.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 6.3 tmm_? -63.66 -28.66 70.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.853 -169.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -93.39 -6.74 46.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.115 0.483 . . . . 0.0 110.687 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.08 20.85 60.07 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.933 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.5 m -69.03 -45.37 70.63 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.569 0.347 . . . . 0.0 111.662 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -137.92 143.85 41.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 110.832 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.807 ' HB3' HD13 ' A' ' 7' ' ' LEU . 54.4 mttm -133.4 130.88 39.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.601 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.66 152.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.258 0.551 . . . . 0.0 111.88 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.629 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.1 p30 -90.36 130.46 36.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.295 173.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.943 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . . . -171.38 157.39 4.9 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.18 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.49 140.41 49.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.743 ' HD1' HG23 ' A' ' 29' ' ' ILE . 42.7 t80 -72.01 130.69 41.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.378 0.609 . . . . 0.0 110.721 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -112.53 -49.73 5.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.237 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.29 148.7 14.44 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.59 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.417 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 27.9 t -118.41 134.41 55.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.954 0.377 . . . . 0.0 110.172 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.98 140.33 29.56 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.775 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 62.68 -78.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.099 0.874 . . . . 0.0 111.282 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -155.63 12.45 0.4 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 47.6 mttm -115.51 160.29 20.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.101 0.476 . . . . 0.0 110.925 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.743 HG23 ' HD1' ' A' ' 21' ' ' PHE . 2.2 mp -112.8 124.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.614 174.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.441 ' O ' HG13 ' A' ' 22' ' ' ILE . 79.0 m-70 -80.32 130.86 35.48 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.943 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 97.6 mt -130.16 140.51 50.76 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.686 -174.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -111.93 110.54 20.92 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.732 ' HB3' ' HZ3' ' A' ' 33' ' ' LYS . 5.1 mtpm? -69.76 170.5 10.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.042 -174.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.42 -20.5 60.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.815 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.475 ' HB2' HG22 ' A' ' 37' ' ' VAL . 7.8 m120 -79.87 -7.72 58.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.137 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.92 0.27 75.04 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.92 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' A' ' 35' ' ' ASN . 43.0 t -75.29 136.65 24.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -100.41 117.21 34.12 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.517 HG13 ' HB2' ' A' ' 31' ' ' LEU . 40.4 pt -119.63 172.1 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.0 110.64 4.02 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 m -112.13 129.39 67.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.879 0.371 . . . . 0.0 110.509 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.74 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -61.51 130.61 46.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.068 0.461 . . . . 0.0 110.181 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . . . -54.88 -26.17 33.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.165 -173.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.46 -10.64 59.76 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.537 ' HD3' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -101.19 17.72 21.77 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.697 178.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 88.8 mt -115.05 -174.8 2.56 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.246 1.022 . . . . 0.0 111.813 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.593 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 34.9 t -97.25 143.71 27.76 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.285 -1.78 . . . . 0.0 108.942 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -60.05 -24.18 64.34 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.918 -174.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -62.76 -47.32 84.04 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.964 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.593 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 3.8 m-20 -64.19 -38.52 91.35 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.441 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.64 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.8 OUTLIER -70.66 -38.33 73.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.952 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.463 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -68.03 -27.23 66.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.303 0.573 . . . . 0.0 109.968 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.588 ' CZ ' HD12 ' A' ' 57' ' ' ILE . 32.5 t80 -74.04 -49.95 21.91 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.198 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 50' ' ' ASP . 3.4 p -70.55 -32.04 48.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.018 0.437 . . . . 0.0 111.085 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.894 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 1.7 pt-20 -68.45 -23.51 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.302 0.572 . . . . 0.0 110.031 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 1.1 ttpp -72.79 -40.44 65.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.588 HD12 ' CZ ' ' A' ' 53' ' ' TYR . 54.2 mt -63.08 -44.69 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.013 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 55' ' ' GLU . 11.2 p -78.37 -43.99 26.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.289 -172.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.94 2.05 28.51 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.485 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.49 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 64.0 m-85 -104.83 -166.19 1.21 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 t -130.99 132.43 45.01 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.894 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 9.7 mt -103.68 29.7 5.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.387 0.613 . . . . 0.0 109.381 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.468 ' OE2' ' HD2' ' A' ' 66' ' ' LYS . 6.2 tp10 -45.0 -48.84 11.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.033 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -65.34 -17.53 64.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -100.8 -4.83 27.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.496 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HD2' ' OE2' ' A' ' 63' ' ' GLU . 97.8 mttt . . . . . 0 CA--C 1.513 -0.471 0 CA-C-O 121.697 0.761 . . . . 0.0 110.836 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.704 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 33.0 p . . . . . 0 CA--C 1.52 -0.187 0 CA-C-O 122.356 1.074 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 10.9 ptp180 -107.98 179.13 4.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.588 -166.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.751 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.9 tm? -88.9 108.95 19.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.852 -173.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.493 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 37.7 m95 -97.54 153.72 17.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.18 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 10' ' ' ASP . 23.5 t -133.68 146.79 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' HA ' HD13 ' A' ' 46' ' ' LEU . 7.8 p-10 -84.24 178.82 7.64 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.143 172.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 11' ' ' ARG . 2.1 tmm_? -81.32 -23.58 37.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 110.947 -174.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.9 t -89.91 -29.31 18.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.875 0.369 . . . . 0.0 110.679 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.89 21.18 19.21 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -76.79 -40.97 46.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.346 -0.427 . . . . 0.0 110.966 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.591 ' HZ ' ' HE3' ' A' ' 45' ' ' LYS . 33.0 p90 -142.2 131.01 22.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.908 0.861 . . . . 0.0 113.157 -174.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.751 ' HB3' HD11 ' A' ' 7' ' ' LEU . 36.0 mtmm -118.86 130.45 55.75 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.252 169.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.38 153.18 21.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.41 0.624 . . . . 0.0 112.371 -173.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.54 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.4 p30 -90.36 129.03 36.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.61 174.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.711 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . . . -178.7 159.54 1.11 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.946 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.704 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 3.8 mm-40 -110.61 144.26 39.77 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 121.251 0.548 . . . . 0.0 110.017 169.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.907 ' HD1' HG21 ' A' ' 29' ' ' ILE . 3.7 t80 -74.9 120.67 20.75 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.339 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.83 -52.77 8.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.079 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.3 141.87 7.76 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.759 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.409 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 24.6 p -101.0 144.04 30.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.39 109.16 4.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.186 -0.206 . . . . 0.0 111.159 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? 53.43 52.28 13.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.103 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.81 -7.01 71.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.124 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -101.44 161.06 13.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.26 0.53 . . . . 0.0 111.283 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.907 HG21 ' HD1' ' A' ' 21' ' ' PHE . 78.0 mt -123.03 120.79 61.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.248 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -87.82 131.7 34.44 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.777 HD21 ' HA ' ' A' ' 21' ' ' PHE . 85.7 mt -129.31 138.99 51.91 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.27 0.557 . . . . 0.0 111.284 -170.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -105.81 104.41 14.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.185 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.62 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 6.3 mtpm? -66.09 169.03 7.46 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.55 -18.66 62.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.301 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -103.86 14.75 30.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.611 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.9 -16.43 59.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.633 171.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HB ' ' HD3' ' A' ' 33' ' ' LYS . 60.7 t -65.43 139.18 21.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.708 0.289 . . . . 0.0 110.654 -178.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -104.31 124.19 48.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.499 HG13 ' HB2' ' A' ' 31' ' ' LEU . 39.1 pt -125.68 160.34 32.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.795 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.49 121.61 23.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.159 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -119.3 148.33 22.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.477 ' HB1' ' OD2' ' A' ' 44' ' ' ASP . . . -78.85 123.73 27.51 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.82 -19.66 65.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.566 0.698 . . . . 0.0 111.123 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.808 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 3.7 p30 -74.53 -14.28 60.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.274 -176.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.591 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -117.12 18.31 14.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.997 0.903 . . . . 0.0 109.201 174.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 10' ' ' ASP . 12.8 tp -100.21 167.79 10.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.434 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.8 t -67.11 137.83 56.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.426 0.632 . . . . 0.0 111.054 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.474 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 53.1 m-20 -58.66 -36.72 74.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.81 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -65.29 -46.04 82.0 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.658 0.742 . . . . 0.0 109.713 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.54 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.5 m-20 -61.78 -36.46 81.11 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.91 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.752 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -66.32 -45.72 79.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.852 176.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.572 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -61.86 -29.24 70.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.46 0.648 . . . . 0.0 110.449 -176.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.621 ' CE2' HD13 ' A' ' 57' ' ' ILE . 29.2 t80 -74.01 -49.93 22.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.232 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 50' ' ' ASP . 4.1 p -70.51 -26.58 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.894 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.752 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.9 mt-10 -51.45 -40.16 58.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.189 0.519 . . . . 0.0 109.872 167.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.584 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -75.78 -36.25 59.86 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.113 -176.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.621 HD13 ' CE2' ' A' ' 53' ' ' TYR . 29.8 mt -64.45 -40.23 88.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.992 175.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.7 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 36.6 p -91.02 -47.43 7.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -169.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.3 -4.73 51.74 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 -170.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.7 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 79.9 m-85 -95.58 162.24 13.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.9 t -110.79 117.08 32.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.219 0.533 . . . . 0.0 110.762 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.566 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 29.5 mt -91.67 17.53 8.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.58 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.812 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -56.61 -41.02 76.34 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.213 178.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -60.25 -20.33 58.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.812 178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.808 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 53.4 m-85 -99.17 -16.72 18.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.843 0.354 . . . . 0.0 110.341 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.812 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 9.4 mtpm? . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.705 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.949 ' H ' ' HG2' ' A' ' 20' ' ' GLU . 38.1 t . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 122.204 1.002 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.587 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 9.7 ptp180 -118.25 175.15 5.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.321 -1.308 . . . . 0.0 110.816 -170.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' A' ' 16' ' ' LYS . 1.3 tm? -83.62 117.12 22.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.943 -174.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.58 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 69.1 m95 -108.9 145.0 36.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.139 175.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 16' ' ' LYS . 88.8 t -131.59 138.43 52.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.22 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.672 ' HA ' HD11 ' A' ' 46' ' ' LEU . 6.4 p-10 -84.92 168.86 14.63 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.598 175.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.641 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 4.6 tpm_? -67.08 -35.22 79.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.514 0.197 . . . . 0.0 111.417 -174.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 m -79.16 -12.26 59.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.97 0.414 . . . . 0.0 111.209 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.5 17.63 75.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.506 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -66.69 -47.73 71.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.994 -0.603 . . . . 0.0 110.656 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 10' ' ' ASP . 16.4 p90 -138.57 132.64 31.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.7 0.762 . . . . 0.0 112.627 -174.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.681 ' HB2' HD12 ' A' ' 7' ' ' LEU . 20.6 ptmt -120.83 129.67 53.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.225 166.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.797 ' HB ' ' HE2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -148.9 159.12 6.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.225 0.536 . . . . 0.0 112.016 -172.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.587 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.5 OUTLIER -93.54 122.83 36.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.478 177.142 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.684 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -162.07 156.36 21.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.589 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.949 ' HG2' ' H ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -109.34 138.89 45.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.014 174.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.625 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 50.7 t80 -67.93 133.15 48.62 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.026 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -116.25 -50.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.158 179.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.16 153.7 24.78 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.465 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.625 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 29.2 t -129.09 130.05 46.0 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.43 134.44 21.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.486 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 63.11 15.53 8.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.236 0.541 . . . . 0.0 111.196 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.23 2.08 71.41 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.272 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 61.4 mttp -93.89 146.79 23.65 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.536 -0.39 . . . . 0.0 110.365 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.595 HD13 ' HB3' ' A' ' 43' ' ' ALA . 17.5 mm -105.09 119.42 54.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.539 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.448 ' O ' HG13 ' A' ' 22' ' ' ILE . 24.1 m170 -89.7 125.53 35.3 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.684 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 92.5 mt -128.74 139.15 52.35 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.23 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -102.18 106.64 17.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.56 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.797 ' HE2' ' HB ' ' A' ' 17' ' ' VAL . 2.5 mmmp? -64.36 152.09 42.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.174 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.12 -13.78 62.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.429 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 6.9 p-10 -98.01 12.63 33.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.894 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.06 -30.8 9.37 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.861 -0.685 . . . . 0.0 114.198 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.94 139.44 21.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.899 0.381 . . . . 0.0 111.795 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.97 122.68 45.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.0 161.75 19.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.928 -176.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.29 106.06 6.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.677 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.7 m -108.38 146.16 14.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -76.1 122.62 24.55 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.608 176.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.664 ' HB2' HD13 ' A' ' 51' ' ' LEU . . . -64.45 -21.47 66.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.581 0.705 . . . . 0.0 109.836 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 12.9 t70 -50.63 -32.95 20.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.341 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -116.52 26.54 9.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.238 0.542 . . . . 0.0 110.93 -178.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.672 HD11 ' HA ' ' A' ' 10' ' ' ASP . 8.6 tp -100.1 173.53 6.59 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.319 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.627 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 19.8 m -79.98 133.85 36.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.613 0.721 . . . . 0.0 110.475 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -55.04 -35.15 64.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.917 -172.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.4 -44.38 83.17 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.338 0.589 . . . . 0.0 109.733 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.627 ' OD1' ' HB2' ' A' ' 47' ' ' SER . 1.4 m-20 -57.77 -40.62 80.2 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.764 175.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.817 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -68.94 -39.54 79.52 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.408 178.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.676 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -59.31 -32.49 70.12 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.434 0.635 . . . . 0.0 109.885 -177.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.731 ' CE2' HD13 ' A' ' 57' ' ' ILE . 49.5 t80 -74.2 -49.61 22.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.551 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 50' ' ' ASP . 1.7 p -68.81 -28.07 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.205 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.817 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 46.9 mt-10 -52.18 -39.85 60.67 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.071 0.462 . . . . 0.0 110.061 167.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.636 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 9.4 mmpt? -78.08 -28.36 48.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.731 HD13 ' CE2' ' A' ' 53' ' ' TYR . 40.9 mt -67.88 -42.97 86.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.145 0.498 . . . . 0.0 110.712 173.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.5 p -90.84 -47.53 7.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.493 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.87 -19.7 15.47 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.893 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -107.04 151.24 25.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.954 0.407 . . . . 0.0 110.203 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -82.86 136.85 34.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.704 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.615 HD13 HG11 ' A' ' 54' ' ' VAL . 23.4 mt -107.0 20.16 19.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.847 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 4.0 tp10 -55.33 -44.38 75.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.967 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.467 ' HB2' ' HZ1' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -66.19 -14.45 61.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.238 178.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 44' ' ' ASP . 62.6 m-85 -105.13 -0.43 26.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 99.2 mttt . . . . . 0 C--N 1.323 -0.582 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.375 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 121.286 0.565 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 16.3 ptp180 -126.64 -178.66 4.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.975 -171.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.683 HD13 ' HB3' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -88.76 105.59 17.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.378 -168.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.469 ' HH2' ' HB ' ' A' ' 54' ' ' VAL . 47.2 m95 -94.46 139.71 30.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.72 176.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 10' ' ' ASP . 72.9 t -129.78 141.99 45.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.974 0.416 . . . . 0.0 111.71 -175.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.611 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.8 t70 -70.58 157.47 37.86 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -79.41 -25.86 42.01 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 p -99.68 7.22 45.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.046 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.77 68.34 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.72 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.548 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 31.8 m -68.27 -40.14 81.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.69 0.281 . . . . 0.0 111.257 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -150.81 150.21 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.144 0.497 . . . . 0.0 111.703 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.683 ' HB3' HD13 ' A' ' 7' ' ' LEU . 94.2 mttt -132.45 132.25 42.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.768 171.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.08 145.51 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.0 0.429 . . . . 0.0 111.807 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 5.9 p-10 -93.6 112.11 23.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.884 0.849 . . . . 0.0 110.133 174.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.422 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . . . -160.28 168.87 24.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.093 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.04 139.91 53.03 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.774 ' HA ' HD23 ' A' ' 31' ' ' LEU . 3.4 t80 -71.6 128.0 34.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.697 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -107.0 -46.91 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.608 -178.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 30' ' ' HIS . . . -153.79 153.54 24.9 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.598 -177.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.2 p -112.89 134.12 54.55 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.08 97.41 5.09 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.593 -173.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 57.56 23.71 9.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.231 173.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.59 -7.55 24.28 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.363 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 61.4 mttp -94.0 160.23 14.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.016 0.436 . . . . 0.0 110.925 175.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.939 HD12 ' HB3' ' A' ' 43' ' ' ALA . 10.7 mm -113.79 115.79 50.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.72 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.529 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -87.52 117.85 26.59 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.774 HD23 ' HA ' ' A' ' 21' ' ' PHE . 96.4 mt -119.99 139.69 52.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.451 0.643 . . . . 0.0 112.213 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -99.21 109.97 22.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.003 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.491 ' HD3' HD12 ' A' ' 39' ' ' ILE . 13.7 mmmm -66.05 155.1 37.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.876 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.41 -15.42 36.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.882 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -105.32 21.77 16.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.43 0.633 . . . . 0.0 110.424 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.87 -16.23 48.02 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.464 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -66.74 154.78 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 35.5 ttmt -122.94 125.62 45.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.953 0.406 . . . . 0.0 110.4 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.491 HD12 ' HD3' ' A' ' 33' ' ' LYS . 33.6 pt -122.5 176.92 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.754 -176.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.13 116.72 6.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.665 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 m -118.13 165.39 13.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.624 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -97.51 134.45 40.72 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.939 ' HB3' HD12 ' A' ' 29' ' ' ILE . . . -67.37 -8.0 29.31 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -72.05 -28.52 63.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -107.63 15.21 24.92 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.657 177.02 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 46' ' ' LEU . 8.2 tp -84.73 159.79 20.42 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.266 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.562 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 50.1 m -71.32 133.96 46.4 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.59 0.71 . . . . 0.0 109.89 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -57.53 -30.42 65.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.783 -171.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -65.83 -46.26 79.19 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.648 0.737 . . . . 0.0 109.349 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.579 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -59.54 -37.89 79.6 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.929 176.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.702 ' HB3' ' HB2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -68.37 -44.95 74.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.899 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.405 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -61.18 -28.43 69.13 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.297 0.57 . . . . 0.0 109.871 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.552 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 32.6 t80 -73.97 -51.79 14.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.335 175.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 50' ' ' ASP . 2.5 p -70.86 -33.53 52.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.971 -0.455 . . . . 0.0 111.226 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 1.037 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 3.7 pt-20 -67.29 -24.93 65.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.03 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -46.27 64.58 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.552 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 56.9 mt -56.13 -43.72 76.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.035 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 7.0 p -80.35 -44.9 18.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.352 -175.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.72 -13.98 22.38 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -174.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.458 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 80.2 m-85 -80.21 -167.7 1.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.059 -0.571 . . . . 0.0 109.813 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.425 ' HA ' ' HB2' ' A' ' 55' ' ' GLU . 8.8 t -135.82 130.33 33.81 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 171.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 1.037 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 12.2 mt -104.87 23.61 13.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.409 0.623 . . . . 0.0 109.617 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 22.3 tt0 -53.35 -39.61 64.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.373 174.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -70.24 -6.08 32.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.772 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -109.05 -2.16 18.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.349 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.463 ' HG3' ' HA ' ' A' ' 63' ' ' GLU . 96.7 mttt . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.481 0.658 . . . . 0.0 109.687 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 CA--C 1.515 -0.402 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 15.3 ptp180 -142.07 -178.81 5.88 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.509 -168.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.832 HD12 ' HB2' ' A' ' 16' ' ' LYS . 2.0 tm? -86.72 103.14 14.89 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.898 -175.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.534 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 33.5 m95 -91.61 144.68 25.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.548 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 10' ' ' ASP . 64.8 t -129.93 145.87 35.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.457 ' HB3' ' CE1' ' A' ' 15' ' ' PHE . 0.9 OUTLIER -89.74 159.79 16.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 173.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -17.42 64.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -171.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 t -86.39 -12.39 49.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.321 0.581 . . . . 0.0 109.866 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.34 37.69 70.56 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.005 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 m -102.12 -42.1 6.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.47 0.176 . . . . 0.0 111.05 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.633 ' CZ ' ' HE3' ' A' ' 45' ' ' LYS . 34.7 p90 -125.1 138.07 54.18 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.821 0.82 . . . . 0.0 112.581 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.832 ' HB2' HD12 ' A' ' 7' ' ' LEU . 8.6 ptpp? -134.89 132.14 38.16 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 113.959 -1.473 . . . . 0.0 108.989 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.446 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -148.51 154.81 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.639 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 12.0 m-20 -92.87 123.79 36.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.235 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -164.54 157.07 16.69 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.201 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.75 146.76 33.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.493 ' HA ' HD21 ' A' ' 31' ' ' LEU . 78.1 t80 -76.64 132.56 39.48 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.089 0.471 . . . . 0.0 110.013 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -111.6 -46.83 5.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.443 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -166.63 148.34 13.29 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.938 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.466 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 6.9 t -122.75 126.81 48.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.793 0.33 . . . . 0.0 110.25 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.52 141.85 20.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.578 -176.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt 56.7 32.04 20.42 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.621 0.575 . . . . 0.0 111.55 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.69 9.36 87.13 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.624 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 72.3 mmtt -109.56 146.05 35.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.027 0.442 . . . . 0.0 110.76 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.612 HD11 ' HB3' ' A' ' 43' ' ' ALA . 42.0 mm -105.14 113.27 41.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.485 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.494 ' O ' HG13 ' A' ' 22' ' ' ILE . 17.9 m170 -82.57 120.78 25.95 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 21' ' ' PHE . 95.8 mt -122.45 140.4 52.76 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 -175.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -100.05 103.82 15.37 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.911 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.894 ' HD3' HD12 ' A' ' 39' ' ' ILE . 12.5 mmmm -61.28 153.62 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.632 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.82 66.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.388 0.613 . . . . 0.0 109.359 172.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.429 HD21 ' C ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -63.07 -32.69 74.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.766 172.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.47 -2.59 27.88 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.295 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -91.94 150.28 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.634 0.255 . . . . 0.0 110.593 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 38' ' ' LYS . 4.4 tmmm? -101.73 125.49 48.41 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.894 HD12 ' HD3' ' A' ' 33' ' ' LYS . 16.1 pt -121.33 163.91 18.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.836 -177.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.79 103.84 7.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.272 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.1 t -110.54 127.04 67.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.501 ' HB2' ' HG3' ' A' ' 45' ' ' LYS . . . -56.18 124.69 18.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.989 0.423 . . . . 0.0 111.665 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.612 ' HB3' HD11 ' A' ' 29' ' ' ILE . . . -61.72 -30.1 70.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.908 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.465 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 3.6 p30 -68.73 -32.67 72.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.566 -173.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.633 ' HE3' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -103.44 15.28 29.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.328 0.585 . . . . 0.0 110.11 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.5 tp -95.44 166.82 11.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.287 -177.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.54 ' O ' HD22 ' A' ' 51' ' ' LEU . 44.0 t -71.38 132.53 44.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.901 0.857 . . . . 0.0 111.001 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.645 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 1.6 m-20 -50.94 -38.1 48.37 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.187 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.82 -49.64 72.7 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.086 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.662 ' O ' HG11 ' A' ' 54' ' ' VAL . 74.0 m-20 -67.3 -32.72 73.89 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.784 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.781 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -69.9 -40.05 75.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.944 177.013 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.5 -32.39 72.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.372 0.606 . . . . 0.0 109.767 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.507 ' CE1' HD13 ' A' ' 57' ' ' ILE . 50.8 t80 -67.95 -50.64 54.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.332 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.711 ' HA ' HG12 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -68.32 -32.47 55.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 120.72 0.295 . . . . 0.0 111.253 -177.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.781 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 45.5 mt-10 -52.56 -35.66 54.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.52 170.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 1.039 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.55 -30.38 33.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.676 -179.369 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.711 HG12 ' HA ' ' A' ' 54' ' ' VAL . 21.7 mm -64.24 -38.71 83.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.6 p -116.56 -46.99 2.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -170.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.41 1.94 24.63 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.578 -173.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -78.88 153.68 30.35 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 t -97.48 101.48 13.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.038 0.447 . . . . 0.0 110.22 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.646 ' HA ' ' HD2' ' A' ' 65' ' ' PHE . 21.3 mt -98.44 19.67 14.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.525 ' HA ' ' HZ1' ' A' ' 66' ' ' LYS . 22.9 tp10 -63.83 -39.71 94.87 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.972 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -69.04 -9.57 53.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.456 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.646 ' HD2' ' HA ' ' A' ' 62' ' ' LEU . 91.4 m-85 -101.37 -4.84 26.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.948 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.645 ' HD3' ' HB3' ' A' ' 48' ' ' ASN . 52.0 mttp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.359 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 19.9 p . . . . . 0 C--O 1.233 0.225 0 CA-C-O 121.088 0.471 . . . . 0.0 111.728 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 11.3 ptp180 -158.64 -177.85 6.83 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.093 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.415 ' CD2' ' HB2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -89.4 107.08 18.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.264 -175.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.65 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 30.1 m95 -90.89 140.21 30.03 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 90.8 t -130.1 158.32 42.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.935 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -91.66 162.21 14.59 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.4 -0.187 . . . . 0.0 110.503 176.304 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' A' ' 11' ' ' ARG . 1.7 tmm_? -57.57 -37.88 73.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.642 0.258 . . . . 0.0 111.144 -176.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 t -83.44 -15.44 49.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.734 0.302 . . . . 0.0 111.373 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.78 16.28 56.72 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.302 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 m -83.5 -37.12 23.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.458 0.647 . . . . 0.0 110.071 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.935 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 5.8 m-85 -95.14 137.95 33.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.023 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 19.0 ptpt -152.21 130.1 11.73 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.529 162.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.08 136.22 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.689 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.3 p-10 -75.99 109.15 9.39 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.218 173.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.857 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . . . -148.13 167.39 25.14 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.508 -170.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.646 ' HB2' ' HB3' ' A' ' 5' ' ' SER . 26.5 tt0 -133.71 124.35 26.54 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.294 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.646 ' HD1' HG23 ' A' ' 29' ' ' ILE . 67.1 t80 -65.39 130.29 42.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.345 0.593 . . . . 0.0 110.367 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.91 -54.28 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.874 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.06 142.02 7.67 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.467 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.449 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 16.4 p -103.28 142.81 33.55 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -178.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.21 126.81 9.45 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.956 -0.297 . . . . 0.0 111.225 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 55.61 41.4 30.62 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.768 0.667 . . . . 0.0 111.206 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.55 -0.74 80.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.642 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -104.28 166.77 10.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 0.0 110.813 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.646 HG23 ' HD1' ' A' ' 21' ' ' PHE . 85.1 mt -124.09 121.65 62.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.085 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -88.48 129.02 35.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.857 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 90.4 mt -124.49 136.76 54.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.845 0.831 . . . . 0.0 111.873 -172.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 14.3 t-80 -98.43 99.59 10.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.994 176.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 36.2 mtpt -61.83 156.96 19.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.817 0.341 . . . . 0.0 110.167 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.77 -12.45 60.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.627 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -90.91 1.82 56.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.394 177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.02 -24.4 31.43 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.707 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -65.3 145.09 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.599 0.238 . . . . 0.0 110.833 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -114.24 131.62 56.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.1 0.476 . . . . 0.0 110.503 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.8 pt -129.52 166.82 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.989 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.45 118.78 19.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.649 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 m -116.78 156.98 17.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.22 128.04 33.78 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.746 -0.382 . . . . 0.0 109.976 175.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.68 -15.23 61.04 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.652 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 8.1 p-10 -91.56 -13.93 31.17 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -173.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.05 19.94 19.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.711 0.767 . . . . 0.0 109.523 176.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 46' ' ' LEU . 8.5 tp -103.48 169.21 8.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.276 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.471 ' O ' HD23 ' A' ' 51' ' ' LEU . 25.2 t -73.61 141.68 46.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.582 0.706 . . . . 0.0 109.367 176.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.56 ' ND2' ' HA ' ' A' ' 66' ' ' LYS . 7.6 m120 -73.89 -18.73 60.87 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.607 -171.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -43.34 81.23 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.564 ' O ' HG13 ' A' ' 54' ' ' VAL . 35.6 m-20 -63.67 -38.01 89.49 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.196 176.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.82 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -66.42 -45.18 80.79 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.134 177.358 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.676 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -59.39 -32.34 70.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.475 0.655 . . . . 0.0 110.241 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.589 ' CE2' HD12 ' A' ' 57' ' ' ILE . 43.9 t80 -72.32 -50.48 26.56 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.379 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 50' ' ' ASP . 3.2 p -68.42 -28.9 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 O-C-N 122.089 -0.382 . . . . 0.0 110.77 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.82 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 44.4 mt-10 -52.5 -41.43 63.42 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.647 0.26 . . . . 0.0 110.471 169.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.506 ' N ' ' HE3' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -73.79 -33.02 64.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.806 -178.239 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.589 HD12 ' CE2' ' A' ' 53' ' ' TYR . 29.9 mt -67.65 -37.37 78.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.281 175.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.471 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 32.4 p -97.78 -45.17 6.44 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -170.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.97 -7.27 37.94 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -172.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.471 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 65.0 m-85 -80.32 175.88 10.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 110.784 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -121.1 114.77 21.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.432 176.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 35.8 mt -103.58 27.28 7.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.571 -176.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -56.59 -42.1 78.12 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.665 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -72.55 -6.45 44.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.341 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.652 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 97.3 m-85 -102.99 0.3 31.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.418 0.628 . . . . 0.0 109.52 176.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.56 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 98.5 mttt . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.778 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 C--O 1.238 0.487 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 6.6 ptp180 -140.66 -178.83 5.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.245 -173.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.35 105.41 16.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.04 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.682 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 52.4 m95 -91.92 145.05 24.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.828 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.438 HG11 ' O ' ' A' ' 10' ' ' ASP . 61.5 t -135.6 146.0 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.443 0.465 . . . . 0.0 110.379 -176.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.974 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -90.42 174.1 7.74 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.78 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 2.4 tpm_? -61.68 -43.36 99.01 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 122.389 -0.194 . . . . 0.0 111.393 -177.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -67.74 -29.74 69.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.236 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.96 12.71 51.99 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.33 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -91.47 -39.37 11.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.507 0.67 . . . . 0.0 109.506 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.974 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 3.7 m-85 -82.46 130.7 35.16 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.417 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.682 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 8.6 ptpt -157.42 128.68 6.77 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.9 169.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.508 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -154.91 145.79 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.032 -173.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.58 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.5 p-10 -88.24 117.51 27.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.062 174.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . . . -164.84 163.66 21.11 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.13 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.42 140.34 52.28 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.723 ' HA ' HD23 ' A' ' 31' ' ' LEU . 48.2 t80 -69.3 132.61 46.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.468 0.651 . . . . 0.0 110.372 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.03 -52.51 5.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.043 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.87 143.38 8.55 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.141 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.539 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 20.0 p -105.61 142.13 35.88 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.98 112.43 8.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 111.439 -173.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.6 tptt 52.68 53.55 12.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.791 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.57 -3.73 77.09 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.118 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 84.9 mttt -110.96 170.48 8.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.068 0.461 . . . . 0.0 110.533 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.533 HG23 ' HD1' ' A' ' 21' ' ' PHE . 59.2 mt -129.0 128.04 66.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.882 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -91.31 127.95 36.95 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.723 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.9 mt -127.3 137.39 52.82 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.583 -174.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -98.13 100.92 12.26 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.351 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.839 ' HD3' HD13 ' A' ' 39' ' ' ILE . 12.1 mmmm -61.77 160.54 11.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.34 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.29 -14.94 63.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.721 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -84.45 -6.81 59.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.959 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.64 7.52 58.95 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.738 174.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.5 155.04 6.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 117.059 0.429 . . . . 0.0 110.377 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -97.9 144.27 27.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 0.0 110.863 177.077 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.839 HD13 ' HD3' ' A' ' 33' ' ' LYS . 37.2 pt -127.53 156.27 39.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.15 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.13 103.73 11.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.243 0.545 . . . . 0.0 110.159 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.8 t -109.4 125.16 66.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.276 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -79.51 130.63 35.58 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.44 -5.81 12.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.458 -174.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.85 -42.74 57.37 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -172.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -99.13 12.13 37.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 0.0 110.319 -176.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.9 tp -83.88 169.35 15.19 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.678 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.564 ' O ' HD23 ' A' ' 51' ' ' LEU . 47.8 t -73.12 138.0 45.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.025 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -47.03 -50.03 20.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.854 0.835 . . . . 0.0 111.248 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.2 -30.36 68.53 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.795 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.605 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -65.65 -38.03 88.21 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.8 177.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.728 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.7 OUTLIER -70.17 -44.21 69.22 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.81 176.211 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.41 65.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.423 0.63 . . . . 0.0 110.224 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.644 ' CE2' HD11 ' A' ' 57' ' ' ILE . 66.5 t80 -73.79 -49.66 24.24 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.421 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.787 HG11 HD13 ' A' ' 62' ' ' LEU . 2.2 p -70.03 -28.25 35.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 O-C-N 122.006 -0.434 . . . . 0.0 110.823 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.728 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 39.3 mt-10 -56.09 -31.47 63.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.724 168.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.871 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 6.6 mmpt? -80.84 -32.25 35.19 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.77 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.644 HD11 ' CE2' ' A' ' 53' ' ' TYR . 39.6 mt -63.32 -41.38 92.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 174.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.562 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 27.4 p -107.41 -46.79 3.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -171.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.31 -5.74 35.97 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.562 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 66.9 m-85 -85.77 136.95 33.13 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.992 0.425 . . . . 0.0 110.29 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 m -75.7 100.94 4.83 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.623 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.787 HD13 HG11 ' A' ' 54' ' ' VAL . 34.3 mt -94.97 18.74 11.42 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.67 0.748 . . . . 0.0 109.389 172.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 1.034 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 24.7 tt0 -73.83 -29.38 62.1 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.894 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -14.88 58.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.954 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.417 ' HD2' ' HA ' ' A' ' 62' ' ' LEU . 96.0 m-85 -105.57 -7.19 18.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.253 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 1.034 ' HG3' ' HA ' ' A' ' 63' ' ' GLU . 43.1 mttp . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 121.521 0.677 . . . . 0.0 110.881 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.855 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 20.1 p . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.145 0.498 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 17.5 ptp180 -148.47 -178.25 6.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.451 -173.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.801 HD12 ' HB3' ' A' ' 16' ' ' LYS . 2.6 tm? -81.44 106.63 13.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.699 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.578 ' HH2' ' HB ' ' A' ' 54' ' ' VAL . 32.2 m95 -92.8 151.29 20.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.165 174.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 36.9 t -123.07 145.32 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.644 0.259 . . . . 0.0 110.72 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.428 ' HA ' HD11 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -83.16 160.29 21.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.403 175.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -51.57 -46.1 63.34 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.536 0.523 . . . . 0.0 111.921 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 m -94.91 9.81 37.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.819 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.7 23.98 69.37 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.12 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -71.55 -34.36 69.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.176 0.512 . . . . 0.0 110.359 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 10' ' ' ASP . 33.0 p90 -143.21 132.61 23.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.386 0.613 . . . . 0.0 111.186 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.801 ' HB3' HD12 ' A' ' 7' ' ' LEU . 88.3 mttt -109.37 129.98 55.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 167.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.11 135.9 42.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.598 0.713 . . . . 0.0 112.887 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 1.1 p30 -78.27 119.94 22.34 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.757 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.781 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -157.43 158.4 35.75 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.505 0.669 . . . . 0.0 111.892 -172.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.855 ' HB2' ' HB3' ' A' ' 5' ' ' SER . 30.9 tt0 -122.59 124.67 44.03 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.786 176.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.75 ' HD1' HG21 ' A' ' 29' ' ' ILE . 4.5 t80 -70.14 123.35 21.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.153 0.502 . . . . 0.0 110.321 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -105.9 -44.07 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.647 -178.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.36 139.93 6.18 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.103 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.406 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 51.9 t -110.04 118.44 36.43 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.93 140.39 29.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.628 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? 65.06 11.7 7.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.131 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.56 -2.79 60.84 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.127 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.709 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 86.6 mttt -102.83 164.45 11.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.0 110.755 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.75 HG21 ' HD1' ' A' ' 21' ' ' PHE . 75.5 mt -114.98 121.22 66.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.015 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.441 ' O ' HG13 ' A' ' 22' ' ' ILE . 20.5 m170 -82.91 124.31 30.23 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.781 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 71.0 mt -124.6 137.49 54.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.432 0.634 . . . . 0.0 111.415 -174.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -107.36 106.18 16.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.577 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 4.1 mtpm? -67.07 166.68 13.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.14 0.495 . . . . 0.0 111.711 -172.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.97 -12.84 60.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.099 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.94 -23.48 38.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.813 173.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.49 -15.08 29.94 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -173.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.2 t -65.86 142.72 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.725 -0.238 . . . . 0.0 110.485 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -108.86 130.21 55.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.157 0.503 . . . . 0.0 110.459 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.439 HG12 ' HB2' ' A' ' 31' ' ' LEU . 12.3 pt -127.39 166.54 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.351 -177.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.1 103.21 5.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.088 0.47 . . . . 0.0 109.994 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.515 HG13 HD12 ' A' ' 46' ' ' LEU . 74.4 t -116.08 126.36 73.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.934 -176.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.709 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -59.35 135.32 57.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.687 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.11 -6.13 12.19 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.374 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -90.15 -41.17 11.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.069 0.462 . . . . 0.0 111.215 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -87.53 22.19 2.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.824 -175.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.515 HD12 HG13 ' A' ' 41' ' ' VAL . 9.1 tp -111.91 167.23 10.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.651 -174.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.554 ' O ' HD21 ' A' ' 51' ' ' LEU . 29.6 t -65.0 129.22 38.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.36 0.6 . . . . 0.0 109.649 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.418 ' HA ' HD22 ' A' ' 51' ' ' LEU . 8.1 m120 -67.2 -21.71 65.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.631 -172.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -60.68 -48.34 82.21 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.695 0.759 . . . . 0.0 109.294 171.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.595 ' O ' HG12 ' A' ' 54' ' ' VAL . 16.2 m-20 -67.59 -31.77 72.05 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.827 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.609 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -69.31 -40.79 77.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.395 176.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -65.24 -27.92 68.99 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.382 0.61 . . . . 0.0 109.541 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.581 ' CE2' HD11 ' A' ' 57' ' ' ILE . 31.1 t80 -73.61 -50.77 19.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.594 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.4 p -70.5 -33.29 52.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 120.885 0.374 . . . . 0.0 111.255 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.907 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 1.6 pt-20 -65.58 -24.63 67.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.11 0.481 . . . . 0.0 109.923 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 1.053 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 5.3 mmpt? -81.31 -27.27 35.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.585 175.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.581 HD11 ' CE2' ' A' ' 53' ' ' TYR . 54.3 mt -64.33 -41.58 92.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.163 0.506 . . . . 0.0 109.728 172.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.472 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 6.4 p -86.34 -47.43 9.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.775 -173.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.7 -9.91 19.01 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -173.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.539 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 66.6 m-85 -89.25 -172.7 3.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.5 ' HA ' ' HB2' ' A' ' 55' ' ' GLU . 17.1 t -131.53 128.28 38.98 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.573 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.907 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 10.2 mt -95.73 25.94 4.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.034 0.445 . . . . 0.0 110.031 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 1.2 tp10 -44.36 -51.1 8.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.81 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -71.03 -9.9 58.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.066 -176.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -100.42 0.53 39.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 0.0 110.012 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 87.3 mttt . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.808 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.445 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 2.0 p . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 3.6 ptp180 -112.48 173.42 6.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.213 -167.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -85.72 114.73 22.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.507 -172.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.538 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 81.1 m95 -105.58 146.17 30.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.2 176.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.719 HG21 ' HG2' ' A' ' 16' ' ' LYS . 66.0 t -136.37 138.26 47.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.187 0.304 . . . . 0.0 110.707 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.544 ' HA ' HD11 ' A' ' 46' ' ' LEU . 6.6 p-10 -84.89 159.74 20.29 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -76.76 -1.98 30.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.029 0.443 . . . . 0.0 111.997 -169.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 t -105.34 -3.51 22.62 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.448 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.5 31.02 70.86 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.418 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.4 m -84.76 -43.06 14.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.848 0.356 . . . . 0.0 110.732 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.787 ' HZ ' ' HE3' ' A' ' 45' ' ' LYS . 24.9 p90 -138.76 136.86 36.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.867 0.841 . . . . 0.0 112.679 -176.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.719 ' HG2' HG21 ' A' ' 9' ' ' VAL . 54.1 mttp -126.07 130.9 52.02 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.207 171.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -139.06 157.94 28.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.391 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 29.5 m-20 -103.74 113.4 26.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.4 158.68 32.61 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.947 -172.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' A' ' 5' ' ' SER . 45.3 mt-10 -106.73 138.64 42.53 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.206 174.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.648 ' HA ' HD21 ' A' ' 31' ' ' LEU . 15.2 t80 -71.88 124.35 24.67 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.197 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -105.94 -43.21 7.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.102 -177.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.9 150.84 13.7 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.505 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' HB2' ' HE2' ' A' ' 21' ' ' PHE . 6.3 t -115.1 136.88 52.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.93 119.97 12.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.606 0.241 . . . . 0.0 110.913 -173.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.9 tptm 55.75 41.17 30.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.314 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' HA2' ' CZ ' ' A' ' 65' ' ' PHE . . . 89.92 -4.84 83.45 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.309 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -109.71 159.93 16.74 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 122.453 -0.439 . . . . 0.0 110.765 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.522 HG21 ' HD2' ' A' ' 21' ' ' PHE . 76.1 mt -122.33 124.82 71.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.979 -174.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 92.2 m-70 -87.6 126.42 34.93 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 21' ' ' PHE . 87.4 mt -125.14 136.76 53.93 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.522 -178.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -102.1 100.38 10.62 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -63.32 159.57 17.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.136 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.28 -15.29 56.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.232 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.14 -25.22 37.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.523 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.9 -6.55 27.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.198 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.97 137.64 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.674 0.273 . . . . 0.0 110.577 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.411 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 36.5 ttmt -102.57 124.74 48.67 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 31.8 pt -123.43 153.68 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -176.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.29 103.43 8.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.129 175.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 m -99.03 153.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.478 ' HB2' ' OD1' ' A' ' 44' ' ' ASP . . . -82.33 122.22 27.69 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.009 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.93 -20.03 63.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.476 0.655 . . . . 0.0 110.923 -176.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.653 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 6.6 p-10 -77.02 -12.13 59.9 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.164 -175.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.787 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -117.43 10.32 13.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.931 0.872 . . . . 0.0 109.012 173.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.544 HD11 ' HA ' ' A' ' 10' ' ' ASP . 14.1 tp -89.82 162.79 15.32 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.646 -177.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.555 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 27.0 m -68.28 142.75 55.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.588 0.709 . . . . 0.0 110.68 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -65.41 -27.85 68.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.267 -173.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -64.72 -48.9 72.95 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.603 0.716 . . . . 0.0 109.598 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.555 ' OD1' ' HB2' ' A' ' 47' ' ' SER . 1.6 m-20 -59.86 -36.29 76.57 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.219 175.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.644 ' HA ' HD13 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -65.47 -47.37 76.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.576 178.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.569 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -62.36 -27.57 69.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.789 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.421 ' O ' HG12 ' A' ' 57' ' ' ILE . 48.8 t80 -71.91 -47.88 49.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.628 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.541 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 61.5 t -62.68 -33.55 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.695 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.622 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 38.2 mt-10 -52.19 -34.77 46.85 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.21 0.529 . . . . 0.0 110.483 173.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 1.045 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.6 mmpt? -82.51 -37.01 25.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.894 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.478 HG22 ' CD1' ' A' ' 21' ' ' PHE . 20.7 mm -69.81 -28.35 36.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.008 0.432 . . . . 0.0 111.202 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.656 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 43.7 p -104.83 -45.38 4.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -173.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.4 4.34 46.84 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -172.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.656 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 96.7 m-85 -102.94 -175.88 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.2 t -125.4 121.75 34.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.102 0.477 . . . . 0.0 110.748 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.644 HD13 ' HA ' ' A' ' 51' ' ' LEU . 25.4 mt -95.94 22.83 6.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.647 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.14 -41.14 74.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.402 0.62 . . . . 0.0 110.458 176.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HE3' ' CE2' ' A' ' 65' ' ' PHE . 48.6 pttt -62.53 -14.17 38.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.673 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.653 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 32.7 m-85 -104.38 -8.86 18.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.908 0.385 . . . . 0.0 111.031 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 95.0 mttt . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 121.101 0.477 . . . . 0.0 109.714 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.583 ' HA ' ' HB2' ' A' ' 20' ' ' GLU . 46.1 t . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 121.866 0.841 . . . . 0.0 112.154 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 14.2 ptp180 -149.42 -179.08 6.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.168 -171.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 16' ' ' LYS . 1.6 tm? -86.43 107.87 18.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.772 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.429 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 46.4 m95 -92.38 149.09 21.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.098 176.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 15.6 t -130.58 154.33 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.818 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -101.65 -179.05 3.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.815 0.341 . . . . 0.0 111.217 -178.515 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -60.41 -52.83 63.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.054 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 m -81.8 -7.29 59.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.184 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.0 28.54 45.26 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.527 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.1 m -99.7 -37.28 9.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.521 0.677 . . . . 0.0 109.468 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.818 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 4.8 m-85 -87.01 125.82 34.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.739 -176.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.451 ' HB3' HD13 ' A' ' 7' ' ' LEU . 50.5 mttp -131.63 129.56 41.01 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 158.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.87 133.59 6.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.455 0.645 . . . . 0.0 112.119 -177.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.589 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 7.3 p-10 -87.73 116.2 25.71 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.732 176.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.637 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . . . -168.49 167.64 11.57 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.102 -174.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 5' ' ' SER . 9.6 tp10 -126.97 136.56 52.43 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.137 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.769 ' HA ' HD22 ' A' ' 31' ' ' LEU . 7.1 t80 -65.53 126.6 28.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.723 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -105.54 -50.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.818 179.281 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.11 148.07 15.97 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.583 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 t -108.9 129.12 55.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.18 133.02 15.02 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.138 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm 63.69 23.72 13.61 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.328 175.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.92 4.59 88.52 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.956 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.688 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 33.1 mmtp -103.23 154.51 19.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.008 0.433 . . . . 0.0 110.166 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 43' ' ' ALA . 40.3 mm -108.71 114.07 45.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.347 174.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.435 ' O ' HG13 ' A' ' 22' ' ' ILE . 65.0 m170 -76.21 125.59 29.44 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 175.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.769 HD22 ' HA ' ' A' ' 21' ' ' PHE . 86.3 mt -129.04 136.69 50.62 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.695 -174.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -106.74 107.94 19.21 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.785 ' HZ2' ' HB3' ' A' ' 33' ' ' LYS . 4.8 mtpm? -67.63 166.14 15.64 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.15 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.64 -14.38 60.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.297 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -93.42 1.96 56.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.904 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.33 -18.08 58.11 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.185 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.1 t -63.67 139.35 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.518 0.199 . . . . 0.0 110.869 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -107.81 121.68 45.22 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 pt -124.42 158.51 31.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.726 -173.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.48 103.39 8.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.152 0.501 . . . . 0.0 110.049 174.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.28 119.97 55.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.688 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -58.79 124.95 21.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.436 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.646 ' HB3' HD11 ' A' ' 29' ' ' ILE . . . -64.96 -26.91 68.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.982 177.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.7 -34.24 71.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.58 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.489 ' HG3' ' HB1' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -110.46 18.38 19.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.034 0.445 . . . . 0.0 110.789 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.677 ' HB3' HD22 ' A' ' 51' ' ' LEU . 10.1 tp -95.18 170.12 9.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.149 -176.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.598 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 35.3 t -83.66 139.48 32.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.033 0.92 . . . . 0.0 110.751 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -51.52 -35.04 38.85 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.272 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.22 -50.54 71.35 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 121.412 0.625 . . . . 0.0 109.99 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.598 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 5.8 m-20 -60.99 -36.41 79.4 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.606 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.781 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 26.4 mt -69.82 -43.21 72.49 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -59.41 -28.88 67.32 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.514 0.673 . . . . 0.0 109.869 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.533 ' CZ ' HD13 ' A' ' 57' ' ' ILE . 29.3 t80 -73.7 -50.34 21.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.146 176.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.0 p -70.28 -29.66 40.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.891 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.781 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 42.8 mt-10 -54.63 -37.12 65.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.465 168.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -39.44 66.6 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.533 HD13 ' CZ ' ' A' ' 53' ' ' TYR . 53.3 mt -64.19 -47.23 90.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.084 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.9 p -80.62 -46.46 15.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.363 -174.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.04 -4.55 41.62 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -173.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -100.35 179.36 4.48 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.501 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 6.4 t -118.98 134.51 55.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.805 0.336 . . . . 0.0 110.479 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 21.8 mt -97.84 35.75 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.123 0.487 . . . . 0.0 110.845 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 5.8 mm-40 -44.61 -58.41 3.05 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.506 1.122 . . . . 0.0 113.365 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -69.11 -10.54 58.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.644 0.259 . . . . 0.0 111.693 -173.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -105.04 -8.97 18.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.286 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.654 ' HA ' HD12 ' A' ' 51' ' ' LEU . 64.2 mttm . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 121.246 0.546 . . . . 0.0 111.867 -173.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 8.2 ptp180 -115.44 178.16 4.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.879 -171.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 7' ' ' LEU . 6.1 mt -84.45 114.32 21.84 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.214 0.531 . . . . 0.0 111.546 -173.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.57 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 43.9 m95 -98.63 140.66 32.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.595 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 10' ' ' ASP . 43.8 t -124.62 144.84 33.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.915 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.508 ' HA ' HD11 ' A' ' 46' ' ' LEU . 7.4 p-10 -84.89 170.55 12.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.0 109.887 173.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -75.47 -14.52 60.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.631 -172.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.528 ' HB2' ' HG1' ' A' ' 14' ' ' THR . 14.8 m -98.13 -16.48 19.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.907 0.384 . . . . 0.0 111.184 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.5 36.85 25.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.661 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.528 ' HG1' ' HB2' ' A' ' 12' ' ' SER . 8.6 m -98.87 -37.69 9.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.189 -0.505 . . . . 0.0 110.724 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 37.8 p90 -137.0 135.15 37.37 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.725 0.774 . . . . 0.0 112.434 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 47.8 mttp -128.92 130.61 47.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.369 173.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.541 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -145.1 146.1 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.987 0.422 . . . . 0.0 112.102 -176.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.576 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 6.3 m-20 -82.12 120.39 25.25 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.513 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . . . -163.16 162.89 25.77 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.74 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.6 138.53 54.53 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 174.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.793 ' HD1' HG21 ' A' ' 29' ' ' ILE . 6.8 t80 -70.91 122.72 20.48 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.508 0.67 . . . . 0.0 110.507 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -100.81 -51.16 9.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.383 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.84 154.35 25.34 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.485 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 22.6 t -120.82 138.58 53.97 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -177.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.1 131.07 15.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.045 -175.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 56.62 27.1 11.98 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.729 0.643 . . . . 0.0 112.311 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.41 -1.53 69.61 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.711 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 57.0 mttp -103.99 158.93 16.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.011 0.434 . . . . 0.0 110.799 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.793 HG21 ' HD1' ' A' ' 21' ' ' PHE . 94.3 mt -116.38 122.8 70.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.117 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.425 ' O ' HG13 ' A' ' 22' ' ' ILE . 39.7 m170 -84.5 126.94 33.73 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.668 HD22 ' HA ' ' A' ' 21' ' ' PHE . 81.8 mt -124.14 135.69 53.69 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.833 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -95.7 103.97 15.87 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.696 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.82 ' HD3' HD11 ' A' ' 39' ' ' ILE . 11.8 mmmm -64.82 158.75 24.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.218 -174.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.8 -20.72 66.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.802 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -66.48 -32.49 73.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.686 173.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.83 -17.26 27.73 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.295 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.4 t -72.59 147.4 10.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.368 -0.416 . . . . 0.0 110.654 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -100.62 128.77 46.56 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.82 HD11 ' HD3' ' A' ' 33' ' ' LYS . 18.1 pt -120.04 159.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.259 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.82 103.55 8.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.069 0.461 . . . . 0.0 110.096 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.1 t -107.29 129.56 60.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -68.18 131.56 45.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.78 0.324 . . . . 0.0 110.191 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HB3' HG13 ' A' ' 29' ' ' ILE . . . -69.07 -6.55 28.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.881 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 2.8 p30 -81.76 -33.81 30.77 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -172.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.491 ' HD3' ' H ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -107.78 19.98 19.4 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.094 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.508 HD11 ' HA ' ' A' ' 10' ' ' ASP . 11.6 tp -93.34 169.69 10.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.799 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.512 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.3 t -74.15 139.47 44.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.561 0.696 . . . . 0.0 110.676 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -63.21 -30.55 71.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.419 -173.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -62.03 -46.98 86.78 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.594 0.712 . . . . 0.0 109.789 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.554 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.3 m-20 -65.54 -34.69 78.85 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.565 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.768 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -69.32 -47.21 65.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.11 177.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.563 ' O ' ' HD2' ' A' ' 56' ' ' LYS . . . -60.94 -30.85 70.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.575 0.702 . . . . 0.0 109.991 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.433 ' CE1' HD12 ' A' ' 57' ' ' ILE . 35.2 t80 -69.22 -52.12 30.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.099 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.742 ' HA ' HG12 ' A' ' 57' ' ' ILE . 3.0 p -69.06 -27.22 34.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.868 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.768 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 71.2 mt-10 -51.09 -49.29 60.99 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.106 0.479 . . . . 0.0 109.894 167.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.563 ' HD2' ' O ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -72.24 -26.62 62.09 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.57 -175.169 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.742 HG12 ' HA ' ' A' ' 54' ' ' VAL . 10.8 mm -67.3 -43.18 88.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.561 174.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.487 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 17.8 p -97.19 -47.25 5.82 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.14 -6.9 19.18 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.487 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 90.8 m-85 -92.71 167.89 11.58 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -117.13 134.46 54.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 27.4 mt -105.3 25.17 10.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.684 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 5.5 tp10 -54.5 -41.59 69.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.3 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -60.27 -19.95 56.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.204 177.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.471 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 57.6 m-85 -101.04 -14.16 17.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.31 0.576 . . . . 0.0 110.081 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.684 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 49.6 mtpt . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.282 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HD3' HG21 ' A' ' 57' ' ' ILE . 63.9 pttt . . . . . 0 C--O 1.237 0.407 0 CA-C-O 121.286 0.565 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.504 ' C ' ' HG2' ' A' ' 20' ' ' GLU . 15.8 mttt -169.63 154.67 5.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.077 -177.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.662 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 1.2 p -56.99 112.63 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.3 0.572 . . . . 0.0 111.157 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 12.1 ptp180 -136.97 -177.09 4.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.054 -171.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.701 HD11 ' HE2' ' A' ' 16' ' ' LYS . 2.2 tm? -91.24 106.68 18.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.41 -174.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.493 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 35.3 m95 -92.12 149.32 21.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.738 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.1 t -135.75 139.96 45.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.825 ' HA ' HD12 ' A' ' 46' ' ' LEU . 1.2 p-10 -80.8 175.14 10.94 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.619 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.53 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 3.7 tpm_? -54.21 -51.21 65.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.836 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -80.21 -14.85 58.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.616 -172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.68 47.31 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.466 -0.653 . . . . 0.0 111.466 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.2 m -86.62 -36.88 18.56 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.735 0.302 . . . . 0.0 110.189 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.486 ' CE2' ' HE2' ' A' ' 45' ' ' LYS . 39.3 p90 -129.99 141.42 50.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.812 0.815 . . . . 0.0 111.985 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.701 ' HE2' HD11 ' A' ' 7' ' ' LEU . 9.5 ptmm? -128.93 131.81 47.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.895 174.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -134.9 140.92 44.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -172.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 8.6 p-10 -81.22 122.4 27.35 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 169.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.678 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -162.01 155.89 21.51 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.594 -175.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.518 ' HG2' ' N ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -116.33 145.93 42.83 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.415 171.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.566 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 62.7 t80 -80.91 129.55 34.59 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.148 0.499 . . . . 0.0 110.395 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -108.75 -49.55 7.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.091 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.42 140.87 6.43 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.901 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.566 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 30.8 t -111.1 130.41 55.62 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.41 137.98 18.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.613 0.244 . . . . 0.0 110.713 -174.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 61.6 24.62 14.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.481 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.6 2.68 75.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.789 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -115.03 161.83 17.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.549 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.522 HG13 ' HB1' ' A' ' 43' ' ' ALA . 69.6 mt -114.36 120.66 64.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.361 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.417 ' O ' HG13 ' A' ' 22' ' ' ILE . 23.0 m-70 -80.48 123.53 28.15 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 97.7 mt -126.34 139.67 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.152 -174.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -112.66 103.13 11.17 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.205 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.8 mtpt -59.65 152.64 21.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.32 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 5' ' ' SER . . . -72.23 -15.17 61.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.217 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.36 -13.29 60.72 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.437 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.27 9.46 51.1 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.154 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.99 142.77 16.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.759 0.279 . . . . 0.0 110.43 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 38' ' ' LYS . 4.1 tmmm? -105.33 125.21 50.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 pt -127.29 172.44 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.888 0.375 . . . . 0.0 111.123 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.9 110.0 11.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.2 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.15 127.03 71.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.875 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 128.4 36.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.708 0.289 . . . . 0.0 110.486 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.522 ' HB1' HG13 ' A' ' 29' ' ' ILE . . . -70.78 -10.16 58.92 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.522 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 11.7 p-10 -96.23 -19.76 19.07 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -172.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HE2' ' CE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -104.84 19.56 20.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.428 0.632 . . . . 0.0 109.953 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.825 HD12 ' HA ' ' A' ' 10' ' ' ASP . 8.1 tp -101.5 176.44 5.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.076 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.663 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 22.2 t -88.38 147.52 24.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.065 0.936 . . . . 0.0 111.005 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.687 HD21 ' HB3' ' A' ' 66' ' ' LYS . 1.1 m120 -56.87 -35.38 68.84 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.455 -172.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.07 -45.55 73.51 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.095 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.663 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 2.2 m-20 -59.21 -40.8 86.95 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.989 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.792 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -68.05 -42.94 79.75 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.288 178.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.597 ' O ' ' HG2' ' A' ' 56' ' ' LYS . . . -58.81 -35.19 72.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.253 0.549 . . . . 0.0 110.051 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.429 ' CE2' HD12 ' A' ' 57' ' ' ILE . 43.6 t80 -68.79 -50.26 51.77 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.151 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.553 HG11 ' O ' ' A' ' 50' ' ' ASP . 2.4 p -68.89 -31.41 50.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.614 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.792 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.0 mt-10 -51.91 -40.95 61.54 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.604 168.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.689 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -75.54 -33.97 60.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 110.574 -174.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.431 HG22 ' HD2' ' A' ' 21' ' ' PHE . 52.2 mt -66.26 -39.65 84.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.971 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 p -92.13 -46.32 7.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -171.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.51 -5.5 35.38 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -89.75 -178.48 5.52 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.515 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 13.8 t -124.25 125.41 44.35 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.166 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 21.3 mt -104.19 24.16 11.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.771 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -53.83 -46.53 71.21 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.897 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -59.43 -24.79 63.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.504 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.522 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 90.9 m-85 -89.17 -14.07 36.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 0.0 110.739 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.687 ' HB3' HD21 ' A' ' 48' ' ' ASN . 93.4 mttt -81.29 129.79 34.76 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.79 -21.73 24.93 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.864 -173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 C--N 1.311 -1.094 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.368 -177.014 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.609 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 2.5 ttpm? . . . . . 0 C--O 1.236 0.38 0 CA-C-O 121.082 0.467 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 4' ' ' LYS . 68.5 mmtt -79.96 80.58 6.35 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.542 0.687 . . . . 0.0 110.37 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -58.47 120.19 8.36 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.385 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 2.8 ptp180 -110.13 174.83 5.68 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.689 -173.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 16' ' ' LYS . 1.7 tm? -94.2 104.72 16.72 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.155 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.775 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 69.3 m95 -91.56 142.73 27.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.825 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.4 t -132.82 142.45 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 O-C-N 123.488 0.492 . . . . 0.0 110.926 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.965 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -90.63 161.2 15.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -68.5 -23.03 64.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.074 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -75.88 -23.37 55.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.132 0.492 . . . . 0.0 110.377 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.11 12.32 60.28 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.941 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -87.66 -48.11 8.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.525 0.679 . . . . 0.0 109.868 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.965 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 2.4 m-85 -79.67 134.33 36.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.034 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.775 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 7.2 ptpp? -159.97 128.96 5.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.493 165.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.45 151.67 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 120.129 -0.629 . . . . 0.0 111.955 -173.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.571 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 8.0 p-10 -84.05 125.48 32.14 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.691 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.41 ' HB2' ' HG ' ' A' ' 31' ' ' LEU . . . -167.93 156.83 9.41 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.183 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.609 ' HG3' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -109.71 149.16 30.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.538 177.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.731 ' HA ' HD11 ' A' ' 31' ' ' LEU . 58.2 t80 -87.39 131.36 34.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.491 -173.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -107.85 -44.98 7.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.823 0.344 . . . . 0.0 110.58 179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.33 161.81 31.07 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 121.129 -0.557 . . . . 0.0 111.836 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 t -141.78 132.58 25.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.286 0.543 . . . . 0.0 110.96 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.09 149.33 26.0 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.12 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.58 21.43 10.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.095 0.558 . . . . 0.0 111.937 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.17 23.06 50.1 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.336 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.646 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 47.1 mmtm -125.59 146.51 49.66 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 120.872 0.367 . . . . 0.0 110.982 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.555 ' CG2' HD12 ' A' ' 31' ' ' LEU . 1.9 mp -106.92 123.95 62.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.354 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.521 ' O ' HG13 ' A' ' 22' ' ' ILE . 36.6 m170 -89.83 120.32 30.97 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.731 HD11 ' HA ' ' A' ' 21' ' ' PHE . 3.0 tp -121.63 153.35 38.22 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.342 -173.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -128.53 107.2 9.52 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.352 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.501 ' HD3' HD11 ' A' ' 39' ' ' ILE . 12.6 mmmm -58.59 161.35 4.69 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.242 -175.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.62 -25.63 68.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.773 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -79.16 -19.61 50.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.081 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.7 26.92 6.23 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.691 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.497 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 47.3 t -102.42 143.01 15.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -105.52 131.12 53.32 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.079 0.466 . . . . 0.0 110.963 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.501 HD11 ' HD3' ' A' ' 33' ' ' LYS . 24.5 pt -135.36 160.27 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.605 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.81 117.87 29.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.039 0.447 . . . . 0.0 110.135 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.2 t -112.11 134.98 52.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.775 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.646 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . . . -69.8 127.03 31.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.724 0.297 . . . . 0.0 110.907 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.11 -14.15 61.28 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.418 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.406 ' OD1' ' HB3' ' A' ' 42' ' ' ALA . 7.1 p-10 -92.88 -14.72 27.29 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 19.4 ptmt -97.51 -2.1 42.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.474 0.654 . . . . 0.0 110.124 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 46' ' ' LEU . 2.6 tp -84.86 159.63 20.34 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.504 -170.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.582 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 48.1 t -71.65 153.34 42.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.4 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.452 ' HA ' HD23 ' A' ' 51' ' ' LEU . 12.6 m-80 -64.12 -28.65 69.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.211 -176.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -66.11 -47.82 72.93 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.865 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.582 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 4.1 m-20 -62.63 -32.14 73.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.486 177.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.697 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -65.98 -51.6 57.02 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.112 177.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -63.71 -27.2 69.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.123 0.487 . . . . 0.0 111.06 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.467 ' CE1' HD11 ' A' ' 57' ' ' ILE . 22.9 t80 -70.0 -48.3 58.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.866 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 50' ' ' ASP . 78.8 t -62.8 -34.3 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.777 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 44.0 mt-10 -54.84 -32.77 60.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.022 0.439 . . . . 0.0 110.512 174.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.552 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -80.18 -47.15 15.13 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.053 -178.008 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.467 HD11 ' CE1' ' A' ' 53' ' ' TYR . 25.0 mt -62.47 -36.63 75.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 111.727 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 55.8 p -103.12 -46.48 4.62 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.22 -8.01 30.87 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -173.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 92.8 m-85 -90.99 135.42 33.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.11 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.1 m -82.11 130.59 35.13 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.766 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 51' ' ' LEU . 48.6 mt -104.63 30.2 5.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.179 0.514 . . . . 0.0 109.875 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -53.95 -47.48 71.24 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.349 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -67.11 -13.55 62.05 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.8 -14.97 27.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.922 0.391 . . . . 0.0 110.235 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 92.2 mttt -86.07 171.05 11.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.599 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.89 72.92 0.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.86 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.163 -178.046 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt . . . . . 0 C--O 1.234 0.27 0 CA-C-O 121.271 0.558 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.625 ' HB2' HH21 ' A' ' 6' ' ' ARG . 31.4 mmmt -122.32 120.9 35.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.879 -174.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 t -61.16 124.56 20.89 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.636 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 9.3 ptp180 -143.39 -179.29 6.32 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.81 -167.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.697 HD13 ' HB3' ' A' ' 16' ' ' LYS . 2.1 tm? -95.24 105.27 17.2 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.856 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.583 ' CE3' ' HB3' ' A' ' 50' ' ' ASP . 37.0 m95 -91.57 139.16 30.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 10' ' ' ASP . 47.6 t -119.31 137.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.846 0.355 . . . . 0.0 110.858 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.558 ' HB3' ' H ' ' A' ' 14' ' ' THR . 9.8 t70 -63.46 158.82 19.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.607 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 44.5 ttp180 -74.11 -35.03 64.12 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.712 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -95.87 11.97 31.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.137 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.71 28.58 73.5 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.897 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.558 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 6.7 m -67.5 -37.07 82.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.745 -0.228 . . . . 0.0 111.111 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -158.39 157.54 32.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.261 0.553 . . . . 0.0 111.407 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.697 ' HB3' HD13 ' A' ' 7' ' ' LEU . 9.1 mtmp? -125.13 132.29 53.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.514 171.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.433 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -135.27 141.39 42.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 112.548 0.574 . . . . 0.0 112.548 -175.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.7 OUTLIER -95.29 115.11 26.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.312 176.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.826 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . . . -170.24 167.19 8.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.16 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.447 ' HG2' ' C ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -117.3 140.33 49.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.898 ' HA ' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -65.72 134.54 53.41 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.993 0.425 . . . . 0.0 109.876 177.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.973 HD11 ' HE3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -110.29 -47.64 6.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.111 177.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.54 139.41 5.78 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.293 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.812 ' HG ' HG12 ' A' ' 29' ' ' ILE . 78.2 m -98.69 126.36 44.27 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.58 136.5 22.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.6 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 tptt 63.8 27.64 14.63 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.643 0.735 . . . . 0.0 110.118 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.56 3.57 88.92 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.211 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.842 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 42.1 mttm -109.95 171.91 7.17 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.812 HG12 ' HG ' ' A' ' 24' ' ' CYS . 57.9 mt -124.67 116.72 48.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.384 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.414 ' O ' HG13 ' A' ' 22' ' ' ILE . 57.3 m-70 -75.88 128.2 34.61 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.898 HD23 ' HA ' ' A' ' 21' ' ' PHE . 77.1 mt -126.82 136.92 53.02 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.363 -172.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.531 ' HB2' HD13 ' A' ' 22' ' ' ILE . 15.1 t-160 -102.31 102.59 12.97 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.345 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.826 ' HD2' ' HB3' ' A' ' 19' ' ' ALA . 1.6 mmmp? -65.13 163.99 13.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.073 -176.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.3 -13.48 62.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.101 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -87.29 -10.49 52.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.592 176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.91 -18.4 52.47 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.922 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.6 p -72.65 147.98 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.945 0.402 . . . . 0.0 110.823 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.973 ' HE3' HD11 ' A' ' 22' ' ' ILE . 84.6 tttt -111.16 132.96 53.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.613 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 pt -126.95 174.69 10.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.484 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.89 103.19 5.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.245 0.545 . . . . 0.0 110.056 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.527 HG12 ' HE3' ' A' ' 45' ' ' LYS . 73.2 t -106.84 118.63 54.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.668 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.842 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -57.85 139.14 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.375 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.14 -9.33 58.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.693 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -84.05 -31.27 25.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.122 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.527 ' HE3' HG12 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -99.24 27.34 5.21 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.362 175.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.535 HD13 HD12 ' A' ' 29' ' ' ILE . 13.9 mt -102.26 163.67 12.11 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 122.338 1.066 . . . . 0.0 112.241 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.551 ' O ' HD23 ' A' ' 51' ' ' LEU . 30.2 t -71.05 135.65 47.87 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.104 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.47 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 3.0 m-20 -48.44 -38.91 21.04 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.842 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.74 -47.07 83.5 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.564 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.583 ' HB3' ' CE3' ' A' ' 8' ' ' TRP . 43.6 m-20 -67.49 -34.97 78.24 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.238 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.781 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -70.95 -41.71 70.76 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.505 176.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.508 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -60.69 -29.44 69.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.515 0.674 . . . . 0.0 110.135 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.454 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 51.1 t80 -71.51 -51.59 22.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.935 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.77 ' HA ' HG12 ' A' ' 57' ' ' ILE . 2.7 p -71.23 -27.66 30.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.607 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.781 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 42.6 mt-10 -51.67 -38.53 55.36 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.165 0.507 . . . . 0.0 109.796 168.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -76.4 -41.11 48.97 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.783 -178.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.77 HG12 ' HA ' ' A' ' 54' ' ' VAL . 7.5 mm -61.69 -36.29 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.8 p -101.88 -49.17 4.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.34 -34.22 4.37 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.989 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -87.98 140.74 29.19 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 117.14 0.47 . . . . 0.0 110.451 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.7 t -79.51 135.73 36.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.424 -171.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 23.8 mt -104.68 22.28 15.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.115 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.587 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 2.2 tp10 -50.69 -38.63 47.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.4 0.619 . . . . 0.0 110.362 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -67.48 -5.92 17.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.843 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -115.94 -12.48 11.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.229 0.537 . . . . 0.0 110.103 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.587 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 45.1 mtpt -90.08 140.37 29.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.831 -174.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.607 ' HB3' ' HD2' ' A' ' 11' ' ' ARG . . . -96.77 54.43 1.3 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.442 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.243 0.746 0 CA-C-O 118.887 -0.577 . . . . 0.0 110.228 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.7 tptm . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 121.339 0.59 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.587 ' HE3' ' HG3' ' A' ' 20' ' ' GLU . 29.7 mtpp -106.71 172.94 6.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.504 -175.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 1.051 ' H ' ' HG2' ' A' ' 20' ' ' GLU . 60.9 p 54.41 105.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.479 -176.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 11.6 ptp180 -118.96 176.52 5.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.798 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 16' ' ' LYS . 1.6 tm? -95.66 105.68 17.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.975 0.417 . . . . 0.0 110.769 -173.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.668 ' HB2' HG23 ' A' ' 17' ' ' VAL . 48.7 m95 -92.4 152.64 19.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.299 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.481 HG23 ' HG2' ' A' ' 16' ' ' LYS . 47.6 t -135.76 142.94 37.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.649 ' HA ' HD12 ' A' ' 46' ' ' LEU . 3.5 p-10 -85.41 178.31 7.49 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.084 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.576 ' HG3' ' HB3' ' A' ' 67' ' ' ALA . 48.2 ttp180 -59.52 -40.48 87.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.83 0.348 . . . . 0.0 111.552 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.8 m -84.5 -18.65 35.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.5 13.93 74.89 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.708 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 m -79.87 -37.02 35.75 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.683 -0.258 . . . . 0.0 111.182 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 47.0 p90 -123.4 125.15 44.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.009 0.909 . . . . 0.0 112.175 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.564 ' HB3' HD12 ' A' ' 7' ' ' LEU . 52.2 mttp -116.61 131.17 57.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.452 174.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.668 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -131.91 136.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.553 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.1 p-10 -90.02 106.11 18.26 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.181 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . . . -161.44 161.79 30.3 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.767 -171.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 1.051 ' HG2' ' H ' ' A' ' 5' ' ' SER . 1.1 mm-40 -107.92 142.79 37.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.563 174.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.623 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 69.4 t80 -73.85 130.32 39.68 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.975 174.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -115.8 -47.62 4.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.408 178.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.83 148.51 14.86 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.86 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.623 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 30.8 t -124.18 126.89 46.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.859 0.329 . . . . 0.0 110.126 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.33 116.69 16.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.112 -173.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.5 tptt 55.2 44.5 27.6 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.201 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.28 2.82 85.19 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.46 175.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -107.06 151.74 24.94 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 117.118 0.459 . . . . 0.0 110.079 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.674 HG13 ' HB1' ' A' ' 43' ' ' ALA . 91.0 mt -119.87 123.76 71.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.286 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.499 ' O ' HG13 ' A' ' 22' ' ' ILE . 34.6 m170 -84.96 124.08 31.27 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 21' ' ' PHE . 96.5 mt -125.63 138.45 53.92 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.83 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -107.37 101.14 10.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.175 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HE3' HG11 ' A' ' 17' ' ' VAL . 38.1 mtpt -64.96 159.06 23.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.471 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.9 -15.68 63.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.54 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.77 -20.07 61.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.566 174.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.57 -20.5 27.37 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.963 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.7 p -79.2 142.12 14.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.293 0.568 . . . . 0.0 111.19 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -99.65 127.8 45.76 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.928 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.1 pt -122.87 162.62 22.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.958 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.91 122.66 38.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.842 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.59 163.55 15.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.42 119.71 32.22 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.411 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.674 ' HB1' HG13 ' A' ' 29' ' ' ILE . . . -64.24 -21.92 66.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.735 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.4 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 27.2 t70 -69.61 -22.41 63.5 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.764 -174.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HE2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -127.22 28.62 5.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.431 0.634 . . . . 0.0 110.377 179.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 10' ' ' ASP . 10.7 tp -95.03 170.58 9.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.592 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.638 ' O ' HD21 ' A' ' 51' ' ' LEU . 33.4 t -72.74 139.73 47.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.422 0.63 . . . . 0.0 110.1 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.475 ' CB ' ' HB3' ' A' ' 66' ' ' LYS . 11.2 p30 -66.06 -24.51 66.74 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.983 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -63.87 -47.77 79.36 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.637 0.732 . . . . 0.0 109.192 174.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.638 ' O ' HG13 ' A' ' 54' ' ' VAL . 3.3 m-20 -58.62 -43.8 89.78 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.712 176.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.776 HD22 ' HA ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -67.57 -42.39 82.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.819 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -61.5 -29.64 70.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.401 0.62 . . . . 0.0 110.134 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.732 ' CE2' HD12 ' A' ' 57' ' ' ILE . 40.9 t80 -74.61 -49.13 22.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.763 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 50' ' ' ASP . 2.2 p -69.48 -27.65 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.119 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.755 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 50.6 mt-10 -51.24 -40.91 59.85 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 167.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 52' ' ' ALA . 9.3 mmpt? -74.14 -38.61 63.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.389 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.732 HD12 ' CE2' ' A' ' 53' ' ' TYR . 31.9 mt -62.84 -39.8 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.976 0.417 . . . . 0.0 111.253 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.595 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 40.3 p -95.22 -43.91 7.85 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -168.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.2 7.46 43.4 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.494 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.595 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 98.1 m-85 -103.7 177.06 4.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -123.69 124.66 43.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.959 0.409 . . . . 0.0 110.034 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 65' ' ' PHE . 62.1 mt -102.89 41.19 1.27 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.45 0.643 . . . . 0.0 110.189 -175.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.702 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 8.5 tp10 -50.62 -59.65 3.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.479 -176.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -70.35 -10.47 59.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.339 0.59 . . . . 0.0 109.917 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.659 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 60.3 m-85 -91.88 -14.2 30.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.566 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.776 ' HA ' HD22 ' A' ' 51' ' ' LEU . 50.8 mtmt -72.34 136.32 46.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.476 -175.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.576 ' HB3' ' HG3' ' A' ' 11' ' ' ARG . . . -65.27 116.42 6.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.319 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.074 177.715 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.6 tptm . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.421 0.153 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 57.9 tttm 64.11 18.55 11.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 122.113 0.958 . . . . 0.0 111.111 173.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.6 p -78.58 144.26 35.71 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.754 -170.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 2.8 ptp180 -136.54 -179.17 5.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.052 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -93.18 115.14 27.77 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.497 -172.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.704 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 62.4 m95 -104.6 149.15 25.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.156 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 59.5 t -136.75 149.92 26.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 123.543 0.527 . . . . 0.0 109.829 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.984 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -96.67 174.09 7.0 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.214 178.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.883 ' HG3' ' HB3' ' A' ' 67' ' ' ALA . 1.6 tmm_? -66.82 -34.29 77.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.705 0.288 . . . . 0.0 110.857 -174.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -75.68 -23.36 56.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.21 2.17 66.3 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.666 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -80.8 -40.48 24.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.349 0.595 . . . . 0.0 109.834 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.984 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 5.7 m-85 -85.93 127.12 34.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.829 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.704 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 8.6 ptmt -153.35 128.57 9.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.917 166.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.412 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -158.36 156.36 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.785 -173.367 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -92.81 118.67 31.35 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.899 174.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -163.86 164.62 23.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.621 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -115.97 138.32 51.3 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.815 ' HD2' HG23 ' A' ' 29' ' ' ILE . 6.6 t80 -74.41 117.91 16.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.324 0.583 . . . . 0.0 109.504 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -96.07 -45.37 13.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.136 -177.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.93 143.21 7.55 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.766 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.588 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 22.1 p -100.82 133.93 44.55 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.74 126.91 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.576 -173.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.3 OUTLIER 61.44 34.2 18.27 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.811 176.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.29 7.42 88.48 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.254 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -104.7 165.91 10.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.028 0.442 . . . . 0.0 110.442 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.815 HG23 ' HD2' ' A' ' 21' ' ' PHE . 84.6 mt -125.51 116.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.52 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.484 ' O ' HG13 ' A' ' 22' ' ' ILE . 11.2 m170 -83.61 126.94 33.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.721 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.7 mt -124.72 138.89 54.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.284 0.564 . . . . 0.0 111.021 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -104.72 105.55 15.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.468 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.592 ' HD3' HD13 ' A' ' 39' ' ' ILE . 13.5 mmmm -61.14 162.89 6.75 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.527 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -68.14 -12.47 60.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.265 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -89.26 -13.46 38.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.195 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.82 2.56 56.19 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.468 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.17 148.14 5.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.554 0.216 . . . . 0.0 110.46 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -100.04 126.41 46.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.041 0.448 . . . . 0.0 110.857 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.592 HD13 ' HD3' ' A' ' 33' ' ' LYS . 24.8 pt -124.86 168.45 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.949 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.88 124.36 18.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.258 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 m -114.05 164.71 9.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.499 ' HB1' ' HG3' ' A' ' 45' ' ' LYS . . . -85.86 127.85 34.68 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.183 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.549 ' HB1' HG13 ' A' ' 29' ' ' ILE . . . -63.97 -5.8 5.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.372 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -110.71 -15.72 13.77 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.624 ' HB2' ' HZ3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -96.26 0.88 51.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 6.6 tp -86.27 169.23 13.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.058 -175.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.626 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.5 t -78.9 138.29 38.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.776 0.798 . . . . 0.0 109.923 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.439 ' ND2' ' HB3' ' A' ' 66' ' ' LYS . 1.2 m-20 -53.53 -32.79 52.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.329 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -62.91 -48.13 80.28 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.046 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.652 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.6 m-20 -59.67 -39.26 83.88 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.555 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.725 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -70.21 -38.89 75.39 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.158 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.644 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -60.33 -30.44 69.51 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.566 0.698 . . . . 0.0 110.197 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.658 ' CE2' HD13 ' A' ' 57' ' ' ILE . 80.2 t80 -74.36 -48.41 28.21 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.507 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -65.17 -26.98 41.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.415 -0.803 . . . . 0.0 110.853 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.725 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 37.8 mt-10 -51.47 -43.53 62.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.26 166.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.591 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 1.6 ppmt? -72.87 -31.58 64.82 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.992 0.425 . . . . 0.0 109.983 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.658 HD13 ' CE2' ' A' ' 53' ' ' TYR . 37.7 mt -66.94 -42.84 89.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.735 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.4 p -104.52 -46.38 4.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -171.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.13 -14.57 23.51 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -79.74 137.64 37.08 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.417 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 20.9 t -89.45 112.04 23.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.938 0.399 . . . . 0.0 110.238 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 30.1 mt -91.51 24.86 2.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.638 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -53.48 -47.37 69.85 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.677 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -73.33 -5.35 39.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.502 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -97.41 -16.13 20.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.102 0.477 . . . . 0.0 110.14 176.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 97.9 mttt -72.94 147.98 44.75 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.877 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.883 ' HB3' ' HG3' ' A' ' 11' ' ' ARG . . . -109.36 166.93 10.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.191 -170.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 . . . . . 0 C--O 1.251 1.164 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.958 -179.868 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.236 0.39 0 CA-C-O 121.264 0.554 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -113.64 134.19 54.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.635 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 25.1 t 69.75 160.12 0.19 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.722 0.639 . . . . 0.0 111.101 -175.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -148.59 -179.82 7.26 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 110.737 178.064 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.444 HD13 ' HB3' ' A' ' 16' ' ' LYS . 2.6 tm? -103.72 108.18 19.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.507 -175.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.591 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 43.1 m95 -93.22 145.46 24.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.046 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.24 148.5 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.598 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -86.66 177.32 7.39 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.187 176.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.821 ' HG2' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -55.11 -44.87 75.35 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.305 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.639 ' N ' ' HD3' ' A' ' 11' ' ' ARG . 64.6 p -85.4 -28.97 24.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.017 0.437 . . . . 0.0 111.436 -173.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.11 20.3 30.92 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.467 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.6 m -78.24 -37.48 45.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.783 0.325 . . . . 0.0 110.297 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.405 ' HZ ' ' HD3' ' A' ' 45' ' ' LYS . 42.0 p90 -132.87 133.56 43.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.84 0.828 . . . . 0.0 112.376 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.444 ' HB3' HD13 ' A' ' 7' ' ' LEU . 21.7 mtmm -123.11 143.89 49.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.608 175.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.698 HG11 ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -137.66 135.85 46.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.657 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 10.3 p-10 -85.89 105.36 16.32 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.486 173.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.763 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . . . -156.21 162.43 40.18 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.329 -171.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -119.1 139.47 51.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.857 172.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.819 ' HD2' HG21 ' A' ' 29' ' ' ILE . 33.6 t80 -68.56 132.22 46.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -113.76 -48.89 5.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.19 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.08 157.59 29.15 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.0 p -116.87 140.87 48.94 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 28' ' ' LYS . . . -135.02 105.59 6.43 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.172 -174.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? 59.12 41.86 19.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.923 0.868 . . . . 0.0 109.573 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.71 -19.18 52.87 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.978 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 42' ' ' ALA . 3.6 ptpp? -89.18 163.72 15.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.406 0.603 . . . . 0.0 110.423 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.819 HG21 ' HD2' ' A' ' 21' ' ' PHE . 57.8 mt -115.39 126.8 73.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.12 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.451 ' O ' HG13 ' A' ' 22' ' ' ILE . 91.4 m-70 -86.16 127.27 34.69 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 169.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.763 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 95.8 mt -125.63 137.8 53.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.91 -176.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -106.3 110.05 22.17 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.271 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.698 ' HE3' HG11 ' A' ' 17' ' ' VAL . 11.8 mmmm -58.05 151.81 17.91 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 123.696 0.623 . . . . 0.0 109.901 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.65 -16.06 63.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.623 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -89.82 -7.13 55.03 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.153 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.45 -23.41 12.33 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.718 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 t -67.44 145.78 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 117.001 0.4 . . . . 0.0 110.88 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -112.37 130.27 56.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.821 0.343 . . . . 0.0 110.196 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.8 pt -126.1 165.68 23.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.385 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.58 124.46 40.0 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.558 HG11 ' HE3' ' A' ' 45' ' ' LYS . 70.4 t -130.4 120.58 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.402 -175.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . . . -66.06 129.27 39.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.2 -18.27 63.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.626 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.721 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 2.9 p30 -72.72 -25.64 61.3 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.094 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.558 ' HE3' HG11 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.43 29.03 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.751 0.786 . . . . 0.0 110.051 176.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.5 tp -108.77 174.5 5.84 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.197 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.557 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 47.6 t -80.21 138.01 36.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.925 0.869 . . . . 0.0 110.766 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -51.2 -41.23 60.1 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.756 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.7 -45.27 87.32 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.132 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.591 ' OD2' ' HA ' ' A' ' 8' ' ' TRP . 3.9 m-20 -60.24 -36.83 78.63 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.166 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.771 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -67.18 -42.72 83.74 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 120.597 -0.441 . . . . 0.0 109.918 176.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.646 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -60.97 -29.65 69.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.486 0.66 . . . . 0.0 110.237 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -73.85 -51.32 16.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.169 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.815 ' HA ' HG12 ' A' ' 57' ' ' ILE . 3.6 p -69.63 -25.7 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.143 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.771 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.0 mt-10 -50.34 -44.38 54.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.101 0.476 . . . . 0.0 109.733 167.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 52' ' ' ALA . 1.1 mpmm? -72.76 -34.55 67.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.492 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.815 HG12 ' HA ' ' A' ' 54' ' ' VAL . 4.9 mm -68.78 -34.15 63.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.067 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.738 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 37.6 p -99.31 -48.1 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -171.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.56 -0.76 34.5 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -171.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.738 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 87.3 m-85 -102.04 141.13 35.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.42 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 17.7 t -88.2 111.7 21.92 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.684 HD12 HG11 ' A' ' 54' ' ' VAL . 50.9 mt -90.3 24.44 2.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.174 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -57.78 -40.97 81.06 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.002 0.43 . . . . 0.0 110.504 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.6 ' HB2' ' HZ1' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -71.35 -5.79 35.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.254 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.721 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 96.4 m-85 -108.68 -4.33 17.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.307 177.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 98.8 mttt -86.01 143.31 28.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.038 -176.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 67.0 86.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 O-C-N 124.221 0.951 . . . . 0.0 111.558 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.821 ' HB3' ' HG2' ' A' ' 11' ' ' ARG . 27.7 t-20 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.354 -0.832 . . . . 0.0 109.517 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.619 ' HE3' ' O ' ' A' ' 5' ' ' SER . 51.6 tptt . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 121.243 0.545 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 4' ' ' LYS . 22.1 mtpp -81.42 153.84 26.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 169.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.876 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 12.1 t 67.91 156.54 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.848 0.717 . . . . 0.0 109.701 -170.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -152.72 174.14 14.39 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.82 -0.55 . . . . 0.0 111.555 -177.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.72 HD12 ' HB3' ' A' ' 16' ' ' LYS . 1.8 tm? -94.75 104.58 16.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.182 -174.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.596 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 63.2 m95 -92.88 143.94 25.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.086 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.489 HG21 ' HG2' ' A' ' 16' ' ' LYS . 45.3 t -128.73 143.35 41.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.525 ' HA ' HD11 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -89.31 160.13 17.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -70.64 -20.76 62.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.586 -170.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 t -82.28 -12.78 57.81 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.245 0.545 . . . . 0.0 109.781 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.4 30.8 61.91 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.915 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.6 m -93.9 -44.4 8.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.413 0.149 . . . . 0.0 110.975 -176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 10' ' ' ASP . 34.8 p90 -127.17 131.74 50.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.912 0.863 . . . . 0.0 112.932 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.72 ' HB3' HD12 ' A' ' 7' ' ' LEU . 86.9 mttt -116.48 130.73 56.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.674 170.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.45 144.66 27.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.626 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 17.9 t70 -94.46 115.07 27.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.196 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.616 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . . . -161.07 162.56 31.67 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.914 -172.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.876 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 5.5 mm-40 -107.94 137.97 45.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.246 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.884 ' HD1' HG23 ' A' ' 29' ' ' ILE . 4.4 t80 -78.95 120.09 23.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.813 HD12 ' HE3' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -105.41 -42.01 6.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.711 -174.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.73 142.15 7.56 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.848 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.518 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 27.5 p -104.73 125.53 50.9 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.24 115.54 20.56 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.117 -172.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 65.67 -76.29 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.112 0.883 . . . . 0.0 111.085 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.49 18.32 1.49 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.949 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -125.77 166.52 16.66 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.472 0.653 . . . . 0.0 111.503 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.884 HG23 ' HD1' ' A' ' 21' ' ' PHE . 67.4 mt -117.24 126.49 74.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.828 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.461 ' O ' HG13 ' A' ' 22' ' ' ILE . 25.2 m170 -91.29 127.42 36.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 2.5 mm? -121.0 140.64 51.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.481 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -104.29 101.33 11.05 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 169.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.6 ' HD2' HD12 ' A' ' 39' ' ' ILE . 44.0 mtpt -68.21 154.67 41.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.165 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.73 -14.05 57.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.551 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.63 ' OD1' HG13 ' A' ' 37' ' ' VAL . 43.2 p30 -80.84 -18.93 45.8 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.935 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.65 -21.11 9.22 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.521 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.63 HG13 ' OD1' ' A' ' 35' ' ' ASN . 9.9 p -85.16 150.75 3.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.276 0.56 . . . . 0.0 111.238 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.813 ' HE3' HD12 ' A' ' 22' ' ' ILE . 85.4 tttt -107.24 125.92 51.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.557 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.6 HD12 ' HD2' ' A' ' 33' ' ' LYS . 16.4 pt -122.07 169.99 12.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.279 -173.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.03 103.68 6.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.607 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.492 HG11 HD12 ' A' ' 46' ' ' LEU . 67.8 t -101.82 122.81 54.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.428 ' HB1' ' OD1' ' A' ' 44' ' ' ASP . . . -60.45 129.57 42.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.259 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 29' ' ' ILE . . . -72.4 -6.38 43.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.01 0.433 . . . . 0.0 111.835 -172.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.428 ' OD1' ' HB1' ' A' ' 42' ' ' ALA . 8.6 p-10 -98.14 -20.23 17.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.823 -173.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.446 ' HE2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -102.82 6.03 39.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.782 0.801 . . . . 0.0 109.78 176.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.525 HD11 ' HA ' ' A' ' 10' ' ' ASP . 13.1 tp -91.62 170.39 9.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.299 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.617 ' O ' HD21 ' A' ' 51' ' ' LEU . 40.7 t -75.65 135.35 40.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.694 0.759 . . . . 0.0 110.444 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.439 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 19.3 m-20 -60.03 -32.15 70.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.949 -174.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.89 -43.78 97.88 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.664 0.745 . . . . 0.0 109.845 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.596 ' OD2' ' HA ' ' A' ' 8' ' ' TRP . 4.0 m-20 -64.75 -37.92 89.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.444 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.76 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -67.73 -39.8 84.25 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.667 177.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.644 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -60.25 -32.13 70.86 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.458 0.647 . . . . 0.0 109.978 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.738 ' CE2' HD13 ' A' ' 57' ' ' ILE . 80.6 t80 -72.21 -48.41 43.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.523 176.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -68.94 -26.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 121.757 -0.589 . . . . 0.0 111.241 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.76 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 48.2 mt-10 -51.3 -38.33 52.33 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.139 0.495 . . . . 0.0 109.764 166.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -73.56 -43.65 59.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.042 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.738 HD13 ' CE2' ' A' ' 53' ' ' TYR . 35.9 mt -57.58 -37.96 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.023 0.44 . . . . 0.0 111.193 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 35.1 p -98.66 -47.1 5.46 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -170.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.76 -3.77 39.2 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -171.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -92.09 172.84 8.17 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.7 t -117.94 128.01 54.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.172 0.51 . . . . 0.0 109.918 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 33.3 mt -106.22 19.76 20.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.941 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -53.17 -42.71 66.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.189 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -59.14 -23.62 62.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.5 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -97.25 -12.78 22.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.668 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 97.3 mttt -76.71 140.15 40.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.428 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.71 108.28 19.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.908 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.438 177.323 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm . . . . . 0 C--O 1.234 0.277 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.616 ' HE3' ' HG3' ' A' ' 20' ' ' GLU . 31.9 mmmt 69.46 158.42 0.17 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.89 0.744 . . . . 0.0 111.077 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.783 ' H ' ' HG2' ' A' ' 20' ' ' GLU . 40.1 t 63.13 112.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 122.052 0.929 . . . . 0.0 110.958 -174.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 13.8 ptp180 -126.12 177.36 6.42 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.447 -171.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 16' ' ' LYS . 1.9 tm? -89.39 119.11 29.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.882 0.372 . . . . 0.0 111.325 -171.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.552 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 41.9 m95 -108.5 148.04 30.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.953 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.516 ' CG1' ' HA2' ' A' ' 13' ' ' GLY . 39.2 t -129.88 143.41 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 123.026 0.204 . . . . 0.0 110.456 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.646 ' HA ' HD11 ' A' ' 46' ' ' LEU . 1.7 p-10 -86.05 -179.47 6.77 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.9 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -52.94 -44.87 67.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.603 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 m -88.1 -20.53 25.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.039 0.447 . . . . 0.0 111.069 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.516 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . 86.81 14.58 64.83 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.629 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 m -74.49 -38.68 62.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.774 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 49.2 p90 -120.21 121.54 38.97 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 122.062 0.934 . . . . 0.0 111.846 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.716 ' HB3' HD13 ' A' ' 7' ' ' LEU . 49.5 mttp -112.41 130.95 55.8 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.005 -1.452 . . . . 0.0 107.611 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.5 146.09 28.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.183 0.516 . . . . 0.0 112.142 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.3 p30 -86.14 124.05 32.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.001 172.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.626 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -169.52 156.81 6.87 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.632 -175.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.783 ' HG2' ' H ' ' A' ' 5' ' ' SER . 0.4 OUTLIER -112.05 139.9 47.18 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.538 172.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.73 ' HE2' ' HB3' ' A' ' 24' ' ' CYS . 28.7 t80 -68.49 133.67 48.95 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.273 176.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -120.94 -48.93 3.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.462 178.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 30' ' ' HIS . . . -148.25 144.41 12.28 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.73 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 30.8 p -123.16 115.18 21.36 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.506 -0.408 . . . . 0.0 109.974 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.78 146.02 22.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 58.24 34.48 24.14 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.625 0.578 . . . . 0.0 111.26 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.89 17.01 64.74 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.401 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 39.4 mmtm -114.74 153.69 29.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.913 0.387 . . . . 0.0 110.039 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.547 HG22 ' HD2' ' A' ' 21' ' ' PHE . 79.0 mt -114.1 113.06 42.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.035 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.523 ' O ' HG13 ' A' ' 22' ' ' ILE . 15.2 m-70 -75.48 119.87 20.14 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.021 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.626 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 91.3 mt -124.57 140.25 53.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.171 0.51 . . . . 0.0 111.498 -172.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.488 ' NE2' ' HA2' ' A' ' 36' ' ' GLY . 17.7 t-80 -108.94 98.58 8.04 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.36 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' HB3' ' HZ1' ' A' ' 33' ' ' LYS . 1.7 mmmp? -57.69 167.09 1.17 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.852 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.19 -28.16 69.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.498 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -86.06 10.35 14.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.488 ' HA2' ' NE2' ' A' ' 32' ' ' HIS . . . 73.89 27.44 66.78 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.465 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.45 137.95 25.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 66.8 mttt -99.47 124.39 44.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.074 0.464 . . . . 0.0 111.383 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.1 pt -126.97 146.4 32.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.126 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.09 103.29 14.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.1 t -103.22 110.99 31.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -56.99 127.48 32.12 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.576 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.36 -8.0 29.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.069 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.442 ' OD2' ' HB1' ' A' ' 42' ' ' ALA . 2.8 p30 -95.59 -10.38 29.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -120.61 17.58 12.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.012 0.911 . . . . 0.0 108.806 171.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.646 HD11 ' HA ' ' A' ' 10' ' ' ASP . 13.7 tp -97.6 166.68 11.39 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.177 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.597 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 47.3 t -74.33 137.31 42.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.636 0.732 . . . . 0.0 110.693 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -58.07 -29.41 65.4 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.744 -177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.49 -50.68 72.6 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.7 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.597 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 3.8 m-20 -61.67 -36.82 81.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.83 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.76 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -68.79 -41.15 79.15 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.55 177.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -64.65 -28.63 69.74 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.544 0.688 . . . . 0.0 109.611 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.765 ' CE2' HD12 ' A' ' 57' ' ' ILE . 16.7 t80 -73.28 -48.02 38.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.49 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.714 HG11 HD22 ' A' ' 62' ' ' LEU . 3.0 p -68.48 -26.68 34.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 121.761 -0.587 . . . . 0.0 110.949 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.76 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.2 mt-10 -52.03 -35.25 46.37 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.11 0.481 . . . . 0.0 110.059 167.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 1.7 tptt -73.2 -50.29 23.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.161 176.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.765 HD12 ' CE2' ' A' ' 53' ' ' TYR . 51.1 mt -49.98 -46.34 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.126 0.489 . . . . 0.0 111.811 -177.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.409 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 34.2 p -105.08 -46.83 4.16 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -170.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.87 -6.7 27.55 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 90.3 m-85 -83.17 141.24 32.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.0 t -90.36 108.74 19.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.043 0.449 . . . . 0.0 110.037 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.714 HD22 HG11 ' A' ' 54' ' ' VAL . 2.6 mm? -87.1 19.41 3.12 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.403 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -53.82 -43.74 69.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.387 0.675 . . . . 0.0 110.756 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -67.44 -12.62 60.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.806 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -108.99 -0.99 19.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.723 0.297 . . . . 0.0 110.776 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 98.9 mttt -76.83 142.09 40.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.81 54.19 2.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -166.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.66 174.01 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.471 ' HZ3' ' CD ' ' A' ' 20' ' ' GLU . 59.5 tttm . . . . . 0 C--O 1.235 0.334 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -144.48 139.66 28.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.808 -171.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.8 t -54.7 118.88 4.59 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.007 0.817 . . . . 0.0 110.128 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 18.6 ptp180 -137.0 -179.13 5.52 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.66 -173.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.91 110.82 21.41 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.139 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.524 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 41.1 m95 -91.93 138.07 31.85 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.7 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 10' ' ' ASP . 58.9 t -129.41 142.54 43.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.459 ' HB3' ' H ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -74.48 159.43 32.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.616 0.722 . . . . 0.0 110.699 172.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.422 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -64.22 -21.36 66.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.403 -172.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.4 m -113.72 6.72 16.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.969 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.38 24.51 72.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.468 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 m -68.82 -40.11 79.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.615 0.245 . . . . 0.0 111.572 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.459 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 5.6 p90 -137.29 142.81 41.93 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.163 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 45.4 mttp -137.56 131.03 31.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.586 HG11 ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -148.51 146.31 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-O 120.912 0.386 . . . . 0.0 111.431 177.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.5 m-20 -83.32 121.51 27.22 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.16 171.94 17.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.237 0.542 . . . . 0.0 111.71 -173.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.471 ' CD ' ' HZ3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -127.93 142.59 51.21 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.62 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.589 ' HA ' HD13 ' A' ' 31' ' ' LEU . 64.6 t80 -77.67 132.23 38.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.104 0.478 . . . . 0.0 110.354 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -112.02 -51.1 5.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.52 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.11 145.94 11.14 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.217 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.539 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 27.0 t -123.8 130.8 53.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.828 0.347 . . . . 0.0 110.493 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.15 143.79 21.63 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 -177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 60.02 29.13 18.72 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.783 0.677 . . . . 0.0 111.601 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.06 1.16 89.82 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.498 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -106.73 161.0 15.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.964 0.412 . . . . 0.0 110.47 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.601 HG23 HD11 ' A' ' 31' ' ' LEU . 94.1 mt -123.11 123.49 68.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.531 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.401 ' O ' HG13 ' A' ' 22' ' ' ILE . 90.0 m-70 -87.76 128.09 35.32 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.601 HD11 HG23 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -124.03 148.42 47.04 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.665 -176.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -110.91 100.14 8.92 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.208 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.731 ' HD2' HD11 ' A' ' 39' ' ' ILE . 59.5 mtpt -71.94 152.0 42.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.784 -173.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.25 -12.0 46.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.99 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.42 -20.6 62.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.087 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.14 0.99 44.77 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.122 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.45 141.46 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.831 0.348 . . . . 0.0 111.207 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -98.26 128.03 44.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.967 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.731 HD11 ' HD2' ' A' ' 33' ' ' LYS . 49.0 pt -127.4 169.28 19.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.111 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.3 109.32 8.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.951 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.597 ' HB ' ' HE3' ' A' ' 45' ' ' LYS . 32.8 m -110.19 147.45 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.9 129.12 37.43 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.78 -16.17 47.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 4.7 p-10 -74.27 -23.2 59.09 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -173.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.597 ' HE3' ' HB ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.54 38.37 1.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.903 0.858 . . . . 0.0 110.163 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.449 HD23 HD13 ' A' ' 29' ' ' ILE . 6.0 mp -115.76 161.63 18.45 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.121 176.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.588 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 43.8 t -74.29 140.46 44.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.754 0.788 . . . . 0.0 110.047 176.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.1 m-20 -49.86 -34.32 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.267 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -59.22 -51.33 70.44 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.599 0.714 . . . . 0.0 109.981 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.626 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.1 m-20 -60.37 -38.24 83.26 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.422 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.796 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.5 OUTLIER -70.3 -43.85 69.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.363 179.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.62 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -58.96 -30.27 67.79 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.551 0.691 . . . . 0.0 110.375 -178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.403 ' O ' HG12 ' A' ' 57' ' ' ILE . 51.6 t80 -73.75 -50.64 19.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.325 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.728 ' HA ' HG12 ' A' ' 57' ' ' ILE . 2.2 p -69.94 -29.1 39.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.401 -176.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.796 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 47.4 mt-10 -51.61 -40.05 59.14 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.193 0.521 . . . . 0.0 109.914 169.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.851 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -78.38 -31.65 48.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.873 -176.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.728 HG12 ' HA ' ' A' ' 54' ' ' VAL . 10.9 mm -66.3 -35.82 75.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.031 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.4 p -107.88 -47.35 3.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -170.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.47 -31.85 4.28 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.389 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.465 ' HZ ' ' HB3' ' A' ' 24' ' ' CYS . 14.9 p90 -87.28 152.64 22.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.177 0.488 . . . . 0.0 110.842 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.432 ' OG ' ' HG2' ' A' ' 63' ' ' GLU . 7.7 t -92.37 140.97 29.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.708 -172.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.6 HD12 HG13 ' A' ' 54' ' ' VAL . 35.3 mt -115.94 31.42 6.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.86 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG2' ' OG ' ' A' ' 61' ' ' SER . 18.5 mm-40 -53.13 -40.69 64.42 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.666 174.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -62.78 -15.2 52.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.971 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.451 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 36.9 m-85 -106.96 -7.32 17.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.245 0.545 . . . . 0.0 110.545 -177.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 48' ' ' ASN . 99.1 mttt -86.56 149.8 24.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.221 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -106.63 113.75 27.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.672 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 t30 . . . . . 0 C--O 1.251 1.146 0 O-C-N 123.78 0.675 . . . . 0.0 111.054 177.537 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.622 ' HA ' ' NH2' ' A' ' 6' ' ' ARG . 62.4 tttm . . . . . 0 C--O 1.23 0.065 0 CA-C-O 121.768 0.794 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.425 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 16.7 ptpt -97.79 179.88 4.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.668 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.7 t -63.07 125.46 24.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.164 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 12.0 ptp180 -131.44 -179.9 5.64 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.107 -170.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.807 HD13 ' HB3' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -95.06 106.22 18.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.814 -171.083 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -92.18 141.77 28.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.474 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 10' ' ' ASP . 96.5 t -132.88 136.84 55.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.989 0.423 . . . . 0.0 111.442 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.563 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.14 153.42 41.66 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.601 0.715 . . . . 0.0 110.379 171.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 6.3 tmm_? -63.66 -28.66 70.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.853 -169.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -93.39 -6.74 46.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.115 0.483 . . . . 0.0 110.687 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.08 20.85 60.07 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.933 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.5 m -69.03 -45.37 70.63 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.569 0.347 . . . . 0.0 111.662 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -137.92 143.85 41.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 110.832 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.807 ' HB3' HD13 ' A' ' 7' ' ' LEU . 54.4 mttm -133.4 130.88 39.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.601 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.66 152.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.258 0.551 . . . . 0.0 111.88 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.629 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.1 p30 -90.36 130.46 36.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.295 173.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.943 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . . . -171.38 157.39 4.9 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.18 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -117.49 140.41 49.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.743 ' HD1' HG23 ' A' ' 29' ' ' ILE . 42.7 t80 -72.01 130.69 41.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.378 0.609 . . . . 0.0 110.721 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -112.53 -49.73 5.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.237 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.29 148.7 14.44 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.59 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.417 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 27.9 t -118.41 134.41 55.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.954 0.377 . . . . 0.0 110.172 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.98 140.33 29.56 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.775 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 62.68 -78.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.099 0.874 . . . . 0.0 111.282 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -155.63 12.45 0.4 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 47.6 mttm -115.51 160.29 20.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.101 0.476 . . . . 0.0 110.925 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.743 HG23 ' HD1' ' A' ' 21' ' ' PHE . 2.2 mp -112.8 124.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.614 174.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.441 ' O ' HG13 ' A' ' 22' ' ' ILE . 79.0 m-70 -80.32 130.86 35.48 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.943 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 97.6 mt -130.16 140.51 50.76 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.686 -174.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -111.93 110.54 20.92 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.732 ' HB3' ' HZ3' ' A' ' 33' ' ' LYS . 5.1 mtpm? -69.76 170.5 10.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.042 -174.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.42 -20.5 60.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.815 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.475 ' HB2' HG22 ' A' ' 37' ' ' VAL . 7.8 m120 -79.87 -7.72 58.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.137 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.92 0.27 75.04 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.92 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' A' ' 35' ' ' ASN . 43.0 t -75.29 136.65 24.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -100.41 117.21 34.12 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.517 HG13 ' HB2' ' A' ' 31' ' ' LEU . 40.4 pt -119.63 172.1 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.0 110.64 4.02 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 m -112.13 129.39 67.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.879 0.371 . . . . 0.0 110.509 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.74 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -61.51 130.61 46.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.068 0.461 . . . . 0.0 110.181 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . . . -54.88 -26.17 33.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.165 -173.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.46 -10.64 59.76 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.537 ' HD3' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -101.19 17.72 21.77 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.697 178.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 88.8 mt -115.05 -174.8 2.56 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.246 1.022 . . . . 0.0 111.813 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.593 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 34.9 t -97.25 143.71 27.76 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.285 -1.78 . . . . 0.0 108.942 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -60.05 -24.18 64.34 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.918 -174.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -62.76 -47.32 84.04 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.964 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.593 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 3.8 m-20 -64.19 -38.52 91.35 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.441 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.64 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.8 OUTLIER -70.66 -38.33 73.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.952 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.463 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -68.03 -27.23 66.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.303 0.573 . . . . 0.0 109.968 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.588 ' CZ ' HD12 ' A' ' 57' ' ' ILE . 32.5 t80 -74.04 -49.95 21.91 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.198 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 50' ' ' ASP . 3.4 p -70.55 -32.04 48.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.018 0.437 . . . . 0.0 111.085 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.894 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 1.7 pt-20 -68.45 -23.51 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.302 0.572 . . . . 0.0 110.031 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 1.1 ttpp -72.79 -40.44 65.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.588 HD12 ' CZ ' ' A' ' 53' ' ' TYR . 54.2 mt -63.08 -44.69 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.013 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 55' ' ' GLU . 11.2 p -78.37 -43.99 26.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.289 -172.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.94 2.05 28.51 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.485 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.49 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 64.0 m-85 -104.83 -166.19 1.21 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 t -130.99 132.43 45.01 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.894 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 9.7 mt -103.68 29.7 5.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.387 0.613 . . . . 0.0 109.381 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.468 ' OE2' ' HD2' ' A' ' 66' ' ' LYS . 6.2 tp10 -45.0 -48.84 11.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.033 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -65.34 -17.53 64.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -100.8 -4.83 27.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.496 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HD2' ' OE2' ' A' ' 63' ' ' GLU . 97.8 mttt -77.47 104.82 8.22 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.697 0.761 . . . . 0.0 110.836 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.09 107.95 16.03 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.26 175.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.528 -176.552 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 3' ' ' LYS . 51.3 mtpt . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.737 0.303 . . . . 0.0 111.371 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 167.77 12.5 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 171.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.704 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 33.0 p 51.51 97.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 122.356 1.074 . . . . 0.0 111.45 -176.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 10.9 ptp180 -107.98 179.13 4.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.588 -166.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.751 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.9 tm? -88.9 108.95 19.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.852 -173.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.493 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 37.7 m95 -97.54 153.72 17.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.18 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 10' ' ' ASP . 23.5 t -133.68 146.79 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' HA ' HD13 ' A' ' 46' ' ' LEU . 7.8 p-10 -84.24 178.82 7.64 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.143 172.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 11' ' ' ARG . 2.1 tmm_? -81.32 -23.58 37.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 110.947 -174.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.9 t -89.91 -29.31 18.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.875 0.369 . . . . 0.0 110.679 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.89 21.18 19.21 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -76.79 -40.97 46.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.346 -0.427 . . . . 0.0 110.966 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.591 ' HZ ' ' HE3' ' A' ' 45' ' ' LYS . 33.0 p90 -142.2 131.01 22.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.908 0.861 . . . . 0.0 113.157 -174.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.751 ' HB3' HD11 ' A' ' 7' ' ' LEU . 36.0 mtmm -118.86 130.45 55.75 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.252 169.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.38 153.18 21.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.41 0.624 . . . . 0.0 112.371 -173.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.54 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.4 p30 -90.36 129.03 36.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.61 174.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.711 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . . . -178.7 159.54 1.11 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.946 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.704 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 3.8 mm-40 -110.61 144.26 39.77 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 121.251 0.548 . . . . 0.0 110.017 169.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.907 ' HD1' HG21 ' A' ' 29' ' ' ILE . 3.7 t80 -74.9 120.67 20.75 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.339 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.83 -52.77 8.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.079 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.3 141.87 7.76 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.759 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.409 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 24.6 p -101.0 144.04 30.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.39 109.16 4.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.186 -0.206 . . . . 0.0 111.159 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? 53.43 52.28 13.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.103 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.81 -7.01 71.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.124 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -101.44 161.06 13.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.26 0.53 . . . . 0.0 111.283 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.907 HG21 ' HD1' ' A' ' 21' ' ' PHE . 78.0 mt -123.03 120.79 61.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.248 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -87.82 131.7 34.44 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.777 HD21 ' HA ' ' A' ' 21' ' ' PHE . 85.7 mt -129.31 138.99 51.91 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.27 0.557 . . . . 0.0 111.284 -170.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -105.81 104.41 14.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.185 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.62 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 6.3 mtpm? -66.09 169.03 7.46 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.55 -18.66 62.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.301 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -103.86 14.75 30.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.611 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.9 -16.43 59.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.633 171.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HB ' ' HD3' ' A' ' 33' ' ' LYS . 60.7 t -65.43 139.18 21.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.708 0.289 . . . . 0.0 110.654 -178.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -104.31 124.19 48.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.499 HG13 ' HB2' ' A' ' 31' ' ' LEU . 39.1 pt -125.68 160.34 32.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.795 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.49 121.61 23.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.159 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -119.3 148.33 22.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' HB1' ' OD2' ' A' ' 44' ' ' ASP . . . -78.85 123.73 27.51 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.82 -19.66 65.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.566 0.698 . . . . 0.0 111.123 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.808 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 3.7 p30 -74.53 -14.28 60.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.274 -176.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.591 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -117.12 18.31 14.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.997 0.903 . . . . 0.0 109.201 174.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 10' ' ' ASP . 12.8 tp -100.21 167.79 10.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.434 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.8 t -67.11 137.83 56.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.426 0.632 . . . . 0.0 111.054 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.474 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 53.1 m-20 -58.66 -36.72 74.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.81 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -65.29 -46.04 82.0 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.658 0.742 . . . . 0.0 109.713 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.54 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.5 m-20 -61.78 -36.46 81.11 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.91 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.752 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -66.32 -45.72 79.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.852 176.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.572 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -61.86 -29.24 70.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.46 0.648 . . . . 0.0 110.449 -176.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.621 ' CE2' HD13 ' A' ' 57' ' ' ILE . 29.2 t80 -74.01 -49.93 22.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.232 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 50' ' ' ASP . 4.1 p -70.51 -26.58 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.894 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.752 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.9 mt-10 -51.45 -40.16 58.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.189 0.519 . . . . 0.0 109.872 167.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.584 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -75.78 -36.25 59.86 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.113 -176.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.621 HD13 ' CE2' ' A' ' 53' ' ' TYR . 29.8 mt -64.45 -40.23 88.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.992 175.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.7 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 36.6 p -91.02 -47.43 7.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -169.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.3 -4.73 51.74 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 -170.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.7 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 79.9 m-85 -95.58 162.24 13.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.9 t -110.79 117.08 32.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.219 0.533 . . . . 0.0 110.762 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.566 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 29.5 mt -91.67 17.53 8.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.58 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.812 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -56.61 -41.02 76.34 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.213 178.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -60.25 -20.33 58.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.812 178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.808 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 53.4 m-85 -99.17 -16.72 18.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.843 0.354 . . . . 0.0 110.341 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.812 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 9.4 mtpm? -75.63 143.96 41.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.705 -176.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -94.25 7.59 44.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.548 0.69 . . . . 0.0 110.752 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.51 ' C ' HD21 ' A' ' 68' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.923 0 CA-C-N 114.766 -1.107 . . . . 0.0 108.598 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.445 0.641 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.65 150.61 39.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.303 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.949 ' H ' ' HG2' ' A' ' 20' ' ' GLU . 38.1 t 59.58 99.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 122.204 1.002 . . . . 0.0 110.987 -176.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.587 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 9.7 ptp180 -118.25 175.15 5.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.321 -1.308 . . . . 0.0 110.816 -170.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' A' ' 16' ' ' LYS . 1.3 tm? -83.62 117.12 22.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.943 -174.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.58 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 69.1 m95 -108.9 145.0 36.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.139 175.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 16' ' ' LYS . 88.8 t -131.59 138.43 52.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.22 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.672 ' HA ' HD11 ' A' ' 46' ' ' LEU . 6.4 p-10 -84.92 168.86 14.63 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.598 175.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.641 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 4.6 tpm_? -67.08 -35.22 79.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.514 0.197 . . . . 0.0 111.417 -174.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 m -79.16 -12.26 59.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.97 0.414 . . . . 0.0 111.209 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.5 17.63 75.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.506 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -66.69 -47.73 71.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.994 -0.603 . . . . 0.0 110.656 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 10' ' ' ASP . 16.4 p90 -138.57 132.64 31.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.7 0.762 . . . . 0.0 112.627 -174.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.681 ' HB2' HD12 ' A' ' 7' ' ' LEU . 20.6 ptmt -120.83 129.67 53.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.225 166.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.797 ' HB ' ' HE2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -148.9 159.12 6.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.225 0.536 . . . . 0.0 112.016 -172.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.587 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.5 OUTLIER -93.54 122.83 36.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.478 177.142 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.684 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -162.07 156.36 21.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.589 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.949 ' HG2' ' H ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -109.34 138.89 45.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.014 174.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.625 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 50.7 t80 -67.93 133.15 48.62 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.026 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -116.25 -50.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.158 179.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.16 153.7 24.78 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.465 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.625 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 29.2 t -129.09 130.05 46.0 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.43 134.44 21.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.486 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 63.11 15.53 8.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.236 0.541 . . . . 0.0 111.196 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.23 2.08 71.41 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.272 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 61.4 mttp -93.89 146.79 23.65 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.536 -0.39 . . . . 0.0 110.365 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.595 HD13 ' HB3' ' A' ' 43' ' ' ALA . 17.5 mm -105.09 119.42 54.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.539 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.448 ' O ' HG13 ' A' ' 22' ' ' ILE . 24.1 m170 -89.7 125.53 35.3 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.684 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 92.5 mt -128.74 139.15 52.35 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.23 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -102.18 106.64 17.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.56 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.797 ' HE2' ' HB ' ' A' ' 17' ' ' VAL . 2.5 mmmp? -64.36 152.09 42.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.174 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.12 -13.78 62.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.429 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 6.9 p-10 -98.01 12.63 33.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.894 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.06 -30.8 9.37 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.861 -0.685 . . . . 0.0 114.198 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.94 139.44 21.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.899 0.381 . . . . 0.0 111.795 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.97 122.68 45.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.0 161.75 19.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.928 -176.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.29 106.06 6.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.677 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.7 m -108.38 146.16 14.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -76.1 122.62 24.55 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.608 176.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.664 ' HB2' HD13 ' A' ' 51' ' ' LEU . . . -64.45 -21.47 66.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.581 0.705 . . . . 0.0 109.836 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 12.9 t70 -50.63 -32.95 20.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.341 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -116.52 26.54 9.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.238 0.542 . . . . 0.0 110.93 -178.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.672 HD11 ' HA ' ' A' ' 10' ' ' ASP . 8.6 tp -100.1 173.53 6.59 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.319 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.627 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 19.8 m -79.98 133.85 36.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.613 0.721 . . . . 0.0 110.475 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -55.04 -35.15 64.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.917 -172.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.4 -44.38 83.17 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.338 0.589 . . . . 0.0 109.733 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.627 ' OD1' ' HB2' ' A' ' 47' ' ' SER . 1.4 m-20 -57.77 -40.62 80.2 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.764 175.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.817 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -68.94 -39.54 79.52 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.408 178.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.676 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -59.31 -32.49 70.12 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.434 0.635 . . . . 0.0 109.885 -177.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.731 ' CE2' HD13 ' A' ' 57' ' ' ILE . 49.5 t80 -74.2 -49.61 22.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.551 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 50' ' ' ASP . 1.7 p -68.81 -28.07 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.205 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.817 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 46.9 mt-10 -52.18 -39.85 60.67 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.071 0.462 . . . . 0.0 110.061 167.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.636 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 9.4 mmpt? -78.08 -28.36 48.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.731 HD13 ' CE2' ' A' ' 53' ' ' TYR . 40.9 mt -67.88 -42.97 86.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.145 0.498 . . . . 0.0 110.712 173.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.5 p -90.84 -47.53 7.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.493 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.87 -19.7 15.47 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.893 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -107.04 151.24 25.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.954 0.407 . . . . 0.0 110.203 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -82.86 136.85 34.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.704 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.615 HD13 HG11 ' A' ' 54' ' ' VAL . 23.4 mt -107.0 20.16 19.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.847 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 4.0 tp10 -55.33 -44.38 75.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.967 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.467 ' HB2' ' HZ1' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -66.19 -14.45 61.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.238 178.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 44' ' ' ASP . 62.6 m-85 -105.13 -0.43 26.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 99.2 mttt -87.38 -175.78 5.38 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.375 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.44 99.91 0.33 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.884 0.373 . . . . 0.0 110.866 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.251 -0.881 . . . . 0.0 109.653 179.342 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.502 ' HB2' ' HZ2' ' A' ' 3' ' ' LYS . 8.6 mtmp? . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.545 0.212 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 66.35 107.63 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.652 0.739 . . . . 0.0 112.105 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.28 123.2 12.15 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.579 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 16.3 ptp180 -126.64 -178.66 4.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.975 -171.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.683 HD13 ' HB3' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -88.76 105.59 17.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.378 -168.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.469 ' HH2' ' HB ' ' A' ' 54' ' ' VAL . 47.2 m95 -94.46 139.71 30.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.72 176.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 10' ' ' ASP . 72.9 t -129.78 141.99 45.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.974 0.416 . . . . 0.0 111.71 -175.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.611 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.8 t70 -70.58 157.47 37.86 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.85 ' HG2' ' HB2' ' A' ' 67' ' ' ALA . 7.0 tpm_? -79.41 -25.86 42.01 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -174.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 p -99.68 7.22 45.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.046 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.77 68.34 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.72 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.548 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 31.8 m -68.27 -40.14 81.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.69 0.281 . . . . 0.0 111.257 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -150.81 150.21 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.144 0.497 . . . . 0.0 111.703 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.683 ' HB3' HD13 ' A' ' 7' ' ' LEU . 94.2 mttt -132.45 132.25 42.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.768 171.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.08 145.51 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.0 0.429 . . . . 0.0 111.807 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 5.9 p-10 -93.6 112.11 23.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.884 0.849 . . . . 0.0 110.133 174.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.422 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . . . -160.28 168.87 24.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.093 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.04 139.91 53.03 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.774 ' HA ' HD23 ' A' ' 31' ' ' LEU . 3.4 t80 -71.6 128.0 34.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.697 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -107.0 -46.91 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.608 -178.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 30' ' ' HIS . . . -153.79 153.54 24.9 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.598 -177.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.2 p -112.89 134.12 54.55 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.08 97.41 5.09 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.593 -173.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 57.56 23.71 9.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.231 173.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.59 -7.55 24.28 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.363 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 61.4 mttp -94.0 160.23 14.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.016 0.436 . . . . 0.0 110.925 175.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.939 HD12 ' HB3' ' A' ' 43' ' ' ALA . 10.7 mm -113.79 115.79 50.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.72 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.529 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -87.52 117.85 26.59 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.774 HD23 ' HA ' ' A' ' 21' ' ' PHE . 96.4 mt -119.99 139.69 52.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.451 0.643 . . . . 0.0 112.213 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -99.21 109.97 22.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.003 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.491 ' HD3' HD12 ' A' ' 39' ' ' ILE . 13.7 mmmm -66.05 155.1 37.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.876 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.41 -15.42 36.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.882 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -105.32 21.77 16.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.43 0.633 . . . . 0.0 110.424 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.87 -16.23 48.02 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.464 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -66.74 154.78 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 35.5 ttmt -122.94 125.62 45.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.953 0.406 . . . . 0.0 110.4 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.491 HD12 ' HD3' ' A' ' 33' ' ' LYS . 33.6 pt -122.5 176.92 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.754 -176.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.13 116.72 6.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.665 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 m -118.13 165.39 13.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.624 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -97.51 134.45 40.72 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.939 ' HB3' HD12 ' A' ' 29' ' ' ILE . . . -67.37 -8.0 29.31 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -72.05 -28.52 63.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -107.63 15.21 24.92 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.657 177.02 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 46' ' ' LEU . 8.2 tp -84.73 159.79 20.42 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.266 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.562 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 50.1 m -71.32 133.96 46.4 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.59 0.71 . . . . 0.0 109.89 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -57.53 -30.42 65.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.783 -171.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -65.83 -46.26 79.19 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.648 0.737 . . . . 0.0 109.349 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.579 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -59.54 -37.89 79.6 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.929 176.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.702 ' HB3' ' HB2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -68.37 -44.95 74.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.899 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -61.18 -28.43 69.13 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.297 0.57 . . . . 0.0 109.871 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.552 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 32.6 t80 -73.97 -51.79 14.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.335 175.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 50' ' ' ASP . 2.5 p -70.86 -33.53 52.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.971 -0.455 . . . . 0.0 111.226 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 1.037 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 3.7 pt-20 -67.29 -24.93 65.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.03 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -46.27 64.58 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.552 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 56.9 mt -56.13 -43.72 76.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.035 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 7.0 p -80.35 -44.9 18.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.352 -175.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.72 -13.98 22.38 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -174.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.458 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 80.2 m-85 -80.21 -167.7 1.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.059 -0.571 . . . . 0.0 109.813 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.425 ' HA ' ' HB2' ' A' ' 55' ' ' GLU . 8.8 t -135.82 130.33 33.81 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 171.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 1.037 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 12.2 mt -104.87 23.61 13.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.409 0.623 . . . . 0.0 109.617 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 22.3 tt0 -53.35 -39.61 64.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.373 174.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -70.24 -6.08 32.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.772 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -109.05 -2.16 18.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.349 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.463 ' HG3' ' HA ' ' A' ' 63' ' ' GLU . 96.7 mttt -74.73 126.35 30.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.481 0.658 . . . . 0.0 109.687 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.85 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -97.37 113.56 25.23 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.577 -171.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.5 t30 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.681 176.621 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.7 mttt . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.01 131.31 36.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.546 -168.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.6 m -65.98 120.74 13.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 15.3 ptp180 -142.07 -178.81 5.88 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.509 -168.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.832 HD12 ' HB2' ' A' ' 16' ' ' LYS . 2.0 tm? -86.72 103.14 14.89 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.898 -175.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.534 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 33.5 m95 -91.61 144.68 25.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.548 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 10' ' ' ASP . 64.8 t -129.93 145.87 35.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.457 ' HB3' ' CE1' ' A' ' 15' ' ' PHE . 0.9 OUTLIER -89.74 159.79 16.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 173.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -17.42 64.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -171.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 t -86.39 -12.39 49.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.321 0.581 . . . . 0.0 109.866 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.34 37.69 70.56 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.005 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 m -102.12 -42.1 6.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.47 0.176 . . . . 0.0 111.05 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.633 ' CZ ' ' HE3' ' A' ' 45' ' ' LYS . 34.7 p90 -125.1 138.07 54.18 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.821 0.82 . . . . 0.0 112.581 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.832 ' HB2' HD12 ' A' ' 7' ' ' LEU . 8.6 ptpp? -134.89 132.14 38.16 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 113.959 -1.473 . . . . 0.0 108.989 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.446 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -148.51 154.81 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.639 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 12.0 m-20 -92.87 123.79 36.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.235 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -164.54 157.07 16.69 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.201 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.75 146.76 33.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.493 ' HA ' HD21 ' A' ' 31' ' ' LEU . 78.1 t80 -76.64 132.56 39.48 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.089 0.471 . . . . 0.0 110.013 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -111.6 -46.83 5.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.443 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -166.63 148.34 13.29 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.938 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.466 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 6.9 t -122.75 126.81 48.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.793 0.33 . . . . 0.0 110.25 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.52 141.85 20.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.578 -176.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt 56.7 32.04 20.42 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.621 0.575 . . . . 0.0 111.55 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.69 9.36 87.13 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.624 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 72.3 mmtt -109.56 146.05 35.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.027 0.442 . . . . 0.0 110.76 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.612 HD11 ' HB3' ' A' ' 43' ' ' ALA . 42.0 mm -105.14 113.27 41.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.485 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.494 ' O ' HG13 ' A' ' 22' ' ' ILE . 17.9 m170 -82.57 120.78 25.95 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 21' ' ' PHE . 95.8 mt -122.45 140.4 52.76 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 -175.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -100.05 103.82 15.37 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.911 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.894 ' HD3' HD12 ' A' ' 39' ' ' ILE . 12.5 mmmm -61.28 153.62 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.632 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.82 66.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.388 0.613 . . . . 0.0 109.359 172.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.429 HD21 ' C ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -63.07 -32.69 74.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.766 172.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.47 -2.59 27.88 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.295 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -91.94 150.28 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.634 0.255 . . . . 0.0 110.593 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 38' ' ' LYS . 4.4 tmmm? -101.73 125.49 48.41 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.894 HD12 ' HD3' ' A' ' 33' ' ' LYS . 16.1 pt -121.33 163.91 18.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.836 -177.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.79 103.84 7.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.272 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.1 t -110.54 127.04 67.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.501 ' HB2' ' HG3' ' A' ' 45' ' ' LYS . . . -56.18 124.69 18.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.989 0.423 . . . . 0.0 111.665 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.612 ' HB3' HD11 ' A' ' 29' ' ' ILE . . . -61.72 -30.1 70.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.908 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.465 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 3.6 p30 -68.73 -32.67 72.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.566 -173.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.633 ' HE3' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -103.44 15.28 29.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.328 0.585 . . . . 0.0 110.11 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.5 tp -95.44 166.82 11.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.287 -177.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.54 ' O ' HD22 ' A' ' 51' ' ' LEU . 44.0 t -71.38 132.53 44.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.901 0.857 . . . . 0.0 111.001 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.645 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 1.6 m-20 -50.94 -38.1 48.37 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.187 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.82 -49.64 72.7 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.086 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.662 ' O ' HG11 ' A' ' 54' ' ' VAL . 74.0 m-20 -67.3 -32.72 73.89 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.784 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.781 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -69.9 -40.05 75.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.944 177.013 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.5 -32.39 72.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.372 0.606 . . . . 0.0 109.767 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.507 ' CE1' HD13 ' A' ' 57' ' ' ILE . 50.8 t80 -67.95 -50.64 54.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.332 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.711 ' HA ' HG12 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -68.32 -32.47 55.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 120.72 0.295 . . . . 0.0 111.253 -177.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.781 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 45.5 mt-10 -52.56 -35.66 54.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.52 170.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 1.039 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.55 -30.38 33.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.676 -179.369 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.711 HG12 ' HA ' ' A' ' 54' ' ' VAL . 21.7 mm -64.24 -38.71 83.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.6 p -116.56 -46.99 2.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -170.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.41 1.94 24.63 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.578 -173.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -78.88 153.68 30.35 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 t -97.48 101.48 13.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.038 0.447 . . . . 0.0 110.22 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.646 ' HA ' ' HD2' ' A' ' 65' ' ' PHE . 21.3 mt -98.44 19.67 14.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.525 ' HA ' ' HZ1' ' A' ' 66' ' ' LYS . 22.9 tp10 -63.83 -39.71 94.87 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.972 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -69.04 -9.57 53.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.456 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.646 ' HD2' ' HA ' ' A' ' 62' ' ' LEU . 91.4 m-85 -101.37 -4.84 26.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.948 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.645 ' HD3' ' HB3' ' A' ' 48' ' ' ASN . 52.0 mttp -82.53 138.95 34.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.359 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.73 90.9 6.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.972 176.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.005 -179.57 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.734 ' HG2' ' H ' ' A' ' 5' ' ' SER . 33.7 ttpt -172.73 -176.07 1.41 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.734 ' H ' ' HG2' ' A' ' 4' ' ' LYS . 19.9 p -50.83 148.44 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.088 0.471 . . . . 0.0 111.728 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 11.3 ptp180 -158.64 -177.85 6.83 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.093 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.415 ' CD2' ' HB2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -89.4 107.08 18.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.264 -175.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.65 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 30.1 m95 -90.89 140.21 30.03 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 90.8 t -130.1 158.32 42.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.935 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -91.66 162.21 14.59 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.4 -0.187 . . . . 0.0 110.503 176.304 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' A' ' 11' ' ' ARG . 1.7 tmm_? -57.57 -37.88 73.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.642 0.258 . . . . 0.0 111.144 -176.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 t -83.44 -15.44 49.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.734 0.302 . . . . 0.0 111.373 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.78 16.28 56.72 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.302 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 m -83.5 -37.12 23.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.458 0.647 . . . . 0.0 110.071 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.935 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 5.8 m-85 -95.14 137.95 33.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.023 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 19.0 ptpt -152.21 130.1 11.73 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.529 162.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.08 136.22 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.689 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.3 p-10 -75.99 109.15 9.39 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.218 173.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.857 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . . . -148.13 167.39 25.14 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.508 -170.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.646 ' HB2' ' HB3' ' A' ' 5' ' ' SER . 26.5 tt0 -133.71 124.35 26.54 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.294 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.646 ' HD1' HG23 ' A' ' 29' ' ' ILE . 67.1 t80 -65.39 130.29 42.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.345 0.593 . . . . 0.0 110.367 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.91 -54.28 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.874 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.06 142.02 7.67 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.467 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.449 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 16.4 p -103.28 142.81 33.55 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -178.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.21 126.81 9.45 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.956 -0.297 . . . . 0.0 111.225 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 55.61 41.4 30.62 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.768 0.667 . . . . 0.0 111.206 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.55 -0.74 80.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.642 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -104.28 166.77 10.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 0.0 110.813 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.646 HG23 ' HD1' ' A' ' 21' ' ' PHE . 85.1 mt -124.09 121.65 62.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.085 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -88.48 129.02 35.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.857 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 90.4 mt -124.49 136.76 54.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.845 0.831 . . . . 0.0 111.873 -172.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 14.3 t-80 -98.43 99.59 10.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.994 176.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 36.2 mtpt -61.83 156.96 19.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.817 0.341 . . . . 0.0 110.167 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.77 -12.45 60.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.627 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -90.91 1.82 56.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.394 177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.02 -24.4 31.43 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.707 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -65.3 145.09 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.599 0.238 . . . . 0.0 110.833 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -114.24 131.62 56.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.1 0.476 . . . . 0.0 110.503 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.8 pt -129.52 166.82 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.989 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.45 118.78 19.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.649 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 m -116.78 156.98 17.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.22 128.04 33.78 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.746 -0.382 . . . . 0.0 109.976 175.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.68 -15.23 61.04 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.652 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 8.1 p-10 -91.56 -13.93 31.17 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -173.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.05 19.94 19.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.711 0.767 . . . . 0.0 109.523 176.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 46' ' ' LEU . 8.5 tp -103.48 169.21 8.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.276 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.471 ' O ' HD23 ' A' ' 51' ' ' LEU . 25.2 t -73.61 141.68 46.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.582 0.706 . . . . 0.0 109.367 176.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.56 ' ND2' ' HA ' ' A' ' 66' ' ' LYS . 7.6 m120 -73.89 -18.73 60.87 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.607 -171.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -43.34 81.23 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.564 ' O ' HG13 ' A' ' 54' ' ' VAL . 35.6 m-20 -63.67 -38.01 89.49 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.196 176.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.82 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -66.42 -45.18 80.79 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.134 177.358 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.676 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -59.39 -32.34 70.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.475 0.655 . . . . 0.0 110.241 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.589 ' CE2' HD12 ' A' ' 57' ' ' ILE . 43.9 t80 -72.32 -50.48 26.56 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.379 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 50' ' ' ASP . 3.2 p -68.42 -28.9 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 O-C-N 122.089 -0.382 . . . . 0.0 110.77 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.82 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 44.4 mt-10 -52.5 -41.43 63.42 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.647 0.26 . . . . 0.0 110.471 169.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' N ' ' HE3' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -73.79 -33.02 64.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.806 -178.239 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.589 HD12 ' CE2' ' A' ' 53' ' ' TYR . 29.9 mt -67.65 -37.37 78.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.281 175.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.471 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 32.4 p -97.78 -45.17 6.44 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -170.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.97 -7.27 37.94 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -172.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.471 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 65.0 m-85 -80.32 175.88 10.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 110.784 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -121.1 114.77 21.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.432 176.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 35.8 mt -103.58 27.28 7.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.571 -176.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -56.59 -42.1 78.12 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.665 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -72.55 -6.45 44.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.341 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.652 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 97.3 m-85 -102.99 0.3 31.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.418 0.628 . . . . 0.0 109.52 176.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.56 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 98.5 mttt -96.54 148.2 23.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.778 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.14 -177.45 5.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.873 0.368 . . . . 0.0 111.57 -171.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.9 m120 . . . . . 0 C--O 1.247 0.952 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.597 -179.203 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.9 mttm . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.8 0.333 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -94.94 167.69 11.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.269 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 t -53.48 142.77 21.27 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.098 173.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 6.6 ptp180 -140.66 -178.83 5.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.245 -173.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.35 105.41 16.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.04 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.682 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 52.4 m95 -91.92 145.05 24.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.828 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.438 HG11 ' O ' ' A' ' 10' ' ' ASP . 61.5 t -135.6 146.0 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.443 0.465 . . . . 0.0 110.379 -176.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.974 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -90.42 174.1 7.74 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.78 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 2.4 tpm_? -61.68 -43.36 99.01 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 122.389 -0.194 . . . . 0.0 111.393 -177.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -67.74 -29.74 69.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.236 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.96 12.71 51.99 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.33 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -91.47 -39.37 11.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.507 0.67 . . . . 0.0 109.506 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.974 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 3.7 m-85 -82.46 130.7 35.16 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.417 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.682 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 8.6 ptpt -157.42 128.68 6.77 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.9 169.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.508 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -154.91 145.79 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.032 -173.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.58 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.5 p-10 -88.24 117.51 27.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.062 174.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . . . -164.84 163.66 21.11 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.13 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.42 140.34 52.28 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.723 ' HA ' HD23 ' A' ' 31' ' ' LEU . 48.2 t80 -69.3 132.61 46.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.468 0.651 . . . . 0.0 110.372 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.03 -52.51 5.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.043 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.87 143.38 8.55 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.141 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.539 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 20.0 p -105.61 142.13 35.88 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.98 112.43 8.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 111.439 -173.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.6 tptt 52.68 53.55 12.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.791 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.57 -3.73 77.09 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.118 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 84.9 mttt -110.96 170.48 8.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.068 0.461 . . . . 0.0 110.533 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.533 HG23 ' HD1' ' A' ' 21' ' ' PHE . 59.2 mt -129.0 128.04 66.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.882 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -91.31 127.95 36.95 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.723 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.9 mt -127.3 137.39 52.82 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.583 -174.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -98.13 100.92 12.26 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.351 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.839 ' HD3' HD13 ' A' ' 39' ' ' ILE . 12.1 mmmm -61.77 160.54 11.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.34 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.29 -14.94 63.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.721 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -84.45 -6.81 59.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.959 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.64 7.52 58.95 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.738 174.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.5 155.04 6.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 117.059 0.429 . . . . 0.0 110.377 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -97.9 144.27 27.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 0.0 110.863 177.077 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.839 HD13 ' HD3' ' A' ' 33' ' ' LYS . 37.2 pt -127.53 156.27 39.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.15 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.13 103.73 11.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.243 0.545 . . . . 0.0 110.159 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.8 t -109.4 125.16 66.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.276 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -79.51 130.63 35.58 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.44 -5.81 12.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.458 -174.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.85 -42.74 57.37 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -172.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -99.13 12.13 37.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 0.0 110.319 -176.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.9 tp -83.88 169.35 15.19 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.678 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.564 ' O ' HD23 ' A' ' 51' ' ' LEU . 47.8 t -73.12 138.0 45.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.025 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -47.03 -50.03 20.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.854 0.835 . . . . 0.0 111.248 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.2 -30.36 68.53 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.795 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.605 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -65.65 -38.03 88.21 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.8 177.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.728 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.7 OUTLIER -70.17 -44.21 69.22 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.81 176.211 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.41 65.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.423 0.63 . . . . 0.0 110.224 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.644 ' CE2' HD11 ' A' ' 57' ' ' ILE . 66.5 t80 -73.79 -49.66 24.24 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.421 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.787 HG11 HD13 ' A' ' 62' ' ' LEU . 2.2 p -70.03 -28.25 35.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 O-C-N 122.006 -0.434 . . . . 0.0 110.823 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.728 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 39.3 mt-10 -56.09 -31.47 63.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.724 168.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.871 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 6.6 mmpt? -80.84 -32.25 35.19 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.77 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.644 HD11 ' CE2' ' A' ' 53' ' ' TYR . 39.6 mt -63.32 -41.38 92.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 174.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.562 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 27.4 p -107.41 -46.79 3.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -171.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.31 -5.74 35.97 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.562 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 66.9 m-85 -85.77 136.95 33.13 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.992 0.425 . . . . 0.0 110.29 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 m -75.7 100.94 4.83 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.623 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.787 HD13 HG11 ' A' ' 54' ' ' VAL . 34.3 mt -94.97 18.74 11.42 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.67 0.748 . . . . 0.0 109.389 172.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 1.034 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 24.7 tt0 -73.83 -29.38 62.1 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.894 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -14.88 58.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.954 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.417 ' HD2' ' HA ' ' A' ' 62' ' ' LEU . 96.0 m-85 -105.57 -7.19 18.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.253 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 1.034 ' HG3' ' HA ' ' A' ' 63' ' ' GLU . 43.1 mttp -60.33 126.86 29.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.521 0.677 . . . . 0.0 110.881 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.23 124.78 51.44 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.31 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.476 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 2.7 m-20 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.991 -177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.1 tptt . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 120.8 0.333 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -89.67 -143.64 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.659 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.855 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 20.1 p -53.17 134.09 39.01 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.515 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 17.5 ptp180 -148.47 -178.25 6.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.451 -173.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.801 HD12 ' HB3' ' A' ' 16' ' ' LYS . 2.6 tm? -81.44 106.63 13.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.699 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.578 ' HH2' ' HB ' ' A' ' 54' ' ' VAL . 32.2 m95 -92.8 151.29 20.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.165 174.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 36.9 t -123.07 145.32 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.644 0.259 . . . . 0.0 110.72 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.428 ' HA ' HD11 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -83.16 160.29 21.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.403 175.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -51.57 -46.1 63.34 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.536 0.523 . . . . 0.0 111.921 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 m -94.91 9.81 37.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.819 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.7 23.98 69.37 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.12 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -71.55 -34.36 69.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.176 0.512 . . . . 0.0 110.359 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 10' ' ' ASP . 33.0 p90 -143.21 132.61 23.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.386 0.613 . . . . 0.0 111.186 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.801 ' HB3' HD12 ' A' ' 7' ' ' LEU . 88.3 mttt -109.37 129.98 55.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 167.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.11 135.9 42.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.598 0.713 . . . . 0.0 112.887 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 1.1 p30 -78.27 119.94 22.34 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.757 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.781 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -157.43 158.4 35.75 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.505 0.669 . . . . 0.0 111.892 -172.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.855 ' HB2' ' HB3' ' A' ' 5' ' ' SER . 30.9 tt0 -122.59 124.67 44.03 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.786 176.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.75 ' HD1' HG21 ' A' ' 29' ' ' ILE . 4.5 t80 -70.14 123.35 21.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.153 0.502 . . . . 0.0 110.321 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -105.9 -44.07 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.647 -178.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.36 139.93 6.18 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.103 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.406 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 51.9 t -110.04 118.44 36.43 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.93 140.39 29.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.628 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? 65.06 11.7 7.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.131 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.56 -2.79 60.84 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.127 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.709 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 86.6 mttt -102.83 164.45 11.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.0 110.755 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.75 HG21 ' HD1' ' A' ' 21' ' ' PHE . 75.5 mt -114.98 121.22 66.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.015 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.441 ' O ' HG13 ' A' ' 22' ' ' ILE . 20.5 m170 -82.91 124.31 30.23 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.781 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 71.0 mt -124.6 137.49 54.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.432 0.634 . . . . 0.0 111.415 -174.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -107.36 106.18 16.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.577 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 4.1 mtpm? -67.07 166.68 13.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.14 0.495 . . . . 0.0 111.711 -172.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.97 -12.84 60.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.099 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.94 -23.48 38.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.813 173.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.49 -15.08 29.94 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -173.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.2 t -65.86 142.72 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.725 -0.238 . . . . 0.0 110.485 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -108.86 130.21 55.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.157 0.503 . . . . 0.0 110.459 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.439 HG12 ' HB2' ' A' ' 31' ' ' LEU . 12.3 pt -127.39 166.54 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.351 -177.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.1 103.21 5.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.088 0.47 . . . . 0.0 109.994 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.515 HG13 HD12 ' A' ' 46' ' ' LEU . 74.4 t -116.08 126.36 73.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.934 -176.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.709 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -59.35 135.32 57.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.687 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.11 -6.13 12.19 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.374 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -90.15 -41.17 11.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.069 0.462 . . . . 0.0 111.215 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -87.53 22.19 2.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.824 -175.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.515 HD12 HG13 ' A' ' 41' ' ' VAL . 9.1 tp -111.91 167.23 10.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.651 -174.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.554 ' O ' HD21 ' A' ' 51' ' ' LEU . 29.6 t -65.0 129.22 38.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.36 0.6 . . . . 0.0 109.649 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.418 ' HA ' HD22 ' A' ' 51' ' ' LEU . 8.1 m120 -67.2 -21.71 65.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.631 -172.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -60.68 -48.34 82.21 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.695 0.759 . . . . 0.0 109.294 171.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.595 ' O ' HG12 ' A' ' 54' ' ' VAL . 16.2 m-20 -67.59 -31.77 72.05 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.827 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.609 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -69.31 -40.79 77.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.395 176.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -65.24 -27.92 68.99 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.382 0.61 . . . . 0.0 109.541 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.581 ' CE2' HD11 ' A' ' 57' ' ' ILE . 31.1 t80 -73.61 -50.77 19.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.594 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.4 p -70.5 -33.29 52.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 120.885 0.374 . . . . 0.0 111.255 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.907 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 1.6 pt-20 -65.58 -24.63 67.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.11 0.481 . . . . 0.0 109.923 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 1.053 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 5.3 mmpt? -81.31 -27.27 35.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.585 175.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.581 HD11 ' CE2' ' A' ' 53' ' ' TYR . 54.3 mt -64.33 -41.58 92.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.163 0.506 . . . . 0.0 109.728 172.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.472 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 6.4 p -86.34 -47.43 9.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.775 -173.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.7 -9.91 19.01 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -173.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.539 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 66.6 m-85 -89.25 -172.7 3.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.5 ' HA ' ' HB2' ' A' ' 55' ' ' GLU . 17.1 t -131.53 128.28 38.98 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.573 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.907 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 10.2 mt -95.73 25.94 4.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.034 0.445 . . . . 0.0 110.031 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 1.2 tp10 -44.36 -51.1 8.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.81 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -71.03 -9.9 58.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.066 -176.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -100.42 0.53 39.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 0.0 110.012 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 87.3 mttt -96.16 143.59 27.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.808 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -92.14 24.44 3.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.732 0.777 . . . . 0.0 109.549 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.2 t30 . . . . . 0 C--O 1.247 0.943 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.629 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 121.459 0.647 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -92.29 -162.12 0.9 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.8 177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.445 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 2.0 p -63.06 119.96 10.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.488 173.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 3.6 ptp180 -112.48 173.42 6.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.213 -167.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -85.72 114.73 22.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.507 -172.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.538 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 81.1 m95 -105.58 146.17 30.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.2 176.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.719 HG21 ' HG2' ' A' ' 16' ' ' LYS . 66.0 t -136.37 138.26 47.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.187 0.304 . . . . 0.0 110.707 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.544 ' HA ' HD11 ' A' ' 46' ' ' LEU . 6.6 p-10 -84.89 159.74 20.29 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -76.76 -1.98 30.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.029 0.443 . . . . 0.0 111.997 -169.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 t -105.34 -3.51 22.62 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.448 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.5 31.02 70.86 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.418 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.4 m -84.76 -43.06 14.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.848 0.356 . . . . 0.0 110.732 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.787 ' HZ ' ' HE3' ' A' ' 45' ' ' LYS . 24.9 p90 -138.76 136.86 36.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.867 0.841 . . . . 0.0 112.679 -176.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.719 ' HG2' HG21 ' A' ' 9' ' ' VAL . 54.1 mttp -126.07 130.9 52.02 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.207 171.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -139.06 157.94 28.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.391 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 29.5 m-20 -103.74 113.4 26.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.4 158.68 32.61 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.947 -172.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' A' ' 5' ' ' SER . 45.3 mt-10 -106.73 138.64 42.53 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.206 174.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.648 ' HA ' HD21 ' A' ' 31' ' ' LEU . 15.2 t80 -71.88 124.35 24.67 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.197 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -105.94 -43.21 7.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.102 -177.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.9 150.84 13.7 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.505 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' HB2' ' HE2' ' A' ' 21' ' ' PHE . 6.3 t -115.1 136.88 52.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.93 119.97 12.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.606 0.241 . . . . 0.0 110.913 -173.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.9 tptm 55.75 41.17 30.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.314 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' HA2' ' CZ ' ' A' ' 65' ' ' PHE . . . 89.92 -4.84 83.45 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.309 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -109.71 159.93 16.74 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 122.453 -0.439 . . . . 0.0 110.765 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.522 HG21 ' HD2' ' A' ' 21' ' ' PHE . 76.1 mt -122.33 124.82 71.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.979 -174.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 92.2 m-70 -87.6 126.42 34.93 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 21' ' ' PHE . 87.4 mt -125.14 136.76 53.93 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.522 -178.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -102.1 100.38 10.62 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -63.32 159.57 17.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.136 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.28 -15.29 56.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.232 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.14 -25.22 37.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.523 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.9 -6.55 27.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.198 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.97 137.64 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.674 0.273 . . . . 0.0 110.577 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 36.5 ttmt -102.57 124.74 48.67 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 31.8 pt -123.43 153.68 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -176.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.29 103.43 8.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.129 175.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 m -99.03 153.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.478 ' HB2' ' OD1' ' A' ' 44' ' ' ASP . . . -82.33 122.22 27.69 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.009 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.93 -20.03 63.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.476 0.655 . . . . 0.0 110.923 -176.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.653 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 6.6 p-10 -77.02 -12.13 59.9 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.164 -175.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.787 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -117.43 10.32 13.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.931 0.872 . . . . 0.0 109.012 173.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.544 HD11 ' HA ' ' A' ' 10' ' ' ASP . 14.1 tp -89.82 162.79 15.32 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.646 -177.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.555 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 27.0 m -68.28 142.75 55.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.588 0.709 . . . . 0.0 110.68 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -65.41 -27.85 68.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.267 -173.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -64.72 -48.9 72.95 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.603 0.716 . . . . 0.0 109.598 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.555 ' OD1' ' HB2' ' A' ' 47' ' ' SER . 1.6 m-20 -59.86 -36.29 76.57 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.219 175.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.644 ' HA ' HD13 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -65.47 -47.37 76.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.576 178.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.569 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -62.36 -27.57 69.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.789 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.421 ' O ' HG12 ' A' ' 57' ' ' ILE . 48.8 t80 -71.91 -47.88 49.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.628 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.541 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 61.5 t -62.68 -33.55 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.695 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.622 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 38.2 mt-10 -52.19 -34.77 46.85 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.21 0.529 . . . . 0.0 110.483 173.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 1.045 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.6 mmpt? -82.51 -37.01 25.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.894 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.478 HG22 ' CD1' ' A' ' 21' ' ' PHE . 20.7 mm -69.81 -28.35 36.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.008 0.432 . . . . 0.0 111.202 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.656 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 43.7 p -104.83 -45.38 4.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -173.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.4 4.34 46.84 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -172.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.656 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 96.7 m-85 -102.94 -175.88 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.2 t -125.4 121.75 34.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.102 0.477 . . . . 0.0 110.748 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.644 HD13 ' HA ' ' A' ' 51' ' ' LEU . 25.4 mt -95.94 22.83 6.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.647 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.14 -41.14 74.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.402 0.62 . . . . 0.0 110.458 176.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HE3' ' CE2' ' A' ' 65' ' ' PHE . 48.6 pttt -62.53 -14.17 38.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.673 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.653 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 32.7 m-85 -104.38 -8.86 18.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.908 0.385 . . . . 0.0 111.031 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 95.0 mttt -84.77 126.17 33.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.101 0.477 . . . . 0.0 109.714 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.77 -84.59 0.07 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.988 -177.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 . . . . . 0 C--N 1.301 -1.509 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.094 175.851 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp . . . . . 0 C--O 1.234 0.251 0 CA-C-O 121.135 0.493 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.677 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -108.31 154.98 21.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.515 -178.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.583 ' HA ' ' HB2' ' A' ' 20' ' ' GLU . 46.1 t 71.8 125.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.866 0.841 . . . . 0.0 112.154 177.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 14.2 ptp180 -149.42 -179.08 6.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.168 -171.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 16' ' ' LYS . 1.6 tm? -86.43 107.87 18.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.772 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.429 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 46.4 m95 -92.38 149.09 21.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.098 176.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 15.6 t -130.58 154.33 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.818 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -101.65 -179.05 3.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.815 0.341 . . . . 0.0 111.217 -178.515 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.463 ' HG2' ' HB1' ' A' ' 67' ' ' ALA . 1.9 tmm_? -60.41 -52.83 63.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.054 -177.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 m -81.8 -7.29 59.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.184 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.0 28.54 45.26 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.527 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.1 m -99.7 -37.28 9.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.521 0.677 . . . . 0.0 109.468 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.818 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 4.8 m-85 -87.01 125.82 34.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.739 -176.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.451 ' HB3' HD13 ' A' ' 7' ' ' LEU . 50.5 mttp -131.63 129.56 41.01 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 158.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.87 133.59 6.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.455 0.645 . . . . 0.0 112.119 -177.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.589 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 7.3 p-10 -87.73 116.2 25.71 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.732 176.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.637 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . . . -168.49 167.64 11.57 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.102 -174.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 5' ' ' SER . 9.6 tp10 -126.97 136.56 52.43 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.137 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.769 ' HA ' HD22 ' A' ' 31' ' ' LEU . 7.1 t80 -65.53 126.6 28.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.723 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -105.54 -50.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.818 179.281 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.11 148.07 15.97 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.583 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 t -108.9 129.12 55.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.18 133.02 15.02 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.138 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm 63.69 23.72 13.61 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.328 175.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.92 4.59 88.52 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.956 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.688 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 33.1 mmtp -103.23 154.51 19.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.008 0.433 . . . . 0.0 110.166 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 43' ' ' ALA . 40.3 mm -108.71 114.07 45.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.347 174.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.435 ' O ' HG13 ' A' ' 22' ' ' ILE . 65.0 m170 -76.21 125.59 29.44 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 175.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.769 HD22 ' HA ' ' A' ' 21' ' ' PHE . 86.3 mt -129.04 136.69 50.62 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.695 -174.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -106.74 107.94 19.21 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.785 ' HZ2' ' HB3' ' A' ' 33' ' ' LYS . 4.8 mtpm? -67.63 166.14 15.64 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.15 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.64 -14.38 60.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.297 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -93.42 1.96 56.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.904 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.33 -18.08 58.11 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.185 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.1 t -63.67 139.35 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.518 0.199 . . . . 0.0 110.869 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -107.81 121.68 45.22 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 pt -124.42 158.51 31.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.726 -173.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.48 103.39 8.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.152 0.501 . . . . 0.0 110.049 174.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.28 119.97 55.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.688 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -58.79 124.95 21.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.436 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.646 ' HB3' HD11 ' A' ' 29' ' ' ILE . . . -64.96 -26.91 68.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.982 177.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.7 -34.24 71.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.58 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.489 ' HG3' ' HB1' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -110.46 18.38 19.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.034 0.445 . . . . 0.0 110.789 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.677 ' HB3' HD22 ' A' ' 51' ' ' LEU . 10.1 tp -95.18 170.12 9.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.149 -176.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.598 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 35.3 t -83.66 139.48 32.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.033 0.92 . . . . 0.0 110.751 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -51.52 -35.04 38.85 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.272 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.22 -50.54 71.35 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 121.412 0.625 . . . . 0.0 109.99 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.598 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 5.8 m-20 -60.99 -36.41 79.4 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.606 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.781 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 26.4 mt -69.82 -43.21 72.49 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -59.41 -28.88 67.32 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.514 0.673 . . . . 0.0 109.869 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.533 ' CZ ' HD13 ' A' ' 57' ' ' ILE . 29.3 t80 -73.7 -50.34 21.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.146 176.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.0 p -70.28 -29.66 40.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.891 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.781 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 42.8 mt-10 -54.63 -37.12 65.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.465 168.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -39.44 66.6 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.533 HD13 ' CZ ' ' A' ' 53' ' ' TYR . 53.3 mt -64.19 -47.23 90.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.084 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.9 p -80.62 -46.46 15.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.363 -174.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.04 -4.55 41.62 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -173.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -100.35 179.36 4.48 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.501 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 6.4 t -118.98 134.51 55.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.805 0.336 . . . . 0.0 110.479 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 21.8 mt -97.84 35.75 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.123 0.487 . . . . 0.0 110.845 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 5.8 mm-40 -44.61 -58.41 3.05 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.506 1.122 . . . . 0.0 113.365 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -69.11 -10.54 58.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.644 0.259 . . . . 0.0 111.693 -173.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -105.04 -8.97 18.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.286 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.654 ' HA ' HD12 ' A' ' 51' ' ' LEU . 64.2 mttm -62.99 147.43 50.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.246 0.546 . . . . 0.0 111.867 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.463 ' HB1' ' HG2' ' A' ' 11' ' ' ARG . . . -71.45 68.06 0.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.803 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 C--O 1.246 0.918 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.942 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.681 ' HG3' ' H ' ' A' ' 4' ' ' LYS . 15.0 ptmt . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.681 ' H ' ' HG3' ' A' ' 3' ' ' LYS . 27.7 mttp 51.78 55.51 9.21 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 122.158 0.98 . . . . 0.0 111.158 -173.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 p -70.25 125.93 28.21 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.696 -1.593 . . . . 0.0 109.944 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 8.2 ptp180 -115.44 178.16 4.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.879 -171.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 7' ' ' LEU . 6.1 mt -84.45 114.32 21.84 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.214 0.531 . . . . 0.0 111.546 -173.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.57 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 43.9 m95 -98.63 140.66 32.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.595 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 10' ' ' ASP . 43.8 t -124.62 144.84 33.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.915 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.508 ' HA ' HD11 ' A' ' 46' ' ' LEU . 7.4 p-10 -84.89 170.55 12.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.0 109.887 173.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -75.47 -14.52 60.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.631 -172.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.528 ' HB2' ' HG1' ' A' ' 14' ' ' THR . 14.8 m -98.13 -16.48 19.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.907 0.384 . . . . 0.0 111.184 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.5 36.85 25.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.661 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.528 ' HG1' ' HB2' ' A' ' 12' ' ' SER . 8.6 m -98.87 -37.69 9.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.189 -0.505 . . . . 0.0 110.724 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 37.8 p90 -137.0 135.15 37.37 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.725 0.774 . . . . 0.0 112.434 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 47.8 mttp -128.92 130.61 47.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.369 173.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.541 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -145.1 146.1 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.987 0.422 . . . . 0.0 112.102 -176.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.576 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 6.3 m-20 -82.12 120.39 25.25 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.513 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . . . -163.16 162.89 25.77 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.74 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -123.6 138.53 54.53 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 174.304 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.793 ' HD1' HG21 ' A' ' 29' ' ' ILE . 6.8 t80 -70.91 122.72 20.48 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.508 0.67 . . . . 0.0 110.507 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -100.81 -51.16 9.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.383 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.84 154.35 25.34 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.485 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 22.6 t -120.82 138.58 53.97 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -177.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.1 131.07 15.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.045 -175.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 56.62 27.1 11.98 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.729 0.643 . . . . 0.0 112.311 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.41 -1.53 69.61 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.711 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 57.0 mttp -103.99 158.93 16.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.011 0.434 . . . . 0.0 110.799 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.793 HG21 ' HD1' ' A' ' 21' ' ' PHE . 94.3 mt -116.38 122.8 70.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.117 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.425 ' O ' HG13 ' A' ' 22' ' ' ILE . 39.7 m170 -84.5 126.94 33.73 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.668 HD22 ' HA ' ' A' ' 21' ' ' PHE . 81.8 mt -124.14 135.69 53.69 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.833 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -95.7 103.97 15.87 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.696 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.82 ' HD3' HD11 ' A' ' 39' ' ' ILE . 11.8 mmmm -64.82 158.75 24.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.218 -174.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.8 -20.72 66.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.802 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -66.48 -32.49 73.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.686 173.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.83 -17.26 27.73 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.295 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.4 t -72.59 147.4 10.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.368 -0.416 . . . . 0.0 110.654 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -100.62 128.77 46.56 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.82 HD11 ' HD3' ' A' ' 33' ' ' LYS . 18.1 pt -120.04 159.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.259 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.82 103.55 8.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.069 0.461 . . . . 0.0 110.096 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.1 t -107.29 129.56 60.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -68.18 131.56 45.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.78 0.324 . . . . 0.0 110.191 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HB3' HG13 ' A' ' 29' ' ' ILE . . . -69.07 -6.55 28.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.881 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 2.8 p30 -81.76 -33.81 30.77 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -172.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.491 ' HD3' ' H ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -107.78 19.98 19.4 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.094 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.508 HD11 ' HA ' ' A' ' 10' ' ' ASP . 11.6 tp -93.34 169.69 10.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.799 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.512 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.3 t -74.15 139.47 44.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.561 0.696 . . . . 0.0 110.676 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -63.21 -30.55 71.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.419 -173.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -62.03 -46.98 86.78 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.594 0.712 . . . . 0.0 109.789 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.554 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.3 m-20 -65.54 -34.69 78.85 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.565 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.768 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -69.32 -47.21 65.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.11 177.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.563 ' O ' ' HD2' ' A' ' 56' ' ' LYS . . . -60.94 -30.85 70.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.575 0.702 . . . . 0.0 109.991 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.433 ' CE1' HD12 ' A' ' 57' ' ' ILE . 35.2 t80 -69.22 -52.12 30.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.099 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.742 ' HA ' HG12 ' A' ' 57' ' ' ILE . 3.0 p -69.06 -27.22 34.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.868 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.768 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 71.2 mt-10 -51.09 -49.29 60.99 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.106 0.479 . . . . 0.0 109.894 167.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.563 ' HD2' ' O ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -72.24 -26.62 62.09 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.57 -175.169 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.742 HG12 ' HA ' ' A' ' 54' ' ' VAL . 10.8 mm -67.3 -43.18 88.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.561 174.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.487 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 17.8 p -97.19 -47.25 5.82 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.14 -6.9 19.18 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.487 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 90.8 m-85 -92.71 167.89 11.58 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -117.13 134.46 54.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 27.4 mt -105.3 25.17 10.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.684 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 5.5 tp10 -54.5 -41.59 69.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.3 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -60.27 -19.95 56.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.204 177.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.471 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 57.6 m-85 -101.04 -14.16 17.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.31 0.576 . . . . 0.0 110.081 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.684 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 49.6 mtpt -81.43 140.05 34.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.282 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -116.89 121.24 40.91 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.905 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.636 -178.992 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 1.2 p . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 121.3 0.572 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 12.1 ptp180 -136.97 -177.09 4.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.054 -171.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.714 HD11 ' HE2' ' A' ' 16' ' ' LYS . 2.2 tm? -91.24 106.68 18.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.41 -174.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.525 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 35.3 m95 -92.12 149.32 21.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.738 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.1 t -135.75 139.96 45.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.844 ' HA ' HD12 ' A' ' 46' ' ' LEU . 1.2 p-10 -80.8 175.14 10.94 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.619 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.528 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 3.7 tpm_? -54.21 -51.21 65.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.836 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -80.21 -14.85 58.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.616 -172.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.68 47.31 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.466 -0.653 . . . . 0.0 111.466 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.2 m -86.62 -36.88 18.56 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.735 0.302 . . . . 0.0 110.189 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.487 ' CE2' ' HE2' ' A' ' 45' ' ' LYS . 39.3 p90 -129.99 141.42 50.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.812 0.815 . . . . 0.0 111.985 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.714 ' HE2' HD11 ' A' ' 7' ' ' LEU . 9.5 ptmm? -128.93 131.81 47.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.895 174.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -134.9 140.92 44.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -172.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.563 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 8.6 p-10 -81.22 122.4 27.35 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 169.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -162.01 155.89 21.51 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.594 -175.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.537 ' HG2' ' N ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -116.33 145.93 42.83 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.415 171.154 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 62.7 t80 -80.91 129.55 34.59 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.148 0.499 . . . . 0.0 110.395 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -108.75 -49.55 7.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.091 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.42 140.87 6.43 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.901 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.595 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 30.8 t -111.1 130.41 55.62 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.41 137.98 18.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.613 0.244 . . . . 0.0 110.713 -174.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 61.6 24.62 14.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.481 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.6 2.68 75.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.789 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -115.03 161.83 17.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.549 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' A' ' 43' ' ' ALA . 69.6 mt -114.36 120.66 64.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.361 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.416 ' O ' HG13 ' A' ' 22' ' ' ILE . 23.0 m-70 -80.48 123.53 28.15 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.646 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 97.7 mt -126.34 139.67 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.152 -174.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -112.66 103.13 11.17 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.205 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.8 mtpt -59.65 152.64 21.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.32 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 5' ' ' SER . . . -72.23 -15.17 61.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.217 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.36 -13.29 60.72 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.437 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.27 9.46 51.1 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.154 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.99 142.77 16.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.759 0.279 . . . . 0.0 110.43 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -105.33 125.21 50.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 pt -127.29 172.44 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.888 0.375 . . . . 0.0 111.123 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.9 110.0 11.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.2 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.15 127.03 71.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.875 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 128.4 36.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.708 0.289 . . . . 0.0 110.486 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.541 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -70.78 -10.16 58.92 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.536 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 11.7 p-10 -96.23 -19.76 19.07 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -172.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.487 ' HE2' ' CE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -104.84 19.56 20.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.428 0.632 . . . . 0.0 109.953 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.844 HD12 ' HA ' ' A' ' 10' ' ' ASP . 8.1 tp -101.5 176.44 5.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.076 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.669 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 22.2 t -88.38 147.52 24.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.065 0.936 . . . . 0.0 111.005 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.737 HD22 ' HB3' ' A' ' 66' ' ' LYS . 1.1 m120 -56.87 -35.38 68.84 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.455 -172.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.07 -45.55 73.51 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.095 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.669 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 2.2 m-20 -59.21 -40.8 86.95 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.989 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.797 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -68.05 -42.94 79.75 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.288 178.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' A' ' 56' ' ' LYS . . . -58.81 -35.19 72.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.253 0.549 . . . . 0.0 110.051 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.438 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 43.6 t80 -68.79 -50.26 51.77 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.151 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.4 p -68.89 -31.41 50.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.614 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.797 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.0 mt-10 -51.91 -40.95 61.54 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.604 168.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.672 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -75.54 -33.97 60.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 110.574 -174.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 52.2 mt -66.26 -39.65 84.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.971 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 p -92.13 -46.32 7.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -171.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.51 -5.5 35.38 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -89.75 -178.48 5.52 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.531 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 13.8 t -124.25 125.41 44.35 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.166 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 21.3 mt -104.19 24.16 11.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.771 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -53.83 -46.53 71.21 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.897 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -59.43 -24.79 63.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.504 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.536 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 90.9 m-85 -89.17 -14.07 36.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 0.0 110.739 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.737 ' HB3' HD22 ' A' ' 48' ' ' ASN . 93.4 mttt . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.444 -0.77 0 CA-C-O 121.44 0.638 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 2.8 ptp180 -110.13 174.83 5.68 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.689 -173.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 16' ' ' LYS . 1.7 tm? -94.2 104.72 16.72 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.155 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.776 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 69.3 m95 -91.56 142.73 27.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.825 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 10' ' ' ASP . 82.4 t -132.82 142.45 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 O-C-N 123.488 0.492 . . . . 0.0 110.926 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.97 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -90.63 161.2 15.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -68.5 -23.03 64.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.074 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -75.88 -23.37 55.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.132 0.492 . . . . 0.0 110.377 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.11 12.32 60.28 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.941 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -87.66 -48.11 8.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.525 0.679 . . . . 0.0 109.868 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.97 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 2.4 m-85 -79.67 134.33 36.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.034 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.776 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 7.2 ptpp? -159.97 128.96 5.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.493 165.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.45 151.67 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 120.129 -0.629 . . . . 0.0 111.955 -173.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 8.0 p-10 -84.05 125.48 32.14 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.691 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.441 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -167.93 156.83 9.41 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.183 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.71 149.16 30.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.538 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.717 ' HA ' HD12 ' A' ' 31' ' ' LEU . 58.2 t80 -87.39 131.36 34.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.491 -173.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -107.85 -44.98 7.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.823 0.344 . . . . 0.0 110.58 179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.33 161.81 31.07 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 121.129 -0.557 . . . . 0.0 111.836 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 t -141.78 132.58 25.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.286 0.543 . . . . 0.0 110.96 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.09 149.33 26.0 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.12 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.58 21.43 10.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.095 0.558 . . . . 0.0 111.937 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.17 23.06 50.1 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.336 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.67 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 47.1 mmtm -125.59 146.51 49.66 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 120.872 0.367 . . . . 0.0 110.982 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.556 ' CG2' HD13 ' A' ' 31' ' ' LEU . 1.9 mp -106.92 123.95 62.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.354 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 22' ' ' ILE . 36.6 m170 -89.83 120.32 30.97 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.717 HD12 ' HA ' ' A' ' 21' ' ' PHE . 3.0 tp -121.63 153.35 38.22 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.342 -173.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -128.53 107.2 9.52 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.352 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.512 ' HD3' HD13 ' A' ' 39' ' ' ILE . 12.6 mmmm -58.59 161.35 4.69 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.242 -175.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.62 -25.63 68.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.773 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -79.16 -19.61 50.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.081 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.7 26.92 6.23 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.691 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.51 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 47.3 t -102.42 143.01 15.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -105.52 131.12 53.32 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.079 0.466 . . . . 0.0 110.963 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.512 HD13 ' HD3' ' A' ' 33' ' ' LYS . 24.5 pt -135.36 160.27 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.605 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.81 117.87 29.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.039 0.447 . . . . 0.0 110.135 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.2 t -112.11 134.98 52.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.775 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.67 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . . . -69.8 127.03 31.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.724 0.297 . . . . 0.0 110.907 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.11 -14.15 61.28 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.418 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.436 ' OD1' ' HB1' ' A' ' 42' ' ' ALA . 7.1 p-10 -92.88 -14.72 27.29 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 19.4 ptmt -97.51 -2.1 42.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.474 0.654 . . . . 0.0 110.124 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 46' ' ' LEU . 2.6 tp -84.86 159.63 20.34 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.504 -170.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.589 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 48.1 t -71.65 153.34 42.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.4 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.472 ' HA ' HD22 ' A' ' 51' ' ' LEU . 12.6 m-80 -64.12 -28.65 69.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.211 -176.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -66.11 -47.82 72.93 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.865 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.589 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 4.1 m-20 -62.63 -32.14 73.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.486 177.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.724 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -65.98 -51.6 57.02 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.112 177.311 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -63.71 -27.2 69.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.123 0.487 . . . . 0.0 111.06 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.475 ' CE1' HD11 ' A' ' 57' ' ' ILE . 22.9 t80 -70.0 -48.3 58.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.866 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 50' ' ' ASP . 78.8 t -62.8 -34.3 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.777 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.691 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 44.0 mt-10 -54.84 -32.77 60.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.022 0.439 . . . . 0.0 110.512 174.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.566 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -80.18 -47.15 15.13 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.053 -178.008 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.475 HD11 ' CE1' ' A' ' 53' ' ' TYR . 25.0 mt -62.47 -36.63 75.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 111.727 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 55.8 p -103.12 -46.48 4.62 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.22 -8.01 30.87 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -173.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 92.8 m-85 -90.99 135.42 33.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.11 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.1 m -82.11 130.59 35.13 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.766 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.724 HD12 ' HA ' ' A' ' 51' ' ' LEU . 48.6 mt -104.63 30.2 5.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.179 0.514 . . . . 0.0 109.875 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -53.95 -47.48 71.24 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.349 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -67.11 -13.55 62.05 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.8 -14.97 27.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.922 0.391 . . . . 0.0 110.235 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 92.2 mttt . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.599 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 CA--C 1.517 -0.306 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 9.3 ptp180 -143.39 -179.29 6.32 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.81 -167.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 16' ' ' LYS . 2.1 tm? -95.24 105.27 17.2 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.856 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.604 ' CE3' ' HB3' ' A' ' 50' ' ' ASP . 37.0 m95 -91.57 139.16 30.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 10' ' ' ASP . 47.6 t -119.31 137.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.846 0.355 . . . . 0.0 110.858 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.6 ' HB3' ' H ' ' A' ' 14' ' ' THR . 9.8 t70 -63.46 158.82 19.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -74.11 -35.03 64.12 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.712 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -95.87 11.97 31.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.137 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.71 28.58 73.5 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.897 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.6 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 6.7 m -67.5 -37.07 82.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.745 -0.228 . . . . 0.0 111.111 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -158.39 157.54 32.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.261 0.553 . . . . 0.0 111.407 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.71 ' HB3' HD11 ' A' ' 7' ' ' LEU . 9.1 mtmp? -125.13 132.29 53.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.514 171.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.448 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -135.27 141.39 42.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 112.548 0.574 . . . . 0.0 112.548 -175.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.7 OUTLIER -95.29 115.11 26.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.312 176.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.875 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . . . -170.24 167.19 8.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.16 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.3 140.33 49.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.912 ' HA ' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -65.72 134.54 53.41 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.993 0.425 . . . . 0.0 109.876 177.449 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.983 HD12 ' HE3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -110.29 -47.64 6.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.111 177.752 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.54 139.41 5.78 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.293 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.616 ' HG ' ' HE2' ' A' ' 21' ' ' PHE . 78.2 m -98.69 126.36 44.27 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.58 136.5 22.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.6 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 tptt 63.8 27.64 14.63 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.643 0.735 . . . . 0.0 110.118 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.56 3.57 88.92 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.211 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.873 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 42.1 mttm -109.95 171.91 7.17 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.66 HG23 ' HD2' ' A' ' 21' ' ' PHE . 57.9 mt -124.67 116.72 48.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.384 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.418 ' O ' HG13 ' A' ' 22' ' ' ILE . 57.3 m-70 -75.88 128.2 34.61 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.912 HD23 ' HA ' ' A' ' 21' ' ' PHE . 77.1 mt -126.82 136.92 53.02 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.363 -172.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.571 ' HB2' HD11 ' A' ' 22' ' ' ILE . 15.1 t-160 -102.31 102.59 12.97 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.345 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.875 ' HD2' ' HB2' ' A' ' 19' ' ' ALA . 1.6 mmmp? -65.13 163.99 13.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.073 -176.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.3 -13.48 62.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.101 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -87.29 -10.49 52.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.592 176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.91 -18.4 52.47 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.922 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.6 p -72.65 147.98 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.945 0.402 . . . . 0.0 110.823 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.983 ' HE3' HD12 ' A' ' 22' ' ' ILE . 84.6 tttt -111.16 132.96 53.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.613 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 pt -126.95 174.69 10.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.484 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.89 103.19 5.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.245 0.545 . . . . 0.0 110.056 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.563 HG13 ' HE3' ' A' ' 45' ' ' LYS . 73.2 t -106.84 118.63 54.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.668 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.873 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -57.85 139.14 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.375 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.14 -9.33 58.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.693 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -84.05 -31.27 25.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.122 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.563 ' HE3' HG13 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -99.24 27.34 5.21 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.362 175.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.546 HD12 HD12 ' A' ' 29' ' ' ILE . 13.9 mt -102.26 163.67 12.11 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 122.338 1.066 . . . . 0.0 112.241 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.567 ' O ' HD22 ' A' ' 51' ' ' LEU . 30.2 t -71.05 135.65 47.87 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.104 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.472 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 3.0 m-20 -48.44 -38.91 21.04 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.842 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.74 -47.07 83.5 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.564 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.604 ' HB3' ' CE3' ' A' ' 8' ' ' TRP . 43.6 m-20 -67.49 -34.97 78.24 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.238 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.789 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -70.95 -41.71 70.76 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.505 176.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.513 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -60.69 -29.44 69.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.515 0.674 . . . . 0.0 110.135 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 51.1 t80 -71.51 -51.59 22.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.935 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.802 ' HA ' HG12 ' A' ' 57' ' ' ILE . 2.7 p -71.23 -27.66 30.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.607 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.789 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 42.6 mt-10 -51.67 -38.53 55.36 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.165 0.507 . . . . 0.0 109.796 168.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -76.4 -41.11 48.97 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.783 -178.393 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.802 HG12 ' HA ' ' A' ' 54' ' ' VAL . 7.5 mm -61.69 -36.29 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.8 p -101.88 -49.17 4.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.34 -34.22 4.37 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.989 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -87.98 140.74 29.19 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 117.14 0.47 . . . . 0.0 110.451 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.7 t -79.51 135.73 36.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.424 -171.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 23.8 mt -104.68 22.28 15.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.115 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.589 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 2.2 tp10 -50.69 -38.63 47.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.4 0.619 . . . . 0.0 110.362 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 18.3 ptmt -67.48 -5.92 17.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.843 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -115.94 -12.48 11.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.229 0.537 . . . . 0.0 110.103 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 45.1 mtpt . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.831 -174.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.736 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 60.9 p . . . . . 0 CA--C 1.522 -0.125 0 CA-C-O 122.403 1.097 . . . . 0.0 112.479 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 11.6 ptp180 -118.96 176.52 5.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.798 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.6 tm? -95.66 105.68 17.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.975 0.417 . . . . 0.0 110.769 -173.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.701 ' HB2' HG23 ' A' ' 17' ' ' VAL . 48.7 m95 -92.4 152.64 19.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.299 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 16' ' ' LYS . 47.6 t -135.76 142.94 37.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.673 ' HA ' HD12 ' A' ' 46' ' ' LEU . 3.5 p-10 -85.41 178.31 7.49 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.084 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -59.52 -40.48 87.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.83 0.348 . . . . 0.0 111.552 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.8 m -84.5 -18.65 35.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.5 13.93 74.89 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.708 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 m -79.87 -37.02 35.75 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.683 -0.258 . . . . 0.0 111.182 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 47.0 p90 -123.4 125.15 44.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.009 0.909 . . . . 0.0 112.175 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.611 ' HB3' HD11 ' A' ' 7' ' ' LEU . 52.2 mttp -116.61 131.17 57.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.452 174.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -131.91 136.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.1 p-10 -90.02 106.11 18.26 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.181 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -161.44 161.79 30.3 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.767 -171.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.736 ' HG2' ' N ' ' A' ' 5' ' ' SER . 1.1 mm-40 -107.92 142.79 37.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.563 174.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.645 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 69.4 t80 -73.85 130.32 39.68 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.975 174.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -115.8 -47.62 4.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.408 178.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.83 148.51 14.86 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.86 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.645 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 30.8 t -124.18 126.89 46.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.859 0.329 . . . . 0.0 110.126 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.33 116.69 16.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.112 -173.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.5 tptt 55.2 44.5 27.6 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.201 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.28 2.82 85.19 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.46 175.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 46.7 mmtm -107.06 151.74 24.94 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 117.118 0.459 . . . . 0.0 110.079 174.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.672 HG13 ' HB2' ' A' ' 43' ' ' ALA . 91.0 mt -119.87 123.76 71.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.286 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.502 ' O ' HG13 ' A' ' 22' ' ' ILE . 34.6 m170 -84.96 124.08 31.27 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 21' ' ' PHE . 96.5 mt -125.63 138.45 53.92 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.83 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -107.37 101.14 10.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.175 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HE3' HG12 ' A' ' 17' ' ' VAL . 38.1 mtpt -64.96 159.06 23.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.471 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.9 -15.68 63.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.54 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.77 -20.07 61.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.566 174.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.57 -20.5 27.37 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.963 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.7 p -79.2 142.12 14.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.293 0.568 . . . . 0.0 111.19 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -99.65 127.8 45.76 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.928 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.1 pt -122.87 162.62 22.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.958 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.91 122.66 38.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.842 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.59 163.55 15.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . . . -92.42 119.71 32.22 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.411 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.672 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -64.24 -21.92 66.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.735 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.61 -22.41 63.5 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.764 -174.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HE2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -127.22 28.62 5.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.431 0.634 . . . . 0.0 110.377 179.566 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 10' ' ' ASP . 10.7 tp -95.03 170.58 9.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.592 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.649 ' O ' HD22 ' A' ' 51' ' ' LEU . 33.4 t -72.74 139.73 47.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.422 0.63 . . . . 0.0 110.1 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.466 ' CB ' ' HB3' ' A' ' 66' ' ' LYS . 11.2 p30 -66.06 -24.51 66.74 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.983 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -63.87 -47.77 79.36 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.637 0.732 . . . . 0.0 109.192 174.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.629 ' O ' HG12 ' A' ' 54' ' ' VAL . 3.3 m-20 -58.62 -43.8 89.78 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.712 176.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.797 HD23 ' HA ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -67.57 -42.39 82.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.819 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -61.5 -29.64 70.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.401 0.62 . . . . 0.0 110.134 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.744 ' CE2' HD11 ' A' ' 57' ' ' ILE . 40.9 t80 -74.61 -49.13 22.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.763 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.2 p -69.48 -27.65 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.119 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.764 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 50.6 mt-10 -51.24 -40.91 59.85 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 167.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 52' ' ' ALA . 9.3 mmpt? -74.14 -38.61 63.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.389 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.744 HD11 ' CE2' ' A' ' 53' ' ' TYR . 31.9 mt -62.84 -39.8 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.976 0.417 . . . . 0.0 111.253 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 40.3 p -95.22 -43.91 7.85 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -168.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.2 7.46 43.4 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.494 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.593 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 98.1 m-85 -103.7 177.06 4.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -123.69 124.66 43.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.959 0.409 . . . . 0.0 110.034 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 65' ' ' PHE . 62.1 mt -102.89 41.19 1.27 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.45 0.643 . . . . 0.0 110.189 -175.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.73 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 8.5 tp10 -50.62 -59.65 3.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.479 -176.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -70.35 -10.47 59.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.339 0.59 . . . . 0.0 109.917 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.677 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 60.3 m-85 -91.88 -14.2 30.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.566 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.797 ' HA ' HD23 ' A' ' 51' ' ' LEU . 50.8 mtmt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.476 -175.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.6 p . . . . . 0 N--CA 1.441 -0.9 0 CA-C-O 121.041 0.448 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 2.8 ptp180 -136.54 -179.17 5.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.052 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -93.18 115.14 27.77 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.497 -172.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.719 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 62.4 m95 -104.6 149.15 25.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.156 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 59.5 t -136.75 149.92 26.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 123.543 0.527 . . . . 0.0 109.829 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.993 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -96.67 174.09 7.0 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.214 178.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 11' ' ' ARG . 1.6 tmm_? -66.82 -34.29 77.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.705 0.288 . . . . 0.0 110.857 -174.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -75.68 -23.36 56.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.21 2.17 66.3 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.666 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -80.8 -40.48 24.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.349 0.595 . . . . 0.0 109.834 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.993 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 5.7 m-85 -85.93 127.12 34.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.829 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.719 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 8.6 ptmt -153.35 128.57 9.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.917 166.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.422 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -158.36 156.36 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.785 -173.367 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -92.81 118.67 31.35 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.899 174.475 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -163.86 164.62 23.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.621 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 138.32 51.3 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.818 ' HD2' HG23 ' A' ' 29' ' ' ILE . 6.6 t80 -74.41 117.91 16.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.324 0.583 . . . . 0.0 109.504 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -96.07 -45.37 13.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.136 -177.153 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.93 143.21 7.55 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.766 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.598 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 22.1 p -100.82 133.93 44.55 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.74 126.91 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.576 -173.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.3 OUTLIER 61.44 34.2 18.27 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.811 176.442 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.29 7.42 88.48 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.254 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -104.7 165.91 10.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.028 0.442 . . . . 0.0 110.442 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.818 HG23 ' HD2' ' A' ' 21' ' ' PHE . 84.6 mt -125.51 116.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.52 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.492 ' O ' HG13 ' A' ' 22' ' ' ILE . 11.2 m170 -83.61 126.94 33.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.725 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.7 mt -124.72 138.89 54.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.284 0.564 . . . . 0.0 111.021 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -104.72 105.55 15.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.468 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HD3' HD13 ' A' ' 39' ' ' ILE . 13.5 mmmm -61.14 162.89 6.75 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.527 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.14 -12.47 60.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.265 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -89.26 -13.46 38.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.195 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.82 2.56 56.19 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.468 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.17 148.14 5.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.554 0.216 . . . . 0.0 110.46 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -100.04 126.41 46.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.041 0.448 . . . . 0.0 110.857 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.624 HD13 ' HD3' ' A' ' 33' ' ' LYS . 24.8 pt -124.86 168.45 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.949 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.88 124.36 18.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.258 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 m -114.05 164.71 9.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.522 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . . . -85.86 127.85 34.68 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.183 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -63.97 -5.8 5.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.372 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -110.71 -15.72 13.77 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.522 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -96.26 0.88 51.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 6.6 tp -86.27 169.23 13.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.058 -175.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.634 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.5 t -78.9 138.29 38.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.776 0.798 . . . . 0.0 109.923 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.45 ' ND2' ' HB3' ' A' ' 66' ' ' LYS . 1.2 m-20 -53.53 -32.79 52.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.329 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -62.91 -48.13 80.28 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.046 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.668 ' O ' HG12 ' A' ' 54' ' ' VAL . 2.6 m-20 -59.67 -39.26 83.88 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.555 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.736 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -70.21 -38.89 75.39 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.158 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -60.33 -30.44 69.51 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.566 0.698 . . . . 0.0 110.197 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.663 ' CE2' HD11 ' A' ' 57' ' ' ILE . 80.2 t80 -74.36 -48.41 28.21 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.507 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -65.17 -26.98 41.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.415 -0.803 . . . . 0.0 110.853 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.736 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 37.8 mt-10 -51.47 -43.53 62.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.26 166.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.599 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 1.6 ppmt? -72.87 -31.58 64.82 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.992 0.425 . . . . 0.0 109.983 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.663 HD11 ' CE2' ' A' ' 53' ' ' TYR . 37.7 mt -66.94 -42.84 89.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.735 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.4 p -104.52 -46.38 4.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -171.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.13 -14.57 23.51 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -79.74 137.64 37.08 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.432 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 20.9 t -89.45 112.04 23.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.938 0.399 . . . . 0.0 110.238 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 30.1 mt -91.51 24.86 2.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.638 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -53.48 -47.37 69.85 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.677 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -73.33 -5.35 39.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.502 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -97.41 -16.13 20.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.102 0.477 . . . . 0.0 110.14 176.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 97.9 mttt . . . . . 0 C--O 1.235 0.341 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.877 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.624 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 25.1 t . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.123 0.487 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -148.59 -179.82 7.26 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 110.737 178.064 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.461 HD11 ' HB3' ' A' ' 16' ' ' LYS . 2.6 tm? -103.72 108.18 19.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.507 -175.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.6 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 43.1 m95 -93.22 145.46 24.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.046 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.24 148.5 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -86.66 177.32 7.39 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.187 176.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.637 ' HD3' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -55.11 -44.87 75.35 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.305 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.637 ' N ' ' HD3' ' A' ' 11' ' ' ARG . 64.6 p -85.4 -28.97 24.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.017 0.437 . . . . 0.0 111.436 -173.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.11 20.3 30.92 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.467 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.6 m -78.24 -37.48 45.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.783 0.325 . . . . 0.0 110.297 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.42 ' HZ ' ' HD3' ' A' ' 45' ' ' LYS . 42.0 p90 -132.87 133.56 43.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.84 0.828 . . . . 0.0 112.376 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HB3' HD11 ' A' ' 7' ' ' LEU . 21.7 mtmm -123.11 143.89 49.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.608 175.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.639 HG12 ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -137.66 135.85 46.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.674 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 10.3 p-10 -85.89 105.36 16.32 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.486 173.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.792 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -156.21 162.43 40.18 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.329 -171.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.624 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -119.1 139.47 51.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.857 172.404 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.805 ' HD2' HG23 ' A' ' 29' ' ' ILE . 33.6 t80 -68.56 132.22 46.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -113.76 -48.89 5.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.19 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.08 157.59 29.15 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.0 p -116.87 140.87 48.94 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 28' ' ' LYS . . . -135.02 105.59 6.43 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.172 -174.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? 59.12 41.86 19.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.923 0.868 . . . . 0.0 109.573 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.71 -19.18 52.87 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.978 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 42' ' ' ALA . 3.6 ptpp? -89.18 163.72 15.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.406 0.603 . . . . 0.0 110.423 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.805 HG23 ' HD2' ' A' ' 21' ' ' PHE . 57.8 mt -115.39 126.8 73.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.12 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.459 ' O ' HG13 ' A' ' 22' ' ' ILE . 91.4 m-70 -86.16 127.27 34.69 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 169.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.792 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 95.8 mt -125.63 137.8 53.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.91 -176.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -106.3 110.05 22.17 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.271 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.674 ' HE2' ' O ' ' A' ' 18' ' ' ASP . 11.8 mmmm -58.05 151.81 17.91 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 123.696 0.623 . . . . 0.0 109.901 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.65 -16.06 63.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.623 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -89.82 -7.13 55.03 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.153 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.45 -23.41 12.33 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.718 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 t -67.44 145.78 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 117.001 0.4 . . . . 0.0 110.88 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -112.37 130.27 56.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.821 0.343 . . . . 0.0 110.196 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.429 HD13 ' HD3' ' A' ' 33' ' ' LYS . 20.8 pt -126.1 165.68 23.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.385 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.58 124.46 40.0 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.59 HG13 ' HE3' ' A' ' 45' ' ' LYS . 70.4 t -130.4 120.58 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.402 -175.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . . . -66.06 129.27 39.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.2 -18.27 63.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.626 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.726 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 2.9 p30 -72.72 -25.64 61.3 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.094 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.59 ' HE3' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.43 29.03 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.751 0.786 . . . . 0.0 110.051 176.413 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.5 tp -108.77 174.5 5.84 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.197 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.559 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 47.6 t -80.21 138.01 36.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.925 0.869 . . . . 0.0 110.766 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -51.2 -41.23 60.1 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.756 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.7 -45.27 87.32 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.132 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.6 ' OD2' ' HA ' ' A' ' 8' ' ' TRP . 3.9 m-20 -60.24 -36.83 78.63 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.166 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.784 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -67.18 -42.72 83.74 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 120.597 -0.441 . . . . 0.0 109.918 176.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -60.97 -29.65 69.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.486 0.66 . . . . 0.0 110.237 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -73.85 -51.32 16.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.169 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.833 ' HA ' HG12 ' A' ' 57' ' ' ILE . 3.6 p -69.63 -25.7 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.143 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.784 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.0 mt-10 -50.34 -44.38 54.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.101 0.476 . . . . 0.0 109.733 167.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 52' ' ' ALA . 1.1 mpmm? -72.76 -34.55 67.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.492 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.833 HG12 ' HA ' ' A' ' 54' ' ' VAL . 4.9 mm -68.78 -34.15 63.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.067 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.732 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 37.6 p -99.31 -48.1 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -171.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.56 -0.76 34.5 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -171.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.732 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 87.3 m-85 -102.04 141.13 35.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.439 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 17.7 t -88.2 111.7 21.92 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.695 HD12 HG13 ' A' ' 54' ' ' VAL . 50.9 mt -90.3 24.44 2.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.174 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -57.78 -40.97 81.06 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.002 0.43 . . . . 0.0 110.504 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' NZ ' ' HB2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -71.35 -5.79 35.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.254 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.726 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 96.4 m-85 -108.68 -4.33 17.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.307 177.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.641 ' HG2' HD23 ' A' ' 51' ' ' LEU . 98.8 mttt . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.038 -176.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.837 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 12.1 t . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -152.72 174.14 14.39 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.82 -0.55 . . . . 0.0 111.555 -177.674 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.8 tm? -94.75 104.58 16.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.182 -174.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.603 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 63.2 m95 -92.88 143.94 25.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.086 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.496 HG22 ' HG2' ' A' ' 16' ' ' LYS . 45.3 t -128.73 143.35 41.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HA ' HD12 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -89.31 160.13 17.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 8.1 tmm_? -70.64 -20.76 62.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.586 -170.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 t -82.28 -12.78 57.81 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.245 0.545 . . . . 0.0 109.781 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.4 30.8 61.91 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.915 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.6 m -93.9 -44.4 8.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.413 0.149 . . . . 0.0 110.975 -176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 10' ' ' ASP . 34.8 p90 -127.17 131.74 50.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.912 0.863 . . . . 0.0 112.932 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.718 ' HB3' HD11 ' A' ' 7' ' ' LEU . 86.9 mttt -116.48 130.73 56.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.674 170.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.45 144.66 27.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.623 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 17.9 t70 -94.46 115.07 27.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.196 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.656 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -161.07 162.56 31.67 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.914 -172.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.837 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 5.5 mm-40 -107.94 137.97 45.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.246 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.887 ' HD1' HG23 ' A' ' 29' ' ' ILE . 4.4 t80 -78.95 120.09 23.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.83 HD12 ' HE3' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -105.41 -42.01 6.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.711 -174.569 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.73 142.15 7.56 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.848 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.526 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 27.5 p -104.73 125.53 50.9 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.24 115.54 20.56 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.117 -172.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 65.67 -76.29 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.112 0.883 . . . . 0.0 111.085 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.49 18.32 1.49 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.949 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -125.77 166.52 16.66 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.472 0.653 . . . . 0.0 111.503 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.887 HG23 ' HD1' ' A' ' 21' ' ' PHE . 67.4 mt -117.24 126.49 74.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.828 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.467 ' O ' HG13 ' A' ' 22' ' ' ILE . 25.2 m170 -91.29 127.42 36.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.656 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.5 mm? -121.0 140.64 51.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.481 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -104.29 101.33 11.05 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 169.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.604 ' HD2' HD13 ' A' ' 39' ' ' ILE . 44.0 mtpt -68.21 154.67 41.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.165 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.73 -14.05 57.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.551 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.641 ' OD1' HG12 ' A' ' 37' ' ' VAL . 43.2 p30 -80.84 -18.93 45.8 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.935 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.65 -21.11 9.22 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.521 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.641 HG12 ' OD1' ' A' ' 35' ' ' ASN . 9.9 p -85.16 150.75 3.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.276 0.56 . . . . 0.0 111.238 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.83 ' HE3' HD12 ' A' ' 22' ' ' ILE . 85.4 tttt -107.24 125.92 51.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.557 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.604 HD13 ' HD2' ' A' ' 33' ' ' LYS . 16.4 pt -122.07 169.99 12.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.279 -173.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.03 103.68 6.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.607 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.517 HG11 HD13 ' A' ' 46' ' ' LEU . 67.8 t -101.82 122.81 54.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB1' ' OD1' ' A' ' 44' ' ' ASP . . . -60.45 129.57 42.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.259 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -72.4 -6.38 43.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.01 0.433 . . . . 0.0 111.835 -172.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.44 ' OD1' ' HB1' ' A' ' 42' ' ' ALA . 8.6 p-10 -98.14 -20.23 17.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.823 -173.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HE2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -102.82 6.03 39.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.782 0.801 . . . . 0.0 109.78 176.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 10' ' ' ASP . 13.1 tp -91.62 170.39 9.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.299 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.626 ' O ' HD22 ' A' ' 51' ' ' LEU . 40.7 t -75.65 135.35 40.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.694 0.759 . . . . 0.0 110.444 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.444 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 19.3 m-20 -60.03 -32.15 70.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.949 -174.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.89 -43.78 97.88 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.664 0.745 . . . . 0.0 109.845 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.615 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.0 m-20 -64.75 -37.92 89.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.444 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.767 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -67.73 -39.8 84.25 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.667 177.328 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.654 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -60.25 -32.13 70.86 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.458 0.647 . . . . 0.0 109.978 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.746 ' CE2' HD11 ' A' ' 57' ' ' ILE . 80.6 t80 -72.21 -48.41 43.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.523 176.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -68.94 -26.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 121.757 -0.589 . . . . 0.0 111.241 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.767 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 48.2 mt-10 -51.3 -38.33 52.33 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.139 0.495 . . . . 0.0 109.764 166.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.559 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -73.56 -43.65 59.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.042 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.746 HD11 ' CE2' ' A' ' 53' ' ' TYR . 35.9 mt -57.58 -37.96 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.023 0.44 . . . . 0.0 111.193 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 35.1 p -98.66 -47.1 5.46 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -170.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.76 -3.77 39.2 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -171.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -92.09 172.84 8.17 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.7 t -117.94 128.01 54.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.172 0.51 . . . . 0.0 109.918 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 33.3 mt -106.22 19.76 20.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.941 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -53.17 -42.71 66.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.189 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -59.14 -23.62 62.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.5 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.408 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 79.2 m-85 -97.25 -12.78 22.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.668 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 97.3 mttt . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.428 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.641 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 40.1 t . . . . . 0 C--O 1.235 0.291 0 CA-C-O 122.052 0.929 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 13.8 ptp180 -126.12 177.36 6.42 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.447 -171.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.709 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.9 tm? -89.39 119.11 29.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.882 0.372 . . . . 0.0 111.325 -171.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.568 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 41.9 m95 -108.5 148.04 30.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.953 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.534 ' CG1' ' HA2' ' A' ' 13' ' ' GLY . 39.2 t -129.88 143.41 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 123.026 0.204 . . . . 0.0 110.456 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.66 ' HA ' HD12 ' A' ' 46' ' ' LEU . 1.7 p-10 -86.05 -179.47 6.77 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.9 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -52.94 -44.87 67.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.603 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 m -88.1 -20.53 25.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.039 0.447 . . . . 0.0 111.069 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.534 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . 86.81 14.58 64.83 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.629 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 m -74.49 -38.68 62.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.774 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 49.2 p90 -120.21 121.54 38.97 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 122.062 0.934 . . . . 0.0 111.846 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.709 ' HB3' HD11 ' A' ' 7' ' ' LEU . 49.5 mttp -112.41 130.95 55.8 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.005 -1.452 . . . . 0.0 107.611 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.5 146.09 28.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.183 0.516 . . . . 0.0 112.142 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.3 p30 -86.14 124.05 32.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.001 172.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -169.52 156.81 6.87 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.632 -175.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.641 ' HG2' ' N ' ' A' ' 5' ' ' SER . 0.4 OUTLIER -112.05 139.9 47.18 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.538 172.535 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.739 ' HE2' ' HB3' ' A' ' 24' ' ' CYS . 28.7 t80 -68.49 133.67 48.95 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.273 176.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -120.94 -48.93 3.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.462 178.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 30' ' ' HIS . . . -148.25 144.41 12.28 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 30.8 p -123.16 115.18 21.36 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.506 -0.408 . . . . 0.0 109.974 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.78 146.02 22.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 58.24 34.48 24.14 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.625 0.578 . . . . 0.0 111.26 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.89 17.01 64.74 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.401 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 39.4 mmtm -114.74 153.69 29.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.913 0.387 . . . . 0.0 110.039 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.555 HG23 ' HD2' ' A' ' 21' ' ' PHE . 79.0 mt -114.1 113.06 42.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.035 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.528 ' O ' HG13 ' A' ' 22' ' ' ILE . 15.2 m-70 -75.48 119.87 20.14 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.021 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.64 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 91.3 mt -124.57 140.25 53.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.171 0.51 . . . . 0.0 111.498 -172.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.5 ' NE2' ' HA2' ' A' ' 36' ' ' GLY . 17.7 t-80 -108.94 98.58 8.04 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.36 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.597 ' HD2' ' HB2' ' A' ' 19' ' ' ALA . 1.7 mmmp? -57.69 167.09 1.17 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.852 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.19 -28.16 69.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.498 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -86.06 10.35 14.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.5 ' HA2' ' NE2' ' A' ' 32' ' ' HIS . . . 73.89 27.44 66.78 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.465 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.45 137.95 25.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 66.8 mttt -99.47 124.39 44.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.074 0.464 . . . . 0.0 111.383 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.1 pt -126.97 146.4 32.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.126 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.09 103.29 14.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.4 ' CG1' HD13 ' A' ' 46' ' ' LEU . 71.1 t -103.22 110.99 31.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -56.99 127.48 32.12 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.576 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.36 -8.0 29.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.069 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.453 ' OD2' ' HB1' ' A' ' 42' ' ' ALA . 2.8 p30 -95.59 -10.38 29.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.55 ' HD2' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -120.61 17.58 12.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.012 0.911 . . . . 0.0 108.806 171.639 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.66 HD12 ' HA ' ' A' ' 10' ' ' ASP . 13.7 tp -97.6 166.68 11.39 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.177 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.602 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 47.3 t -74.33 137.31 42.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.636 0.732 . . . . 0.0 110.693 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -58.07 -29.41 65.4 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.744 -177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.49 -50.68 72.6 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.7 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.602 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 3.8 m-20 -61.67 -36.82 81.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.83 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.773 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -68.79 -41.15 79.15 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.55 177.664 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.557 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -64.65 -28.63 69.74 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.544 0.688 . . . . 0.0 109.611 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.777 ' CE2' HD11 ' A' ' 57' ' ' ILE . 16.7 t80 -73.28 -48.02 38.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.49 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.654 HG13 HD23 ' A' ' 62' ' ' LEU . 3.0 p -68.48 -26.68 34.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 121.761 -0.587 . . . . 0.0 110.949 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.773 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.2 mt-10 -52.03 -35.25 46.37 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.11 0.481 . . . . 0.0 110.059 167.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 1.7 tptt -73.2 -50.29 23.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.161 176.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.777 HD11 ' CE2' ' A' ' 53' ' ' TYR . 51.1 mt -49.98 -46.34 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.126 0.489 . . . . 0.0 111.811 -177.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.406 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 34.2 p -105.08 -46.83 4.16 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -170.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.87 -6.7 27.55 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 90.3 m-85 -83.17 141.24 32.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.0 t -90.36 108.74 19.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.043 0.449 . . . . 0.0 110.037 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.737 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 2.6 mm? -87.1 19.41 3.12 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.403 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -53.82 -43.74 69.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.387 0.675 . . . . 0.0 110.756 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -67.44 -12.62 60.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.806 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 44' ' ' ASP . 72.1 m-85 -108.99 -0.99 19.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.723 0.297 . . . . 0.0 110.776 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 98.9 mttt . . . . . 0 C--N 1.327 -0.381 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.8 t . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.587 0.708 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 18.6 ptp180 -137.0 -179.13 5.52 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.66 -173.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.91 110.82 21.41 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.139 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.524 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 41.1 m95 -91.93 138.07 31.85 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.7 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 10' ' ' ASP . 58.9 t -129.41 142.54 43.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -74.48 159.43 32.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.616 0.722 . . . . 0.0 110.699 172.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.429 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -64.22 -21.36 66.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.403 -172.739 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.4 m -113.72 6.72 16.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.969 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.38 24.51 72.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.468 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 m -68.82 -40.11 79.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.615 0.245 . . . . 0.0 111.572 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.484 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 5.6 p90 -137.29 142.81 41.93 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.163 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 45.4 mttp -137.56 131.03 31.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.475 HG11 ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -148.51 146.31 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-O 120.912 0.386 . . . . 0.0 111.431 177.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.5 m-20 -83.32 121.51 27.22 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.16 171.94 17.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.237 0.542 . . . . 0.0 111.71 -173.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.93 142.59 51.21 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.62 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.617 ' HA ' HD12 ' A' ' 31' ' ' LEU . 64.6 t80 -77.67 132.23 38.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.104 0.478 . . . . 0.0 110.354 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -112.02 -51.1 5.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.52 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.11 145.94 11.14 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.217 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.569 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 27.0 t -123.8 130.8 53.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.828 0.347 . . . . 0.0 110.493 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.15 143.79 21.63 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 -177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 60.02 29.13 18.72 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.783 0.677 . . . . 0.0 111.601 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.06 1.16 89.82 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.498 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -106.73 161.0 15.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.964 0.412 . . . . 0.0 110.47 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.606 HG22 HD13 ' A' ' 31' ' ' LEU . 94.1 mt -123.11 123.49 68.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.531 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.409 ' O ' HG13 ' A' ' 22' ' ' ILE . 90.0 m-70 -87.76 128.09 35.32 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.617 HD12 ' HA ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -124.03 148.42 47.04 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.665 -176.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -110.91 100.14 8.92 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.208 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.764 ' HD2' HD13 ' A' ' 39' ' ' ILE . 59.5 mtpt -71.94 152.0 42.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.784 -173.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.25 -12.0 46.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.99 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -71.42 -20.6 62.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.087 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.14 0.99 44.77 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.122 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.45 141.46 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.831 0.348 . . . . 0.0 111.207 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -98.26 128.03 44.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.967 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.764 HD13 ' HD2' ' A' ' 33' ' ' LYS . 49.0 pt -127.4 169.28 19.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.111 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.3 109.32 8.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.951 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.628 ' HB ' ' HE3' ' A' ' 45' ' ' LYS . 32.8 m -110.19 147.45 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.9 129.12 37.43 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.78 -16.17 47.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.466 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 4.7 p-10 -74.27 -23.2 59.09 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -173.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.628 ' HE3' ' HB ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.54 38.37 1.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.903 0.858 . . . . 0.0 110.163 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.485 HD22 HD12 ' A' ' 29' ' ' ILE . 6.0 mp -115.76 161.63 18.45 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.121 176.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.595 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 43.8 t -74.29 140.46 44.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.754 0.788 . . . . 0.0 110.047 176.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -49.86 -34.32 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.267 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -59.22 -51.33 70.44 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.599 0.714 . . . . 0.0 109.981 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.634 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.1 m-20 -60.37 -38.24 83.26 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.422 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.802 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.5 OUTLIER -70.3 -43.85 69.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.363 179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.63 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -58.96 -30.27 67.79 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.551 0.691 . . . . 0.0 110.375 -178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.401 ' O ' HG12 ' A' ' 57' ' ' ILE . 51.6 t80 -73.75 -50.64 19.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.325 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.762 ' HA ' HG12 ' A' ' 57' ' ' ILE . 2.2 p -69.94 -29.1 39.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.401 -176.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.802 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 47.4 mt-10 -51.61 -40.05 59.14 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.193 0.521 . . . . 0.0 109.914 169.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.893 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -78.38 -31.65 48.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.873 -176.538 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.762 HG12 ' HA ' ' A' ' 54' ' ' VAL . 10.9 mm -66.3 -35.82 75.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.031 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.4 p -107.88 -47.35 3.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -170.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.47 -31.85 4.28 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.389 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.467 ' HZ ' ' HB3' ' A' ' 24' ' ' CYS . 14.9 p90 -87.28 152.64 22.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.177 0.488 . . . . 0.0 110.842 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.451 ' OG ' ' HG2' ' A' ' 63' ' ' GLU . 7.7 t -92.37 140.97 29.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.708 -172.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 35.3 mt -115.94 31.42 6.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.86 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.451 ' HG2' ' OG ' ' A' ' 61' ' ' SER . 18.5 mm-40 -53.13 -40.69 64.42 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.666 174.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -62.78 -15.2 52.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.971 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.466 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 36.9 m-85 -106.96 -7.32 17.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.245 0.545 . . . . 0.0 110.545 -177.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.221 -179.727 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 12.0 ptp180 -131.44 -179.9 5.64 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.107 -170.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -95.06 106.22 18.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.814 -171.083 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -92.18 141.77 28.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.474 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 10' ' ' ASP . 96.5 t -132.88 136.84 55.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.989 0.423 . . . . 0.0 111.442 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.14 153.42 41.66 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.601 0.715 . . . . 0.0 110.379 171.539 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 6.3 tmm_? -63.66 -28.66 70.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.853 -169.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -93.39 -6.74 46.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.115 0.483 . . . . 0.0 110.687 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.08 20.85 60.07 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.933 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.5 m -69.03 -45.37 70.63 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.569 0.347 . . . . 0.0 111.662 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -137.92 143.85 41.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 110.832 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.832 ' HB3' HD11 ' A' ' 7' ' ' LEU . 54.4 mttm -133.4 130.88 39.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.601 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.66 152.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.258 0.551 . . . . 0.0 111.88 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.619 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.1 p30 -90.36 130.46 36.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.295 173.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.96 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -171.38 157.39 4.9 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.18 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.49 140.41 49.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.734 ' HD1' HG23 ' A' ' 29' ' ' ILE . 42.7 t80 -72.01 130.69 41.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.378 0.609 . . . . 0.0 110.721 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -112.53 -49.73 5.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.237 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.29 148.7 14.44 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.59 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 27.9 t -118.41 134.41 55.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.954 0.377 . . . . 0.0 110.172 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.98 140.33 29.56 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.775 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 62.68 -78.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.099 0.874 . . . . 0.0 111.282 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -155.63 12.45 0.4 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.75 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 47.6 mttm -115.51 160.29 20.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.101 0.476 . . . . 0.0 110.925 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.734 HG23 ' HD1' ' A' ' 21' ' ' PHE . 2.2 mp -112.8 124.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.614 174.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.444 ' O ' HG13 ' A' ' 22' ' ' ILE . 79.0 m-70 -80.32 130.86 35.48 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.96 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 97.6 mt -130.16 140.51 50.76 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.686 -174.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -111.93 110.54 20.92 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.555 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 5.1 mtpm? -69.76 170.5 10.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.042 -174.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.42 -20.5 60.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.815 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.482 ' HB2' HG23 ' A' ' 37' ' ' VAL . 7.8 m120 -79.87 -7.72 58.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.137 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.92 0.27 75.04 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.92 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 35' ' ' ASN . 43.0 t -75.29 136.65 24.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -100.41 117.21 34.12 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.535 HG13 ' HB2' ' A' ' 31' ' ' LEU . 40.4 pt -119.63 172.1 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.0 110.64 4.02 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 m -112.13 129.39 67.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.879 0.371 . . . . 0.0 110.509 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.75 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -61.51 130.61 46.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.068 0.461 . . . . 0.0 110.181 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . . . -54.88 -26.17 33.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.165 -173.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.46 -10.64 59.76 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.554 ' HD3' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -101.19 17.72 21.77 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.697 178.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 88.8 mt -115.05 -174.8 2.56 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.246 1.022 . . . . 0.0 111.813 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.601 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 34.9 t -97.25 143.71 27.76 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.285 -1.78 . . . . 0.0 108.942 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -60.05 -24.18 64.34 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.918 -174.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -62.76 -47.32 84.04 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.964 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.601 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 3.8 m-20 -64.19 -38.52 91.35 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.441 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.659 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.8 OUTLIER -70.66 -38.33 73.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.952 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.485 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -68.03 -27.23 66.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.303 0.573 . . . . 0.0 109.968 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.593 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 32.5 t80 -74.04 -49.95 21.91 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.198 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 50' ' ' ASP . 3.4 p -70.55 -32.04 48.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.018 0.437 . . . . 0.0 111.085 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.917 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 1.7 pt-20 -68.45 -23.51 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.302 0.572 . . . . 0.0 110.031 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 1.1 ttpp -72.79 -40.44 65.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.593 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 54.2 mt -63.08 -44.69 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.013 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.2 p -78.37 -43.99 26.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.289 -172.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.94 2.05 28.51 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.485 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 64.0 m-85 -104.83 -166.19 1.21 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 t -130.99 132.43 45.01 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.917 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 9.7 mt -103.68 29.7 5.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.387 0.613 . . . . 0.0 109.381 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.482 ' OE2' ' HD2' ' A' ' 66' ' ' LYS . 6.2 tp10 -45.0 -48.84 11.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.033 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -65.34 -17.53 64.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -100.8 -4.83 27.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.496 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.482 ' HD2' ' OE2' ' A' ' 63' ' ' GLU . 97.8 mttt . . . . . 0 CA--C 1.513 -0.471 0 CA-C-O 121.697 0.761 . . . . 0.0 110.836 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.683 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 33.0 p . . . . . 0 CA--C 1.52 -0.187 0 CA-C-O 122.356 1.074 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 10.9 ptp180 -107.98 179.13 4.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.588 -166.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.769 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.9 tm? -88.9 108.95 19.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.852 -173.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.514 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 37.7 m95 -97.54 153.72 17.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.18 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.431 HG13 ' HG2' ' A' ' 16' ' ' LYS . 23.5 t -133.68 146.79 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.59 ' HA ' HD12 ' A' ' 46' ' ' LEU . 7.8 p-10 -84.24 178.82 7.64 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.143 172.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.509 ' HD2' ' O ' ' A' ' 11' ' ' ARG . 2.1 tmm_? -81.32 -23.58 37.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 110.947 -174.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.9 t -89.91 -29.31 18.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.875 0.369 . . . . 0.0 110.679 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.89 21.18 19.21 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -76.79 -40.97 46.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.346 -0.427 . . . . 0.0 110.966 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.582 ' HZ ' ' HE3' ' A' ' 45' ' ' LYS . 33.0 p90 -142.2 131.01 22.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.908 0.861 . . . . 0.0 113.157 -174.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.769 ' HB3' HD11 ' A' ' 7' ' ' LEU . 36.0 mtmm -118.86 130.45 55.75 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.252 169.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.38 153.18 21.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.41 0.624 . . . . 0.0 112.371 -173.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.4 p30 -90.36 129.03 36.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.61 174.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -178.7 159.54 1.11 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.946 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.683 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 3.8 mm-40 -110.61 144.26 39.77 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 121.251 0.548 . . . . 0.0 110.017 169.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.906 ' HD1' HG23 ' A' ' 29' ' ' ILE . 3.7 t80 -74.9 120.67 20.75 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.339 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.83 -52.77 8.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.079 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.3 141.87 7.76 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.759 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 24.6 p -101.0 144.04 30.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.39 109.16 4.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.186 -0.206 . . . . 0.0 111.159 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? 53.43 52.28 13.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.103 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.81 -7.01 71.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.124 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -101.44 161.06 13.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.26 0.53 . . . . 0.0 111.283 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.906 HG23 ' HD1' ' A' ' 21' ' ' PHE . 78.0 mt -123.03 120.79 61.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.248 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -87.82 131.7 34.44 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.794 HD23 ' HA ' ' A' ' 21' ' ' PHE . 85.7 mt -129.31 138.99 51.91 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.27 0.557 . . . . 0.0 111.284 -170.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -105.81 104.41 14.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.185 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.621 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 6.3 mtpm? -66.09 169.03 7.46 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.55 -18.66 62.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.301 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -103.86 14.75 30.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.611 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.9 -16.43 59.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.633 171.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.434 ' HB ' ' HD3' ' A' ' 33' ' ' LYS . 60.7 t -65.43 139.18 21.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.708 0.289 . . . . 0.0 110.654 -178.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -104.31 124.19 48.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.521 HG13 ' HB2' ' A' ' 31' ' ' LEU . 39.1 pt -125.68 160.34 32.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.795 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.49 121.61 23.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.159 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -119.3 148.33 22.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.482 ' HB1' ' OD2' ' A' ' 44' ' ' ASP . . . -78.85 123.73 27.51 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.82 -19.66 65.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.566 0.698 . . . . 0.0 111.123 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.816 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 3.7 p30 -74.53 -14.28 60.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.274 -176.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.582 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -117.12 18.31 14.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.997 0.903 . . . . 0.0 109.201 174.659 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.59 HD12 ' HA ' ' A' ' 10' ' ' ASP . 12.8 tp -100.21 167.79 10.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.434 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.8 t -67.11 137.83 56.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.426 0.632 . . . . 0.0 111.054 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.485 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 53.1 m-20 -58.66 -36.72 74.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.81 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -65.29 -46.04 82.0 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.658 0.742 . . . . 0.0 109.713 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.547 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.5 m-20 -61.78 -36.46 81.11 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.91 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.757 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -66.32 -45.72 79.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.852 176.562 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.578 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -61.86 -29.24 70.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.46 0.648 . . . . 0.0 110.449 -176.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.638 ' CE2' HD11 ' A' ' 57' ' ' ILE . 29.2 t80 -74.01 -49.93 22.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.232 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 50' ' ' ASP . 4.1 p -70.51 -26.58 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.894 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.757 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.9 mt-10 -51.45 -40.16 58.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.189 0.519 . . . . 0.0 109.872 167.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.623 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -75.78 -36.25 59.86 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.113 -176.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.638 HD11 ' CE2' ' A' ' 53' ' ' TYR . 29.8 mt -64.45 -40.23 88.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.992 175.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.698 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 36.6 p -91.02 -47.43 7.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -169.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.3 -4.73 51.74 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 -170.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.698 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 79.9 m-85 -95.58 162.24 13.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.9 t -110.79 117.08 32.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.219 0.533 . . . . 0.0 110.762 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.613 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 29.5 mt -91.67 17.53 8.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.58 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.813 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -56.61 -41.02 76.34 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.213 178.42 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -60.25 -20.33 58.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.812 178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.816 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 53.4 m-85 -99.17 -16.72 18.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.843 0.354 . . . . 0.0 110.341 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.813 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 9.4 mtpm? . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.705 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.627 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 38.1 t . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 122.204 1.002 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 9.7 ptp180 -118.25 175.15 5.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.321 -1.308 . . . . 0.0 110.816 -170.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.706 HD11 ' HB2' ' A' ' 16' ' ' LYS . 1.3 tm? -83.62 117.12 22.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.943 -174.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.602 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 69.1 m95 -108.9 145.0 36.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.139 175.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 16' ' ' LYS . 88.8 t -131.59 138.43 52.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.22 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.705 ' HA ' HD12 ' A' ' 46' ' ' LEU . 6.4 p-10 -84.92 168.86 14.63 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.598 175.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.647 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 4.6 tpm_? -67.08 -35.22 79.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.514 0.197 . . . . 0.0 111.417 -174.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 m -79.16 -12.26 59.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.97 0.414 . . . . 0.0 111.209 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.5 17.63 75.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.506 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -66.69 -47.73 71.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.994 -0.603 . . . . 0.0 110.656 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 10' ' ' ASP . 16.4 p90 -138.57 132.64 31.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.7 0.762 . . . . 0.0 112.627 -174.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.706 ' HB2' HD11 ' A' ' 7' ' ' LEU . 20.6 ptmt -120.83 129.67 53.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.225 166.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.808 ' HB ' ' HE2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -148.9 159.12 6.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.225 0.536 . . . . 0.0 112.016 -172.484 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.59 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.5 OUTLIER -93.54 122.83 36.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.478 177.142 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.716 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -162.07 156.36 21.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.589 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.627 ' HG2' ' N ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -109.34 138.89 45.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.014 174.657 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.64 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 50.7 t80 -67.93 133.15 48.62 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.026 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -116.25 -50.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.158 179.505 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.16 153.7 24.78 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.465 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.64 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 29.2 t -129.09 130.05 46.0 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.43 134.44 21.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.486 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 63.11 15.53 8.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.236 0.541 . . . . 0.0 111.196 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.23 2.08 71.41 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.272 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 61.4 mttp -93.89 146.79 23.65 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.536 -0.39 . . . . 0.0 110.365 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.556 HD11 ' HB2' ' A' ' 43' ' ' ALA . 17.5 mm -105.09 119.42 54.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.539 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.457 ' O ' HG13 ' A' ' 22' ' ' ILE . 24.1 m170 -89.7 125.53 35.3 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.716 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 92.5 mt -128.74 139.15 52.35 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.23 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -102.18 106.64 17.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.56 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.808 ' HE2' ' HB ' ' A' ' 17' ' ' VAL . 2.5 mmmp? -64.36 152.09 42.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.174 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.12 -13.78 62.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.429 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 6.9 p-10 -98.01 12.63 33.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.894 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.06 -30.8 9.37 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.861 -0.685 . . . . 0.0 114.198 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.94 139.44 21.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.899 0.381 . . . . 0.0 111.795 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.97 122.68 45.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.0 161.75 19.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.928 -176.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.29 106.06 6.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.677 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.7 m -108.38 146.16 14.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -76.1 122.62 24.55 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.608 176.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.703 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -64.45 -21.47 66.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.581 0.705 . . . . 0.0 109.836 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 12.9 t70 -50.63 -32.95 20.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.341 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 26.54 9.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.238 0.542 . . . . 0.0 110.93 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.705 HD12 ' HA ' ' A' ' 10' ' ' ASP . 8.6 tp -100.1 173.53 6.59 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.319 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.644 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 19.8 m -79.98 133.85 36.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.613 0.721 . . . . 0.0 110.475 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -55.04 -35.15 64.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.917 -172.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.4 -44.38 83.17 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.338 0.589 . . . . 0.0 109.733 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.644 ' OD1' ' HB2' ' A' ' 47' ' ' SER . 1.4 m-20 -57.77 -40.62 80.2 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.764 175.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.82 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -68.94 -39.54 79.52 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.408 178.135 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.684 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -59.31 -32.49 70.12 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.434 0.635 . . . . 0.0 109.885 -177.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.75 ' CE2' HD11 ' A' ' 57' ' ' ILE . 49.5 t80 -74.2 -49.61 22.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.551 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 50' ' ' ASP . 1.7 p -68.81 -28.07 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.205 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.82 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 46.9 mt-10 -52.18 -39.85 60.67 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.071 0.462 . . . . 0.0 110.061 167.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.622 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 9.4 mmpt? -78.08 -28.36 48.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.75 HD11 ' CE2' ' A' ' 53' ' ' TYR . 40.9 mt -67.88 -42.97 86.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.145 0.498 . . . . 0.0 110.712 173.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.5 p -90.84 -47.53 7.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.493 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.87 -19.7 15.47 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.893 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -107.04 151.24 25.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.954 0.407 . . . . 0.0 110.203 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -82.86 136.85 34.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.704 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.622 HD12 HG13 ' A' ' 54' ' ' VAL . 23.4 mt -107.0 20.16 19.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.847 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.408 ' OE2' ' HD2' ' A' ' 66' ' ' LYS . 4.0 tp10 -55.33 -44.38 75.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.967 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -14.45 61.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.238 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' ASP . 62.6 m-85 -105.13 -0.43 26.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.621 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 99.2 mttt . . . . . 0 C--N 1.323 -0.582 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.375 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 121.286 0.565 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 16.3 ptp180 -126.64 -178.66 4.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.975 -171.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.709 HD11 ' HB3' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -88.76 105.59 17.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.378 -168.675 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.481 ' HH2' ' HB ' ' A' ' 54' ' ' VAL . 47.2 m95 -94.46 139.71 30.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.72 176.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 10' ' ' ASP . 72.9 t -129.78 141.99 45.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.974 0.416 . . . . 0.0 111.71 -175.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.639 ' O ' HG12 ' A' ' 9' ' ' VAL . 9.8 t70 -70.58 157.47 37.86 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -79.41 -25.86 42.01 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 p -99.68 7.22 45.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.046 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.77 68.34 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.72 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.598 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 31.8 m -68.27 -40.14 81.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.69 0.281 . . . . 0.0 111.257 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -150.81 150.21 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.144 0.497 . . . . 0.0 111.703 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.709 ' HB3' HD11 ' A' ' 7' ' ' LEU . 94.2 mttt -132.45 132.25 42.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.768 171.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.08 145.51 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.0 0.429 . . . . 0.0 111.807 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 5.9 p-10 -93.6 112.11 23.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.884 0.849 . . . . 0.0 110.133 174.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.433 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . . . -160.28 168.87 24.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.093 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.04 139.91 53.03 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.781 ' HA ' HD23 ' A' ' 31' ' ' LEU . 3.4 t80 -71.6 128.0 34.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.697 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -107.0 -46.91 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.608 -178.091 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 30' ' ' HIS . . . -153.79 153.54 24.9 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.598 -177.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.2 p -112.89 134.12 54.55 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.08 97.41 5.09 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.593 -173.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 57.56 23.71 9.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.231 173.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.59 -7.55 24.28 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.363 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 61.4 mttp -94.0 160.23 14.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.016 0.436 . . . . 0.0 110.925 175.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.929 HD11 ' HB2' ' A' ' 43' ' ' ALA . 10.7 mm -113.79 115.79 50.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.72 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -87.52 117.85 26.59 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.781 HD23 ' HA ' ' A' ' 21' ' ' PHE . 96.4 mt -119.99 139.69 52.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.451 0.643 . . . . 0.0 112.213 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -99.21 109.97 22.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.003 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HD3' HD13 ' A' ' 39' ' ' ILE . 13.7 mmmm -66.05 155.1 37.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.876 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.41 -15.42 36.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.882 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -105.32 21.77 16.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.43 0.633 . . . . 0.0 110.424 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.87 -16.23 48.02 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.464 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -66.74 154.78 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 35.5 ttmt -122.94 125.62 45.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.953 0.406 . . . . 0.0 110.4 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.506 HD13 ' HD3' ' A' ' 33' ' ' LYS . 33.6 pt -122.5 176.92 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.754 -176.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.13 116.72 6.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.665 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 m -118.13 165.39 13.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -97.51 134.45 40.72 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.929 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -67.37 -8.0 29.31 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -72.05 -28.52 63.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HD3' ' H ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -107.63 15.21 24.92 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.657 177.02 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 46' ' ' LEU . 8.2 tp -84.73 159.79 20.42 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.266 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.579 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 50.1 m -71.32 133.96 46.4 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.59 0.71 . . . . 0.0 109.89 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -57.53 -30.42 65.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.783 -171.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -65.83 -46.26 79.19 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.648 0.737 . . . . 0.0 109.349 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.587 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -59.54 -37.89 79.6 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.929 176.353 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.711 ' HB3' ' HB2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -68.37 -44.95 74.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.899 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.429 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -61.18 -28.43 69.13 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.297 0.57 . . . . 0.0 109.871 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.567 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 32.6 t80 -73.97 -51.79 14.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.335 175.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.5 p -70.86 -33.53 52.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.971 -0.455 . . . . 0.0 111.226 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 1.074 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 3.7 pt-20 -67.29 -24.93 65.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.03 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -46.27 64.58 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.567 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 56.9 mt -56.13 -43.72 76.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.035 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 7.0 p -80.35 -44.9 18.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.352 -175.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.72 -13.98 22.38 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -174.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.458 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 80.2 m-85 -80.21 -167.7 1.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.059 -0.571 . . . . 0.0 109.813 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.42 ' HA ' ' CD ' ' A' ' 55' ' ' GLU . 8.8 t -135.82 130.33 33.81 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 171.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.074 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 12.2 mt -104.87 23.61 13.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.409 0.623 . . . . 0.0 109.617 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.482 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 22.3 tt0 -53.35 -39.61 64.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.373 174.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -70.24 -6.08 32.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.772 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -109.05 -2.16 18.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.349 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' A' ' 63' ' ' GLU . 96.7 mttt . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.481 0.658 . . . . 0.0 109.687 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 CA--C 1.515 -0.402 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 15.3 ptp180 -142.07 -178.81 5.88 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.509 -168.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.835 HD11 ' HB2' ' A' ' 16' ' ' LYS . 2.0 tm? -86.72 103.14 14.89 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.898 -175.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 33.5 m95 -91.61 144.68 25.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.548 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 10' ' ' ASP . 64.8 t -129.93 145.87 35.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -89.74 159.79 16.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 173.335 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -17.42 64.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -171.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 t -86.39 -12.39 49.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.321 0.581 . . . . 0.0 109.866 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.34 37.69 70.56 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.005 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 m -102.12 -42.1 6.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.47 0.176 . . . . 0.0 111.05 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.644 ' CZ ' ' HE3' ' A' ' 45' ' ' LYS . 34.7 p90 -125.1 138.07 54.18 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.821 0.82 . . . . 0.0 112.581 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.835 ' HB2' HD11 ' A' ' 7' ' ' LEU . 8.6 ptpp? -134.89 132.14 38.16 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 113.959 -1.473 . . . . 0.0 108.989 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.458 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -148.51 154.81 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.26 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.627 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 12.0 m-20 -92.87 123.79 36.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.235 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -164.54 157.07 16.69 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.201 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.75 146.76 33.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.509 ' HA ' HD23 ' A' ' 31' ' ' LEU . 78.1 t80 -76.64 132.56 39.48 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.089 0.471 . . . . 0.0 110.013 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -111.6 -46.83 5.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.443 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -166.63 148.34 13.29 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.938 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.491 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 6.9 t -122.75 126.81 48.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.793 0.33 . . . . 0.0 110.25 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.52 141.85 20.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.578 -176.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt 56.7 32.04 20.42 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.621 0.575 . . . . 0.0 111.55 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.69 9.36 87.13 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.624 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 72.3 mmtt -109.56 146.05 35.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.027 0.442 . . . . 0.0 110.76 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' A' ' 43' ' ' ALA . 42.0 mm -105.14 113.27 41.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.485 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.503 ' O ' HG13 ' A' ' 22' ' ' ILE . 17.9 m170 -82.57 120.78 25.95 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.8 mt -122.45 140.4 52.76 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 -175.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -100.05 103.82 15.37 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.911 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.922 ' HD3' HD13 ' A' ' 39' ' ' ILE . 12.5 mmmm -61.28 153.62 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.632 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.82 66.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.388 0.613 . . . . 0.0 109.359 172.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.42 HD22 ' C ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -63.07 -32.69 74.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.766 172.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.47 -2.59 27.88 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.295 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -91.94 150.28 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.634 0.255 . . . . 0.0 110.593 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 38' ' ' LYS . 4.4 tmmm? -101.73 125.49 48.41 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.922 HD13 ' HD3' ' A' ' 33' ' ' LYS . 16.1 pt -121.33 163.91 18.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.836 -177.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.79 103.84 7.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.272 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.1 t -110.54 127.04 67.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.515 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . . . -56.18 124.69 18.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.989 0.423 . . . . 0.0 111.665 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -61.72 -30.1 70.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.908 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.476 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 3.6 p30 -68.73 -32.67 72.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.566 -173.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.644 ' HE3' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -103.44 15.28 29.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.328 0.585 . . . . 0.0 110.11 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.5 tp -95.44 166.82 11.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.287 -177.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.552 ' O ' HD22 ' A' ' 51' ' ' LEU . 44.0 t -71.38 132.53 44.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.901 0.857 . . . . 0.0 111.001 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.647 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 1.6 m-20 -50.94 -38.1 48.37 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.187 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.82 -49.64 72.7 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.086 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.67 ' O ' HG12 ' A' ' 54' ' ' VAL . 74.0 m-20 -67.3 -32.72 73.89 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.784 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.786 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -69.9 -40.05 75.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.944 177.013 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.5 -32.39 72.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.372 0.606 . . . . 0.0 109.767 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.52 ' CE1' HD11 ' A' ' 57' ' ' ILE . 50.8 t80 -67.95 -50.64 54.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.332 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.736 ' HA ' HG12 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -68.32 -32.47 55.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 120.72 0.295 . . . . 0.0 111.253 -177.491 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.786 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 45.5 mt-10 -52.56 -35.66 54.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.52 170.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 1.05 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.55 -30.38 33.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.676 -179.369 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.736 HG12 ' HA ' ' A' ' 54' ' ' VAL . 21.7 mm -64.24 -38.71 83.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.6 p -116.56 -46.99 2.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -170.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.41 1.94 24.63 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.578 -173.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -78.88 153.68 30.35 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 t -97.48 101.48 13.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.038 0.447 . . . . 0.0 110.22 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.654 ' HA ' ' HD2' ' A' ' 65' ' ' PHE . 21.3 mt -98.44 19.67 14.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -63.83 -39.71 94.87 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.972 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -69.04 -9.57 53.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.456 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.654 ' HD2' ' HA ' ' A' ' 62' ' ' LEU . 91.4 m-85 -101.37 -4.84 26.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.948 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.647 ' HD3' ' HB3' ' A' ' 48' ' ' ASN . 52.0 mttp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.359 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 19.9 p . . . . . 0 C--O 1.233 0.225 0 CA-C-O 121.088 0.471 . . . . 0.0 111.728 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 11.3 ptp180 -158.64 -177.85 6.83 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.093 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.421 ' CD2' ' HB2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -89.4 107.08 18.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.264 -175.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.649 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 30.1 m95 -90.89 140.21 30.03 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 90.8 t -130.1 158.32 42.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.963 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -91.66 162.21 14.59 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.4 -0.187 . . . . 0.0 110.503 176.304 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.431 ' HE ' ' HB3' ' A' ' 11' ' ' ARG . 1.7 tmm_? -57.57 -37.88 73.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.642 0.258 . . . . 0.0 111.144 -176.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 t -83.44 -15.44 49.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.734 0.302 . . . . 0.0 111.373 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.78 16.28 56.72 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.302 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 m -83.5 -37.12 23.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.458 0.647 . . . . 0.0 110.071 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.963 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 5.8 m-85 -95.14 137.95 33.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.023 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 19.0 ptpt -152.21 130.1 11.73 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.529 162.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.08 136.22 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.689 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.3 p-10 -75.99 109.15 9.39 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.218 173.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -148.13 167.39 25.14 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.508 -170.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 5' ' ' SER . 26.5 tt0 -133.71 124.35 26.54 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.294 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.654 ' HD1' HG23 ' A' ' 29' ' ' ILE . 67.1 t80 -65.39 130.29 42.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.345 0.593 . . . . 0.0 110.367 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.91 -54.28 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.874 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.06 142.02 7.67 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.467 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.468 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 16.4 p -103.28 142.81 33.55 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -178.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.21 126.81 9.45 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.956 -0.297 . . . . 0.0 111.225 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 55.61 41.4 30.62 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.768 0.667 . . . . 0.0 111.206 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.55 -0.74 80.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.642 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -104.28 166.77 10.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 0.0 110.813 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.654 HG23 ' HD1' ' A' ' 21' ' ' PHE . 85.1 mt -124.09 121.65 62.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.085 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -88.48 129.02 35.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.912 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 90.4 mt -124.49 136.76 54.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.845 0.831 . . . . 0.0 111.873 -172.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 14.3 t-80 -98.43 99.59 10.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.994 176.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 36.2 mtpt -61.83 156.96 19.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.817 0.341 . . . . 0.0 110.167 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.77 -12.45 60.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.627 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -90.91 1.82 56.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.394 177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.02 -24.4 31.43 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.707 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -65.3 145.09 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.599 0.238 . . . . 0.0 110.833 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -114.24 131.62 56.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.1 0.476 . . . . 0.0 110.503 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.8 pt -129.52 166.82 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.989 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.45 118.78 19.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.649 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 m -116.78 156.98 17.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.22 128.04 33.78 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.746 -0.382 . . . . 0.0 109.976 175.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.423 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -64.68 -15.23 61.04 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -174.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.665 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 8.1 p-10 -91.56 -13.93 31.17 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -173.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.05 19.94 19.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.711 0.767 . . . . 0.0 109.523 176.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 8.5 tp -103.48 169.21 8.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.276 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.482 ' O ' HD22 ' A' ' 51' ' ' LEU . 25.2 t -73.61 141.68 46.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.582 0.706 . . . . 0.0 109.367 176.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.448 ' HA ' ' CD2' ' A' ' 51' ' ' LEU . 33.5 m-20 -73.89 -18.73 60.87 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.607 -171.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -43.34 81.23 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.563 ' O ' HG12 ' A' ' 54' ' ' VAL . 35.6 m-20 -63.67 -38.01 89.49 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.196 176.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.822 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -66.42 -45.18 80.79 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.134 177.358 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.68 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -59.39 -32.34 70.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.475 0.655 . . . . 0.0 110.241 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.607 ' CE2' HD11 ' A' ' 57' ' ' ILE . 43.9 t80 -72.32 -50.48 26.56 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.379 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 50' ' ' ASP . 3.2 p -68.42 -28.9 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 O-C-N 122.089 -0.382 . . . . 0.0 110.77 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.822 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 44.4 mt-10 -52.5 -41.43 63.42 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.647 0.26 . . . . 0.0 110.471 169.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.502 ' N ' ' HE3' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -73.79 -33.02 64.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.806 -178.239 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.607 HD11 ' CE2' ' A' ' 53' ' ' TYR . 29.9 mt -67.65 -37.37 78.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.281 175.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.471 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 32.4 p -97.78 -45.17 6.44 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -170.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.97 -7.27 37.94 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -172.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.471 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 65.0 m-85 -80.32 175.88 10.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 110.784 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -121.1 114.77 21.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.432 176.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 35.8 mt -103.58 27.28 7.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.571 -176.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -56.59 -42.1 78.12 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.665 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -72.55 -6.45 44.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.341 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.665 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 97.3 m-85 -102.99 0.3 31.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.418 0.628 . . . . 0.0 109.52 176.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 98.5 mttt . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.778 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 C--O 1.238 0.487 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.581 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 6.6 ptp180 -140.66 -178.83 5.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.245 -173.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.35 105.41 16.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.04 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.688 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 52.4 m95 -91.92 145.05 24.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.828 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 10' ' ' ASP . 61.5 t -135.6 146.0 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.443 0.465 . . . . 0.0 110.379 -176.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.976 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -90.42 174.1 7.74 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.661 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.778 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 2.4 tpm_? -61.68 -43.36 99.01 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 122.389 -0.194 . . . . 0.0 111.393 -177.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -67.74 -29.74 69.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.236 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.96 12.71 51.99 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.33 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -91.47 -39.37 11.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.507 0.67 . . . . 0.0 109.506 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.976 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 3.7 m-85 -82.46 130.7 35.16 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.417 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 8.6 ptpt -157.42 128.68 6.77 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.9 169.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.51 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -154.91 145.79 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.032 -173.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.581 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.5 p-10 -88.24 117.51 27.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.062 174.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.775 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . . . -164.84 163.66 21.11 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.13 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.42 140.34 52.28 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.742 ' HA ' HD23 ' A' ' 31' ' ' LEU . 48.2 t80 -69.3 132.61 46.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.468 0.651 . . . . 0.0 110.372 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.03 -52.51 5.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.043 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.87 143.38 8.55 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.141 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.553 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 20.0 p -105.61 142.13 35.88 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.98 112.43 8.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 111.439 -173.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.6 tptt 52.68 53.55 12.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.791 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.57 -3.73 77.09 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.118 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 84.9 mttt -110.96 170.48 8.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.068 0.461 . . . . 0.0 110.533 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.531 HG23 ' HD1' ' A' ' 21' ' ' PHE . 59.2 mt -129.0 128.04 66.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.882 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -91.31 127.95 36.95 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.9 mt -127.3 137.39 52.82 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.583 -174.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -98.13 100.92 12.26 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.351 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.829 ' HD3' HD13 ' A' ' 39' ' ' ILE . 12.1 mmmm -61.77 160.54 11.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.34 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.29 -14.94 63.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.721 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -84.45 -6.81 59.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.959 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.64 7.52 58.95 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.738 174.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.5 155.04 6.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 117.059 0.429 . . . . 0.0 110.377 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -97.9 144.27 27.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 0.0 110.863 177.077 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.829 HD13 ' HD3' ' A' ' 33' ' ' LYS . 37.2 pt -127.53 156.27 39.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.15 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.13 103.73 11.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.243 0.545 . . . . 0.0 110.159 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.8 t -109.4 125.16 66.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.276 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -79.51 130.63 35.58 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.44 -5.81 12.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.458 -174.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.85 -42.74 57.37 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -172.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -99.13 12.13 37.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 0.0 110.319 -176.772 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.9 tp -83.88 169.35 15.19 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.678 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.569 ' O ' HD22 ' A' ' 51' ' ' LEU . 47.8 t -73.12 138.0 45.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.025 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -47.03 -50.03 20.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.854 0.835 . . . . 0.0 111.248 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.2 -30.36 68.53 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.795 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.609 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -65.65 -38.03 88.21 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.8 177.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.736 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.7 OUTLIER -70.17 -44.21 69.22 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.81 176.211 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.41 65.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.423 0.63 . . . . 0.0 110.224 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.655 ' CE2' HD11 ' A' ' 57' ' ' ILE . 66.5 t80 -73.79 -49.66 24.24 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.421 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.777 HG13 HD12 ' A' ' 62' ' ' LEU . 2.2 p -70.03 -28.25 35.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 O-C-N 122.006 -0.434 . . . . 0.0 110.823 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.736 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 39.3 mt-10 -56.09 -31.47 63.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.724 168.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.859 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 6.6 mmpt? -80.84 -32.25 35.19 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.77 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.655 HD11 ' CE2' ' A' ' 53' ' ' TYR . 39.6 mt -63.32 -41.38 92.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 174.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.563 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 27.4 p -107.41 -46.79 3.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -171.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.31 -5.74 35.97 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.563 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 66.9 m-85 -85.77 136.95 33.13 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.992 0.425 . . . . 0.0 110.29 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 m -75.7 100.94 4.83 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.623 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.777 HD12 HG13 ' A' ' 54' ' ' VAL . 34.3 mt -94.97 18.74 11.42 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.67 0.748 . . . . 0.0 109.389 172.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 1.07 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 24.7 tt0 -73.83 -29.38 62.1 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.894 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -14.88 58.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.954 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.432 ' HD2' ' HA ' ' A' ' 62' ' ' LEU . 96.0 m-85 -105.57 -7.19 18.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.253 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.07 ' HG3' ' HA ' ' A' ' 63' ' ' GLU . 43.1 mttp . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 121.521 0.677 . . . . 0.0 110.881 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.869 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 20.1 p . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.145 0.498 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 17.5 ptp180 -148.47 -178.25 6.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.451 -173.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.833 HD11 ' HB3' ' A' ' 16' ' ' LYS . 2.6 tm? -81.44 106.63 13.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.699 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.583 ' HH2' ' HB ' ' A' ' 54' ' ' VAL . 32.2 m95 -92.8 151.29 20.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.165 174.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 36.9 t -123.07 145.32 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.644 0.259 . . . . 0.0 110.72 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -83.16 160.29 21.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.403 175.852 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -51.57 -46.1 63.34 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.536 0.523 . . . . 0.0 111.921 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 m -94.91 9.81 37.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.819 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.7 23.98 69.37 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.12 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -71.55 -34.36 69.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.176 0.512 . . . . 0.0 110.359 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 10' ' ' ASP . 33.0 p90 -143.21 132.61 23.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.386 0.613 . . . . 0.0 111.186 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.833 ' HB3' HD11 ' A' ' 7' ' ' LEU . 88.3 mttt -109.37 129.98 55.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 167.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.11 135.9 42.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.598 0.713 . . . . 0.0 112.887 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 1.1 p30 -78.27 119.94 22.34 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.757 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.811 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -157.43 158.4 35.75 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.505 0.669 . . . . 0.0 111.892 -172.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.869 ' HB2' ' HB3' ' A' ' 5' ' ' SER . 30.9 tt0 -122.59 124.67 44.03 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.786 176.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.755 ' HD1' HG23 ' A' ' 29' ' ' ILE . 4.5 t80 -70.14 123.35 21.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.153 0.502 . . . . 0.0 110.321 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -105.9 -44.07 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.647 -178.55 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.36 139.93 6.18 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.103 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.43 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 51.9 t -110.04 118.44 36.43 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.93 140.39 29.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.628 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? 65.06 11.7 7.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.131 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.56 -2.79 60.84 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.127 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.734 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 86.6 mttt -102.83 164.45 11.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.0 110.755 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.755 HG23 ' HD1' ' A' ' 21' ' ' PHE . 75.5 mt -114.98 121.22 66.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.015 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.443 ' O ' HG13 ' A' ' 22' ' ' ILE . 20.5 m170 -82.91 124.31 30.23 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.811 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 71.0 mt -124.6 137.49 54.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.432 0.634 . . . . 0.0 111.415 -174.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -107.36 106.18 16.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.577 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 4.1 mtpm? -67.07 166.68 13.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.14 0.495 . . . . 0.0 111.711 -172.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.97 -12.84 60.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.099 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.94 -23.48 38.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.813 173.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.49 -15.08 29.94 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -173.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.2 t -65.86 142.72 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.725 -0.238 . . . . 0.0 110.485 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -108.86 130.21 55.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.157 0.503 . . . . 0.0 110.459 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.457 HG12 ' HB2' ' A' ' 31' ' ' LEU . 12.3 pt -127.39 166.54 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.351 -177.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.1 103.21 5.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.088 0.47 . . . . 0.0 109.994 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 46' ' ' LEU . 74.4 t -116.08 126.36 73.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.934 -176.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -59.35 135.32 57.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.687 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.11 -6.13 12.19 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.374 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -90.15 -41.17 11.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.069 0.462 . . . . 0.0 111.215 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -87.53 22.19 2.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.824 -175.851 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.514 HD13 HG11 ' A' ' 41' ' ' VAL . 9.1 tp -111.91 167.23 10.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.651 -174.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.564 ' O ' HD22 ' A' ' 51' ' ' LEU . 29.6 t -65.0 129.22 38.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.36 0.6 . . . . 0.0 109.649 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.429 ' HA ' HD23 ' A' ' 51' ' ' LEU . 39.3 m-20 -67.2 -21.71 65.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.631 -172.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -60.68 -48.34 82.21 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.695 0.759 . . . . 0.0 109.294 171.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.598 ' O ' HG12 ' A' ' 54' ' ' VAL . 16.2 m-20 -67.59 -31.77 72.05 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.827 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -69.31 -40.79 77.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.395 176.799 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -65.24 -27.92 68.99 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.382 0.61 . . . . 0.0 109.541 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.595 ' CE2' HD11 ' A' ' 57' ' ' ILE . 31.1 t80 -73.61 -50.77 19.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.594 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.4 p -70.5 -33.29 52.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 120.885 0.374 . . . . 0.0 111.255 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.926 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 1.6 pt-20 -65.58 -24.63 67.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.11 0.481 . . . . 0.0 109.923 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 1.035 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 5.3 mmpt? -81.31 -27.27 35.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.585 175.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.595 HD11 ' CE2' ' A' ' 53' ' ' TYR . 54.3 mt -64.33 -41.58 92.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.163 0.506 . . . . 0.0 109.728 172.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.474 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 6.4 p -86.34 -47.43 9.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.775 -173.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.7 -9.91 19.01 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -173.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.551 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 66.6 m-85 -89.25 -172.7 3.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 55' ' ' GLU . 17.1 t -131.53 128.28 38.98 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.573 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.926 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 10.2 mt -95.73 25.94 4.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.034 0.445 . . . . 0.0 110.031 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.429 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 1.2 tp10 -44.36 -51.1 8.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.81 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -71.03 -9.9 58.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.066 -176.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -100.42 0.53 39.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 0.0 110.012 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 87.3 mttt . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.808 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.439 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 2.0 p . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 3.6 ptp180 -112.48 173.42 6.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.213 -167.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -85.72 114.73 22.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.507 -172.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.544 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 81.1 m95 -105.58 146.17 30.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.2 176.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.711 HG22 ' HG2' ' A' ' 16' ' ' LYS . 66.0 t -136.37 138.26 47.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.187 0.304 . . . . 0.0 110.707 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.584 ' HA ' HD12 ' A' ' 46' ' ' LEU . 6.6 p-10 -84.89 159.74 20.29 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -76.76 -1.98 30.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.029 0.443 . . . . 0.0 111.997 -169.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 t -105.34 -3.51 22.62 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.448 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.5 31.02 70.86 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.418 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.4 m -84.76 -43.06 14.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.848 0.356 . . . . 0.0 110.732 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.804 ' HZ ' ' HE3' ' A' ' 45' ' ' LYS . 24.9 p90 -138.76 136.86 36.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.867 0.841 . . . . 0.0 112.679 -176.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.711 ' HG2' HG22 ' A' ' 9' ' ' VAL . 54.1 mttp -126.07 130.9 52.02 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.207 171.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -139.06 157.94 28.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.391 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 29.5 m-20 -103.74 113.4 26.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -159.4 158.68 32.61 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.947 -172.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.439 ' HG3' ' HA ' ' A' ' 5' ' ' SER . 45.3 mt-10 -106.73 138.64 42.53 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.206 174.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.665 ' HA ' HD23 ' A' ' 31' ' ' LEU . 15.2 t80 -71.88 124.35 24.67 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.197 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -105.94 -43.21 7.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.102 -177.841 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.9 150.84 13.7 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.505 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.47 ' HB2' ' HE2' ' A' ' 21' ' ' PHE . 6.3 t -115.1 136.88 52.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.93 119.97 12.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.606 0.241 . . . . 0.0 110.913 -173.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 26' ' ' LYS . 17.9 tptm 55.75 41.17 30.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.314 174.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 65' ' ' PHE . . . 89.92 -4.84 83.45 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.309 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -109.71 159.93 16.74 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 122.453 -0.439 . . . . 0.0 110.765 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.522 HG23 ' HD2' ' A' ' 21' ' ' PHE . 76.1 mt -122.33 124.82 71.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.979 -174.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 92.2 m-70 -87.6 126.42 34.93 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 21' ' ' PHE . 87.4 mt -125.14 136.76 53.93 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.522 -178.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -102.1 100.38 10.62 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -63.32 159.57 17.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.136 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.28 -15.29 56.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.232 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.14 -25.22 37.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.523 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.9 -6.55 27.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.198 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.97 137.64 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.674 0.273 . . . . 0.0 110.577 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 36.5 ttmt -102.57 124.74 48.67 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 31.8 pt -123.43 153.68 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -176.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.29 103.43 8.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.129 175.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 m -99.03 153.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.487 ' HB1' ' OD1' ' A' ' 44' ' ' ASP . . . -82.33 122.22 27.69 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.009 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.93 -20.03 63.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.476 0.655 . . . . 0.0 110.923 -176.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.661 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 6.6 p-10 -77.02 -12.13 59.9 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.164 -175.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.804 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -117.43 10.32 13.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.931 0.872 . . . . 0.0 109.012 173.858 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 10' ' ' ASP . 14.1 tp -89.82 162.79 15.32 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.646 -177.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.572 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 27.0 m -68.28 142.75 55.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.588 0.709 . . . . 0.0 110.68 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -65.41 -27.85 68.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.267 -173.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -64.72 -48.9 72.95 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.603 0.716 . . . . 0.0 109.598 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.572 ' OD1' ' HB2' ' A' ' 47' ' ' SER . 1.6 m-20 -59.86 -36.29 76.57 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.219 175.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.686 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -65.47 -47.37 76.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.576 178.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -62.36 -27.57 69.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.789 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.428 ' O ' HG12 ' A' ' 57' ' ' ILE . 48.8 t80 -71.91 -47.88 49.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.628 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' A' ' 62' ' ' LEU . 61.5 t -62.68 -33.55 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.695 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.632 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 38.2 mt-10 -52.19 -34.77 46.85 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.21 0.529 . . . . 0.0 110.483 173.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 1.033 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.6 mmpt? -82.51 -37.01 25.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.894 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.44 HG21 ' CD1' ' A' ' 21' ' ' PHE . 20.7 mm -69.81 -28.35 36.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.008 0.432 . . . . 0.0 111.202 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.656 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 43.7 p -104.83 -45.38 4.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -173.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.4 4.34 46.84 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -172.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.656 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 96.7 m-85 -102.94 -175.88 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.2 t -125.4 121.75 34.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.102 0.477 . . . . 0.0 110.748 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 51' ' ' LEU . 25.4 mt -95.94 22.83 6.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.647 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.14 -41.14 74.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.402 0.62 . . . . 0.0 110.458 176.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HE3' ' CE2' ' A' ' 65' ' ' PHE . 48.6 pttt -62.53 -14.17 38.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.673 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.661 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 32.7 m-85 -104.38 -8.86 18.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.908 0.385 . . . . 0.0 111.031 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 95.0 mttt . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 121.101 0.477 . . . . 0.0 109.714 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.582 ' CA ' ' HB2' ' A' ' 20' ' ' GLU . 46.1 t . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 121.866 0.841 . . . . 0.0 112.154 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 14.2 ptp180 -149.42 -179.08 6.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.168 -171.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.6 tm? -86.43 107.87 18.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.772 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.456 ' CE3' ' HB3' ' A' ' 50' ' ' ASP . 46.4 m95 -92.38 149.09 21.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.098 176.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 15.6 t -130.58 154.33 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.831 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -101.65 -179.05 3.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.815 0.341 . . . . 0.0 111.217 -178.515 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -60.41 -52.83 63.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.054 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 m -81.8 -7.29 59.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.184 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.0 28.54 45.26 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.527 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.1 m -99.7 -37.28 9.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.521 0.677 . . . . 0.0 109.468 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.831 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 4.8 m-85 -87.01 125.82 34.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.739 -176.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.457 ' HB3' HD11 ' A' ' 7' ' ' LEU . 50.5 mttp -131.63 129.56 41.01 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 158.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.87 133.59 6.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.455 0.645 . . . . 0.0 112.119 -177.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 7.3 p-10 -87.73 116.2 25.71 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.732 176.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -168.49 167.64 11.57 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.102 -174.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' CA ' ' A' ' 5' ' ' SER . 9.6 tp10 -126.97 136.56 52.43 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.137 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.779 ' HA ' HD23 ' A' ' 31' ' ' LEU . 7.1 t80 -65.53 126.6 28.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.723 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -105.54 -50.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.818 179.281 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.11 148.07 15.97 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.583 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 t -108.9 129.12 55.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.18 133.02 15.02 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.138 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm 63.69 23.72 13.61 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.328 175.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.92 4.59 88.52 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.956 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 33.1 mmtp -103.23 154.51 19.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.008 0.433 . . . . 0.0 110.166 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.647 HG23 ' HD1' ' A' ' 21' ' ' PHE . 40.3 mm -108.71 114.07 45.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.347 174.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.448 ' O ' HG13 ' A' ' 22' ' ' ILE . 65.0 m170 -76.21 125.59 29.44 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 175.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.779 HD23 ' HA ' ' A' ' 21' ' ' PHE . 86.3 mt -129.04 136.69 50.62 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.695 -174.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -106.74 107.94 19.21 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.574 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 4.8 mtpm? -67.63 166.14 15.64 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.15 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.64 -14.38 60.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.297 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -93.42 1.96 56.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.904 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.33 -18.08 58.11 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.185 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.1 t -63.67 139.35 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.518 0.199 . . . . 0.0 110.869 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -107.81 121.68 45.22 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 pt -124.42 158.51 31.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.726 -173.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.48 103.39 8.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.152 0.501 . . . . 0.0 110.049 174.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.28 119.97 55.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -58.79 124.95 21.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.436 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -64.96 -26.91 68.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.982 177.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.7 -34.24 71.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.58 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -110.46 18.38 19.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.034 0.445 . . . . 0.0 110.789 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.684 ' HB3' HD21 ' A' ' 51' ' ' LEU . 10.1 tp -95.18 170.12 9.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.149 -176.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.608 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 35.3 t -83.66 139.48 32.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.033 0.92 . . . . 0.0 110.751 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -51.52 -35.04 38.85 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.272 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.22 -50.54 71.35 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 121.412 0.625 . . . . 0.0 109.99 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.608 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 5.8 m-20 -60.99 -36.41 79.4 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.606 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.772 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 26.4 mt -69.82 -43.21 72.49 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -59.41 -28.88 67.32 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.514 0.673 . . . . 0.0 109.869 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.547 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 29.3 t80 -73.7 -50.34 21.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.146 176.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.0 p -70.28 -29.66 40.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.891 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.772 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 42.8 mt-10 -54.63 -37.12 65.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.465 168.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -39.44 66.6 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.547 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 53.3 mt -64.19 -47.23 90.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.084 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.9 p -80.62 -46.46 15.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.363 -174.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.04 -4.55 41.62 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -173.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -100.35 179.36 4.48 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.52 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 6.4 t -118.98 134.51 55.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.805 0.336 . . . . 0.0 110.479 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.531 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 21.8 mt -97.84 35.75 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.123 0.487 . . . . 0.0 110.845 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.44 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 5.8 mm-40 -44.61 -58.41 3.05 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.506 1.122 . . . . 0.0 113.365 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -69.11 -10.54 58.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.644 0.259 . . . . 0.0 111.693 -173.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -105.04 -8.97 18.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.286 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.666 ' HA ' HD12 ' A' ' 51' ' ' LEU . 64.2 mttm . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 121.246 0.546 . . . . 0.0 111.867 -173.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 8.2 ptp180 -115.44 178.16 4.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.879 -171.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 7' ' ' LEU . 6.1 mt -84.45 114.32 21.84 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.214 0.531 . . . . 0.0 111.546 -173.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.581 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 43.9 m95 -98.63 140.66 32.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.595 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 10' ' ' ASP . 43.8 t -124.62 144.84 33.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.915 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.532 ' HA ' HD12 ' A' ' 46' ' ' LEU . 7.4 p-10 -84.89 170.55 12.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.0 109.887 173.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -75.47 -14.52 60.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.631 -172.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -98.13 -16.48 19.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.907 0.384 . . . . 0.0 111.184 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.5 36.85 25.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.661 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -98.87 -37.69 9.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.189 -0.505 . . . . 0.0 110.724 -175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 37.8 p90 -137.0 135.15 37.37 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.725 0.774 . . . . 0.0 112.434 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 47.8 mttp -128.92 130.61 47.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.369 173.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.559 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -145.1 146.1 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.987 0.422 . . . . 0.0 112.102 -176.708 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 6.3 m-20 -82.12 120.39 25.25 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.513 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.674 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -163.16 162.89 25.77 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.74 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.6 138.53 54.53 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 174.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.8 ' HD1' HG23 ' A' ' 29' ' ' ILE . 6.8 t80 -70.91 122.72 20.48 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.508 0.67 . . . . 0.0 110.507 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -100.81 -51.16 9.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.383 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.84 154.35 25.34 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.485 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.412 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 22.6 t -120.82 138.58 53.97 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -177.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.1 131.07 15.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.045 -175.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 56.62 27.1 11.98 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.729 0.643 . . . . 0.0 112.311 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.41 -1.53 69.61 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.711 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 57.0 mttp -103.99 158.93 16.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.011 0.434 . . . . 0.0 110.799 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.8 HG23 ' HD1' ' A' ' 21' ' ' PHE . 94.3 mt -116.38 122.8 70.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.117 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.435 ' O ' HG13 ' A' ' 22' ' ' ILE . 39.7 m170 -84.5 126.94 33.73 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 21' ' ' PHE . 81.8 mt -124.14 135.69 53.69 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.833 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -95.7 103.97 15.87 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.696 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.866 ' HD3' HD13 ' A' ' 39' ' ' ILE . 11.8 mmmm -64.82 158.75 24.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.218 -174.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.8 -20.72 66.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.802 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -66.48 -32.49 73.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.686 173.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.83 -17.26 27.73 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.295 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.4 t -72.59 147.4 10.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.368 -0.416 . . . . 0.0 110.654 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -100.62 128.77 46.56 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.866 HD13 ' HD3' ' A' ' 33' ' ' LYS . 18.1 pt -120.04 159.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.259 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.82 103.55 8.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.069 0.461 . . . . 0.0 110.096 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.1 t -107.29 129.56 60.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -68.18 131.56 45.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.78 0.324 . . . . 0.0 110.191 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -69.07 -6.55 28.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.881 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 2.8 p30 -81.76 -33.81 30.77 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -172.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.588 ' HD3' ' H ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -107.78 19.98 19.4 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.094 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.532 HD12 ' HA ' ' A' ' 10' ' ' ASP . 11.6 tp -93.34 169.69 10.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.799 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.515 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.3 t -74.15 139.47 44.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.561 0.696 . . . . 0.0 110.676 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -63.21 -30.55 71.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.419 -173.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -62.03 -46.98 86.78 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.594 0.712 . . . . 0.0 109.789 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.573 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.3 m-20 -65.54 -34.69 78.85 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.565 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.779 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -69.32 -47.21 65.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.11 177.611 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.576 ' O ' ' HD2' ' A' ' 56' ' ' LYS . . . -60.94 -30.85 70.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.575 0.702 . . . . 0.0 109.991 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.442 ' CE1' HD11 ' A' ' 57' ' ' ILE . 35.2 t80 -69.22 -52.12 30.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.099 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.768 ' HA ' HG12 ' A' ' 57' ' ' ILE . 3.0 p -69.06 -27.22 34.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.868 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.779 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 71.2 mt-10 -51.09 -49.29 60.99 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.106 0.479 . . . . 0.0 109.894 167.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -72.24 -26.62 62.09 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.57 -175.169 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.768 HG12 ' HA ' ' A' ' 54' ' ' VAL . 10.8 mm -67.3 -43.18 88.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.561 174.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 17.8 p -97.19 -47.25 5.82 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.14 -6.9 19.18 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.486 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 90.8 m-85 -92.71 167.89 11.58 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -117.13 134.46 54.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 27.4 mt -105.3 25.17 10.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.685 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 5.5 tp10 -54.5 -41.59 69.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.3 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -60.27 -19.95 56.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.204 177.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.484 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 57.6 m-85 -101.04 -14.16 17.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.31 0.576 . . . . 0.0 110.081 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.685 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 49.6 mtpt . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.282 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.462 ' HD3' HG23 ' A' ' 57' ' ' ILE . 63.9 pttt . . . . . 0 C--O 1.237 0.407 0 CA-C-O 121.286 0.565 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.52 ' C ' ' HG2' ' A' ' 20' ' ' GLU . 15.8 mttt -169.63 154.67 5.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.077 -177.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 1.2 p -56.99 112.63 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.3 0.572 . . . . 0.0 111.157 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 12.1 ptp180 -136.97 -177.09 4.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.054 -171.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.714 HD11 ' HE2' ' A' ' 16' ' ' LYS . 2.2 tm? -91.24 106.68 18.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.41 -174.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.525 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 35.3 m95 -92.12 149.32 21.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.738 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.1 t -135.75 139.96 45.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.844 ' HA ' HD12 ' A' ' 46' ' ' LEU . 1.2 p-10 -80.8 175.14 10.94 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.619 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.528 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 3.7 tpm_? -54.21 -51.21 65.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.836 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -80.21 -14.85 58.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.616 -172.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.68 47.31 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.466 -0.653 . . . . 0.0 111.466 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.2 m -86.62 -36.88 18.56 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.735 0.302 . . . . 0.0 110.189 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.487 ' CE2' ' HE2' ' A' ' 45' ' ' LYS . 39.3 p90 -129.99 141.42 50.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.812 0.815 . . . . 0.0 111.985 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.714 ' HE2' HD11 ' A' ' 7' ' ' LEU . 9.5 ptmm? -128.93 131.81 47.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.895 174.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -134.9 140.92 44.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -172.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.563 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 8.6 p-10 -81.22 122.4 27.35 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 169.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -162.01 155.89 21.51 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.594 -175.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.537 ' HG2' ' N ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -116.33 145.93 42.83 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.415 171.154 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 62.7 t80 -80.91 129.55 34.59 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.148 0.499 . . . . 0.0 110.395 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -108.75 -49.55 7.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.091 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.42 140.87 6.43 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.901 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.595 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 30.8 t -111.1 130.41 55.62 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.41 137.98 18.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.613 0.244 . . . . 0.0 110.713 -174.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 61.6 24.62 14.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.481 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.6 2.68 75.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.789 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -115.03 161.83 17.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.549 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' A' ' 43' ' ' ALA . 69.6 mt -114.36 120.66 64.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.361 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.416 ' O ' HG13 ' A' ' 22' ' ' ILE . 23.0 m-70 -80.48 123.53 28.15 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.646 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 97.7 mt -126.34 139.67 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.152 -174.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -112.66 103.13 11.17 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.205 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.8 mtpt -59.65 152.64 21.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.32 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 5' ' ' SER . . . -72.23 -15.17 61.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.217 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.36 -13.29 60.72 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.437 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.27 9.46 51.1 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.154 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.99 142.77 16.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.759 0.279 . . . . 0.0 110.43 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -105.33 125.21 50.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 pt -127.29 172.44 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.888 0.375 . . . . 0.0 111.123 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.9 110.0 11.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.2 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.15 127.03 71.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.875 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 128.4 36.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.708 0.289 . . . . 0.0 110.486 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.541 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -70.78 -10.16 58.92 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.536 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 11.7 p-10 -96.23 -19.76 19.07 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -172.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.487 ' HE2' ' CE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -104.84 19.56 20.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.428 0.632 . . . . 0.0 109.953 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.844 HD12 ' HA ' ' A' ' 10' ' ' ASP . 8.1 tp -101.5 176.44 5.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.076 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.669 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 22.2 t -88.38 147.52 24.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.065 0.936 . . . . 0.0 111.005 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.737 HD22 ' HB3' ' A' ' 66' ' ' LYS . 1.1 m120 -56.87 -35.38 68.84 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.455 -172.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.07 -45.55 73.51 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.095 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.669 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 2.2 m-20 -59.21 -40.8 86.95 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.989 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.797 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -68.05 -42.94 79.75 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.288 178.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' A' ' 56' ' ' LYS . . . -58.81 -35.19 72.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.253 0.549 . . . . 0.0 110.051 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.438 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 43.6 t80 -68.79 -50.26 51.77 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.151 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.4 p -68.89 -31.41 50.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.614 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.797 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.0 mt-10 -51.91 -40.95 61.54 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.604 168.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.672 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -75.54 -33.97 60.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 110.574 -174.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.462 HG23 ' HD3' ' A' ' 3' ' ' LYS . 52.2 mt -66.26 -39.65 84.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.971 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 p -92.13 -46.32 7.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -171.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.51 -5.5 35.38 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -89.75 -178.48 5.52 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.531 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 13.8 t -124.25 125.41 44.35 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.166 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 21.3 mt -104.19 24.16 11.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.771 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -53.83 -46.53 71.21 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.897 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -59.43 -24.79 63.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.504 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.536 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 90.9 m-85 -89.17 -14.07 36.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 0.0 110.739 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.737 ' HB3' HD22 ' A' ' 48' ' ' ASN . 93.4 mttt -81.29 129.79 34.76 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.79 -21.73 24.93 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.864 -173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 C--N 1.311 -1.094 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.368 -177.014 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.613 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 2.5 ttpm? . . . . . 0 C--O 1.236 0.38 0 CA-C-O 121.082 0.467 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 68.5 mmtt -79.96 80.58 6.35 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.542 0.687 . . . . 0.0 110.37 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -58.47 120.19 8.36 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.385 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 2.8 ptp180 -110.13 174.83 5.68 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.689 -173.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 16' ' ' LYS . 1.7 tm? -94.2 104.72 16.72 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.155 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.776 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 69.3 m95 -91.56 142.73 27.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.825 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 10' ' ' ASP . 82.4 t -132.82 142.45 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 O-C-N 123.488 0.492 . . . . 0.0 110.926 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.97 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -90.63 161.2 15.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -68.5 -23.03 64.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.074 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -75.88 -23.37 55.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.132 0.492 . . . . 0.0 110.377 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.11 12.32 60.28 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.941 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -87.66 -48.11 8.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.525 0.679 . . . . 0.0 109.868 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.97 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 2.4 m-85 -79.67 134.33 36.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.034 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.776 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 7.2 ptpp? -159.97 128.96 5.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.493 165.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.45 151.67 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 120.129 -0.629 . . . . 0.0 111.955 -173.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 8.0 p-10 -84.05 125.48 32.14 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.691 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.441 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -167.93 156.83 9.41 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.183 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.613 ' HG3' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -109.71 149.16 30.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.538 177.66 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.717 ' HA ' HD12 ' A' ' 31' ' ' LEU . 58.2 t80 -87.39 131.36 34.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.491 -173.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -107.85 -44.98 7.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.823 0.344 . . . . 0.0 110.58 179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.33 161.81 31.07 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 121.129 -0.557 . . . . 0.0 111.836 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 t -141.78 132.58 25.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.286 0.543 . . . . 0.0 110.96 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.09 149.33 26.0 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.12 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.58 21.43 10.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.095 0.558 . . . . 0.0 111.937 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.17 23.06 50.1 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.336 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.67 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 47.1 mmtm -125.59 146.51 49.66 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 120.872 0.367 . . . . 0.0 110.982 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.556 ' CG2' HD13 ' A' ' 31' ' ' LEU . 1.9 mp -106.92 123.95 62.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.354 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 22' ' ' ILE . 36.6 m170 -89.83 120.32 30.97 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.717 HD12 ' HA ' ' A' ' 21' ' ' PHE . 3.0 tp -121.63 153.35 38.22 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.342 -173.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -128.53 107.2 9.52 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.352 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.512 ' HD3' HD13 ' A' ' 39' ' ' ILE . 12.6 mmmm -58.59 161.35 4.69 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.242 -175.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.62 -25.63 68.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.773 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -79.16 -19.61 50.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.081 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.7 26.92 6.23 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.691 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.51 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 47.3 t -102.42 143.01 15.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -105.52 131.12 53.32 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.079 0.466 . . . . 0.0 110.963 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.512 HD13 ' HD3' ' A' ' 33' ' ' LYS . 24.5 pt -135.36 160.27 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.605 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.81 117.87 29.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.039 0.447 . . . . 0.0 110.135 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.2 t -112.11 134.98 52.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.775 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.67 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . . . -69.8 127.03 31.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.724 0.297 . . . . 0.0 110.907 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.11 -14.15 61.28 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.418 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.436 ' OD1' ' HB1' ' A' ' 42' ' ' ALA . 7.1 p-10 -92.88 -14.72 27.29 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 19.4 ptmt -97.51 -2.1 42.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.474 0.654 . . . . 0.0 110.124 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 46' ' ' LEU . 2.6 tp -84.86 159.63 20.34 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.504 -170.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.589 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 48.1 t -71.65 153.34 42.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.4 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.472 ' HA ' HD22 ' A' ' 51' ' ' LEU . 12.6 m-80 -64.12 -28.65 69.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.211 -176.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -66.11 -47.82 72.93 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.865 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.589 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 4.1 m-20 -62.63 -32.14 73.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.486 177.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.724 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -65.98 -51.6 57.02 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.112 177.311 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -63.71 -27.2 69.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.123 0.487 . . . . 0.0 111.06 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.475 ' CE1' HD11 ' A' ' 57' ' ' ILE . 22.9 t80 -70.0 -48.3 58.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.866 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 50' ' ' ASP . 78.8 t -62.8 -34.3 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.777 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.691 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 44.0 mt-10 -54.84 -32.77 60.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.022 0.439 . . . . 0.0 110.512 174.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.566 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -80.18 -47.15 15.13 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.053 -178.008 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.475 HD11 ' CE1' ' A' ' 53' ' ' TYR . 25.0 mt -62.47 -36.63 75.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 111.727 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 55.8 p -103.12 -46.48 4.62 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.22 -8.01 30.87 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -173.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 92.8 m-85 -90.99 135.42 33.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.11 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.1 m -82.11 130.59 35.13 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.766 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.724 HD12 ' HA ' ' A' ' 51' ' ' LEU . 48.6 mt -104.63 30.2 5.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.179 0.514 . . . . 0.0 109.875 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -53.95 -47.48 71.24 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.349 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -67.11 -13.55 62.05 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.8 -14.97 27.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.922 0.391 . . . . 0.0 110.235 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 92.2 mttt -86.07 171.05 11.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.599 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.89 72.92 0.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.86 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.9 m120 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.163 -178.046 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt . . . . . 0 C--O 1.234 0.27 0 CA-C-O 121.271 0.558 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.648 ' HB2' HH21 ' A' ' 6' ' ' ARG . 31.4 mmmt -122.32 120.9 35.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.879 -174.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 t -61.16 124.56 20.89 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.648 HH21 ' HB2' ' A' ' 4' ' ' LYS . 9.3 ptp180 -143.39 -179.29 6.32 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.81 -167.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 16' ' ' LYS . 2.1 tm? -95.24 105.27 17.2 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.856 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.604 ' CE3' ' HB3' ' A' ' 50' ' ' ASP . 37.0 m95 -91.57 139.16 30.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 10' ' ' ASP . 47.6 t -119.31 137.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.846 0.355 . . . . 0.0 110.858 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.6 ' HB3' ' H ' ' A' ' 14' ' ' THR . 9.8 t70 -63.46 158.82 19.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.552 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 44.5 ttp180 -74.11 -35.03 64.12 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.712 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -95.87 11.97 31.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.137 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.71 28.58 73.5 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.897 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.6 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 6.7 m -67.5 -37.07 82.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.745 -0.228 . . . . 0.0 111.111 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -158.39 157.54 32.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.261 0.553 . . . . 0.0 111.407 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.71 ' HB3' HD11 ' A' ' 7' ' ' LEU . 9.1 mtmp? -125.13 132.29 53.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.514 171.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.448 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -135.27 141.39 42.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 112.548 0.574 . . . . 0.0 112.548 -175.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.7 OUTLIER -95.29 115.11 26.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.312 176.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.875 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . . . -170.24 167.19 8.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.16 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.464 ' HG2' ' C ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -117.3 140.33 49.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.217 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.912 ' HA ' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -65.72 134.54 53.41 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.993 0.425 . . . . 0.0 109.876 177.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.983 HD12 ' HE3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -110.29 -47.64 6.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.111 177.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.54 139.41 5.78 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.293 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.616 ' HG ' ' HE2' ' A' ' 21' ' ' PHE . 78.2 m -98.69 126.36 44.27 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.58 136.5 22.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.6 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 tptt 63.8 27.64 14.63 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.643 0.735 . . . . 0.0 110.118 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.56 3.57 88.92 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.211 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.873 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 42.1 mttm -109.95 171.91 7.17 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.66 HG23 ' HD2' ' A' ' 21' ' ' PHE . 57.9 mt -124.67 116.72 48.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.384 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.418 ' O ' HG13 ' A' ' 22' ' ' ILE . 57.3 m-70 -75.88 128.2 34.61 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.912 HD23 ' HA ' ' A' ' 21' ' ' PHE . 77.1 mt -126.82 136.92 53.02 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.363 -172.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.571 ' HB2' HD11 ' A' ' 22' ' ' ILE . 15.1 t-160 -102.31 102.59 12.97 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.345 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.875 ' HD2' ' HB2' ' A' ' 19' ' ' ALA . 1.6 mmmp? -65.13 163.99 13.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.073 -176.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.3 -13.48 62.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.101 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -87.29 -10.49 52.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.592 176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.91 -18.4 52.47 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.922 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.6 p -72.65 147.98 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.945 0.402 . . . . 0.0 110.823 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.983 ' HE3' HD12 ' A' ' 22' ' ' ILE . 84.6 tttt -111.16 132.96 53.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.613 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 pt -126.95 174.69 10.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.484 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.89 103.19 5.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.245 0.545 . . . . 0.0 110.056 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.563 HG13 ' HE3' ' A' ' 45' ' ' LYS . 73.2 t -106.84 118.63 54.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.668 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.873 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -57.85 139.14 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.375 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.14 -9.33 58.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.693 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -84.05 -31.27 25.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.122 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.563 ' HE3' HG13 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -99.24 27.34 5.21 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.362 175.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.546 HD12 HD12 ' A' ' 29' ' ' ILE . 13.9 mt -102.26 163.67 12.11 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 122.338 1.066 . . . . 0.0 112.241 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.567 ' O ' HD22 ' A' ' 51' ' ' LEU . 30.2 t -71.05 135.65 47.87 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.104 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.472 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 3.0 m-20 -48.44 -38.91 21.04 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.842 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.74 -47.07 83.5 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.564 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.604 ' HB3' ' CE3' ' A' ' 8' ' ' TRP . 43.6 m-20 -67.49 -34.97 78.24 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.238 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.789 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -70.95 -41.71 70.76 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.505 176.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.513 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -60.69 -29.44 69.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.515 0.674 . . . . 0.0 110.135 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 51.1 t80 -71.51 -51.59 22.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.935 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.802 ' HA ' HG12 ' A' ' 57' ' ' ILE . 2.7 p -71.23 -27.66 30.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.607 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.789 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 42.6 mt-10 -51.67 -38.53 55.36 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.165 0.507 . . . . 0.0 109.796 168.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -76.4 -41.11 48.97 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.783 -178.393 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.802 HG12 ' HA ' ' A' ' 54' ' ' VAL . 7.5 mm -61.69 -36.29 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.8 p -101.88 -49.17 4.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.34 -34.22 4.37 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.989 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -87.98 140.74 29.19 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 117.14 0.47 . . . . 0.0 110.451 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.7 t -79.51 135.73 36.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.424 -171.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 23.8 mt -104.68 22.28 15.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.115 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.589 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 2.2 tp10 -50.69 -38.63 47.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.4 0.619 . . . . 0.0 110.362 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 18.3 ptmt -67.48 -5.92 17.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.843 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -115.94 -12.48 11.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.229 0.537 . . . . 0.0 110.103 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 45.1 mtpt -90.08 140.37 29.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.831 -174.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.552 ' HB2' ' HD2' ' A' ' 11' ' ' ARG . . . -96.77 54.43 1.3 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.442 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.243 0.746 0 CA-C-O 118.887 -0.577 . . . . 0.0 110.228 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.7 tptm . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 121.339 0.59 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.586 ' HE3' ' HG3' ' A' ' 20' ' ' GLU . 29.7 mtpp -106.71 172.94 6.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.504 -175.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 1.084 ' H ' ' HG2' ' A' ' 20' ' ' GLU . 60.9 p 54.41 105.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.479 -176.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 11.6 ptp180 -118.96 176.52 5.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.798 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.6 tm? -95.66 105.68 17.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.975 0.417 . . . . 0.0 110.769 -173.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.701 ' HB2' HG23 ' A' ' 17' ' ' VAL . 48.7 m95 -92.4 152.64 19.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.299 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 16' ' ' LYS . 47.6 t -135.76 142.94 37.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.673 ' HA ' HD12 ' A' ' 46' ' ' LEU . 3.5 p-10 -85.41 178.31 7.49 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.084 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.534 ' HG3' ' HB1' ' A' ' 67' ' ' ALA . 48.2 ttp180 -59.52 -40.48 87.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.83 0.348 . . . . 0.0 111.552 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.8 m -84.5 -18.65 35.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.5 13.93 74.89 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.708 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 m -79.87 -37.02 35.75 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.683 -0.258 . . . . 0.0 111.182 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 47.0 p90 -123.4 125.15 44.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.009 0.909 . . . . 0.0 112.175 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.611 ' HB3' HD11 ' A' ' 7' ' ' LEU . 52.2 mttp -116.61 131.17 57.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.452 174.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -131.91 136.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.1 p-10 -90.02 106.11 18.26 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.181 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -161.44 161.79 30.3 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.767 -171.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 1.084 ' HG2' ' H ' ' A' ' 5' ' ' SER . 1.1 mm-40 -107.92 142.79 37.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.563 174.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.645 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 69.4 t80 -73.85 130.32 39.68 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.975 174.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -115.8 -47.62 4.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.408 178.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.83 148.51 14.86 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.86 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.645 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 30.8 t -124.18 126.89 46.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.859 0.329 . . . . 0.0 110.126 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.33 116.69 16.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.112 -173.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.5 tptt 55.2 44.5 27.6 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.201 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.28 2.82 85.19 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.46 175.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 46.7 mmtm -107.06 151.74 24.94 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 117.118 0.459 . . . . 0.0 110.079 174.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.672 HG13 ' HB2' ' A' ' 43' ' ' ALA . 91.0 mt -119.87 123.76 71.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.286 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.502 ' O ' HG13 ' A' ' 22' ' ' ILE . 34.6 m170 -84.96 124.08 31.27 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 21' ' ' PHE . 96.5 mt -125.63 138.45 53.92 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.83 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -107.37 101.14 10.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.175 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HE3' HG12 ' A' ' 17' ' ' VAL . 38.1 mtpt -64.96 159.06 23.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.471 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.9 -15.68 63.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.54 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.77 -20.07 61.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.566 174.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.57 -20.5 27.37 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.963 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.7 p -79.2 142.12 14.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.293 0.568 . . . . 0.0 111.19 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -99.65 127.8 45.76 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.928 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.1 pt -122.87 162.62 22.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.958 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.91 122.66 38.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.842 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.59 163.55 15.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . . . -92.42 119.71 32.22 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.411 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.672 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -64.24 -21.92 66.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.735 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.61 -22.41 63.5 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.764 -174.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HE2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -127.22 28.62 5.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.431 0.634 . . . . 0.0 110.377 179.566 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 10' ' ' ASP . 10.7 tp -95.03 170.58 9.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.592 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.649 ' O ' HD22 ' A' ' 51' ' ' LEU . 33.4 t -72.74 139.73 47.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.422 0.63 . . . . 0.0 110.1 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.466 ' CB ' ' HB3' ' A' ' 66' ' ' LYS . 11.2 p30 -66.06 -24.51 66.74 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.983 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -63.87 -47.77 79.36 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.637 0.732 . . . . 0.0 109.192 174.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.629 ' O ' HG12 ' A' ' 54' ' ' VAL . 3.3 m-20 -58.62 -43.8 89.78 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.712 176.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.797 HD23 ' HA ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -67.57 -42.39 82.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.819 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -61.5 -29.64 70.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.401 0.62 . . . . 0.0 110.134 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.744 ' CE2' HD11 ' A' ' 57' ' ' ILE . 40.9 t80 -74.61 -49.13 22.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.763 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.2 p -69.48 -27.65 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.119 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.764 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 50.6 mt-10 -51.24 -40.91 59.85 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 167.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 52' ' ' ALA . 9.3 mmpt? -74.14 -38.61 63.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.389 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.744 HD11 ' CE2' ' A' ' 53' ' ' TYR . 31.9 mt -62.84 -39.8 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.976 0.417 . . . . 0.0 111.253 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 40.3 p -95.22 -43.91 7.85 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -168.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.2 7.46 43.4 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.494 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.593 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 98.1 m-85 -103.7 177.06 4.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -123.69 124.66 43.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.959 0.409 . . . . 0.0 110.034 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 65' ' ' PHE . 62.1 mt -102.89 41.19 1.27 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.45 0.643 . . . . 0.0 110.189 -175.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.73 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 8.5 tp10 -50.62 -59.65 3.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.479 -176.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -70.35 -10.47 59.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.339 0.59 . . . . 0.0 109.917 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.677 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 60.3 m-85 -91.88 -14.2 30.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.566 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.797 ' HA ' HD23 ' A' ' 51' ' ' LEU . 50.8 mtmt -72.34 136.32 46.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.476 -175.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.534 ' HB1' ' HG3' ' A' ' 11' ' ' ARG . . . -65.27 116.42 6.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.319 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.074 177.715 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.6 tptm . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.421 0.153 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 57.9 tttm 64.11 18.55 11.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 122.113 0.958 . . . . 0.0 111.111 173.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.6 p -78.58 144.26 35.71 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.754 -170.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 2.8 ptp180 -136.54 -179.17 5.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.052 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -93.18 115.14 27.77 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.497 -172.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.719 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 62.4 m95 -104.6 149.15 25.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.156 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 59.5 t -136.75 149.92 26.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 123.543 0.527 . . . . 0.0 109.829 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.993 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -96.67 174.09 7.0 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.214 178.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.896 ' HG3' ' HB3' ' A' ' 67' ' ' ALA . 1.6 tmm_? -66.82 -34.29 77.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.705 0.288 . . . . 0.0 110.857 -174.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -75.68 -23.36 56.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.21 2.17 66.3 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.666 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -80.8 -40.48 24.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.349 0.595 . . . . 0.0 109.834 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.993 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 5.7 m-85 -85.93 127.12 34.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.829 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.719 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 8.6 ptmt -153.35 128.57 9.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.917 166.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.422 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -158.36 156.36 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.785 -173.367 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -92.81 118.67 31.35 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.899 174.475 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -163.86 164.62 23.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.621 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -115.97 138.32 51.3 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.818 ' HD2' HG23 ' A' ' 29' ' ' ILE . 6.6 t80 -74.41 117.91 16.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.324 0.583 . . . . 0.0 109.504 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -96.07 -45.37 13.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.136 -177.153 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.93 143.21 7.55 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.766 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.598 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 22.1 p -100.82 133.93 44.55 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.74 126.91 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.576 -173.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.3 OUTLIER 61.44 34.2 18.27 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.811 176.442 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.29 7.42 88.48 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.254 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -104.7 165.91 10.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.028 0.442 . . . . 0.0 110.442 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.818 HG23 ' HD2' ' A' ' 21' ' ' PHE . 84.6 mt -125.51 116.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.52 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.492 ' O ' HG13 ' A' ' 22' ' ' ILE . 11.2 m170 -83.61 126.94 33.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.725 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.7 mt -124.72 138.89 54.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.284 0.564 . . . . 0.0 111.021 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -104.72 105.55 15.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.468 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HD3' HD13 ' A' ' 39' ' ' ILE . 13.5 mmmm -61.14 162.89 6.75 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.527 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.14 -12.47 60.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.265 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -89.26 -13.46 38.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.195 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.82 2.56 56.19 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.468 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.17 148.14 5.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.554 0.216 . . . . 0.0 110.46 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -100.04 126.41 46.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.041 0.448 . . . . 0.0 110.857 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.624 HD13 ' HD3' ' A' ' 33' ' ' LYS . 24.8 pt -124.86 168.45 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.949 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.88 124.36 18.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.258 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 m -114.05 164.71 9.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.522 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . . . -85.86 127.85 34.68 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.183 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -63.97 -5.8 5.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.372 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -110.71 -15.72 13.77 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.522 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -96.26 0.88 51.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 6.6 tp -86.27 169.23 13.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.058 -175.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.634 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.5 t -78.9 138.29 38.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.776 0.798 . . . . 0.0 109.923 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.45 ' ND2' ' HB3' ' A' ' 66' ' ' LYS . 1.2 m-20 -53.53 -32.79 52.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.329 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -62.91 -48.13 80.28 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.046 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.668 ' O ' HG12 ' A' ' 54' ' ' VAL . 2.6 m-20 -59.67 -39.26 83.88 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.555 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.736 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -70.21 -38.89 75.39 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.158 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -60.33 -30.44 69.51 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.566 0.698 . . . . 0.0 110.197 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.663 ' CE2' HD11 ' A' ' 57' ' ' ILE . 80.2 t80 -74.36 -48.41 28.21 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.507 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -65.17 -26.98 41.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.415 -0.803 . . . . 0.0 110.853 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.736 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 37.8 mt-10 -51.47 -43.53 62.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.26 166.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.599 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 1.6 ppmt? -72.87 -31.58 64.82 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.992 0.425 . . . . 0.0 109.983 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.663 HD11 ' CE2' ' A' ' 53' ' ' TYR . 37.7 mt -66.94 -42.84 89.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.735 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.4 p -104.52 -46.38 4.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -171.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.13 -14.57 23.51 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -79.74 137.64 37.08 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.432 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 20.9 t -89.45 112.04 23.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.938 0.399 . . . . 0.0 110.238 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 30.1 mt -91.51 24.86 2.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.638 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -53.48 -47.37 69.85 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.677 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -73.33 -5.35 39.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.502 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -97.41 -16.13 20.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.102 0.477 . . . . 0.0 110.14 176.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 97.9 mttt -72.94 147.98 44.75 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.877 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.896 ' HB3' ' HG3' ' A' ' 11' ' ' ARG . . . -109.36 166.93 10.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.191 -170.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 . . . . . 0 C--O 1.251 1.164 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.958 -179.868 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.236 0.39 0 CA-C-O 121.264 0.554 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 5' ' ' SER . 66.6 mttm -113.64 134.19 54.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.624 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 25.1 t 69.75 160.12 0.19 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.722 0.639 . . . . 0.0 111.101 -175.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -148.59 -179.82 7.26 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 110.737 178.064 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.461 HD11 ' HB3' ' A' ' 16' ' ' LYS . 2.6 tm? -103.72 108.18 19.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.507 -175.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.6 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 43.1 m95 -93.22 145.46 24.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.046 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.24 148.5 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -86.66 177.32 7.39 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.187 176.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.839 ' HG2' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -55.11 -44.87 75.35 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.305 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.637 ' N ' ' HD3' ' A' ' 11' ' ' ARG . 64.6 p -85.4 -28.97 24.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.017 0.437 . . . . 0.0 111.436 -173.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.11 20.3 30.92 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.467 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.6 m -78.24 -37.48 45.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.783 0.325 . . . . 0.0 110.297 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.42 ' HZ ' ' HD3' ' A' ' 45' ' ' LYS . 42.0 p90 -132.87 133.56 43.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.84 0.828 . . . . 0.0 112.376 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HB3' HD11 ' A' ' 7' ' ' LEU . 21.7 mtmm -123.11 143.89 49.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.608 175.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.639 HG12 ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -137.66 135.85 46.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.674 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 10.3 p-10 -85.89 105.36 16.32 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.486 173.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.792 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -156.21 162.43 40.18 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.329 -171.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.624 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -119.1 139.47 51.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.857 172.404 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.805 ' HD2' HG23 ' A' ' 29' ' ' ILE . 33.6 t80 -68.56 132.22 46.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -113.76 -48.89 5.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.19 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.08 157.59 29.15 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.0 p -116.87 140.87 48.94 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 28' ' ' LYS . . . -135.02 105.59 6.43 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.172 -174.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? 59.12 41.86 19.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.923 0.868 . . . . 0.0 109.573 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.71 -19.18 52.87 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.978 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 42' ' ' ALA . 3.6 ptpp? -89.18 163.72 15.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.406 0.603 . . . . 0.0 110.423 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.805 HG23 ' HD2' ' A' ' 21' ' ' PHE . 57.8 mt -115.39 126.8 73.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.12 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.459 ' O ' HG13 ' A' ' 22' ' ' ILE . 91.4 m-70 -86.16 127.27 34.69 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 169.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.792 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 95.8 mt -125.63 137.8 53.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.91 -176.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -106.3 110.05 22.17 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.271 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.674 ' HE2' ' O ' ' A' ' 18' ' ' ASP . 11.8 mmmm -58.05 151.81 17.91 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 123.696 0.623 . . . . 0.0 109.901 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.65 -16.06 63.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.623 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -89.82 -7.13 55.03 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.153 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.45 -23.41 12.33 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.718 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 t -67.44 145.78 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 117.001 0.4 . . . . 0.0 110.88 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -112.37 130.27 56.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.821 0.343 . . . . 0.0 110.196 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.429 HD13 ' HD3' ' A' ' 33' ' ' LYS . 20.8 pt -126.1 165.68 23.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.385 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.58 124.46 40.0 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.59 HG13 ' HE3' ' A' ' 45' ' ' LYS . 70.4 t -130.4 120.58 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.402 -175.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . . . -66.06 129.27 39.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.2 -18.27 63.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.626 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.726 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 2.9 p30 -72.72 -25.64 61.3 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.094 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.59 ' HE3' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.43 29.03 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.751 0.786 . . . . 0.0 110.051 176.413 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.5 tp -108.77 174.5 5.84 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.197 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.559 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 47.6 t -80.21 138.01 36.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.925 0.869 . . . . 0.0 110.766 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -51.2 -41.23 60.1 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.756 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.7 -45.27 87.32 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.132 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.6 ' OD2' ' HA ' ' A' ' 8' ' ' TRP . 3.9 m-20 -60.24 -36.83 78.63 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.166 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.784 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -67.18 -42.72 83.74 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 120.597 -0.441 . . . . 0.0 109.918 176.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -60.97 -29.65 69.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.486 0.66 . . . . 0.0 110.237 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -73.85 -51.32 16.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.169 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.833 ' HA ' HG12 ' A' ' 57' ' ' ILE . 3.6 p -69.63 -25.7 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.143 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.784 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.0 mt-10 -50.34 -44.38 54.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.101 0.476 . . . . 0.0 109.733 167.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 52' ' ' ALA . 1.1 mpmm? -72.76 -34.55 67.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.492 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.833 HG12 ' HA ' ' A' ' 54' ' ' VAL . 4.9 mm -68.78 -34.15 63.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.067 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.732 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 37.6 p -99.31 -48.1 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -171.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.56 -0.76 34.5 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -171.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.732 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 87.3 m-85 -102.04 141.13 35.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.439 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 17.7 t -88.2 111.7 21.92 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.695 HD12 HG13 ' A' ' 54' ' ' VAL . 50.9 mt -90.3 24.44 2.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.174 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -57.78 -40.97 81.06 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.002 0.43 . . . . 0.0 110.504 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' NZ ' ' HB2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -71.35 -5.79 35.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.254 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.726 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 96.4 m-85 -108.68 -4.33 17.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.307 177.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.641 ' HG2' HD23 ' A' ' 51' ' ' LEU . 98.8 mttt -86.01 143.31 28.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.038 -176.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 67.0 86.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 O-C-N 124.221 0.951 . . . . 0.0 111.558 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.839 ' HB3' ' HG2' ' A' ' 11' ' ' ARG . 27.7 t-20 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.354 -0.832 . . . . 0.0 109.517 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.622 ' HE3' ' O ' ' A' ' 5' ' ' SER . 51.6 tptt . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 121.243 0.545 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 4' ' ' LYS . 22.1 mtpp -81.42 153.84 26.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 169.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.837 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 12.1 t 67.91 156.54 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.848 0.717 . . . . 0.0 109.701 -170.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -152.72 174.14 14.39 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.82 -0.55 . . . . 0.0 111.555 -177.674 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.8 tm? -94.75 104.58 16.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.182 -174.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.603 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 63.2 m95 -92.88 143.94 25.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.086 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.496 HG22 ' HG2' ' A' ' 16' ' ' LYS . 45.3 t -128.73 143.35 41.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HA ' HD12 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -89.31 160.13 17.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 8.1 tmm_? -70.64 -20.76 62.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.586 -170.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 t -82.28 -12.78 57.81 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.245 0.545 . . . . 0.0 109.781 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.4 30.8 61.91 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.915 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.6 m -93.9 -44.4 8.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.413 0.149 . . . . 0.0 110.975 -176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 10' ' ' ASP . 34.8 p90 -127.17 131.74 50.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.912 0.863 . . . . 0.0 112.932 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.718 ' HB3' HD11 ' A' ' 7' ' ' LEU . 86.9 mttt -116.48 130.73 56.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.674 170.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.45 144.66 27.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.623 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 17.9 t70 -94.46 115.07 27.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.196 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.656 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -161.07 162.56 31.67 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.914 -172.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.837 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 5.5 mm-40 -107.94 137.97 45.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.246 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.887 ' HD1' HG23 ' A' ' 29' ' ' ILE . 4.4 t80 -78.95 120.09 23.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.83 HD12 ' HE3' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -105.41 -42.01 6.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.711 -174.569 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.73 142.15 7.56 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.848 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.526 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 27.5 p -104.73 125.53 50.9 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.24 115.54 20.56 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.117 -172.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 65.67 -76.29 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.112 0.883 . . . . 0.0 111.085 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.49 18.32 1.49 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.949 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -125.77 166.52 16.66 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.472 0.653 . . . . 0.0 111.503 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.887 HG23 ' HD1' ' A' ' 21' ' ' PHE . 67.4 mt -117.24 126.49 74.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.828 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.467 ' O ' HG13 ' A' ' 22' ' ' ILE . 25.2 m170 -91.29 127.42 36.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.656 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.5 mm? -121.0 140.64 51.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.481 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -104.29 101.33 11.05 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 169.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.604 ' HD2' HD13 ' A' ' 39' ' ' ILE . 44.0 mtpt -68.21 154.67 41.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.165 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.73 -14.05 57.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.551 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.641 ' OD1' HG12 ' A' ' 37' ' ' VAL . 43.2 p30 -80.84 -18.93 45.8 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.935 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.65 -21.11 9.22 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.521 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.641 HG12 ' OD1' ' A' ' 35' ' ' ASN . 9.9 p -85.16 150.75 3.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.276 0.56 . . . . 0.0 111.238 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.83 ' HE3' HD12 ' A' ' 22' ' ' ILE . 85.4 tttt -107.24 125.92 51.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.557 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.604 HD13 ' HD2' ' A' ' 33' ' ' LYS . 16.4 pt -122.07 169.99 12.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.279 -173.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.03 103.68 6.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.607 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.517 HG11 HD13 ' A' ' 46' ' ' LEU . 67.8 t -101.82 122.81 54.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB1' ' OD1' ' A' ' 44' ' ' ASP . . . -60.45 129.57 42.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.259 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -72.4 -6.38 43.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.01 0.433 . . . . 0.0 111.835 -172.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.44 ' OD1' ' HB1' ' A' ' 42' ' ' ALA . 8.6 p-10 -98.14 -20.23 17.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.823 -173.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HE2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -102.82 6.03 39.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.782 0.801 . . . . 0.0 109.78 176.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 10' ' ' ASP . 13.1 tp -91.62 170.39 9.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.299 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.626 ' O ' HD22 ' A' ' 51' ' ' LEU . 40.7 t -75.65 135.35 40.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.694 0.759 . . . . 0.0 110.444 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.444 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 19.3 m-20 -60.03 -32.15 70.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.949 -174.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.89 -43.78 97.88 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.664 0.745 . . . . 0.0 109.845 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.615 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.0 m-20 -64.75 -37.92 89.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.444 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.767 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -67.73 -39.8 84.25 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.667 177.328 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.654 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -60.25 -32.13 70.86 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.458 0.647 . . . . 0.0 109.978 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.746 ' CE2' HD11 ' A' ' 57' ' ' ILE . 80.6 t80 -72.21 -48.41 43.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.523 176.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -68.94 -26.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 121.757 -0.589 . . . . 0.0 111.241 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.767 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 48.2 mt-10 -51.3 -38.33 52.33 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.139 0.495 . . . . 0.0 109.764 166.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.559 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -73.56 -43.65 59.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.042 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.746 HD11 ' CE2' ' A' ' 53' ' ' TYR . 35.9 mt -57.58 -37.96 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.023 0.44 . . . . 0.0 111.193 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 35.1 p -98.66 -47.1 5.46 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -170.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.76 -3.77 39.2 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -171.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -92.09 172.84 8.17 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.7 t -117.94 128.01 54.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.172 0.51 . . . . 0.0 109.918 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 33.3 mt -106.22 19.76 20.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.941 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -53.17 -42.71 66.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.189 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -59.14 -23.62 62.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.5 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.408 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 79.2 m-85 -97.25 -12.78 22.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.668 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 97.3 mttt -76.71 140.15 40.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.428 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.71 108.28 19.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.908 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.438 177.323 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm . . . . . 0 C--O 1.234 0.277 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.621 ' HE3' ' HG3' ' A' ' 20' ' ' GLU . 31.9 mmmt 69.46 158.42 0.17 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.89 0.744 . . . . 0.0 111.077 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.926 ' H ' ' HG2' ' A' ' 20' ' ' GLU . 40.1 t 63.13 112.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 122.052 0.929 . . . . 0.0 110.958 -174.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 13.8 ptp180 -126.12 177.36 6.42 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.447 -171.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.709 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.9 tm? -89.39 119.11 29.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.882 0.372 . . . . 0.0 111.325 -171.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.568 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 41.9 m95 -108.5 148.04 30.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.953 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.534 ' CG1' ' HA2' ' A' ' 13' ' ' GLY . 39.2 t -129.88 143.41 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 123.026 0.204 . . . . 0.0 110.456 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.66 ' HA ' HD12 ' A' ' 46' ' ' LEU . 1.7 p-10 -86.05 -179.47 6.77 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.9 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -52.94 -44.87 67.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.603 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 m -88.1 -20.53 25.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.039 0.447 . . . . 0.0 111.069 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.534 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . 86.81 14.58 64.83 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.629 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 m -74.49 -38.68 62.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.774 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 49.2 p90 -120.21 121.54 38.97 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 122.062 0.934 . . . . 0.0 111.846 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.709 ' HB3' HD11 ' A' ' 7' ' ' LEU . 49.5 mttp -112.41 130.95 55.8 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.005 -1.452 . . . . 0.0 107.611 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.5 146.09 28.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.183 0.516 . . . . 0.0 112.142 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.3 p30 -86.14 124.05 32.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.001 172.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -169.52 156.81 6.87 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.632 -175.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.926 ' HG2' ' H ' ' A' ' 5' ' ' SER . 0.4 OUTLIER -112.05 139.9 47.18 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.538 172.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.739 ' HE2' ' HB3' ' A' ' 24' ' ' CYS . 28.7 t80 -68.49 133.67 48.95 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.273 176.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -120.94 -48.93 3.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.462 178.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 30' ' ' HIS . . . -148.25 144.41 12.28 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 30.8 p -123.16 115.18 21.36 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.506 -0.408 . . . . 0.0 109.974 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.78 146.02 22.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 58.24 34.48 24.14 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.625 0.578 . . . . 0.0 111.26 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.89 17.01 64.74 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.401 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 39.4 mmtm -114.74 153.69 29.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.913 0.387 . . . . 0.0 110.039 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.555 HG23 ' HD2' ' A' ' 21' ' ' PHE . 79.0 mt -114.1 113.06 42.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.035 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.528 ' O ' HG13 ' A' ' 22' ' ' ILE . 15.2 m-70 -75.48 119.87 20.14 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.021 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.64 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 91.3 mt -124.57 140.25 53.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.171 0.51 . . . . 0.0 111.498 -172.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.5 ' NE2' ' HA2' ' A' ' 36' ' ' GLY . 17.7 t-80 -108.94 98.58 8.04 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.36 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.597 ' HD2' ' HB2' ' A' ' 19' ' ' ALA . 1.7 mmmp? -57.69 167.09 1.17 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.852 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.19 -28.16 69.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.498 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -86.06 10.35 14.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.5 ' HA2' ' NE2' ' A' ' 32' ' ' HIS . . . 73.89 27.44 66.78 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.465 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.45 137.95 25.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 66.8 mttt -99.47 124.39 44.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.074 0.464 . . . . 0.0 111.383 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.1 pt -126.97 146.4 32.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.126 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.09 103.29 14.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.4 ' CG1' HD13 ' A' ' 46' ' ' LEU . 71.1 t -103.22 110.99 31.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -56.99 127.48 32.12 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.576 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.36 -8.0 29.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.069 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' OD2' ' HB1' ' A' ' 42' ' ' ALA . 2.8 p30 -95.59 -10.38 29.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.55 ' HD2' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -120.61 17.58 12.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.012 0.911 . . . . 0.0 108.806 171.639 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.66 HD12 ' HA ' ' A' ' 10' ' ' ASP . 13.7 tp -97.6 166.68 11.39 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.177 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.602 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 47.3 t -74.33 137.31 42.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.636 0.732 . . . . 0.0 110.693 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -58.07 -29.41 65.4 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.744 -177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.49 -50.68 72.6 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.7 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.602 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 3.8 m-20 -61.67 -36.82 81.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.83 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.773 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -68.79 -41.15 79.15 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.55 177.664 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.557 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -64.65 -28.63 69.74 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.544 0.688 . . . . 0.0 109.611 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.777 ' CE2' HD11 ' A' ' 57' ' ' ILE . 16.7 t80 -73.28 -48.02 38.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.49 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.654 HG13 HD23 ' A' ' 62' ' ' LEU . 3.0 p -68.48 -26.68 34.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 121.761 -0.587 . . . . 0.0 110.949 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.773 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.2 mt-10 -52.03 -35.25 46.37 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.11 0.481 . . . . 0.0 110.059 167.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 1.7 tptt -73.2 -50.29 23.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.161 176.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.777 HD11 ' CE2' ' A' ' 53' ' ' TYR . 51.1 mt -49.98 -46.34 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.126 0.489 . . . . 0.0 111.811 -177.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.406 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 34.2 p -105.08 -46.83 4.16 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -170.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.87 -6.7 27.55 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 90.3 m-85 -83.17 141.24 32.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.0 t -90.36 108.74 19.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.043 0.449 . . . . 0.0 110.037 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.737 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 2.6 mm? -87.1 19.41 3.12 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.403 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -53.82 -43.74 69.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.387 0.675 . . . . 0.0 110.756 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -67.44 -12.62 60.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.806 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 44' ' ' ASP . 72.1 m-85 -108.99 -0.99 19.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.723 0.297 . . . . 0.0 110.776 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 98.9 mttt -76.83 142.09 40.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.81 54.19 2.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -166.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.66 174.01 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.5 tttm . . . . . 0 C--O 1.235 0.334 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -144.48 139.66 28.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.808 -171.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.8 t -54.7 118.88 4.59 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.007 0.817 . . . . 0.0 110.128 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 18.6 ptp180 -137.0 -179.13 5.52 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.66 -173.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.91 110.82 21.41 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.139 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.524 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 41.1 m95 -91.93 138.07 31.85 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.7 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 10' ' ' ASP . 58.9 t -129.41 142.54 43.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -74.48 159.43 32.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.616 0.722 . . . . 0.0 110.699 172.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.429 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -64.22 -21.36 66.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.403 -172.739 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.4 m -113.72 6.72 16.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.969 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.38 24.51 72.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.468 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 m -68.82 -40.11 79.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.615 0.245 . . . . 0.0 111.572 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.484 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 5.6 p90 -137.29 142.81 41.93 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.163 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 45.4 mttp -137.56 131.03 31.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.475 HG11 ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -148.51 146.31 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-O 120.912 0.386 . . . . 0.0 111.431 177.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.5 m-20 -83.32 121.51 27.22 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.16 171.94 17.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.237 0.542 . . . . 0.0 111.71 -173.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.93 142.59 51.21 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.62 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.617 ' HA ' HD12 ' A' ' 31' ' ' LEU . 64.6 t80 -77.67 132.23 38.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.104 0.478 . . . . 0.0 110.354 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -112.02 -51.1 5.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.52 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.11 145.94 11.14 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.217 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.569 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 27.0 t -123.8 130.8 53.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.828 0.347 . . . . 0.0 110.493 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.15 143.79 21.63 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 -177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 60.02 29.13 18.72 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.783 0.677 . . . . 0.0 111.601 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.06 1.16 89.82 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.498 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -106.73 161.0 15.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.964 0.412 . . . . 0.0 110.47 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.606 HG22 HD13 ' A' ' 31' ' ' LEU . 94.1 mt -123.11 123.49 68.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.531 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.409 ' O ' HG13 ' A' ' 22' ' ' ILE . 90.0 m-70 -87.76 128.09 35.32 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.617 HD12 ' HA ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -124.03 148.42 47.04 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.665 -176.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -110.91 100.14 8.92 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.208 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.764 ' HD2' HD13 ' A' ' 39' ' ' ILE . 59.5 mtpt -71.94 152.0 42.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.784 -173.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.25 -12.0 46.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.99 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -71.42 -20.6 62.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.087 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.14 0.99 44.77 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.122 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.45 141.46 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.831 0.348 . . . . 0.0 111.207 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -98.26 128.03 44.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.967 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.764 HD13 ' HD2' ' A' ' 33' ' ' LYS . 49.0 pt -127.4 169.28 19.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.111 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.3 109.32 8.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.951 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.628 ' HB ' ' HE3' ' A' ' 45' ' ' LYS . 32.8 m -110.19 147.45 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.9 129.12 37.43 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.78 -16.17 47.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.466 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 4.7 p-10 -74.27 -23.2 59.09 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -173.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.628 ' HE3' ' HB ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.54 38.37 1.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.903 0.858 . . . . 0.0 110.163 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.485 HD22 HD12 ' A' ' 29' ' ' ILE . 6.0 mp -115.76 161.63 18.45 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.121 176.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.595 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 43.8 t -74.29 140.46 44.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.754 0.788 . . . . 0.0 110.047 176.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -49.86 -34.32 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.267 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -59.22 -51.33 70.44 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.599 0.714 . . . . 0.0 109.981 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.634 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.1 m-20 -60.37 -38.24 83.26 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.422 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.802 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.5 OUTLIER -70.3 -43.85 69.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.363 179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.63 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -58.96 -30.27 67.79 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.551 0.691 . . . . 0.0 110.375 -178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.401 ' O ' HG12 ' A' ' 57' ' ' ILE . 51.6 t80 -73.75 -50.64 19.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.325 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.762 ' HA ' HG12 ' A' ' 57' ' ' ILE . 2.2 p -69.94 -29.1 39.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.401 -176.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.802 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 47.4 mt-10 -51.61 -40.05 59.14 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.193 0.521 . . . . 0.0 109.914 169.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.893 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -78.38 -31.65 48.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.873 -176.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.762 HG12 ' HA ' ' A' ' 54' ' ' VAL . 10.9 mm -66.3 -35.82 75.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.031 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.4 p -107.88 -47.35 3.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -170.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.47 -31.85 4.28 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.389 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.467 ' HZ ' ' HB3' ' A' ' 24' ' ' CYS . 14.9 p90 -87.28 152.64 22.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.177 0.488 . . . . 0.0 110.842 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.451 ' OG ' ' HG2' ' A' ' 63' ' ' GLU . 7.7 t -92.37 140.97 29.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.708 -172.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 35.3 mt -115.94 31.42 6.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.86 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.451 ' HG2' ' OG ' ' A' ' 61' ' ' SER . 18.5 mm-40 -53.13 -40.69 64.42 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.666 174.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -62.78 -15.2 52.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.971 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.466 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 36.9 m-85 -106.96 -7.32 17.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.245 0.545 . . . . 0.0 110.545 -177.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.56 149.8 24.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.221 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -106.63 113.75 27.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.672 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 t30 . . . . . 0 C--O 1.251 1.146 0 O-C-N 123.78 0.675 . . . . 0.0 111.054 177.537 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.609 ' HA ' ' NH2' ' A' ' 6' ' ' ARG . 62.4 tttm . . . . . 0 C--O 1.23 0.065 0 CA-C-O 121.768 0.794 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 16.7 ptpt -97.79 179.88 4.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.668 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.7 t -63.07 125.46 24.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.164 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 12.0 ptp180 -131.44 -179.9 5.64 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.107 -170.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -95.06 106.22 18.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.814 -171.083 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -92.18 141.77 28.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.474 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 10' ' ' ASP . 96.5 t -132.88 136.84 55.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.989 0.423 . . . . 0.0 111.442 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.14 153.42 41.66 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.601 0.715 . . . . 0.0 110.379 171.539 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 6.3 tmm_? -63.66 -28.66 70.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.853 -169.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -93.39 -6.74 46.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.115 0.483 . . . . 0.0 110.687 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.08 20.85 60.07 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.933 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.5 m -69.03 -45.37 70.63 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.569 0.347 . . . . 0.0 111.662 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -137.92 143.85 41.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 110.832 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.832 ' HB3' HD11 ' A' ' 7' ' ' LEU . 54.4 mttm -133.4 130.88 39.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.601 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.66 152.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.258 0.551 . . . . 0.0 111.88 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.619 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.1 p30 -90.36 130.46 36.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.295 173.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.96 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -171.38 157.39 4.9 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.18 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -117.49 140.41 49.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.572 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.734 ' HD1' HG23 ' A' ' 29' ' ' ILE . 42.7 t80 -72.01 130.69 41.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.378 0.609 . . . . 0.0 110.721 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -112.53 -49.73 5.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.237 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.29 148.7 14.44 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.59 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 27.9 t -118.41 134.41 55.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.954 0.377 . . . . 0.0 110.172 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.98 140.33 29.56 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.775 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 62.68 -78.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.099 0.874 . . . . 0.0 111.282 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -155.63 12.45 0.4 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.75 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 47.6 mttm -115.51 160.29 20.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.101 0.476 . . . . 0.0 110.925 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.734 HG23 ' HD1' ' A' ' 21' ' ' PHE . 2.2 mp -112.8 124.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.614 174.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.444 ' O ' HG13 ' A' ' 22' ' ' ILE . 79.0 m-70 -80.32 130.86 35.48 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.96 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 97.6 mt -130.16 140.51 50.76 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.686 -174.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -111.93 110.54 20.92 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.555 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 5.1 mtpm? -69.76 170.5 10.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.042 -174.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.42 -20.5 60.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.815 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.482 ' HB2' HG23 ' A' ' 37' ' ' VAL . 7.8 m120 -79.87 -7.72 58.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.137 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.92 0.27 75.04 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.92 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 35' ' ' ASN . 43.0 t -75.29 136.65 24.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -100.41 117.21 34.12 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.535 HG13 ' HB2' ' A' ' 31' ' ' LEU . 40.4 pt -119.63 172.1 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.0 110.64 4.02 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 m -112.13 129.39 67.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.879 0.371 . . . . 0.0 110.509 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.75 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -61.51 130.61 46.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.068 0.461 . . . . 0.0 110.181 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . . . -54.88 -26.17 33.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.165 -173.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.46 -10.64 59.76 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.554 ' HD3' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -101.19 17.72 21.77 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.697 178.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 88.8 mt -115.05 -174.8 2.56 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.246 1.022 . . . . 0.0 111.813 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.601 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 34.9 t -97.25 143.71 27.76 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.285 -1.78 . . . . 0.0 108.942 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -60.05 -24.18 64.34 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.918 -174.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -62.76 -47.32 84.04 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.964 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.601 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 3.8 m-20 -64.19 -38.52 91.35 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.441 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.659 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.8 OUTLIER -70.66 -38.33 73.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.952 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.485 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -68.03 -27.23 66.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.303 0.573 . . . . 0.0 109.968 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.593 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 32.5 t80 -74.04 -49.95 21.91 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.198 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 50' ' ' ASP . 3.4 p -70.55 -32.04 48.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.018 0.437 . . . . 0.0 111.085 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.917 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 1.7 pt-20 -68.45 -23.51 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.302 0.572 . . . . 0.0 110.031 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 1.1 ttpp -72.79 -40.44 65.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.593 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 54.2 mt -63.08 -44.69 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.013 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.2 p -78.37 -43.99 26.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.289 -172.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.94 2.05 28.51 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.485 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 64.0 m-85 -104.83 -166.19 1.21 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 t -130.99 132.43 45.01 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.917 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 9.7 mt -103.68 29.7 5.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.387 0.613 . . . . 0.0 109.381 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.482 ' OE2' ' HD2' ' A' ' 66' ' ' LYS . 6.2 tp10 -45.0 -48.84 11.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.033 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -65.34 -17.53 64.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -100.8 -4.83 27.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.496 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.482 ' HD2' ' OE2' ' A' ' 63' ' ' GLU . 97.8 mttt -77.47 104.82 8.22 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.697 0.761 . . . . 0.0 110.836 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.09 107.95 16.03 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.26 175.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.528 -176.552 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HB3' ' HE2' ' A' ' 3' ' ' LYS . 51.3 mtpt . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.737 0.303 . . . . 0.0 111.371 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 167.77 12.5 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 171.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.683 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 33.0 p 51.51 97.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 122.356 1.074 . . . . 0.0 111.45 -176.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 10.9 ptp180 -107.98 179.13 4.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.588 -166.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.769 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.9 tm? -88.9 108.95 19.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.852 -173.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.514 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 37.7 m95 -97.54 153.72 17.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.18 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.431 HG13 ' HG2' ' A' ' 16' ' ' LYS . 23.5 t -133.68 146.79 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.59 ' HA ' HD12 ' A' ' 46' ' ' LEU . 7.8 p-10 -84.24 178.82 7.64 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.143 172.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.509 ' HD2' ' O ' ' A' ' 11' ' ' ARG . 2.1 tmm_? -81.32 -23.58 37.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 110.947 -174.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.9 t -89.91 -29.31 18.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.875 0.369 . . . . 0.0 110.679 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.89 21.18 19.21 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -76.79 -40.97 46.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.346 -0.427 . . . . 0.0 110.966 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.582 ' HZ ' ' HE3' ' A' ' 45' ' ' LYS . 33.0 p90 -142.2 131.01 22.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.908 0.861 . . . . 0.0 113.157 -174.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.769 ' HB3' HD11 ' A' ' 7' ' ' LEU . 36.0 mtmm -118.86 130.45 55.75 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.252 169.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.38 153.18 21.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.41 0.624 . . . . 0.0 112.371 -173.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.4 p30 -90.36 129.03 36.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.61 174.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -178.7 159.54 1.11 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.946 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.683 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 3.8 mm-40 -110.61 144.26 39.77 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 121.251 0.548 . . . . 0.0 110.017 169.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.906 ' HD1' HG23 ' A' ' 29' ' ' ILE . 3.7 t80 -74.9 120.67 20.75 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.339 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.83 -52.77 8.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.079 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.3 141.87 7.76 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.759 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 24.6 p -101.0 144.04 30.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.39 109.16 4.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.186 -0.206 . . . . 0.0 111.159 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? 53.43 52.28 13.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.103 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.81 -7.01 71.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.124 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -101.44 161.06 13.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.26 0.53 . . . . 0.0 111.283 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.906 HG23 ' HD1' ' A' ' 21' ' ' PHE . 78.0 mt -123.03 120.79 61.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.248 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -87.82 131.7 34.44 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.794 HD23 ' HA ' ' A' ' 21' ' ' PHE . 85.7 mt -129.31 138.99 51.91 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.27 0.557 . . . . 0.0 111.284 -170.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -105.81 104.41 14.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.185 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.621 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 6.3 mtpm? -66.09 169.03 7.46 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.55 -18.66 62.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.301 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -103.86 14.75 30.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.611 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.9 -16.43 59.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.633 171.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.434 ' HB ' ' HD3' ' A' ' 33' ' ' LYS . 60.7 t -65.43 139.18 21.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.708 0.289 . . . . 0.0 110.654 -178.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -104.31 124.19 48.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.521 HG13 ' HB2' ' A' ' 31' ' ' LEU . 39.1 pt -125.68 160.34 32.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.795 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.49 121.61 23.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.159 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -119.3 148.33 22.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.482 ' HB1' ' OD2' ' A' ' 44' ' ' ASP . . . -78.85 123.73 27.51 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.82 -19.66 65.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.566 0.698 . . . . 0.0 111.123 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.816 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 3.7 p30 -74.53 -14.28 60.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.274 -176.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.582 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -117.12 18.31 14.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.997 0.903 . . . . 0.0 109.201 174.659 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.59 HD12 ' HA ' ' A' ' 10' ' ' ASP . 12.8 tp -100.21 167.79 10.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.434 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.8 t -67.11 137.83 56.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.426 0.632 . . . . 0.0 111.054 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.485 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 53.1 m-20 -58.66 -36.72 74.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.81 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -65.29 -46.04 82.0 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.658 0.742 . . . . 0.0 109.713 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.547 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.5 m-20 -61.78 -36.46 81.11 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.91 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.757 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -66.32 -45.72 79.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.852 176.562 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.578 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -61.86 -29.24 70.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.46 0.648 . . . . 0.0 110.449 -176.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.638 ' CE2' HD11 ' A' ' 57' ' ' ILE . 29.2 t80 -74.01 -49.93 22.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.232 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 50' ' ' ASP . 4.1 p -70.51 -26.58 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.894 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.757 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.9 mt-10 -51.45 -40.16 58.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.189 0.519 . . . . 0.0 109.872 167.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.623 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -75.78 -36.25 59.86 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.113 -176.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.638 HD11 ' CE2' ' A' ' 53' ' ' TYR . 29.8 mt -64.45 -40.23 88.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.992 175.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.698 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 36.6 p -91.02 -47.43 7.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -169.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.3 -4.73 51.74 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 -170.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.698 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 79.9 m-85 -95.58 162.24 13.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.9 t -110.79 117.08 32.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.219 0.533 . . . . 0.0 110.762 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.613 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 29.5 mt -91.67 17.53 8.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.58 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.813 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -56.61 -41.02 76.34 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.213 178.42 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -60.25 -20.33 58.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.812 178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.816 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 53.4 m-85 -99.17 -16.72 18.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.843 0.354 . . . . 0.0 110.341 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.813 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 9.4 mtpm? -75.63 143.96 41.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.705 -176.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -94.25 7.59 44.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.548 0.69 . . . . 0.0 110.752 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 . . . . . 0 C--O 1.247 0.923 0 CA-C-N 114.766 -1.107 . . . . 0.0 108.598 179.411 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.445 0.641 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.65 150.61 39.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.303 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . 1.063 ' H ' ' HG2' ' A' ' 20' ' ' GLU . 38.1 t 59.58 99.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 122.204 1.002 . . . . 0.0 110.987 -176.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 9.7 ptp180 -118.25 175.15 5.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.321 -1.308 . . . . 0.0 110.816 -170.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.706 HD11 ' HB2' ' A' ' 16' ' ' LYS . 1.3 tm? -83.62 117.12 22.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.943 -174.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.602 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 69.1 m95 -108.9 145.0 36.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.139 175.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 16' ' ' LYS . 88.8 t -131.59 138.43 52.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.22 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.705 ' HA ' HD12 ' A' ' 46' ' ' LEU . 6.4 p-10 -84.92 168.86 14.63 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.598 175.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.647 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 4.6 tpm_? -67.08 -35.22 79.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.514 0.197 . . . . 0.0 111.417 -174.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 m -79.16 -12.26 59.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.97 0.414 . . . . 0.0 111.209 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.5 17.63 75.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.506 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -66.69 -47.73 71.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.994 -0.603 . . . . 0.0 110.656 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 10' ' ' ASP . 16.4 p90 -138.57 132.64 31.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.7 0.762 . . . . 0.0 112.627 -174.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.706 ' HB2' HD11 ' A' ' 7' ' ' LEU . 20.6 ptmt -120.83 129.67 53.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.225 166.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.808 ' HB ' ' HE2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -148.9 159.12 6.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.225 0.536 . . . . 0.0 112.016 -172.484 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.59 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.5 OUTLIER -93.54 122.83 36.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.478 177.142 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.716 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -162.07 156.36 21.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.589 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 1.063 ' HG2' ' H ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -109.34 138.89 45.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.014 174.657 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.64 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 50.7 t80 -67.93 133.15 48.62 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.026 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -116.25 -50.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.158 179.505 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.16 153.7 24.78 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.465 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.64 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 29.2 t -129.09 130.05 46.0 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.43 134.44 21.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.486 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 63.11 15.53 8.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.236 0.541 . . . . 0.0 111.196 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.23 2.08 71.41 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.272 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 61.4 mttp -93.89 146.79 23.65 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.536 -0.39 . . . . 0.0 110.365 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.556 HD11 ' HB2' ' A' ' 43' ' ' ALA . 17.5 mm -105.09 119.42 54.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.539 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.457 ' O ' HG13 ' A' ' 22' ' ' ILE . 24.1 m170 -89.7 125.53 35.3 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.716 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 92.5 mt -128.74 139.15 52.35 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.23 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -102.18 106.64 17.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.56 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.808 ' HE2' ' HB ' ' A' ' 17' ' ' VAL . 2.5 mmmp? -64.36 152.09 42.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.174 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.12 -13.78 62.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.429 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 6.9 p-10 -98.01 12.63 33.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.894 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.06 -30.8 9.37 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.861 -0.685 . . . . 0.0 114.198 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.94 139.44 21.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.899 0.381 . . . . 0.0 111.795 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.97 122.68 45.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.0 161.75 19.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.928 -176.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.29 106.06 6.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.677 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.7 m -108.38 146.16 14.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -76.1 122.62 24.55 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.608 176.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.703 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -64.45 -21.47 66.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.581 0.705 . . . . 0.0 109.836 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 12.9 t70 -50.63 -32.95 20.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.341 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 26.54 9.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.238 0.542 . . . . 0.0 110.93 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.705 HD12 ' HA ' ' A' ' 10' ' ' ASP . 8.6 tp -100.1 173.53 6.59 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.319 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.644 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 19.8 m -79.98 133.85 36.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.613 0.721 . . . . 0.0 110.475 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -55.04 -35.15 64.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.917 -172.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.4 -44.38 83.17 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.338 0.589 . . . . 0.0 109.733 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.644 ' OD1' ' HB2' ' A' ' 47' ' ' SER . 1.4 m-20 -57.77 -40.62 80.2 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.764 175.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.82 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -68.94 -39.54 79.52 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.408 178.135 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.684 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -59.31 -32.49 70.12 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.434 0.635 . . . . 0.0 109.885 -177.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.75 ' CE2' HD11 ' A' ' 57' ' ' ILE . 49.5 t80 -74.2 -49.61 22.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.551 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 50' ' ' ASP . 1.7 p -68.81 -28.07 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.205 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.82 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 46.9 mt-10 -52.18 -39.85 60.67 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.071 0.462 . . . . 0.0 110.061 167.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.622 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 9.4 mmpt? -78.08 -28.36 48.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.75 HD11 ' CE2' ' A' ' 53' ' ' TYR . 40.9 mt -67.88 -42.97 86.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.145 0.498 . . . . 0.0 110.712 173.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.5 p -90.84 -47.53 7.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.493 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.87 -19.7 15.47 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.893 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -107.04 151.24 25.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.954 0.407 . . . . 0.0 110.203 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -82.86 136.85 34.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.704 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.622 HD12 HG13 ' A' ' 54' ' ' VAL . 23.4 mt -107.0 20.16 19.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.847 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.408 ' OE2' ' HD2' ' A' ' 66' ' ' LYS . 4.0 tp10 -55.33 -44.38 75.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.967 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -14.45 61.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.238 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' ASP . 62.6 m-85 -105.13 -0.43 26.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.621 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 99.2 mttt -87.38 -175.78 5.38 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.375 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.44 99.91 0.33 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.884 0.373 . . . . 0.0 110.866 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.251 -0.881 . . . . 0.0 109.653 179.342 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' NZ ' ' HB2' ' A' ' 3' ' ' LYS . 8.6 mtmp? . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.545 0.212 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 66.35 107.63 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.652 0.739 . . . . 0.0 112.105 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.28 123.2 12.15 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.579 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 16.3 ptp180 -126.64 -178.66 4.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.975 -171.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.709 HD11 ' HB3' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -88.76 105.59 17.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.378 -168.675 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.481 ' HH2' ' HB ' ' A' ' 54' ' ' VAL . 47.2 m95 -94.46 139.71 30.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.72 176.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 10' ' ' ASP . 72.9 t -129.78 141.99 45.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.974 0.416 . . . . 0.0 111.71 -175.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.639 ' O ' HG12 ' A' ' 9' ' ' VAL . 9.8 t70 -70.58 157.47 37.86 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.856 ' HG2' ' HB3' ' A' ' 67' ' ' ALA . 7.0 tpm_? -79.41 -25.86 42.01 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -174.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 p -99.68 7.22 45.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.046 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.77 68.34 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.72 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.598 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 31.8 m -68.27 -40.14 81.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.69 0.281 . . . . 0.0 111.257 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -150.81 150.21 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.144 0.497 . . . . 0.0 111.703 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.709 ' HB3' HD11 ' A' ' 7' ' ' LEU . 94.2 mttt -132.45 132.25 42.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.768 171.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.08 145.51 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.0 0.429 . . . . 0.0 111.807 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 5.9 p-10 -93.6 112.11 23.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.884 0.849 . . . . 0.0 110.133 174.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.433 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . . . -160.28 168.87 24.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.093 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.04 139.91 53.03 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.781 ' HA ' HD23 ' A' ' 31' ' ' LEU . 3.4 t80 -71.6 128.0 34.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.697 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -107.0 -46.91 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.608 -178.091 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 30' ' ' HIS . . . -153.79 153.54 24.9 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.598 -177.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.2 p -112.89 134.12 54.55 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.08 97.41 5.09 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.593 -173.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 57.56 23.71 9.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.231 173.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.59 -7.55 24.28 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.363 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 61.4 mttp -94.0 160.23 14.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.016 0.436 . . . . 0.0 110.925 175.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.929 HD11 ' HB2' ' A' ' 43' ' ' ALA . 10.7 mm -113.79 115.79 50.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.72 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -87.52 117.85 26.59 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.781 HD23 ' HA ' ' A' ' 21' ' ' PHE . 96.4 mt -119.99 139.69 52.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.451 0.643 . . . . 0.0 112.213 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -99.21 109.97 22.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.003 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HD3' HD13 ' A' ' 39' ' ' ILE . 13.7 mmmm -66.05 155.1 37.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.876 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.41 -15.42 36.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.882 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -105.32 21.77 16.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.43 0.633 . . . . 0.0 110.424 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.87 -16.23 48.02 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.464 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -66.74 154.78 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 35.5 ttmt -122.94 125.62 45.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.953 0.406 . . . . 0.0 110.4 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.506 HD13 ' HD3' ' A' ' 33' ' ' LYS . 33.6 pt -122.5 176.92 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.754 -176.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.13 116.72 6.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.665 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 m -118.13 165.39 13.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -97.51 134.45 40.72 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.929 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -67.37 -8.0 29.31 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -72.05 -28.52 63.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HD3' ' H ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -107.63 15.21 24.92 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.657 177.02 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 46' ' ' LEU . 8.2 tp -84.73 159.79 20.42 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.266 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.579 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 50.1 m -71.32 133.96 46.4 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.59 0.71 . . . . 0.0 109.89 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -57.53 -30.42 65.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.783 -171.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -65.83 -46.26 79.19 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.648 0.737 . . . . 0.0 109.349 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.587 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -59.54 -37.89 79.6 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.929 176.353 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.711 ' HB3' ' HB2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -68.37 -44.95 74.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.899 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.429 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -61.18 -28.43 69.13 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.297 0.57 . . . . 0.0 109.871 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.567 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 32.6 t80 -73.97 -51.79 14.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.335 175.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.5 p -70.86 -33.53 52.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.971 -0.455 . . . . 0.0 111.226 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 1.074 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 3.7 pt-20 -67.29 -24.93 65.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.03 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -46.27 64.58 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.567 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 56.9 mt -56.13 -43.72 76.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.035 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 7.0 p -80.35 -44.9 18.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.352 -175.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.72 -13.98 22.38 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -174.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.458 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 80.2 m-85 -80.21 -167.7 1.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.059 -0.571 . . . . 0.0 109.813 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.42 ' HA ' ' CD ' ' A' ' 55' ' ' GLU . 8.8 t -135.82 130.33 33.81 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 171.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.074 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 12.2 mt -104.87 23.61 13.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.409 0.623 . . . . 0.0 109.617 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.482 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 22.3 tt0 -53.35 -39.61 64.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.373 174.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -70.24 -6.08 32.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.772 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -109.05 -2.16 18.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.349 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' A' ' 63' ' ' GLU . 96.7 mttt -74.73 126.35 30.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.481 0.658 . . . . 0.0 109.687 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.856 ' HB3' ' HG2' ' A' ' 11' ' ' ARG . . . -97.37 113.56 25.23 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.577 -171.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.5 t30 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.681 176.621 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.7 mttt . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.01 131.31 36.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.546 -168.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.6 m -65.98 120.74 13.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 15.3 ptp180 -142.07 -178.81 5.88 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.509 -168.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.835 HD11 ' HB2' ' A' ' 16' ' ' LYS . 2.0 tm? -86.72 103.14 14.89 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.898 -175.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 33.5 m95 -91.61 144.68 25.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.548 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 10' ' ' ASP . 64.8 t -129.93 145.87 35.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -89.74 159.79 16.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 173.335 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -17.42 64.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -171.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 t -86.39 -12.39 49.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.321 0.581 . . . . 0.0 109.866 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.34 37.69 70.56 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.005 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 m -102.12 -42.1 6.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.47 0.176 . . . . 0.0 111.05 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.644 ' CZ ' ' HE3' ' A' ' 45' ' ' LYS . 34.7 p90 -125.1 138.07 54.18 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.821 0.82 . . . . 0.0 112.581 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.835 ' HB2' HD11 ' A' ' 7' ' ' LEU . 8.6 ptpp? -134.89 132.14 38.16 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 113.959 -1.473 . . . . 0.0 108.989 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.458 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -148.51 154.81 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.26 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.627 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 12.0 m-20 -92.87 123.79 36.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.235 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -164.54 157.07 16.69 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.201 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.75 146.76 33.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.509 ' HA ' HD23 ' A' ' 31' ' ' LEU . 78.1 t80 -76.64 132.56 39.48 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.089 0.471 . . . . 0.0 110.013 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -111.6 -46.83 5.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.443 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -166.63 148.34 13.29 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.938 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.491 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 6.9 t -122.75 126.81 48.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.793 0.33 . . . . 0.0 110.25 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.52 141.85 20.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.578 -176.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt 56.7 32.04 20.42 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.621 0.575 . . . . 0.0 111.55 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.69 9.36 87.13 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.624 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 72.3 mmtt -109.56 146.05 35.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.027 0.442 . . . . 0.0 110.76 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' A' ' 43' ' ' ALA . 42.0 mm -105.14 113.27 41.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.485 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.503 ' O ' HG13 ' A' ' 22' ' ' ILE . 17.9 m170 -82.57 120.78 25.95 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.8 mt -122.45 140.4 52.76 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 -175.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -100.05 103.82 15.37 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.911 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.922 ' HD3' HD13 ' A' ' 39' ' ' ILE . 12.5 mmmm -61.28 153.62 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.632 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.82 66.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.388 0.613 . . . . 0.0 109.359 172.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.42 HD22 ' C ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -63.07 -32.69 74.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.766 172.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.47 -2.59 27.88 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.295 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -91.94 150.28 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.634 0.255 . . . . 0.0 110.593 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 38' ' ' LYS . 4.4 tmmm? -101.73 125.49 48.41 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.922 HD13 ' HD3' ' A' ' 33' ' ' LYS . 16.1 pt -121.33 163.91 18.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.836 -177.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.79 103.84 7.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.272 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.1 t -110.54 127.04 67.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.515 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . . . -56.18 124.69 18.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.989 0.423 . . . . 0.0 111.665 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -61.72 -30.1 70.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.908 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.476 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 3.6 p30 -68.73 -32.67 72.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.566 -173.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.644 ' HE3' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -103.44 15.28 29.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.328 0.585 . . . . 0.0 110.11 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.5 tp -95.44 166.82 11.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.287 -177.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.552 ' O ' HD22 ' A' ' 51' ' ' LEU . 44.0 t -71.38 132.53 44.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.901 0.857 . . . . 0.0 111.001 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.647 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 1.6 m-20 -50.94 -38.1 48.37 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.187 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.82 -49.64 72.7 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.086 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.67 ' O ' HG12 ' A' ' 54' ' ' VAL . 74.0 m-20 -67.3 -32.72 73.89 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.784 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.786 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -69.9 -40.05 75.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.944 177.013 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.5 -32.39 72.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.372 0.606 . . . . 0.0 109.767 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.52 ' CE1' HD11 ' A' ' 57' ' ' ILE . 50.8 t80 -67.95 -50.64 54.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.332 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.736 ' HA ' HG12 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -68.32 -32.47 55.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 120.72 0.295 . . . . 0.0 111.253 -177.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.786 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 45.5 mt-10 -52.56 -35.66 54.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.52 170.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 1.05 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.55 -30.38 33.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.676 -179.369 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.736 HG12 ' HA ' ' A' ' 54' ' ' VAL . 21.7 mm -64.24 -38.71 83.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.6 p -116.56 -46.99 2.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -170.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.41 1.94 24.63 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.578 -173.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -78.88 153.68 30.35 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 t -97.48 101.48 13.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.038 0.447 . . . . 0.0 110.22 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.654 ' HA ' ' HD2' ' A' ' 65' ' ' PHE . 21.3 mt -98.44 19.67 14.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -63.83 -39.71 94.87 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.972 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -69.04 -9.57 53.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.456 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.654 ' HD2' ' HA ' ' A' ' 62' ' ' LEU . 91.4 m-85 -101.37 -4.84 26.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.948 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.647 ' HD3' ' HB3' ' A' ' 48' ' ' ASN . 52.0 mttp -82.53 138.95 34.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.359 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.73 90.9 6.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.972 176.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.005 -179.57 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.76 ' HG2' ' H ' ' A' ' 5' ' ' SER . 33.7 ttpt -172.73 -176.07 1.41 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.76 ' H ' ' HG2' ' A' ' 4' ' ' LYS . 19.9 p -50.83 148.44 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.088 0.471 . . . . 0.0 111.728 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 11.3 ptp180 -158.64 -177.85 6.83 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.093 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.421 ' CD2' ' HB2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -89.4 107.08 18.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.264 -175.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.649 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 30.1 m95 -90.89 140.21 30.03 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 90.8 t -130.1 158.32 42.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.963 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -91.66 162.21 14.59 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.4 -0.187 . . . . 0.0 110.503 176.304 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.431 ' HE ' ' HB3' ' A' ' 11' ' ' ARG . 1.7 tmm_? -57.57 -37.88 73.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.642 0.258 . . . . 0.0 111.144 -176.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 t -83.44 -15.44 49.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.734 0.302 . . . . 0.0 111.373 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.78 16.28 56.72 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.302 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 m -83.5 -37.12 23.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.458 0.647 . . . . 0.0 110.071 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.963 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 5.8 m-85 -95.14 137.95 33.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.023 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 19.0 ptpt -152.21 130.1 11.73 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.529 162.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.08 136.22 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.689 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.3 p-10 -75.99 109.15 9.39 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.218 173.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -148.13 167.39 25.14 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.508 -170.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 5' ' ' SER . 26.5 tt0 -133.71 124.35 26.54 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.294 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.654 ' HD1' HG23 ' A' ' 29' ' ' ILE . 67.1 t80 -65.39 130.29 42.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.345 0.593 . . . . 0.0 110.367 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.91 -54.28 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.874 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.06 142.02 7.67 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.467 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.468 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 16.4 p -103.28 142.81 33.55 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -178.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.21 126.81 9.45 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.956 -0.297 . . . . 0.0 111.225 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 55.61 41.4 30.62 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.768 0.667 . . . . 0.0 111.206 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.55 -0.74 80.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.642 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -104.28 166.77 10.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 0.0 110.813 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.654 HG23 ' HD1' ' A' ' 21' ' ' PHE . 85.1 mt -124.09 121.65 62.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.085 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -88.48 129.02 35.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.912 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 90.4 mt -124.49 136.76 54.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.845 0.831 . . . . 0.0 111.873 -172.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 14.3 t-80 -98.43 99.59 10.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.994 176.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 36.2 mtpt -61.83 156.96 19.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.817 0.341 . . . . 0.0 110.167 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.77 -12.45 60.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.627 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -90.91 1.82 56.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.394 177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.02 -24.4 31.43 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.707 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -65.3 145.09 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.599 0.238 . . . . 0.0 110.833 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -114.24 131.62 56.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.1 0.476 . . . . 0.0 110.503 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.8 pt -129.52 166.82 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.989 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.45 118.78 19.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.649 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 m -116.78 156.98 17.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.22 128.04 33.78 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.746 -0.382 . . . . 0.0 109.976 175.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.423 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -64.68 -15.23 61.04 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -174.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.665 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 8.1 p-10 -91.56 -13.93 31.17 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -173.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.05 19.94 19.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.711 0.767 . . . . 0.0 109.523 176.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 8.5 tp -103.48 169.21 8.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.276 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.482 ' O ' HD22 ' A' ' 51' ' ' LEU . 25.2 t -73.61 141.68 46.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.582 0.706 . . . . 0.0 109.367 176.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.504 HD22 ' H ' ' A' ' 67' ' ' ALA . 33.5 m-20 -73.89 -18.73 60.87 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.607 -171.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -43.34 81.23 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.563 ' O ' HG12 ' A' ' 54' ' ' VAL . 35.6 m-20 -63.67 -38.01 89.49 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.196 176.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.822 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -66.42 -45.18 80.79 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.134 177.358 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.68 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -59.39 -32.34 70.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.475 0.655 . . . . 0.0 110.241 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.607 ' CE2' HD11 ' A' ' 57' ' ' ILE . 43.9 t80 -72.32 -50.48 26.56 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.379 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 50' ' ' ASP . 3.2 p -68.42 -28.9 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 O-C-N 122.089 -0.382 . . . . 0.0 110.77 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.822 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 44.4 mt-10 -52.5 -41.43 63.42 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.647 0.26 . . . . 0.0 110.471 169.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.502 ' N ' ' HE3' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -73.79 -33.02 64.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.806 -178.239 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.607 HD11 ' CE2' ' A' ' 53' ' ' TYR . 29.9 mt -67.65 -37.37 78.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.281 175.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.471 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 32.4 p -97.78 -45.17 6.44 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -170.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.97 -7.27 37.94 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -172.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.471 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 65.0 m-85 -80.32 175.88 10.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 110.784 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -121.1 114.77 21.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.432 176.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 35.8 mt -103.58 27.28 7.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.571 -176.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -56.59 -42.1 78.12 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.665 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -72.55 -6.45 44.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.341 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.665 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 97.3 m-85 -102.99 0.3 31.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.418 0.628 . . . . 0.0 109.52 176.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 98.5 mttt -96.54 148.2 23.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.778 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.504 ' H ' HD22 ' A' ' 48' ' ' ASN . . . -149.14 -177.45 5.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.873 0.368 . . . . 0.0 111.57 -171.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.9 m120 . . . . . 0 C--O 1.247 0.952 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.597 -179.203 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.9 mttm . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.8 0.333 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -94.94 167.69 11.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.269 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 t -53.48 142.77 21.27 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.098 173.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.581 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 6.6 ptp180 -140.66 -178.83 5.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.245 -173.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.35 105.41 16.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.04 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.688 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 52.4 m95 -91.92 145.05 24.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.828 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 10' ' ' ASP . 61.5 t -135.6 146.0 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.443 0.465 . . . . 0.0 110.379 -176.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.976 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -90.42 174.1 7.74 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.661 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.778 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 2.4 tpm_? -61.68 -43.36 99.01 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 122.389 -0.194 . . . . 0.0 111.393 -177.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -67.74 -29.74 69.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.236 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.96 12.71 51.99 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.33 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -91.47 -39.37 11.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.507 0.67 . . . . 0.0 109.506 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.976 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 3.7 m-85 -82.46 130.7 35.16 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.417 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 8.6 ptpt -157.42 128.68 6.77 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.9 169.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.51 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -154.91 145.79 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.032 -173.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.581 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.5 p-10 -88.24 117.51 27.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.062 174.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.775 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . . . -164.84 163.66 21.11 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.13 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.42 140.34 52.28 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.742 ' HA ' HD23 ' A' ' 31' ' ' LEU . 48.2 t80 -69.3 132.61 46.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.468 0.651 . . . . 0.0 110.372 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.03 -52.51 5.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.043 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.87 143.38 8.55 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.141 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.553 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 20.0 p -105.61 142.13 35.88 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.98 112.43 8.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 111.439 -173.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.6 tptt 52.68 53.55 12.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.791 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.57 -3.73 77.09 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.118 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 84.9 mttt -110.96 170.48 8.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.068 0.461 . . . . 0.0 110.533 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.531 HG23 ' HD1' ' A' ' 21' ' ' PHE . 59.2 mt -129.0 128.04 66.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.882 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -91.31 127.95 36.95 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.9 mt -127.3 137.39 52.82 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.583 -174.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -98.13 100.92 12.26 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.351 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.829 ' HD3' HD13 ' A' ' 39' ' ' ILE . 12.1 mmmm -61.77 160.54 11.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.34 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.29 -14.94 63.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.721 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -84.45 -6.81 59.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.959 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.64 7.52 58.95 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.738 174.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.5 155.04 6.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 117.059 0.429 . . . . 0.0 110.377 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -97.9 144.27 27.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 0.0 110.863 177.077 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.829 HD13 ' HD3' ' A' ' 33' ' ' LYS . 37.2 pt -127.53 156.27 39.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.15 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.13 103.73 11.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.243 0.545 . . . . 0.0 110.159 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.8 t -109.4 125.16 66.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.276 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -79.51 130.63 35.58 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.44 -5.81 12.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.458 -174.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.85 -42.74 57.37 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -172.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -99.13 12.13 37.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 0.0 110.319 -176.772 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.9 tp -83.88 169.35 15.19 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.678 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.569 ' O ' HD22 ' A' ' 51' ' ' LEU . 47.8 t -73.12 138.0 45.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.025 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -47.03 -50.03 20.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.854 0.835 . . . . 0.0 111.248 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.2 -30.36 68.53 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.795 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.609 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -65.65 -38.03 88.21 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.8 177.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.736 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.7 OUTLIER -70.17 -44.21 69.22 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.81 176.211 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.41 65.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.423 0.63 . . . . 0.0 110.224 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.655 ' CE2' HD11 ' A' ' 57' ' ' ILE . 66.5 t80 -73.79 -49.66 24.24 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.421 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.777 HG13 HD12 ' A' ' 62' ' ' LEU . 2.2 p -70.03 -28.25 35.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 O-C-N 122.006 -0.434 . . . . 0.0 110.823 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.736 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 39.3 mt-10 -56.09 -31.47 63.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.724 168.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.859 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 6.6 mmpt? -80.84 -32.25 35.19 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.77 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.655 HD11 ' CE2' ' A' ' 53' ' ' TYR . 39.6 mt -63.32 -41.38 92.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 174.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.563 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 27.4 p -107.41 -46.79 3.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -171.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.31 -5.74 35.97 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.563 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 66.9 m-85 -85.77 136.95 33.13 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.992 0.425 . . . . 0.0 110.29 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 m -75.7 100.94 4.83 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.623 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.777 HD12 HG13 ' A' ' 54' ' ' VAL . 34.3 mt -94.97 18.74 11.42 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.67 0.748 . . . . 0.0 109.389 172.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 1.07 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 24.7 tt0 -73.83 -29.38 62.1 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.894 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -14.88 58.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.954 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.432 ' HD2' ' HA ' ' A' ' 62' ' ' LEU . 96.0 m-85 -105.57 -7.19 18.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.253 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.07 ' HG3' ' HA ' ' A' ' 63' ' ' GLU . 43.1 mttp -60.33 126.86 29.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.521 0.677 . . . . 0.0 110.881 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.23 124.78 51.44 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.31 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.494 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 2.7 m-20 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.991 -177.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.1 tptt . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 120.8 0.333 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -89.67 -143.64 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.659 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.869 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 20.1 p -53.17 134.09 39.01 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.515 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 17.5 ptp180 -148.47 -178.25 6.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.451 -173.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.833 HD11 ' HB3' ' A' ' 16' ' ' LYS . 2.6 tm? -81.44 106.63 13.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.699 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.583 ' HH2' ' HB ' ' A' ' 54' ' ' VAL . 32.2 m95 -92.8 151.29 20.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.165 174.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 36.9 t -123.07 145.32 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.644 0.259 . . . . 0.0 110.72 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -83.16 160.29 21.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.403 175.852 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -51.57 -46.1 63.34 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.536 0.523 . . . . 0.0 111.921 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 m -94.91 9.81 37.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.819 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.7 23.98 69.37 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.12 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -71.55 -34.36 69.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.176 0.512 . . . . 0.0 110.359 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 10' ' ' ASP . 33.0 p90 -143.21 132.61 23.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.386 0.613 . . . . 0.0 111.186 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.833 ' HB3' HD11 ' A' ' 7' ' ' LEU . 88.3 mttt -109.37 129.98 55.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 167.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.11 135.9 42.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.598 0.713 . . . . 0.0 112.887 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 1.1 p30 -78.27 119.94 22.34 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.757 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.811 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -157.43 158.4 35.75 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.505 0.669 . . . . 0.0 111.892 -172.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.869 ' HB2' ' HB3' ' A' ' 5' ' ' SER . 30.9 tt0 -122.59 124.67 44.03 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.786 176.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.755 ' HD1' HG23 ' A' ' 29' ' ' ILE . 4.5 t80 -70.14 123.35 21.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.153 0.502 . . . . 0.0 110.321 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -105.9 -44.07 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.647 -178.55 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.36 139.93 6.18 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.103 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.43 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 51.9 t -110.04 118.44 36.43 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.93 140.39 29.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.628 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? 65.06 11.7 7.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.131 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.56 -2.79 60.84 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.127 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.734 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 86.6 mttt -102.83 164.45 11.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.0 110.755 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.755 HG23 ' HD1' ' A' ' 21' ' ' PHE . 75.5 mt -114.98 121.22 66.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.015 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.443 ' O ' HG13 ' A' ' 22' ' ' ILE . 20.5 m170 -82.91 124.31 30.23 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.811 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 71.0 mt -124.6 137.49 54.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.432 0.634 . . . . 0.0 111.415 -174.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -107.36 106.18 16.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.577 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 4.1 mtpm? -67.07 166.68 13.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.14 0.495 . . . . 0.0 111.711 -172.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.97 -12.84 60.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.099 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.94 -23.48 38.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.813 173.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.49 -15.08 29.94 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -173.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.2 t -65.86 142.72 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.725 -0.238 . . . . 0.0 110.485 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -108.86 130.21 55.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.157 0.503 . . . . 0.0 110.459 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.457 HG12 ' HB2' ' A' ' 31' ' ' LEU . 12.3 pt -127.39 166.54 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.351 -177.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.1 103.21 5.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.088 0.47 . . . . 0.0 109.994 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 46' ' ' LEU . 74.4 t -116.08 126.36 73.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.934 -176.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -59.35 135.32 57.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.687 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.11 -6.13 12.19 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.374 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -90.15 -41.17 11.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.069 0.462 . . . . 0.0 111.215 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -87.53 22.19 2.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.824 -175.851 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.514 HD13 HG11 ' A' ' 41' ' ' VAL . 9.1 tp -111.91 167.23 10.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.651 -174.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.564 ' O ' HD22 ' A' ' 51' ' ' LEU . 29.6 t -65.0 129.22 38.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.36 0.6 . . . . 0.0 109.649 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.437 ' ND2' ' H ' ' A' ' 67' ' ' ALA . 39.3 m-20 -67.2 -21.71 65.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.631 -172.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -60.68 -48.34 82.21 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.695 0.759 . . . . 0.0 109.294 171.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.598 ' O ' HG12 ' A' ' 54' ' ' VAL . 16.2 m-20 -67.59 -31.77 72.05 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.827 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -69.31 -40.79 77.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.395 176.799 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -65.24 -27.92 68.99 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.382 0.61 . . . . 0.0 109.541 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.595 ' CE2' HD11 ' A' ' 57' ' ' ILE . 31.1 t80 -73.61 -50.77 19.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.594 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.4 p -70.5 -33.29 52.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 120.885 0.374 . . . . 0.0 111.255 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.926 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 1.6 pt-20 -65.58 -24.63 67.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.11 0.481 . . . . 0.0 109.923 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 1.035 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 5.3 mmpt? -81.31 -27.27 35.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.585 175.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.595 HD11 ' CE2' ' A' ' 53' ' ' TYR . 54.3 mt -64.33 -41.58 92.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.163 0.506 . . . . 0.0 109.728 172.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.474 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 6.4 p -86.34 -47.43 9.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.775 -173.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.7 -9.91 19.01 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -173.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.551 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 66.6 m-85 -89.25 -172.7 3.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 55' ' ' GLU . 17.1 t -131.53 128.28 38.98 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.573 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.926 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 10.2 mt -95.73 25.94 4.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.034 0.445 . . . . 0.0 110.031 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.429 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 1.2 tp10 -44.36 -51.1 8.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.81 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -71.03 -9.9 58.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.066 -176.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -100.42 0.53 39.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 0.0 110.012 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 87.3 mttt -96.16 143.59 27.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.808 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.437 ' H ' ' ND2' ' A' ' 48' ' ' ASN . . . -92.14 24.44 3.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.732 0.777 . . . . 0.0 109.549 177.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.2 t30 . . . . . 0 C--O 1.247 0.943 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.629 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 121.459 0.647 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -92.29 -162.12 0.9 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.8 177.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.439 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 2.0 p -63.06 119.96 10.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.488 173.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 3.6 ptp180 -112.48 173.42 6.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.213 -167.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -85.72 114.73 22.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.507 -172.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.544 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 81.1 m95 -105.58 146.17 30.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.2 176.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.711 HG22 ' HG2' ' A' ' 16' ' ' LYS . 66.0 t -136.37 138.26 47.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.187 0.304 . . . . 0.0 110.707 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.584 ' HA ' HD12 ' A' ' 46' ' ' LEU . 6.6 p-10 -84.89 159.74 20.29 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -76.76 -1.98 30.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.029 0.443 . . . . 0.0 111.997 -169.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 t -105.34 -3.51 22.62 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.448 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.5 31.02 70.86 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.418 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.4 m -84.76 -43.06 14.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.848 0.356 . . . . 0.0 110.732 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.804 ' HZ ' ' HE3' ' A' ' 45' ' ' LYS . 24.9 p90 -138.76 136.86 36.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.867 0.841 . . . . 0.0 112.679 -176.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.711 ' HG2' HG22 ' A' ' 9' ' ' VAL . 54.1 mttp -126.07 130.9 52.02 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.207 171.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -139.06 157.94 28.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.391 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 29.5 m-20 -103.74 113.4 26.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -159.4 158.68 32.61 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.947 -172.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.439 ' HG3' ' HA ' ' A' ' 5' ' ' SER . 45.3 mt-10 -106.73 138.64 42.53 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.206 174.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.665 ' HA ' HD23 ' A' ' 31' ' ' LEU . 15.2 t80 -71.88 124.35 24.67 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.197 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -105.94 -43.21 7.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.102 -177.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.9 150.84 13.7 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.505 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.47 ' HB2' ' HE2' ' A' ' 21' ' ' PHE . 6.3 t -115.1 136.88 52.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.93 119.97 12.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.606 0.241 . . . . 0.0 110.913 -173.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 26' ' ' LYS . 17.9 tptm 55.75 41.17 30.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.314 174.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 65' ' ' PHE . . . 89.92 -4.84 83.45 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.309 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -109.71 159.93 16.74 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 122.453 -0.439 . . . . 0.0 110.765 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.522 HG23 ' HD2' ' A' ' 21' ' ' PHE . 76.1 mt -122.33 124.82 71.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.979 -174.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 92.2 m-70 -87.6 126.42 34.93 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 21' ' ' PHE . 87.4 mt -125.14 136.76 53.93 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.522 -178.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -102.1 100.38 10.62 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -63.32 159.57 17.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.136 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.28 -15.29 56.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.232 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.14 -25.22 37.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.523 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.9 -6.55 27.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.198 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.97 137.64 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.674 0.273 . . . . 0.0 110.577 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 36.5 ttmt -102.57 124.74 48.67 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 31.8 pt -123.43 153.68 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -176.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.29 103.43 8.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.129 175.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 m -99.03 153.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.487 ' HB1' ' OD1' ' A' ' 44' ' ' ASP . . . -82.33 122.22 27.69 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.009 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.93 -20.03 63.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.476 0.655 . . . . 0.0 110.923 -176.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.661 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 6.6 p-10 -77.02 -12.13 59.9 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.164 -175.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.804 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -117.43 10.32 13.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.931 0.872 . . . . 0.0 109.012 173.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 10' ' ' ASP . 14.1 tp -89.82 162.79 15.32 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.646 -177.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.572 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 27.0 m -68.28 142.75 55.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.588 0.709 . . . . 0.0 110.68 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -65.41 -27.85 68.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.267 -173.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -64.72 -48.9 72.95 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.603 0.716 . . . . 0.0 109.598 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.572 ' OD1' ' HB2' ' A' ' 47' ' ' SER . 1.6 m-20 -59.86 -36.29 76.57 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.219 175.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.686 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -65.47 -47.37 76.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.576 178.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -62.36 -27.57 69.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.789 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.428 ' O ' HG12 ' A' ' 57' ' ' ILE . 48.8 t80 -71.91 -47.88 49.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.628 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' A' ' 62' ' ' LEU . 61.5 t -62.68 -33.55 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.695 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.632 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 38.2 mt-10 -52.19 -34.77 46.85 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.21 0.529 . . . . 0.0 110.483 173.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 1.033 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.6 mmpt? -82.51 -37.01 25.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.894 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.44 HG21 ' CD1' ' A' ' 21' ' ' PHE . 20.7 mm -69.81 -28.35 36.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.008 0.432 . . . . 0.0 111.202 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.656 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 43.7 p -104.83 -45.38 4.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -173.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.4 4.34 46.84 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -172.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.656 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 96.7 m-85 -102.94 -175.88 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.2 t -125.4 121.75 34.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.102 0.477 . . . . 0.0 110.748 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 51' ' ' LEU . 25.4 mt -95.94 22.83 6.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.647 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.14 -41.14 74.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.402 0.62 . . . . 0.0 110.458 176.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HE3' ' CE2' ' A' ' 65' ' ' PHE . 48.6 pttt -62.53 -14.17 38.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.673 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.661 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 32.7 m-85 -104.38 -8.86 18.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.908 0.385 . . . . 0.0 111.031 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 95.0 mttt -84.77 126.17 33.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.101 0.477 . . . . 0.0 109.714 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.77 -84.59 0.07 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.988 -177.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 . . . . . 0 C--N 1.301 -1.509 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.094 175.851 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp . . . . . 0 C--O 1.234 0.251 0 CA-C-O 121.135 0.493 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.773 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -108.31 154.98 21.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.515 -178.76 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.582 ' CA ' ' HB2' ' A' ' 20' ' ' GLU . 46.1 t 71.8 125.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.866 0.841 . . . . 0.0 112.154 177.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 14.2 ptp180 -149.42 -179.08 6.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.168 -171.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.6 tm? -86.43 107.87 18.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.772 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.456 ' CE3' ' HB3' ' A' ' 50' ' ' ASP . 46.4 m95 -92.38 149.09 21.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.098 176.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 15.6 t -130.58 154.33 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.831 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -101.65 -179.05 3.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.815 0.341 . . . . 0.0 111.217 -178.515 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.432 ' HG2' ' CB ' ' A' ' 67' ' ' ALA . 1.9 tmm_? -60.41 -52.83 63.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.054 -177.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 m -81.8 -7.29 59.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.184 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.0 28.54 45.26 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.527 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.1 m -99.7 -37.28 9.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.521 0.677 . . . . 0.0 109.468 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.831 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 4.8 m-85 -87.01 125.82 34.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.739 -176.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.457 ' HB3' HD11 ' A' ' 7' ' ' LEU . 50.5 mttp -131.63 129.56 41.01 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 158.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.87 133.59 6.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.455 0.645 . . . . 0.0 112.119 -177.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 7.3 p-10 -87.73 116.2 25.71 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.732 176.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -168.49 167.64 11.57 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.102 -174.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' CA ' ' A' ' 5' ' ' SER . 9.6 tp10 -126.97 136.56 52.43 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.137 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.779 ' HA ' HD23 ' A' ' 31' ' ' LEU . 7.1 t80 -65.53 126.6 28.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.723 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -105.54 -50.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.818 179.281 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.11 148.07 15.97 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.583 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 t -108.9 129.12 55.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.18 133.02 15.02 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.138 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm 63.69 23.72 13.61 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.328 175.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.92 4.59 88.52 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.956 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 33.1 mmtp -103.23 154.51 19.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.008 0.433 . . . . 0.0 110.166 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.647 HG23 ' HD1' ' A' ' 21' ' ' PHE . 40.3 mm -108.71 114.07 45.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.347 174.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.448 ' O ' HG13 ' A' ' 22' ' ' ILE . 65.0 m170 -76.21 125.59 29.44 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 175.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.779 HD23 ' HA ' ' A' ' 21' ' ' PHE . 86.3 mt -129.04 136.69 50.62 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.695 -174.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -106.74 107.94 19.21 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.574 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 4.8 mtpm? -67.63 166.14 15.64 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.15 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.64 -14.38 60.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.297 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -93.42 1.96 56.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.904 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.33 -18.08 58.11 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.185 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.1 t -63.67 139.35 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.518 0.199 . . . . 0.0 110.869 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -107.81 121.68 45.22 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 pt -124.42 158.51 31.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.726 -173.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.48 103.39 8.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.152 0.501 . . . . 0.0 110.049 174.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.28 119.97 55.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -58.79 124.95 21.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.436 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -64.96 -26.91 68.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.982 177.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.7 -34.24 71.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.58 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -110.46 18.38 19.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.034 0.445 . . . . 0.0 110.789 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.684 ' HB3' HD21 ' A' ' 51' ' ' LEU . 10.1 tp -95.18 170.12 9.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.149 -176.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.608 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 35.3 t -83.66 139.48 32.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.033 0.92 . . . . 0.0 110.751 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -51.52 -35.04 38.85 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.272 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.22 -50.54 71.35 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 121.412 0.625 . . . . 0.0 109.99 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.608 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 5.8 m-20 -60.99 -36.41 79.4 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.606 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.772 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 26.4 mt -69.82 -43.21 72.49 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -59.41 -28.88 67.32 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.514 0.673 . . . . 0.0 109.869 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.547 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 29.3 t80 -73.7 -50.34 21.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.146 176.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.0 p -70.28 -29.66 40.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.891 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.772 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 42.8 mt-10 -54.63 -37.12 65.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.465 168.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -39.44 66.6 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.547 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 53.3 mt -64.19 -47.23 90.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.084 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.9 p -80.62 -46.46 15.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.363 -174.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.04 -4.55 41.62 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -173.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -100.35 179.36 4.48 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.52 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 6.4 t -118.98 134.51 55.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.805 0.336 . . . . 0.0 110.479 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.531 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 21.8 mt -97.84 35.75 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.123 0.487 . . . . 0.0 110.845 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.44 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 5.8 mm-40 -44.61 -58.41 3.05 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.506 1.122 . . . . 0.0 113.365 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -69.11 -10.54 58.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.644 0.259 . . . . 0.0 111.693 -173.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -105.04 -8.97 18.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.286 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.666 ' HA ' HD12 ' A' ' 51' ' ' LEU . 64.2 mttm -62.99 147.43 50.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.246 0.546 . . . . 0.0 111.867 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.432 ' CB ' ' HG2' ' A' ' 11' ' ' ARG . . . -71.45 68.06 0.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.803 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 C--O 1.246 0.918 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.942 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.685 ' HG3' ' H ' ' A' ' 4' ' ' LYS . 15.0 ptmt . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.685 ' H ' ' HG3' ' A' ' 3' ' ' LYS . 27.7 mttp 51.78 55.51 9.21 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 122.158 0.98 . . . . 0.0 111.158 -173.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 p -70.25 125.93 28.21 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.696 -1.593 . . . . 0.0 109.944 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 8.2 ptp180 -115.44 178.16 4.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.879 -171.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 7' ' ' LEU . 6.1 mt -84.45 114.32 21.84 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.214 0.531 . . . . 0.0 111.546 -173.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.581 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 43.9 m95 -98.63 140.66 32.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.595 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 10' ' ' ASP . 43.8 t -124.62 144.84 33.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.915 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.532 ' HA ' HD12 ' A' ' 46' ' ' LEU . 7.4 p-10 -84.89 170.55 12.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.0 109.887 173.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.443 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 36.4 ttp180 -75.47 -14.52 60.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.631 -172.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -98.13 -16.48 19.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.907 0.384 . . . . 0.0 111.184 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.5 36.85 25.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.661 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -98.87 -37.69 9.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.189 -0.505 . . . . 0.0 110.724 -175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 37.8 p90 -137.0 135.15 37.37 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.725 0.774 . . . . 0.0 112.434 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 47.8 mttp -128.92 130.61 47.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.369 173.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.559 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -145.1 146.1 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.987 0.422 . . . . 0.0 112.102 -176.708 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 6.3 m-20 -82.12 120.39 25.25 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.513 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.674 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -163.16 162.89 25.77 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.74 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -123.6 138.53 54.53 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 174.304 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.8 ' HD1' HG23 ' A' ' 29' ' ' ILE . 6.8 t80 -70.91 122.72 20.48 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.508 0.67 . . . . 0.0 110.507 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -100.81 -51.16 9.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.383 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.84 154.35 25.34 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.485 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.412 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 22.6 t -120.82 138.58 53.97 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -177.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.1 131.07 15.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.045 -175.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 56.62 27.1 11.98 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.729 0.643 . . . . 0.0 112.311 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.41 -1.53 69.61 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.711 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 57.0 mttp -103.99 158.93 16.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.011 0.434 . . . . 0.0 110.799 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.8 HG23 ' HD1' ' A' ' 21' ' ' PHE . 94.3 mt -116.38 122.8 70.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.117 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.435 ' O ' HG13 ' A' ' 22' ' ' ILE . 39.7 m170 -84.5 126.94 33.73 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 21' ' ' PHE . 81.8 mt -124.14 135.69 53.69 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.833 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -95.7 103.97 15.87 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.696 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.866 ' HD3' HD13 ' A' ' 39' ' ' ILE . 11.8 mmmm -64.82 158.75 24.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.218 -174.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.8 -20.72 66.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.802 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -66.48 -32.49 73.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.686 173.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.83 -17.26 27.73 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.295 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.4 t -72.59 147.4 10.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.368 -0.416 . . . . 0.0 110.654 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -100.62 128.77 46.56 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.866 HD13 ' HD3' ' A' ' 33' ' ' LYS . 18.1 pt -120.04 159.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.259 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.82 103.55 8.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.069 0.461 . . . . 0.0 110.096 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.1 t -107.29 129.56 60.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -68.18 131.56 45.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.78 0.324 . . . . 0.0 110.191 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -69.07 -6.55 28.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.881 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 2.8 p30 -81.76 -33.81 30.77 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -172.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.588 ' HD3' ' H ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -107.78 19.98 19.4 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.094 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.532 HD12 ' HA ' ' A' ' 10' ' ' ASP . 11.6 tp -93.34 169.69 10.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.799 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.515 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.3 t -74.15 139.47 44.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.561 0.696 . . . . 0.0 110.676 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -63.21 -30.55 71.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.419 -173.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -62.03 -46.98 86.78 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.594 0.712 . . . . 0.0 109.789 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.573 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.3 m-20 -65.54 -34.69 78.85 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.565 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.779 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -69.32 -47.21 65.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.11 177.611 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.576 ' O ' ' HD2' ' A' ' 56' ' ' LYS . . . -60.94 -30.85 70.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.575 0.702 . . . . 0.0 109.991 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.442 ' CE1' HD11 ' A' ' 57' ' ' ILE . 35.2 t80 -69.22 -52.12 30.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.099 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.768 ' HA ' HG12 ' A' ' 57' ' ' ILE . 3.0 p -69.06 -27.22 34.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.868 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.779 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 71.2 mt-10 -51.09 -49.29 60.99 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.106 0.479 . . . . 0.0 109.894 167.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -72.24 -26.62 62.09 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.57 -175.169 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.768 HG12 ' HA ' ' A' ' 54' ' ' VAL . 10.8 mm -67.3 -43.18 88.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.561 174.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 17.8 p -97.19 -47.25 5.82 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.14 -6.9 19.18 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.486 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 90.8 m-85 -92.71 167.89 11.58 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -117.13 134.46 54.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 27.4 mt -105.3 25.17 10.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.685 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 5.5 tp10 -54.5 -41.59 69.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.3 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -60.27 -19.95 56.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.204 177.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.484 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 57.6 m-85 -101.04 -14.16 17.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.31 0.576 . . . . 0.0 110.081 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.685 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 49.6 mtpt -81.43 140.05 34.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.282 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.443 ' HB3' ' HD2' ' A' ' 11' ' ' ARG . . . -116.89 121.24 40.91 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.905 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.636 -178.992 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 1.2 p . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 121.3 0.572 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 12.1 ptp180 -136.97 -177.09 4.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.054 -171.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.714 HD11 ' HE2' ' A' ' 16' ' ' LYS . 2.2 tm? -91.24 106.68 18.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.41 -174.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.525 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 35.3 m95 -92.12 149.32 21.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.738 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.1 t -135.75 139.96 45.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.844 ' HA ' HD12 ' A' ' 46' ' ' LEU . 1.2 p-10 -80.8 175.14 10.94 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.619 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.528 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 3.7 tpm_? -54.21 -51.21 65.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.836 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -80.21 -14.85 58.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.616 -172.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.68 47.31 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.466 -0.653 . . . . 0.0 111.466 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.2 m -86.62 -36.88 18.56 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.735 0.302 . . . . 0.0 110.189 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.487 ' CE2' ' HE2' ' A' ' 45' ' ' LYS . 39.3 p90 -129.99 141.42 50.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.812 0.815 . . . . 0.0 111.985 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.714 ' HE2' HD11 ' A' ' 7' ' ' LEU . 9.5 ptmm? -128.93 131.81 47.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.895 174.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -134.9 140.92 44.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -172.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.563 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 8.6 p-10 -81.22 122.4 27.35 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 169.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -162.01 155.89 21.51 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.594 -175.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.537 ' HG2' ' N ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -116.33 145.93 42.83 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.415 171.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 62.7 t80 -80.91 129.55 34.59 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.148 0.499 . . . . 0.0 110.395 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -108.75 -49.55 7.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.091 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.42 140.87 6.43 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.901 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.595 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 30.8 t -111.1 130.41 55.62 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.41 137.98 18.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.613 0.244 . . . . 0.0 110.713 -174.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 61.6 24.62 14.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.481 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.6 2.68 75.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.789 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -115.03 161.83 17.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.549 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' A' ' 43' ' ' ALA . 69.6 mt -114.36 120.66 64.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.361 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.416 ' O ' HG13 ' A' ' 22' ' ' ILE . 23.0 m-70 -80.48 123.53 28.15 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.646 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 97.7 mt -126.34 139.67 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.152 -174.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -112.66 103.13 11.17 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.205 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.8 mtpt -59.65 152.64 21.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.32 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 5' ' ' SER . . . -72.23 -15.17 61.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.217 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.36 -13.29 60.72 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.437 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.27 9.46 51.1 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.154 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.99 142.77 16.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.759 0.279 . . . . 0.0 110.43 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -105.33 125.21 50.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 pt -127.29 172.44 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.888 0.375 . . . . 0.0 111.123 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.9 110.0 11.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.2 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.15 127.03 71.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.875 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 128.4 36.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.708 0.289 . . . . 0.0 110.486 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.541 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -70.78 -10.16 58.92 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.536 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 11.7 p-10 -96.23 -19.76 19.07 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -172.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.487 ' HE2' ' CE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -104.84 19.56 20.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.428 0.632 . . . . 0.0 109.953 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.844 HD12 ' HA ' ' A' ' 10' ' ' ASP . 8.1 tp -101.5 176.44 5.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.076 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.669 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 22.2 t -88.38 147.52 24.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.065 0.936 . . . . 0.0 111.005 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.737 HD22 ' HB3' ' A' ' 66' ' ' LYS . 1.1 m120 -56.87 -35.38 68.84 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.455 -172.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.07 -45.55 73.51 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.095 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.669 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 2.2 m-20 -59.21 -40.8 86.95 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.989 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.797 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -68.05 -42.94 79.75 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.288 178.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' A' ' 56' ' ' LYS . . . -58.81 -35.19 72.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.253 0.549 . . . . 0.0 110.051 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.438 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 43.6 t80 -68.79 -50.26 51.77 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.151 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.4 p -68.89 -31.41 50.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.614 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.797 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.0 mt-10 -51.91 -40.95 61.54 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.604 168.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.672 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -75.54 -33.97 60.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 110.574 -174.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 52.2 mt -66.26 -39.65 84.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.971 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 p -92.13 -46.32 7.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -171.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.51 -5.5 35.38 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -89.75 -178.48 5.52 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.531 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 13.8 t -124.25 125.41 44.35 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.166 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 21.3 mt -104.19 24.16 11.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.771 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -53.83 -46.53 71.21 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.897 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -59.43 -24.79 63.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.504 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.536 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 90.9 m-85 -89.17 -14.07 36.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 0.0 110.739 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.737 ' HB3' HD22 ' A' ' 48' ' ' ASN . 93.4 mttt . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.444 -0.77 0 CA-C-O 121.44 0.638 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 2.8 ptp180 -110.13 174.83 5.68 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.689 -173.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 16' ' ' LYS . 1.7 tm? -94.2 104.72 16.72 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.155 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.776 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 69.3 m95 -91.56 142.73 27.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.825 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 10' ' ' ASP . 82.4 t -132.82 142.45 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 O-C-N 123.488 0.492 . . . . 0.0 110.926 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.97 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -90.63 161.2 15.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -68.5 -23.03 64.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.074 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -75.88 -23.37 55.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.132 0.492 . . . . 0.0 110.377 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.11 12.32 60.28 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.941 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -87.66 -48.11 8.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.525 0.679 . . . . 0.0 109.868 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.97 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 2.4 m-85 -79.67 134.33 36.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.034 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.776 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 7.2 ptpp? -159.97 128.96 5.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.493 165.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.45 151.67 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 120.129 -0.629 . . . . 0.0 111.955 -173.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 8.0 p-10 -84.05 125.48 32.14 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.691 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.441 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -167.93 156.83 9.41 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.183 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.71 149.16 30.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.538 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.717 ' HA ' HD12 ' A' ' 31' ' ' LEU . 58.2 t80 -87.39 131.36 34.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.491 -173.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -107.85 -44.98 7.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.823 0.344 . . . . 0.0 110.58 179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.33 161.81 31.07 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 121.129 -0.557 . . . . 0.0 111.836 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 t -141.78 132.58 25.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.286 0.543 . . . . 0.0 110.96 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.09 149.33 26.0 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.12 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.58 21.43 10.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.095 0.558 . . . . 0.0 111.937 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.17 23.06 50.1 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.336 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.67 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 47.1 mmtm -125.59 146.51 49.66 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 120.872 0.367 . . . . 0.0 110.982 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.556 ' CG2' HD13 ' A' ' 31' ' ' LEU . 1.9 mp -106.92 123.95 62.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.354 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 22' ' ' ILE . 36.6 m170 -89.83 120.32 30.97 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.717 HD12 ' HA ' ' A' ' 21' ' ' PHE . 3.0 tp -121.63 153.35 38.22 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.342 -173.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -128.53 107.2 9.52 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.352 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.512 ' HD3' HD13 ' A' ' 39' ' ' ILE . 12.6 mmmm -58.59 161.35 4.69 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.242 -175.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.62 -25.63 68.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.773 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -79.16 -19.61 50.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.081 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.7 26.92 6.23 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.691 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.51 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 47.3 t -102.42 143.01 15.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -105.52 131.12 53.32 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.079 0.466 . . . . 0.0 110.963 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.512 HD13 ' HD3' ' A' ' 33' ' ' LYS . 24.5 pt -135.36 160.27 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.605 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.81 117.87 29.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.039 0.447 . . . . 0.0 110.135 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.2 t -112.11 134.98 52.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.775 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.67 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . . . -69.8 127.03 31.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.724 0.297 . . . . 0.0 110.907 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.11 -14.15 61.28 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.418 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.436 ' OD1' ' HB1' ' A' ' 42' ' ' ALA . 7.1 p-10 -92.88 -14.72 27.29 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 19.4 ptmt -97.51 -2.1 42.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.474 0.654 . . . . 0.0 110.124 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 46' ' ' LEU . 2.6 tp -84.86 159.63 20.34 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.504 -170.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.589 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 48.1 t -71.65 153.34 42.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.4 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.472 ' HA ' HD22 ' A' ' 51' ' ' LEU . 12.6 m-80 -64.12 -28.65 69.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.211 -176.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -66.11 -47.82 72.93 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.865 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.589 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 4.1 m-20 -62.63 -32.14 73.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.486 177.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.724 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -65.98 -51.6 57.02 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.112 177.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -63.71 -27.2 69.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.123 0.487 . . . . 0.0 111.06 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.475 ' CE1' HD11 ' A' ' 57' ' ' ILE . 22.9 t80 -70.0 -48.3 58.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.866 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 50' ' ' ASP . 78.8 t -62.8 -34.3 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.777 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.691 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 44.0 mt-10 -54.84 -32.77 60.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.022 0.439 . . . . 0.0 110.512 174.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.566 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -80.18 -47.15 15.13 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.053 -178.008 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.475 HD11 ' CE1' ' A' ' 53' ' ' TYR . 25.0 mt -62.47 -36.63 75.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 111.727 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 55.8 p -103.12 -46.48 4.62 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.22 -8.01 30.87 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -173.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 92.8 m-85 -90.99 135.42 33.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.11 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.1 m -82.11 130.59 35.13 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.766 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.724 HD12 ' HA ' ' A' ' 51' ' ' LEU . 48.6 mt -104.63 30.2 5.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.179 0.514 . . . . 0.0 109.875 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -53.95 -47.48 71.24 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.349 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -67.11 -13.55 62.05 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.8 -14.97 27.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.922 0.391 . . . . 0.0 110.235 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 92.2 mttt . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.599 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 CA--C 1.517 -0.306 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 9.3 ptp180 -143.39 -179.29 6.32 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.81 -167.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 16' ' ' LYS . 2.1 tm? -95.24 105.27 17.2 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.856 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.604 ' CE3' ' HB3' ' A' ' 50' ' ' ASP . 37.0 m95 -91.57 139.16 30.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 10' ' ' ASP . 47.6 t -119.31 137.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.846 0.355 . . . . 0.0 110.858 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.6 ' HB3' ' H ' ' A' ' 14' ' ' THR . 9.8 t70 -63.46 158.82 19.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -74.11 -35.03 64.12 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.712 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -95.87 11.97 31.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.137 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.71 28.58 73.5 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.897 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.6 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 6.7 m -67.5 -37.07 82.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.745 -0.228 . . . . 0.0 111.111 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -158.39 157.54 32.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.261 0.553 . . . . 0.0 111.407 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.71 ' HB3' HD11 ' A' ' 7' ' ' LEU . 9.1 mtmp? -125.13 132.29 53.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.514 171.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.448 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -135.27 141.39 42.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 112.548 0.574 . . . . 0.0 112.548 -175.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.7 OUTLIER -95.29 115.11 26.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.312 176.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.875 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . . . -170.24 167.19 8.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.16 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.3 140.33 49.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.912 ' HA ' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -65.72 134.54 53.41 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.993 0.425 . . . . 0.0 109.876 177.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.983 HD12 ' HE3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -110.29 -47.64 6.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.111 177.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.54 139.41 5.78 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.293 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.616 ' HG ' ' HE2' ' A' ' 21' ' ' PHE . 78.2 m -98.69 126.36 44.27 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.58 136.5 22.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.6 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 tptt 63.8 27.64 14.63 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.643 0.735 . . . . 0.0 110.118 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.56 3.57 88.92 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.211 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.873 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 42.1 mttm -109.95 171.91 7.17 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.66 HG23 ' HD2' ' A' ' 21' ' ' PHE . 57.9 mt -124.67 116.72 48.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.384 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.418 ' O ' HG13 ' A' ' 22' ' ' ILE . 57.3 m-70 -75.88 128.2 34.61 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.912 HD23 ' HA ' ' A' ' 21' ' ' PHE . 77.1 mt -126.82 136.92 53.02 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.363 -172.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.571 ' HB2' HD11 ' A' ' 22' ' ' ILE . 15.1 t-160 -102.31 102.59 12.97 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.345 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.875 ' HD2' ' HB2' ' A' ' 19' ' ' ALA . 1.6 mmmp? -65.13 163.99 13.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.073 -176.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.3 -13.48 62.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.101 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -87.29 -10.49 52.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.592 176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.91 -18.4 52.47 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.922 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.6 p -72.65 147.98 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.945 0.402 . . . . 0.0 110.823 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.983 ' HE3' HD12 ' A' ' 22' ' ' ILE . 84.6 tttt -111.16 132.96 53.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.613 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 pt -126.95 174.69 10.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.484 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.89 103.19 5.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.245 0.545 . . . . 0.0 110.056 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.563 HG13 ' HE3' ' A' ' 45' ' ' LYS . 73.2 t -106.84 118.63 54.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.668 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.873 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -57.85 139.14 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.375 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.14 -9.33 58.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.693 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -84.05 -31.27 25.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.122 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.563 ' HE3' HG13 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -99.24 27.34 5.21 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.362 175.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.546 HD12 HD12 ' A' ' 29' ' ' ILE . 13.9 mt -102.26 163.67 12.11 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 122.338 1.066 . . . . 0.0 112.241 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.567 ' O ' HD22 ' A' ' 51' ' ' LEU . 30.2 t -71.05 135.65 47.87 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.104 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.472 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 3.0 m-20 -48.44 -38.91 21.04 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.842 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.74 -47.07 83.5 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.564 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.604 ' HB3' ' CE3' ' A' ' 8' ' ' TRP . 43.6 m-20 -67.49 -34.97 78.24 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.238 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.789 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -70.95 -41.71 70.76 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.505 176.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.513 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -60.69 -29.44 69.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.515 0.674 . . . . 0.0 110.135 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 51.1 t80 -71.51 -51.59 22.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.935 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.802 ' HA ' HG12 ' A' ' 57' ' ' ILE . 2.7 p -71.23 -27.66 30.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.607 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.789 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 42.6 mt-10 -51.67 -38.53 55.36 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.165 0.507 . . . . 0.0 109.796 168.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -76.4 -41.11 48.97 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.783 -178.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.802 HG12 ' HA ' ' A' ' 54' ' ' VAL . 7.5 mm -61.69 -36.29 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.8 p -101.88 -49.17 4.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.34 -34.22 4.37 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.989 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -87.98 140.74 29.19 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 117.14 0.47 . . . . 0.0 110.451 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.7 t -79.51 135.73 36.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.424 -171.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 23.8 mt -104.68 22.28 15.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.115 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.589 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 2.2 tp10 -50.69 -38.63 47.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.4 0.619 . . . . 0.0 110.362 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 18.3 ptmt -67.48 -5.92 17.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.843 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -115.94 -12.48 11.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.229 0.537 . . . . 0.0 110.103 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 45.1 mtpt . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.831 -174.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.736 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 60.9 p . . . . . 0 CA--C 1.522 -0.125 0 CA-C-O 122.403 1.097 . . . . 0.0 112.479 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 11.6 ptp180 -118.96 176.52 5.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.798 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.6 tm? -95.66 105.68 17.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.975 0.417 . . . . 0.0 110.769 -173.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.701 ' HB2' HG23 ' A' ' 17' ' ' VAL . 48.7 m95 -92.4 152.64 19.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.299 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 16' ' ' LYS . 47.6 t -135.76 142.94 37.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.673 ' HA ' HD12 ' A' ' 46' ' ' LEU . 3.5 p-10 -85.41 178.31 7.49 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.084 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -59.52 -40.48 87.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.83 0.348 . . . . 0.0 111.552 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.8 m -84.5 -18.65 35.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.5 13.93 74.89 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.708 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 m -79.87 -37.02 35.75 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.683 -0.258 . . . . 0.0 111.182 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 47.0 p90 -123.4 125.15 44.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.009 0.909 . . . . 0.0 112.175 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.611 ' HB3' HD11 ' A' ' 7' ' ' LEU . 52.2 mttp -116.61 131.17 57.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.452 174.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -131.91 136.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.1 p-10 -90.02 106.11 18.26 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.181 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -161.44 161.79 30.3 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.767 -171.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.736 ' HG2' ' N ' ' A' ' 5' ' ' SER . 1.1 mm-40 -107.92 142.79 37.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.563 174.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.645 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 69.4 t80 -73.85 130.32 39.68 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.975 174.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -115.8 -47.62 4.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.408 178.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.83 148.51 14.86 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.86 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.645 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 30.8 t -124.18 126.89 46.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.859 0.329 . . . . 0.0 110.126 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.33 116.69 16.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.112 -173.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.5 tptt 55.2 44.5 27.6 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.201 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.28 2.82 85.19 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.46 175.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 46.7 mmtm -107.06 151.74 24.94 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 117.118 0.459 . . . . 0.0 110.079 174.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.672 HG13 ' HB2' ' A' ' 43' ' ' ALA . 91.0 mt -119.87 123.76 71.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.286 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.502 ' O ' HG13 ' A' ' 22' ' ' ILE . 34.6 m170 -84.96 124.08 31.27 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 21' ' ' PHE . 96.5 mt -125.63 138.45 53.92 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.83 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -107.37 101.14 10.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.175 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HE3' HG12 ' A' ' 17' ' ' VAL . 38.1 mtpt -64.96 159.06 23.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.471 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.9 -15.68 63.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.54 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.77 -20.07 61.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.566 174.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.57 -20.5 27.37 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.963 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.7 p -79.2 142.12 14.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.293 0.568 . . . . 0.0 111.19 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -99.65 127.8 45.76 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.928 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.1 pt -122.87 162.62 22.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.958 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.91 122.66 38.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.842 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.59 163.55 15.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . . . -92.42 119.71 32.22 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.411 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.672 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -64.24 -21.92 66.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.735 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.61 -22.41 63.5 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.764 -174.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HE2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -127.22 28.62 5.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.431 0.634 . . . . 0.0 110.377 179.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 10' ' ' ASP . 10.7 tp -95.03 170.58 9.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.592 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.649 ' O ' HD22 ' A' ' 51' ' ' LEU . 33.4 t -72.74 139.73 47.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.422 0.63 . . . . 0.0 110.1 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.466 ' CB ' ' HB3' ' A' ' 66' ' ' LYS . 11.2 p30 -66.06 -24.51 66.74 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.983 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -63.87 -47.77 79.36 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.637 0.732 . . . . 0.0 109.192 174.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.629 ' O ' HG12 ' A' ' 54' ' ' VAL . 3.3 m-20 -58.62 -43.8 89.78 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.712 176.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.797 HD23 ' HA ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -67.57 -42.39 82.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.819 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -61.5 -29.64 70.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.401 0.62 . . . . 0.0 110.134 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.744 ' CE2' HD11 ' A' ' 57' ' ' ILE . 40.9 t80 -74.61 -49.13 22.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.763 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.2 p -69.48 -27.65 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.119 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.764 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 50.6 mt-10 -51.24 -40.91 59.85 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 167.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 52' ' ' ALA . 9.3 mmpt? -74.14 -38.61 63.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.389 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.744 HD11 ' CE2' ' A' ' 53' ' ' TYR . 31.9 mt -62.84 -39.8 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.976 0.417 . . . . 0.0 111.253 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 40.3 p -95.22 -43.91 7.85 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -168.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.2 7.46 43.4 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.494 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.593 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 98.1 m-85 -103.7 177.06 4.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -123.69 124.66 43.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.959 0.409 . . . . 0.0 110.034 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 65' ' ' PHE . 62.1 mt -102.89 41.19 1.27 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.45 0.643 . . . . 0.0 110.189 -175.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.73 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 8.5 tp10 -50.62 -59.65 3.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.479 -176.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -70.35 -10.47 59.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.339 0.59 . . . . 0.0 109.917 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.677 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 60.3 m-85 -91.88 -14.2 30.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.566 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.797 ' HA ' HD23 ' A' ' 51' ' ' LEU . 50.8 mtmt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.476 -175.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.6 p . . . . . 0 N--CA 1.441 -0.9 0 CA-C-O 121.041 0.448 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 2.8 ptp180 -136.54 -179.17 5.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.052 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -93.18 115.14 27.77 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.497 -172.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.719 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 62.4 m95 -104.6 149.15 25.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.156 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 59.5 t -136.75 149.92 26.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 123.543 0.527 . . . . 0.0 109.829 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.993 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -96.67 174.09 7.0 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.214 178.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 11' ' ' ARG . 1.6 tmm_? -66.82 -34.29 77.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.705 0.288 . . . . 0.0 110.857 -174.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -75.68 -23.36 56.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.21 2.17 66.3 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.666 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -80.8 -40.48 24.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.349 0.595 . . . . 0.0 109.834 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.993 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 5.7 m-85 -85.93 127.12 34.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.829 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.719 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 8.6 ptmt -153.35 128.57 9.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.917 166.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.422 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -158.36 156.36 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.785 -173.367 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -92.81 118.67 31.35 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.899 174.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -163.86 164.62 23.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.621 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 138.32 51.3 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.818 ' HD2' HG23 ' A' ' 29' ' ' ILE . 6.6 t80 -74.41 117.91 16.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.324 0.583 . . . . 0.0 109.504 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -96.07 -45.37 13.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.136 -177.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.93 143.21 7.55 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.766 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.598 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 22.1 p -100.82 133.93 44.55 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.74 126.91 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.576 -173.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.3 OUTLIER 61.44 34.2 18.27 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.811 176.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.29 7.42 88.48 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.254 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -104.7 165.91 10.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.028 0.442 . . . . 0.0 110.442 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.818 HG23 ' HD2' ' A' ' 21' ' ' PHE . 84.6 mt -125.51 116.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.52 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.492 ' O ' HG13 ' A' ' 22' ' ' ILE . 11.2 m170 -83.61 126.94 33.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.725 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.7 mt -124.72 138.89 54.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.284 0.564 . . . . 0.0 111.021 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -104.72 105.55 15.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.468 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HD3' HD13 ' A' ' 39' ' ' ILE . 13.5 mmmm -61.14 162.89 6.75 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.527 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.14 -12.47 60.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.265 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -89.26 -13.46 38.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.195 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.82 2.56 56.19 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.468 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.17 148.14 5.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.554 0.216 . . . . 0.0 110.46 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -100.04 126.41 46.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.041 0.448 . . . . 0.0 110.857 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.624 HD13 ' HD3' ' A' ' 33' ' ' LYS . 24.8 pt -124.86 168.45 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.949 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.88 124.36 18.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.258 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 m -114.05 164.71 9.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.522 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . . . -85.86 127.85 34.68 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.183 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -63.97 -5.8 5.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.372 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -110.71 -15.72 13.77 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.522 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -96.26 0.88 51.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 6.6 tp -86.27 169.23 13.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.058 -175.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.634 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.5 t -78.9 138.29 38.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.776 0.798 . . . . 0.0 109.923 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.45 ' ND2' ' HB3' ' A' ' 66' ' ' LYS . 1.2 m-20 -53.53 -32.79 52.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.329 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -62.91 -48.13 80.28 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.046 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.668 ' O ' HG12 ' A' ' 54' ' ' VAL . 2.6 m-20 -59.67 -39.26 83.88 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.555 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.736 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -70.21 -38.89 75.39 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.158 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -60.33 -30.44 69.51 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.566 0.698 . . . . 0.0 110.197 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.663 ' CE2' HD11 ' A' ' 57' ' ' ILE . 80.2 t80 -74.36 -48.41 28.21 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.507 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -65.17 -26.98 41.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.415 -0.803 . . . . 0.0 110.853 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.736 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 37.8 mt-10 -51.47 -43.53 62.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.26 166.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.599 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 1.6 ppmt? -72.87 -31.58 64.82 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.992 0.425 . . . . 0.0 109.983 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.663 HD11 ' CE2' ' A' ' 53' ' ' TYR . 37.7 mt -66.94 -42.84 89.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.735 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.4 p -104.52 -46.38 4.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -171.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.13 -14.57 23.51 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -79.74 137.64 37.08 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.432 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 20.9 t -89.45 112.04 23.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.938 0.399 . . . . 0.0 110.238 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 30.1 mt -91.51 24.86 2.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.638 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -53.48 -47.37 69.85 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.677 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -73.33 -5.35 39.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.502 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -97.41 -16.13 20.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.102 0.477 . . . . 0.0 110.14 176.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 97.9 mttt . . . . . 0 C--O 1.235 0.341 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.877 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.624 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 25.1 t . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.123 0.487 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -148.59 -179.82 7.26 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 110.737 178.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.461 HD11 ' HB3' ' A' ' 16' ' ' LYS . 2.6 tm? -103.72 108.18 19.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.507 -175.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.6 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 43.1 m95 -93.22 145.46 24.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.046 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.24 148.5 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -86.66 177.32 7.39 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.187 176.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.637 ' HD3' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -55.11 -44.87 75.35 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.637 ' N ' ' HD3' ' A' ' 11' ' ' ARG . 64.6 p -85.4 -28.97 24.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.017 0.437 . . . . 0.0 111.436 -173.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.11 20.3 30.92 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.467 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.6 m -78.24 -37.48 45.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.783 0.325 . . . . 0.0 110.297 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.42 ' HZ ' ' HD3' ' A' ' 45' ' ' LYS . 42.0 p90 -132.87 133.56 43.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.84 0.828 . . . . 0.0 112.376 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HB3' HD11 ' A' ' 7' ' ' LEU . 21.7 mtmm -123.11 143.89 49.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.608 175.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.639 HG12 ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -137.66 135.85 46.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.674 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 10.3 p-10 -85.89 105.36 16.32 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.486 173.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.792 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -156.21 162.43 40.18 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.329 -171.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.624 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -119.1 139.47 51.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.857 172.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.805 ' HD2' HG23 ' A' ' 29' ' ' ILE . 33.6 t80 -68.56 132.22 46.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -113.76 -48.89 5.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.19 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.08 157.59 29.15 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.0 p -116.87 140.87 48.94 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 28' ' ' LYS . . . -135.02 105.59 6.43 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.172 -174.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? 59.12 41.86 19.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.923 0.868 . . . . 0.0 109.573 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.71 -19.18 52.87 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.978 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 42' ' ' ALA . 3.6 ptpp? -89.18 163.72 15.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.406 0.603 . . . . 0.0 110.423 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.805 HG23 ' HD2' ' A' ' 21' ' ' PHE . 57.8 mt -115.39 126.8 73.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.12 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.459 ' O ' HG13 ' A' ' 22' ' ' ILE . 91.4 m-70 -86.16 127.27 34.69 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 169.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.792 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 95.8 mt -125.63 137.8 53.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.91 -176.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -106.3 110.05 22.17 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.271 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.674 ' HE2' ' O ' ' A' ' 18' ' ' ASP . 11.8 mmmm -58.05 151.81 17.91 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 123.696 0.623 . . . . 0.0 109.901 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.65 -16.06 63.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.623 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -89.82 -7.13 55.03 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.153 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.45 -23.41 12.33 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.718 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 t -67.44 145.78 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 117.001 0.4 . . . . 0.0 110.88 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -112.37 130.27 56.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.821 0.343 . . . . 0.0 110.196 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.429 HD13 ' HD3' ' A' ' 33' ' ' LYS . 20.8 pt -126.1 165.68 23.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.385 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.58 124.46 40.0 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.59 HG13 ' HE3' ' A' ' 45' ' ' LYS . 70.4 t -130.4 120.58 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.402 -175.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . . . -66.06 129.27 39.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.2 -18.27 63.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.626 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.726 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 2.9 p30 -72.72 -25.64 61.3 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.094 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.59 ' HE3' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.43 29.03 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.751 0.786 . . . . 0.0 110.051 176.413 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.5 tp -108.77 174.5 5.84 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.197 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.559 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 47.6 t -80.21 138.01 36.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.925 0.869 . . . . 0.0 110.766 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -51.2 -41.23 60.1 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.756 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.7 -45.27 87.32 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.132 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.6 ' OD2' ' HA ' ' A' ' 8' ' ' TRP . 3.9 m-20 -60.24 -36.83 78.63 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.166 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.784 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -67.18 -42.72 83.74 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 120.597 -0.441 . . . . 0.0 109.918 176.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -60.97 -29.65 69.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.486 0.66 . . . . 0.0 110.237 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -73.85 -51.32 16.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.169 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.833 ' HA ' HG12 ' A' ' 57' ' ' ILE . 3.6 p -69.63 -25.7 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.143 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.784 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.0 mt-10 -50.34 -44.38 54.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.101 0.476 . . . . 0.0 109.733 167.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 52' ' ' ALA . 1.1 mpmm? -72.76 -34.55 67.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.492 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.833 HG12 ' HA ' ' A' ' 54' ' ' VAL . 4.9 mm -68.78 -34.15 63.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.067 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.732 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 37.6 p -99.31 -48.1 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -171.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.56 -0.76 34.5 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -171.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.732 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 87.3 m-85 -102.04 141.13 35.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.439 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 17.7 t -88.2 111.7 21.92 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.695 HD12 HG13 ' A' ' 54' ' ' VAL . 50.9 mt -90.3 24.44 2.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.174 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -57.78 -40.97 81.06 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.002 0.43 . . . . 0.0 110.504 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' NZ ' ' HB2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -71.35 -5.79 35.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.254 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.726 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 96.4 m-85 -108.68 -4.33 17.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.307 177.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.641 ' HG2' HD23 ' A' ' 51' ' ' LEU . 98.8 mttt . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.038 -176.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.837 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 12.1 t . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -152.72 174.14 14.39 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.82 -0.55 . . . . 0.0 111.555 -177.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.8 tm? -94.75 104.58 16.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.182 -174.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.603 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 63.2 m95 -92.88 143.94 25.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.086 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.496 HG22 ' HG2' ' A' ' 16' ' ' LYS . 45.3 t -128.73 143.35 41.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HA ' HD12 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -89.31 160.13 17.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 8.1 tmm_? -70.64 -20.76 62.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.586 -170.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 t -82.28 -12.78 57.81 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.245 0.545 . . . . 0.0 109.781 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.4 30.8 61.91 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.915 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.6 m -93.9 -44.4 8.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.413 0.149 . . . . 0.0 110.975 -176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 10' ' ' ASP . 34.8 p90 -127.17 131.74 50.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.912 0.863 . . . . 0.0 112.932 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.718 ' HB3' HD11 ' A' ' 7' ' ' LEU . 86.9 mttt -116.48 130.73 56.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.674 170.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.45 144.66 27.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.623 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 17.9 t70 -94.46 115.07 27.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.196 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.656 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -161.07 162.56 31.67 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.914 -172.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.837 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 5.5 mm-40 -107.94 137.97 45.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.246 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.887 ' HD1' HG23 ' A' ' 29' ' ' ILE . 4.4 t80 -78.95 120.09 23.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.83 HD12 ' HE3' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -105.41 -42.01 6.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.711 -174.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.73 142.15 7.56 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.848 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.526 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 27.5 p -104.73 125.53 50.9 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.24 115.54 20.56 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.117 -172.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 65.67 -76.29 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.112 0.883 . . . . 0.0 111.085 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.49 18.32 1.49 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.949 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -125.77 166.52 16.66 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.472 0.653 . . . . 0.0 111.503 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.887 HG23 ' HD1' ' A' ' 21' ' ' PHE . 67.4 mt -117.24 126.49 74.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.828 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.467 ' O ' HG13 ' A' ' 22' ' ' ILE . 25.2 m170 -91.29 127.42 36.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.656 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.5 mm? -121.0 140.64 51.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.481 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -104.29 101.33 11.05 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 169.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.604 ' HD2' HD13 ' A' ' 39' ' ' ILE . 44.0 mtpt -68.21 154.67 41.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.165 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.73 -14.05 57.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.551 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.641 ' OD1' HG12 ' A' ' 37' ' ' VAL . 43.2 p30 -80.84 -18.93 45.8 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.935 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.65 -21.11 9.22 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.521 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.641 HG12 ' OD1' ' A' ' 35' ' ' ASN . 9.9 p -85.16 150.75 3.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.276 0.56 . . . . 0.0 111.238 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.83 ' HE3' HD12 ' A' ' 22' ' ' ILE . 85.4 tttt -107.24 125.92 51.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.557 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.604 HD13 ' HD2' ' A' ' 33' ' ' LYS . 16.4 pt -122.07 169.99 12.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.279 -173.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.03 103.68 6.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.607 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.517 HG11 HD13 ' A' ' 46' ' ' LEU . 67.8 t -101.82 122.81 54.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB1' ' OD1' ' A' ' 44' ' ' ASP . . . -60.45 129.57 42.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.259 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -72.4 -6.38 43.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.01 0.433 . . . . 0.0 111.835 -172.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.44 ' OD1' ' HB1' ' A' ' 42' ' ' ALA . 8.6 p-10 -98.14 -20.23 17.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.823 -173.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HE2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -102.82 6.03 39.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.782 0.801 . . . . 0.0 109.78 176.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 10' ' ' ASP . 13.1 tp -91.62 170.39 9.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.299 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.626 ' O ' HD22 ' A' ' 51' ' ' LEU . 40.7 t -75.65 135.35 40.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.694 0.759 . . . . 0.0 110.444 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.444 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 19.3 m-20 -60.03 -32.15 70.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.949 -174.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.89 -43.78 97.88 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.664 0.745 . . . . 0.0 109.845 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.615 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.0 m-20 -64.75 -37.92 89.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.444 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.767 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -67.73 -39.8 84.25 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.667 177.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.654 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -60.25 -32.13 70.86 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.458 0.647 . . . . 0.0 109.978 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.746 ' CE2' HD11 ' A' ' 57' ' ' ILE . 80.6 t80 -72.21 -48.41 43.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.523 176.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -68.94 -26.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 121.757 -0.589 . . . . 0.0 111.241 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.767 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 48.2 mt-10 -51.3 -38.33 52.33 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.139 0.495 . . . . 0.0 109.764 166.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.559 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -73.56 -43.65 59.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.042 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.746 HD11 ' CE2' ' A' ' 53' ' ' TYR . 35.9 mt -57.58 -37.96 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.023 0.44 . . . . 0.0 111.193 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 35.1 p -98.66 -47.1 5.46 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -170.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.76 -3.77 39.2 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -171.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -92.09 172.84 8.17 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.7 t -117.94 128.01 54.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.172 0.51 . . . . 0.0 109.918 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 33.3 mt -106.22 19.76 20.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.941 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -53.17 -42.71 66.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.189 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -59.14 -23.62 62.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.5 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.408 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 79.2 m-85 -97.25 -12.78 22.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.668 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 97.3 mttt . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.428 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.641 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 40.1 t . . . . . 0 C--O 1.235 0.291 0 CA-C-O 122.052 0.929 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 13.8 ptp180 -126.12 177.36 6.42 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.447 -171.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.709 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.9 tm? -89.39 119.11 29.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.882 0.372 . . . . 0.0 111.325 -171.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.568 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 41.9 m95 -108.5 148.04 30.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.953 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.534 ' CG1' ' HA2' ' A' ' 13' ' ' GLY . 39.2 t -129.88 143.41 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 123.026 0.204 . . . . 0.0 110.456 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.66 ' HA ' HD12 ' A' ' 46' ' ' LEU . 1.7 p-10 -86.05 -179.47 6.77 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.9 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -52.94 -44.87 67.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.603 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 m -88.1 -20.53 25.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.039 0.447 . . . . 0.0 111.069 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.534 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . 86.81 14.58 64.83 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.629 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 m -74.49 -38.68 62.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.774 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 49.2 p90 -120.21 121.54 38.97 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 122.062 0.934 . . . . 0.0 111.846 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.709 ' HB3' HD11 ' A' ' 7' ' ' LEU . 49.5 mttp -112.41 130.95 55.8 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.005 -1.452 . . . . 0.0 107.611 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.5 146.09 28.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.183 0.516 . . . . 0.0 112.142 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.3 p30 -86.14 124.05 32.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.001 172.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -169.52 156.81 6.87 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.632 -175.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.641 ' HG2' ' N ' ' A' ' 5' ' ' SER . 0.4 OUTLIER -112.05 139.9 47.18 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.538 172.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.739 ' HE2' ' HB3' ' A' ' 24' ' ' CYS . 28.7 t80 -68.49 133.67 48.95 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.273 176.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -120.94 -48.93 3.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.462 178.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 30' ' ' HIS . . . -148.25 144.41 12.28 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 30.8 p -123.16 115.18 21.36 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.506 -0.408 . . . . 0.0 109.974 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.78 146.02 22.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 58.24 34.48 24.14 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.625 0.578 . . . . 0.0 111.26 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.89 17.01 64.74 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.401 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 39.4 mmtm -114.74 153.69 29.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.913 0.387 . . . . 0.0 110.039 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.555 HG23 ' HD2' ' A' ' 21' ' ' PHE . 79.0 mt -114.1 113.06 42.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.035 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.528 ' O ' HG13 ' A' ' 22' ' ' ILE . 15.2 m-70 -75.48 119.87 20.14 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.021 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.64 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 91.3 mt -124.57 140.25 53.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.171 0.51 . . . . 0.0 111.498 -172.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.5 ' NE2' ' HA2' ' A' ' 36' ' ' GLY . 17.7 t-80 -108.94 98.58 8.04 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.36 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.597 ' HD2' ' HB2' ' A' ' 19' ' ' ALA . 1.7 mmmp? -57.69 167.09 1.17 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.852 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.19 -28.16 69.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.498 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -86.06 10.35 14.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.5 ' HA2' ' NE2' ' A' ' 32' ' ' HIS . . . 73.89 27.44 66.78 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.465 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.45 137.95 25.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 66.8 mttt -99.47 124.39 44.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.074 0.464 . . . . 0.0 111.383 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.1 pt -126.97 146.4 32.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.126 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.09 103.29 14.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.4 ' CG1' HD13 ' A' ' 46' ' ' LEU . 71.1 t -103.22 110.99 31.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -56.99 127.48 32.12 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.576 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.36 -8.0 29.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.069 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.453 ' OD2' ' HB1' ' A' ' 42' ' ' ALA . 2.8 p30 -95.59 -10.38 29.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.55 ' HD2' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -120.61 17.58 12.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.012 0.911 . . . . 0.0 108.806 171.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.66 HD12 ' HA ' ' A' ' 10' ' ' ASP . 13.7 tp -97.6 166.68 11.39 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.177 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.602 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 47.3 t -74.33 137.31 42.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.636 0.732 . . . . 0.0 110.693 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -58.07 -29.41 65.4 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.744 -177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.49 -50.68 72.6 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.7 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.602 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 3.8 m-20 -61.67 -36.82 81.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.83 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.773 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -68.79 -41.15 79.15 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.55 177.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.557 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -64.65 -28.63 69.74 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.544 0.688 . . . . 0.0 109.611 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.777 ' CE2' HD11 ' A' ' 57' ' ' ILE . 16.7 t80 -73.28 -48.02 38.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.49 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.654 HG13 HD23 ' A' ' 62' ' ' LEU . 3.0 p -68.48 -26.68 34.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 121.761 -0.587 . . . . 0.0 110.949 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.773 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.2 mt-10 -52.03 -35.25 46.37 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.11 0.481 . . . . 0.0 110.059 167.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 1.7 tptt -73.2 -50.29 23.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.161 176.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.777 HD11 ' CE2' ' A' ' 53' ' ' TYR . 51.1 mt -49.98 -46.34 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.126 0.489 . . . . 0.0 111.811 -177.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.406 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 34.2 p -105.08 -46.83 4.16 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -170.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.87 -6.7 27.55 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 90.3 m-85 -83.17 141.24 32.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.0 t -90.36 108.74 19.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.043 0.449 . . . . 0.0 110.037 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.737 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 2.6 mm? -87.1 19.41 3.12 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.403 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -53.82 -43.74 69.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.387 0.675 . . . . 0.0 110.756 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -67.44 -12.62 60.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.806 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 44' ' ' ASP . 72.1 m-85 -108.99 -0.99 19.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.723 0.297 . . . . 0.0 110.776 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 98.9 mttt . . . . . 0 C--N 1.327 -0.381 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.8 t . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.587 0.708 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 18.6 ptp180 -137.0 -179.13 5.52 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.66 -173.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.91 110.82 21.41 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.139 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.524 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 41.1 m95 -91.93 138.07 31.85 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.7 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 10' ' ' ASP . 58.9 t -129.41 142.54 43.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -74.48 159.43 32.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.616 0.722 . . . . 0.0 110.699 172.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.429 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -64.22 -21.36 66.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.403 -172.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.4 m -113.72 6.72 16.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.969 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.38 24.51 72.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.468 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 m -68.82 -40.11 79.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.615 0.245 . . . . 0.0 111.572 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.484 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 5.6 p90 -137.29 142.81 41.93 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.163 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 45.4 mttp -137.56 131.03 31.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.475 HG11 ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -148.51 146.31 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-O 120.912 0.386 . . . . 0.0 111.431 177.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.5 m-20 -83.32 121.51 27.22 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.16 171.94 17.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.237 0.542 . . . . 0.0 111.71 -173.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.93 142.59 51.21 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.62 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.617 ' HA ' HD12 ' A' ' 31' ' ' LEU . 64.6 t80 -77.67 132.23 38.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.104 0.478 . . . . 0.0 110.354 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -112.02 -51.1 5.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.52 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.11 145.94 11.14 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.217 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.569 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 27.0 t -123.8 130.8 53.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.828 0.347 . . . . 0.0 110.493 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.15 143.79 21.63 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 -177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 60.02 29.13 18.72 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.783 0.677 . . . . 0.0 111.601 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.06 1.16 89.82 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.498 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -106.73 161.0 15.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.964 0.412 . . . . 0.0 110.47 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.606 HG22 HD13 ' A' ' 31' ' ' LEU . 94.1 mt -123.11 123.49 68.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.531 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.409 ' O ' HG13 ' A' ' 22' ' ' ILE . 90.0 m-70 -87.76 128.09 35.32 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.617 HD12 ' HA ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -124.03 148.42 47.04 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.665 -176.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -110.91 100.14 8.92 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.208 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.764 ' HD2' HD13 ' A' ' 39' ' ' ILE . 59.5 mtpt -71.94 152.0 42.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.784 -173.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.25 -12.0 46.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.99 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.42 -20.6 62.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.087 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.14 0.99 44.77 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.122 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.45 141.46 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.831 0.348 . . . . 0.0 111.207 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -98.26 128.03 44.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.967 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.764 HD13 ' HD2' ' A' ' 33' ' ' LYS . 49.0 pt -127.4 169.28 19.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.111 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.3 109.32 8.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.951 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.628 ' HB ' ' HE3' ' A' ' 45' ' ' LYS . 32.8 m -110.19 147.45 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.9 129.12 37.43 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.78 -16.17 47.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.466 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 4.7 p-10 -74.27 -23.2 59.09 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -173.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.628 ' HE3' ' HB ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.54 38.37 1.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.903 0.858 . . . . 0.0 110.163 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.485 HD22 HD12 ' A' ' 29' ' ' ILE . 6.0 mp -115.76 161.63 18.45 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.121 176.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.595 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 43.8 t -74.29 140.46 44.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.754 0.788 . . . . 0.0 110.047 176.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -49.86 -34.32 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.267 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -59.22 -51.33 70.44 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.599 0.714 . . . . 0.0 109.981 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.634 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.1 m-20 -60.37 -38.24 83.26 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.422 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.802 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.5 OUTLIER -70.3 -43.85 69.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.363 179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.63 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -58.96 -30.27 67.79 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.551 0.691 . . . . 0.0 110.375 -178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.401 ' O ' HG12 ' A' ' 57' ' ' ILE . 51.6 t80 -73.75 -50.64 19.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.325 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.762 ' HA ' HG12 ' A' ' 57' ' ' ILE . 2.2 p -69.94 -29.1 39.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.401 -176.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.802 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 47.4 mt-10 -51.61 -40.05 59.14 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.193 0.521 . . . . 0.0 109.914 169.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.893 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -78.38 -31.65 48.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.873 -176.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.762 HG12 ' HA ' ' A' ' 54' ' ' VAL . 10.9 mm -66.3 -35.82 75.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.031 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.4 p -107.88 -47.35 3.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -170.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.47 -31.85 4.28 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.389 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.467 ' HZ ' ' HB3' ' A' ' 24' ' ' CYS . 14.9 p90 -87.28 152.64 22.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.177 0.488 . . . . 0.0 110.842 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.451 ' OG ' ' HG2' ' A' ' 63' ' ' GLU . 7.7 t -92.37 140.97 29.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.708 -172.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 35.3 mt -115.94 31.42 6.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.86 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.451 ' HG2' ' OG ' ' A' ' 61' ' ' SER . 18.5 mm-40 -53.13 -40.69 64.42 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.666 174.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -62.78 -15.2 52.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.971 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.466 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 36.9 m-85 -106.96 -7.32 17.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.245 0.545 . . . . 0.0 110.545 -177.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.221 -179.727 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 12.0 ptp180 -131.44 -179.9 5.64 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.107 -170.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -95.06 106.22 18.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.814 -171.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -92.18 141.77 28.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.474 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 10' ' ' ASP . 96.5 t -132.88 136.84 55.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.989 0.423 . . . . 0.0 111.442 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.14 153.42 41.66 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.601 0.715 . . . . 0.0 110.379 171.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 6.3 tmm_? -63.66 -28.66 70.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.853 -169.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -93.39 -6.74 46.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.115 0.483 . . . . 0.0 110.687 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.08 20.85 60.07 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.933 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.5 m -69.03 -45.37 70.63 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.569 0.347 . . . . 0.0 111.662 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -137.92 143.85 41.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 110.832 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.832 ' HB3' HD11 ' A' ' 7' ' ' LEU . 54.4 mttm -133.4 130.88 39.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.601 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.66 152.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.258 0.551 . . . . 0.0 111.88 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.619 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.1 p30 -90.36 130.46 36.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.295 173.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.96 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -171.38 157.39 4.9 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.18 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.49 140.41 49.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.734 ' HD1' HG23 ' A' ' 29' ' ' ILE . 42.7 t80 -72.01 130.69 41.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.378 0.609 . . . . 0.0 110.721 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -112.53 -49.73 5.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.237 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.29 148.7 14.44 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.59 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 27.9 t -118.41 134.41 55.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.954 0.377 . . . . 0.0 110.172 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.98 140.33 29.56 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.775 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 62.68 -78.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.099 0.874 . . . . 0.0 111.282 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -155.63 12.45 0.4 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.75 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 47.6 mttm -115.51 160.29 20.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.101 0.476 . . . . 0.0 110.925 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.734 HG23 ' HD1' ' A' ' 21' ' ' PHE . 2.2 mp -112.8 124.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.614 174.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.444 ' O ' HG13 ' A' ' 22' ' ' ILE . 79.0 m-70 -80.32 130.86 35.48 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.96 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 97.6 mt -130.16 140.51 50.76 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.686 -174.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -111.93 110.54 20.92 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.555 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 5.1 mtpm? -69.76 170.5 10.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.042 -174.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.42 -20.5 60.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.815 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.482 ' HB2' HG23 ' A' ' 37' ' ' VAL . 7.8 m120 -79.87 -7.72 58.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.137 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.92 0.27 75.04 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.92 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 35' ' ' ASN . 43.0 t -75.29 136.65 24.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -100.41 117.21 34.12 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.535 HG13 ' HB2' ' A' ' 31' ' ' LEU . 40.4 pt -119.63 172.1 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.0 110.64 4.02 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 m -112.13 129.39 67.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.879 0.371 . . . . 0.0 110.509 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.75 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -61.51 130.61 46.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.068 0.461 . . . . 0.0 110.181 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . . . -54.88 -26.17 33.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.165 -173.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.46 -10.64 59.76 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.554 ' HD3' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -101.19 17.72 21.77 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.697 178.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 88.8 mt -115.05 -174.8 2.56 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.246 1.022 . . . . 0.0 111.813 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.601 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 34.9 t -97.25 143.71 27.76 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.285 -1.78 . . . . 0.0 108.942 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -60.05 -24.18 64.34 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.918 -174.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -62.76 -47.32 84.04 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.964 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.601 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 3.8 m-20 -64.19 -38.52 91.35 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.441 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.659 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.8 OUTLIER -70.66 -38.33 73.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.952 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.485 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -68.03 -27.23 66.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.303 0.573 . . . . 0.0 109.968 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.593 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 32.5 t80 -74.04 -49.95 21.91 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.198 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 50' ' ' ASP . 3.4 p -70.55 -32.04 48.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.018 0.437 . . . . 0.0 111.085 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.917 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 1.7 pt-20 -68.45 -23.51 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.302 0.572 . . . . 0.0 110.031 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 1.1 ttpp -72.79 -40.44 65.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.593 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 54.2 mt -63.08 -44.69 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.013 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.2 p -78.37 -43.99 26.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.289 -172.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.94 2.05 28.51 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.485 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 64.0 m-85 -104.83 -166.19 1.21 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 t -130.99 132.43 45.01 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.917 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 9.7 mt -103.68 29.7 5.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.387 0.613 . . . . 0.0 109.381 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.482 ' OE2' ' HD2' ' A' ' 66' ' ' LYS . 6.2 tp10 -45.0 -48.84 11.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.033 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -65.34 -17.53 64.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -100.8 -4.83 27.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.496 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.482 ' HD2' ' OE2' ' A' ' 63' ' ' GLU . 97.8 mttt . . . . . 0 CA--C 1.513 -0.471 0 CA-C-O 121.697 0.761 . . . . 0.0 110.836 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.683 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 33.0 p . . . . . 0 CA--C 1.52 -0.187 0 CA-C-O 122.356 1.074 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 10.9 ptp180 -107.98 179.13 4.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.588 -166.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.769 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.9 tm? -88.9 108.95 19.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.852 -173.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.514 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 37.7 m95 -97.54 153.72 17.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.18 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.431 HG13 ' HG2' ' A' ' 16' ' ' LYS . 23.5 t -133.68 146.79 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.59 ' HA ' HD12 ' A' ' 46' ' ' LEU . 7.8 p-10 -84.24 178.82 7.64 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.143 172.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.509 ' HD2' ' O ' ' A' ' 11' ' ' ARG . 2.1 tmm_? -81.32 -23.58 37.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 110.947 -174.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.9 t -89.91 -29.31 18.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.875 0.369 . . . . 0.0 110.679 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.89 21.18 19.21 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -76.79 -40.97 46.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.346 -0.427 . . . . 0.0 110.966 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.582 ' HZ ' ' HE3' ' A' ' 45' ' ' LYS . 33.0 p90 -142.2 131.01 22.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.908 0.861 . . . . 0.0 113.157 -174.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.769 ' HB3' HD11 ' A' ' 7' ' ' LEU . 36.0 mtmm -118.86 130.45 55.75 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.252 169.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.38 153.18 21.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.41 0.624 . . . . 0.0 112.371 -173.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.4 p30 -90.36 129.03 36.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.61 174.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -178.7 159.54 1.11 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.946 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.683 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 3.8 mm-40 -110.61 144.26 39.77 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 121.251 0.548 . . . . 0.0 110.017 169.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.906 ' HD1' HG23 ' A' ' 29' ' ' ILE . 3.7 t80 -74.9 120.67 20.75 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.339 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.83 -52.77 8.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.079 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.3 141.87 7.76 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.759 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 24.6 p -101.0 144.04 30.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.39 109.16 4.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.186 -0.206 . . . . 0.0 111.159 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? 53.43 52.28 13.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.103 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.81 -7.01 71.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.124 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -101.44 161.06 13.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.26 0.53 . . . . 0.0 111.283 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.906 HG23 ' HD1' ' A' ' 21' ' ' PHE . 78.0 mt -123.03 120.79 61.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.248 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -87.82 131.7 34.44 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.794 HD23 ' HA ' ' A' ' 21' ' ' PHE . 85.7 mt -129.31 138.99 51.91 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.27 0.557 . . . . 0.0 111.284 -170.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -105.81 104.41 14.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.185 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.621 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 6.3 mtpm? -66.09 169.03 7.46 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.55 -18.66 62.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.301 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -103.86 14.75 30.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.611 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.9 -16.43 59.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.633 171.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.434 ' HB ' ' HD3' ' A' ' 33' ' ' LYS . 60.7 t -65.43 139.18 21.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.708 0.289 . . . . 0.0 110.654 -178.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -104.31 124.19 48.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.521 HG13 ' HB2' ' A' ' 31' ' ' LEU . 39.1 pt -125.68 160.34 32.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.795 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.49 121.61 23.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.159 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -119.3 148.33 22.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.482 ' HB1' ' OD2' ' A' ' 44' ' ' ASP . . . -78.85 123.73 27.51 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.82 -19.66 65.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.566 0.698 . . . . 0.0 111.123 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.816 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 3.7 p30 -74.53 -14.28 60.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.274 -176.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.582 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -117.12 18.31 14.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.997 0.903 . . . . 0.0 109.201 174.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.59 HD12 ' HA ' ' A' ' 10' ' ' ASP . 12.8 tp -100.21 167.79 10.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.434 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.8 t -67.11 137.83 56.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.426 0.632 . . . . 0.0 111.054 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.485 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 53.1 m-20 -58.66 -36.72 74.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.81 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -65.29 -46.04 82.0 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.658 0.742 . . . . 0.0 109.713 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.547 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.5 m-20 -61.78 -36.46 81.11 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.91 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.757 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -66.32 -45.72 79.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.852 176.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.578 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -61.86 -29.24 70.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.46 0.648 . . . . 0.0 110.449 -176.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.638 ' CE2' HD11 ' A' ' 57' ' ' ILE . 29.2 t80 -74.01 -49.93 22.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.232 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 50' ' ' ASP . 4.1 p -70.51 -26.58 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.894 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.757 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.9 mt-10 -51.45 -40.16 58.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.189 0.519 . . . . 0.0 109.872 167.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.623 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -75.78 -36.25 59.86 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.113 -176.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.638 HD11 ' CE2' ' A' ' 53' ' ' TYR . 29.8 mt -64.45 -40.23 88.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.992 175.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.698 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 36.6 p -91.02 -47.43 7.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -169.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.3 -4.73 51.74 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 -170.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.698 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 79.9 m-85 -95.58 162.24 13.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.9 t -110.79 117.08 32.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.219 0.533 . . . . 0.0 110.762 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.613 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 29.5 mt -91.67 17.53 8.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.58 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.813 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -56.61 -41.02 76.34 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.213 178.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -60.25 -20.33 58.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.812 178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.816 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 53.4 m-85 -99.17 -16.72 18.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.843 0.354 . . . . 0.0 110.341 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.813 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 9.4 mtpm? . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.705 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.627 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 38.1 t . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 122.204 1.002 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 9.7 ptp180 -118.25 175.15 5.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.321 -1.308 . . . . 0.0 110.816 -170.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.706 HD11 ' HB2' ' A' ' 16' ' ' LYS . 1.3 tm? -83.62 117.12 22.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.943 -174.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.602 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 69.1 m95 -108.9 145.0 36.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.139 175.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 16' ' ' LYS . 88.8 t -131.59 138.43 52.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.22 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.705 ' HA ' HD12 ' A' ' 46' ' ' LEU . 6.4 p-10 -84.92 168.86 14.63 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.598 175.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.647 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 4.6 tpm_? -67.08 -35.22 79.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.514 0.197 . . . . 0.0 111.417 -174.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 m -79.16 -12.26 59.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.97 0.414 . . . . 0.0 111.209 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.5 17.63 75.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.506 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -66.69 -47.73 71.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.994 -0.603 . . . . 0.0 110.656 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 10' ' ' ASP . 16.4 p90 -138.57 132.64 31.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.7 0.762 . . . . 0.0 112.627 -174.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.706 ' HB2' HD11 ' A' ' 7' ' ' LEU . 20.6 ptmt -120.83 129.67 53.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.225 166.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.808 ' HB ' ' HE2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -148.9 159.12 6.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.225 0.536 . . . . 0.0 112.016 -172.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.59 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.5 OUTLIER -93.54 122.83 36.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.478 177.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.716 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -162.07 156.36 21.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.589 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.627 ' HG2' ' N ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -109.34 138.89 45.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.014 174.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.64 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 50.7 t80 -67.93 133.15 48.62 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.026 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -116.25 -50.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.158 179.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.16 153.7 24.78 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.465 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.64 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 29.2 t -129.09 130.05 46.0 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.43 134.44 21.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.486 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 63.11 15.53 8.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.236 0.541 . . . . 0.0 111.196 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.23 2.08 71.41 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.272 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 61.4 mttp -93.89 146.79 23.65 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.536 -0.39 . . . . 0.0 110.365 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.556 HD11 ' HB2' ' A' ' 43' ' ' ALA . 17.5 mm -105.09 119.42 54.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.539 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.457 ' O ' HG13 ' A' ' 22' ' ' ILE . 24.1 m170 -89.7 125.53 35.3 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.716 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 92.5 mt -128.74 139.15 52.35 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.23 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -102.18 106.64 17.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.56 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.808 ' HE2' ' HB ' ' A' ' 17' ' ' VAL . 2.5 mmmp? -64.36 152.09 42.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.174 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.12 -13.78 62.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.429 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 6.9 p-10 -98.01 12.63 33.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.894 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.06 -30.8 9.37 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.861 -0.685 . . . . 0.0 114.198 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.94 139.44 21.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.899 0.381 . . . . 0.0 111.795 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.97 122.68 45.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.0 161.75 19.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.928 -176.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.29 106.06 6.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.677 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.7 m -108.38 146.16 14.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -76.1 122.62 24.55 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.608 176.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.703 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -64.45 -21.47 66.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.581 0.705 . . . . 0.0 109.836 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 12.9 t70 -50.63 -32.95 20.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.341 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 26.54 9.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.238 0.542 . . . . 0.0 110.93 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.705 HD12 ' HA ' ' A' ' 10' ' ' ASP . 8.6 tp -100.1 173.53 6.59 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.319 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.644 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 19.8 m -79.98 133.85 36.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.613 0.721 . . . . 0.0 110.475 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -55.04 -35.15 64.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.917 -172.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.4 -44.38 83.17 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.338 0.589 . . . . 0.0 109.733 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.644 ' OD1' ' HB2' ' A' ' 47' ' ' SER . 1.4 m-20 -57.77 -40.62 80.2 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.764 175.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.82 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -68.94 -39.54 79.52 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.408 178.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.684 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -59.31 -32.49 70.12 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.434 0.635 . . . . 0.0 109.885 -177.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.75 ' CE2' HD11 ' A' ' 57' ' ' ILE . 49.5 t80 -74.2 -49.61 22.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.551 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 50' ' ' ASP . 1.7 p -68.81 -28.07 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.205 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.82 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 46.9 mt-10 -52.18 -39.85 60.67 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.071 0.462 . . . . 0.0 110.061 167.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.622 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 9.4 mmpt? -78.08 -28.36 48.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.75 HD11 ' CE2' ' A' ' 53' ' ' TYR . 40.9 mt -67.88 -42.97 86.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.145 0.498 . . . . 0.0 110.712 173.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.5 p -90.84 -47.53 7.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.493 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.87 -19.7 15.47 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.893 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -107.04 151.24 25.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.954 0.407 . . . . 0.0 110.203 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -82.86 136.85 34.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.704 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.622 HD12 HG13 ' A' ' 54' ' ' VAL . 23.4 mt -107.0 20.16 19.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.847 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.408 ' OE2' ' HD2' ' A' ' 66' ' ' LYS . 4.0 tp10 -55.33 -44.38 75.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.967 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -14.45 61.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.238 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' ASP . 62.6 m-85 -105.13 -0.43 26.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.621 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 99.2 mttt . . . . . 0 C--N 1.323 -0.582 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.375 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 121.286 0.565 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 16.3 ptp180 -126.64 -178.66 4.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.975 -171.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.709 HD11 ' HB3' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -88.76 105.59 17.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.378 -168.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.481 ' HH2' ' HB ' ' A' ' 54' ' ' VAL . 47.2 m95 -94.46 139.71 30.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.72 176.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 10' ' ' ASP . 72.9 t -129.78 141.99 45.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.974 0.416 . . . . 0.0 111.71 -175.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.639 ' O ' HG12 ' A' ' 9' ' ' VAL . 9.8 t70 -70.58 157.47 37.86 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -79.41 -25.86 42.01 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 p -99.68 7.22 45.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.046 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.77 68.34 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.72 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.598 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 31.8 m -68.27 -40.14 81.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.69 0.281 . . . . 0.0 111.257 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -150.81 150.21 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.144 0.497 . . . . 0.0 111.703 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.709 ' HB3' HD11 ' A' ' 7' ' ' LEU . 94.2 mttt -132.45 132.25 42.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.768 171.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.08 145.51 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.0 0.429 . . . . 0.0 111.807 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 5.9 p-10 -93.6 112.11 23.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.884 0.849 . . . . 0.0 110.133 174.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.433 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . . . -160.28 168.87 24.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.093 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.04 139.91 53.03 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.781 ' HA ' HD23 ' A' ' 31' ' ' LEU . 3.4 t80 -71.6 128.0 34.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.697 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -107.0 -46.91 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.608 -178.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 30' ' ' HIS . . . -153.79 153.54 24.9 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.598 -177.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.2 p -112.89 134.12 54.55 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.08 97.41 5.09 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.593 -173.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 57.56 23.71 9.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.231 173.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.59 -7.55 24.28 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.363 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 61.4 mttp -94.0 160.23 14.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.016 0.436 . . . . 0.0 110.925 175.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.929 HD11 ' HB2' ' A' ' 43' ' ' ALA . 10.7 mm -113.79 115.79 50.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.72 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -87.52 117.85 26.59 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.781 HD23 ' HA ' ' A' ' 21' ' ' PHE . 96.4 mt -119.99 139.69 52.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.451 0.643 . . . . 0.0 112.213 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -99.21 109.97 22.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.003 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HD3' HD13 ' A' ' 39' ' ' ILE . 13.7 mmmm -66.05 155.1 37.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.876 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.41 -15.42 36.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.882 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -105.32 21.77 16.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.43 0.633 . . . . 0.0 110.424 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.87 -16.23 48.02 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.464 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -66.74 154.78 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 35.5 ttmt -122.94 125.62 45.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.953 0.406 . . . . 0.0 110.4 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.506 HD13 ' HD3' ' A' ' 33' ' ' LYS . 33.6 pt -122.5 176.92 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.754 -176.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.13 116.72 6.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.665 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 m -118.13 165.39 13.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -97.51 134.45 40.72 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.929 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -67.37 -8.0 29.31 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -72.05 -28.52 63.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HD3' ' H ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -107.63 15.21 24.92 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.657 177.02 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 46' ' ' LEU . 8.2 tp -84.73 159.79 20.42 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.266 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.579 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 50.1 m -71.32 133.96 46.4 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.59 0.71 . . . . 0.0 109.89 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -57.53 -30.42 65.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.783 -171.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -65.83 -46.26 79.19 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.648 0.737 . . . . 0.0 109.349 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.587 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -59.54 -37.89 79.6 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.929 176.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.711 ' HB3' ' HB2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -68.37 -44.95 74.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.899 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.429 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -61.18 -28.43 69.13 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.297 0.57 . . . . 0.0 109.871 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.567 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 32.6 t80 -73.97 -51.79 14.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.335 175.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.5 p -70.86 -33.53 52.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.971 -0.455 . . . . 0.0 111.226 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 1.074 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 3.7 pt-20 -67.29 -24.93 65.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.03 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -46.27 64.58 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.567 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 56.9 mt -56.13 -43.72 76.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.035 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 7.0 p -80.35 -44.9 18.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.352 -175.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.72 -13.98 22.38 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -174.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.458 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 80.2 m-85 -80.21 -167.7 1.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.059 -0.571 . . . . 0.0 109.813 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.42 ' HA ' ' CD ' ' A' ' 55' ' ' GLU . 8.8 t -135.82 130.33 33.81 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 171.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.074 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 12.2 mt -104.87 23.61 13.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.409 0.623 . . . . 0.0 109.617 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.482 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 22.3 tt0 -53.35 -39.61 64.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.373 174.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -70.24 -6.08 32.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.772 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -109.05 -2.16 18.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.349 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' A' ' 63' ' ' GLU . 96.7 mttt . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.481 0.658 . . . . 0.0 109.687 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 CA--C 1.515 -0.402 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 15.3 ptp180 -142.07 -178.81 5.88 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.509 -168.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.835 HD11 ' HB2' ' A' ' 16' ' ' LYS . 2.0 tm? -86.72 103.14 14.89 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.898 -175.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 33.5 m95 -91.61 144.68 25.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.548 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 10' ' ' ASP . 64.8 t -129.93 145.87 35.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -89.74 159.79 16.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 173.335 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -17.42 64.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -171.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 t -86.39 -12.39 49.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.321 0.581 . . . . 0.0 109.866 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.34 37.69 70.56 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.005 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 m -102.12 -42.1 6.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.47 0.176 . . . . 0.0 111.05 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.644 ' CZ ' ' HE3' ' A' ' 45' ' ' LYS . 34.7 p90 -125.1 138.07 54.18 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.821 0.82 . . . . 0.0 112.581 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.835 ' HB2' HD11 ' A' ' 7' ' ' LEU . 8.6 ptpp? -134.89 132.14 38.16 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 113.959 -1.473 . . . . 0.0 108.989 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.458 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -148.51 154.81 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.627 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 12.0 m-20 -92.87 123.79 36.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.235 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -164.54 157.07 16.69 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.201 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.75 146.76 33.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.509 ' HA ' HD23 ' A' ' 31' ' ' LEU . 78.1 t80 -76.64 132.56 39.48 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.089 0.471 . . . . 0.0 110.013 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -111.6 -46.83 5.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.443 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -166.63 148.34 13.29 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.938 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.491 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 6.9 t -122.75 126.81 48.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.793 0.33 . . . . 0.0 110.25 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.52 141.85 20.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.578 -176.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt 56.7 32.04 20.42 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.621 0.575 . . . . 0.0 111.55 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.69 9.36 87.13 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.624 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 72.3 mmtt -109.56 146.05 35.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.027 0.442 . . . . 0.0 110.76 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' A' ' 43' ' ' ALA . 42.0 mm -105.14 113.27 41.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.485 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.503 ' O ' HG13 ' A' ' 22' ' ' ILE . 17.9 m170 -82.57 120.78 25.95 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.8 mt -122.45 140.4 52.76 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 -175.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -100.05 103.82 15.37 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.911 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.922 ' HD3' HD13 ' A' ' 39' ' ' ILE . 12.5 mmmm -61.28 153.62 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.632 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.82 66.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.388 0.613 . . . . 0.0 109.359 172.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.42 HD22 ' C ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -63.07 -32.69 74.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.766 172.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.47 -2.59 27.88 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.295 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -91.94 150.28 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.634 0.255 . . . . 0.0 110.593 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 38' ' ' LYS . 4.4 tmmm? -101.73 125.49 48.41 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.922 HD13 ' HD3' ' A' ' 33' ' ' LYS . 16.1 pt -121.33 163.91 18.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.836 -177.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.79 103.84 7.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.272 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.1 t -110.54 127.04 67.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.515 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . . . -56.18 124.69 18.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.989 0.423 . . . . 0.0 111.665 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -61.72 -30.1 70.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.908 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.476 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 3.6 p30 -68.73 -32.67 72.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.566 -173.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.644 ' HE3' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -103.44 15.28 29.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.328 0.585 . . . . 0.0 110.11 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.5 tp -95.44 166.82 11.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.287 -177.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.552 ' O ' HD22 ' A' ' 51' ' ' LEU . 44.0 t -71.38 132.53 44.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.901 0.857 . . . . 0.0 111.001 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.647 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 1.6 m-20 -50.94 -38.1 48.37 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.187 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.82 -49.64 72.7 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.086 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.67 ' O ' HG12 ' A' ' 54' ' ' VAL . 74.0 m-20 -67.3 -32.72 73.89 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.784 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.786 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -69.9 -40.05 75.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.944 177.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.5 -32.39 72.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.372 0.606 . . . . 0.0 109.767 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.52 ' CE1' HD11 ' A' ' 57' ' ' ILE . 50.8 t80 -67.95 -50.64 54.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.332 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.736 ' HA ' HG12 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -68.32 -32.47 55.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 120.72 0.295 . . . . 0.0 111.253 -177.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.786 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 45.5 mt-10 -52.56 -35.66 54.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.52 170.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 1.05 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.55 -30.38 33.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.676 -179.369 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.736 HG12 ' HA ' ' A' ' 54' ' ' VAL . 21.7 mm -64.24 -38.71 83.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.6 p -116.56 -46.99 2.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -170.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.41 1.94 24.63 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.578 -173.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -78.88 153.68 30.35 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 t -97.48 101.48 13.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.038 0.447 . . . . 0.0 110.22 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.654 ' HA ' ' HD2' ' A' ' 65' ' ' PHE . 21.3 mt -98.44 19.67 14.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -63.83 -39.71 94.87 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.972 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -69.04 -9.57 53.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.456 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.654 ' HD2' ' HA ' ' A' ' 62' ' ' LEU . 91.4 m-85 -101.37 -4.84 26.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.948 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.647 ' HD3' ' HB3' ' A' ' 48' ' ' ASN . 52.0 mttp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.359 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 19.9 p . . . . . 0 C--O 1.233 0.225 0 CA-C-O 121.088 0.471 . . . . 0.0 111.728 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 11.3 ptp180 -158.64 -177.85 6.83 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.093 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.421 ' CD2' ' HB2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -89.4 107.08 18.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.264 -175.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.649 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 30.1 m95 -90.89 140.21 30.03 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 90.8 t -130.1 158.32 42.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.963 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -91.66 162.21 14.59 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.4 -0.187 . . . . 0.0 110.503 176.304 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.431 ' HE ' ' HB3' ' A' ' 11' ' ' ARG . 1.7 tmm_? -57.57 -37.88 73.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.642 0.258 . . . . 0.0 111.144 -176.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 t -83.44 -15.44 49.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.734 0.302 . . . . 0.0 111.373 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.78 16.28 56.72 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.302 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 m -83.5 -37.12 23.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.458 0.647 . . . . 0.0 110.071 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.963 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 5.8 m-85 -95.14 137.95 33.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.023 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 19.0 ptpt -152.21 130.1 11.73 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.529 162.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.08 136.22 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.689 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.3 p-10 -75.99 109.15 9.39 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.218 173.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -148.13 167.39 25.14 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.508 -170.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 5' ' ' SER . 26.5 tt0 -133.71 124.35 26.54 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.294 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.654 ' HD1' HG23 ' A' ' 29' ' ' ILE . 67.1 t80 -65.39 130.29 42.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.345 0.593 . . . . 0.0 110.367 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.91 -54.28 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.874 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.06 142.02 7.67 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.467 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.468 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 16.4 p -103.28 142.81 33.55 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -178.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.21 126.81 9.45 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.956 -0.297 . . . . 0.0 111.225 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 55.61 41.4 30.62 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.768 0.667 . . . . 0.0 111.206 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.55 -0.74 80.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.642 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -104.28 166.77 10.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 0.0 110.813 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.654 HG23 ' HD1' ' A' ' 21' ' ' PHE . 85.1 mt -124.09 121.65 62.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.085 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -88.48 129.02 35.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.912 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 90.4 mt -124.49 136.76 54.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.845 0.831 . . . . 0.0 111.873 -172.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 14.3 t-80 -98.43 99.59 10.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.994 176.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 36.2 mtpt -61.83 156.96 19.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.817 0.341 . . . . 0.0 110.167 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.77 -12.45 60.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.627 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -90.91 1.82 56.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.394 177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.02 -24.4 31.43 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.707 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -65.3 145.09 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.599 0.238 . . . . 0.0 110.833 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -114.24 131.62 56.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.1 0.476 . . . . 0.0 110.503 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.8 pt -129.52 166.82 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.989 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.45 118.78 19.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.649 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 m -116.78 156.98 17.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.22 128.04 33.78 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.746 -0.382 . . . . 0.0 109.976 175.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.423 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -64.68 -15.23 61.04 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -174.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.665 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 8.1 p-10 -91.56 -13.93 31.17 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -173.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.05 19.94 19.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.711 0.767 . . . . 0.0 109.523 176.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 8.5 tp -103.48 169.21 8.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.276 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.482 ' O ' HD22 ' A' ' 51' ' ' LEU . 25.2 t -73.61 141.68 46.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.582 0.706 . . . . 0.0 109.367 176.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.581 ' ND2' ' HA ' ' A' ' 66' ' ' LYS . 7.6 m120 -73.89 -18.73 60.87 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.607 -171.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -43.34 81.23 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.563 ' O ' HG12 ' A' ' 54' ' ' VAL . 35.6 m-20 -63.67 -38.01 89.49 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.196 176.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.822 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -66.42 -45.18 80.79 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.134 177.358 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.68 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -59.39 -32.34 70.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.475 0.655 . . . . 0.0 110.241 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.607 ' CE2' HD11 ' A' ' 57' ' ' ILE . 43.9 t80 -72.32 -50.48 26.56 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.379 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 50' ' ' ASP . 3.2 p -68.42 -28.9 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 O-C-N 122.089 -0.382 . . . . 0.0 110.77 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.822 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 44.4 mt-10 -52.5 -41.43 63.42 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.647 0.26 . . . . 0.0 110.471 169.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.502 ' N ' ' HE3' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -73.79 -33.02 64.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.806 -178.239 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.607 HD11 ' CE2' ' A' ' 53' ' ' TYR . 29.9 mt -67.65 -37.37 78.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.281 175.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.471 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 32.4 p -97.78 -45.17 6.44 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -170.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.97 -7.27 37.94 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -172.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.471 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 65.0 m-85 -80.32 175.88 10.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 110.784 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -121.1 114.77 21.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.432 176.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 35.8 mt -103.58 27.28 7.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.571 -176.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -56.59 -42.1 78.12 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.665 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -72.55 -6.45 44.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.341 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.665 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 97.3 m-85 -102.99 0.3 31.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.418 0.628 . . . . 0.0 109.52 176.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.581 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 98.5 mttt . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.778 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 C--O 1.238 0.487 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.581 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 6.6 ptp180 -140.66 -178.83 5.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.245 -173.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.35 105.41 16.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.04 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.688 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 52.4 m95 -91.92 145.05 24.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.828 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 10' ' ' ASP . 61.5 t -135.6 146.0 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.443 0.465 . . . . 0.0 110.379 -176.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.976 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -90.42 174.1 7.74 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.778 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 2.4 tpm_? -61.68 -43.36 99.01 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 122.389 -0.194 . . . . 0.0 111.393 -177.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -67.74 -29.74 69.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.236 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.96 12.71 51.99 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.33 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -91.47 -39.37 11.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.507 0.67 . . . . 0.0 109.506 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.976 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 3.7 m-85 -82.46 130.7 35.16 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.417 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 8.6 ptpt -157.42 128.68 6.77 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.9 169.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.51 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -154.91 145.79 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.032 -173.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.581 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.5 p-10 -88.24 117.51 27.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.062 174.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.775 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . . . -164.84 163.66 21.11 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.13 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.42 140.34 52.28 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.742 ' HA ' HD23 ' A' ' 31' ' ' LEU . 48.2 t80 -69.3 132.61 46.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.468 0.651 . . . . 0.0 110.372 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.03 -52.51 5.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.043 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.87 143.38 8.55 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.141 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.553 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 20.0 p -105.61 142.13 35.88 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.98 112.43 8.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 111.439 -173.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.6 tptt 52.68 53.55 12.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.791 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.57 -3.73 77.09 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.118 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 84.9 mttt -110.96 170.48 8.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.068 0.461 . . . . 0.0 110.533 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.531 HG23 ' HD1' ' A' ' 21' ' ' PHE . 59.2 mt -129.0 128.04 66.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.882 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -91.31 127.95 36.95 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.9 mt -127.3 137.39 52.82 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.583 -174.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -98.13 100.92 12.26 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.351 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.829 ' HD3' HD13 ' A' ' 39' ' ' ILE . 12.1 mmmm -61.77 160.54 11.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.34 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.29 -14.94 63.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.721 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -84.45 -6.81 59.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.959 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.64 7.52 58.95 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.738 174.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.5 155.04 6.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 117.059 0.429 . . . . 0.0 110.377 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -97.9 144.27 27.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 0.0 110.863 177.077 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.829 HD13 ' HD3' ' A' ' 33' ' ' LYS . 37.2 pt -127.53 156.27 39.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.15 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.13 103.73 11.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.243 0.545 . . . . 0.0 110.159 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.8 t -109.4 125.16 66.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.276 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -79.51 130.63 35.58 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.44 -5.81 12.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.458 -174.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.85 -42.74 57.37 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -172.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -99.13 12.13 37.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 0.0 110.319 -176.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.9 tp -83.88 169.35 15.19 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.678 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.569 ' O ' HD22 ' A' ' 51' ' ' LEU . 47.8 t -73.12 138.0 45.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.025 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -47.03 -50.03 20.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.854 0.835 . . . . 0.0 111.248 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.2 -30.36 68.53 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.795 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.609 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -65.65 -38.03 88.21 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.8 177.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.736 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.7 OUTLIER -70.17 -44.21 69.22 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.81 176.211 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.41 65.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.423 0.63 . . . . 0.0 110.224 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.655 ' CE2' HD11 ' A' ' 57' ' ' ILE . 66.5 t80 -73.79 -49.66 24.24 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.421 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.777 HG13 HD12 ' A' ' 62' ' ' LEU . 2.2 p -70.03 -28.25 35.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 O-C-N 122.006 -0.434 . . . . 0.0 110.823 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.736 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 39.3 mt-10 -56.09 -31.47 63.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.724 168.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.859 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 6.6 mmpt? -80.84 -32.25 35.19 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.77 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.655 HD11 ' CE2' ' A' ' 53' ' ' TYR . 39.6 mt -63.32 -41.38 92.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 174.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.563 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 27.4 p -107.41 -46.79 3.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -171.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.31 -5.74 35.97 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.563 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 66.9 m-85 -85.77 136.95 33.13 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.992 0.425 . . . . 0.0 110.29 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 m -75.7 100.94 4.83 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.623 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.777 HD12 HG13 ' A' ' 54' ' ' VAL . 34.3 mt -94.97 18.74 11.42 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.67 0.748 . . . . 0.0 109.389 172.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 1.07 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 24.7 tt0 -73.83 -29.38 62.1 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.894 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -14.88 58.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.954 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.432 ' HD2' ' HA ' ' A' ' 62' ' ' LEU . 96.0 m-85 -105.57 -7.19 18.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.253 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.07 ' HG3' ' HA ' ' A' ' 63' ' ' GLU . 43.1 mttp . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 121.521 0.677 . . . . 0.0 110.881 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.869 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 20.1 p . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.145 0.498 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 17.5 ptp180 -148.47 -178.25 6.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.451 -173.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.833 HD11 ' HB3' ' A' ' 16' ' ' LYS . 2.6 tm? -81.44 106.63 13.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.699 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.583 ' HH2' ' HB ' ' A' ' 54' ' ' VAL . 32.2 m95 -92.8 151.29 20.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.165 174.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 36.9 t -123.07 145.32 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.644 0.259 . . . . 0.0 110.72 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -83.16 160.29 21.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.403 175.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -51.57 -46.1 63.34 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.536 0.523 . . . . 0.0 111.921 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 m -94.91 9.81 37.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.819 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.7 23.98 69.37 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.12 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -71.55 -34.36 69.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.176 0.512 . . . . 0.0 110.359 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 10' ' ' ASP . 33.0 p90 -143.21 132.61 23.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.386 0.613 . . . . 0.0 111.186 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.833 ' HB3' HD11 ' A' ' 7' ' ' LEU . 88.3 mttt -109.37 129.98 55.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 167.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.11 135.9 42.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.598 0.713 . . . . 0.0 112.887 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 1.1 p30 -78.27 119.94 22.34 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.757 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.811 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -157.43 158.4 35.75 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.505 0.669 . . . . 0.0 111.892 -172.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.869 ' HB2' ' HB3' ' A' ' 5' ' ' SER . 30.9 tt0 -122.59 124.67 44.03 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.786 176.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.755 ' HD1' HG23 ' A' ' 29' ' ' ILE . 4.5 t80 -70.14 123.35 21.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.153 0.502 . . . . 0.0 110.321 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -105.9 -44.07 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.647 -178.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.36 139.93 6.18 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.103 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.43 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 51.9 t -110.04 118.44 36.43 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.93 140.39 29.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.628 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? 65.06 11.7 7.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.131 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.56 -2.79 60.84 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.127 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.734 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 86.6 mttt -102.83 164.45 11.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.0 110.755 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.755 HG23 ' HD1' ' A' ' 21' ' ' PHE . 75.5 mt -114.98 121.22 66.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.015 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.443 ' O ' HG13 ' A' ' 22' ' ' ILE . 20.5 m170 -82.91 124.31 30.23 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.811 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 71.0 mt -124.6 137.49 54.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.432 0.634 . . . . 0.0 111.415 -174.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -107.36 106.18 16.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.577 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 4.1 mtpm? -67.07 166.68 13.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.14 0.495 . . . . 0.0 111.711 -172.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.97 -12.84 60.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.099 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.94 -23.48 38.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.813 173.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.49 -15.08 29.94 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -173.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.2 t -65.86 142.72 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.725 -0.238 . . . . 0.0 110.485 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -108.86 130.21 55.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.157 0.503 . . . . 0.0 110.459 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.457 HG12 ' HB2' ' A' ' 31' ' ' LEU . 12.3 pt -127.39 166.54 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.351 -177.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.1 103.21 5.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.088 0.47 . . . . 0.0 109.994 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 46' ' ' LEU . 74.4 t -116.08 126.36 73.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.934 -176.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -59.35 135.32 57.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.687 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.11 -6.13 12.19 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.374 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -90.15 -41.17 11.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.069 0.462 . . . . 0.0 111.215 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -87.53 22.19 2.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.824 -175.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.514 HD13 HG11 ' A' ' 41' ' ' VAL . 9.1 tp -111.91 167.23 10.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.651 -174.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.564 ' O ' HD22 ' A' ' 51' ' ' LEU . 29.6 t -65.0 129.22 38.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.36 0.6 . . . . 0.0 109.649 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.429 ' HA ' HD23 ' A' ' 51' ' ' LEU . 8.1 m120 -67.2 -21.71 65.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.631 -172.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -60.68 -48.34 82.21 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.695 0.759 . . . . 0.0 109.294 171.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.598 ' O ' HG12 ' A' ' 54' ' ' VAL . 16.2 m-20 -67.59 -31.77 72.05 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.827 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -69.31 -40.79 77.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.395 176.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -65.24 -27.92 68.99 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.382 0.61 . . . . 0.0 109.541 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.595 ' CE2' HD11 ' A' ' 57' ' ' ILE . 31.1 t80 -73.61 -50.77 19.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.594 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.4 p -70.5 -33.29 52.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 120.885 0.374 . . . . 0.0 111.255 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.926 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 1.6 pt-20 -65.58 -24.63 67.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.11 0.481 . . . . 0.0 109.923 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 1.035 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 5.3 mmpt? -81.31 -27.27 35.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.585 175.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.595 HD11 ' CE2' ' A' ' 53' ' ' TYR . 54.3 mt -64.33 -41.58 92.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.163 0.506 . . . . 0.0 109.728 172.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.474 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 6.4 p -86.34 -47.43 9.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.775 -173.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.7 -9.91 19.01 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -173.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.551 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 66.6 m-85 -89.25 -172.7 3.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 55' ' ' GLU . 17.1 t -131.53 128.28 38.98 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.573 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.926 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 10.2 mt -95.73 25.94 4.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.034 0.445 . . . . 0.0 110.031 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.429 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 1.2 tp10 -44.36 -51.1 8.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.81 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -71.03 -9.9 58.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.066 -176.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -100.42 0.53 39.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 0.0 110.012 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 87.3 mttt . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.808 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.439 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 2.0 p . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 3.6 ptp180 -112.48 173.42 6.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.213 -167.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -85.72 114.73 22.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.507 -172.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.544 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 81.1 m95 -105.58 146.17 30.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.2 176.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.711 HG22 ' HG2' ' A' ' 16' ' ' LYS . 66.0 t -136.37 138.26 47.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.187 0.304 . . . . 0.0 110.707 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.584 ' HA ' HD12 ' A' ' 46' ' ' LEU . 6.6 p-10 -84.89 159.74 20.29 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -76.76 -1.98 30.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.029 0.443 . . . . 0.0 111.997 -169.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 t -105.34 -3.51 22.62 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.448 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.5 31.02 70.86 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.418 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.4 m -84.76 -43.06 14.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.848 0.356 . . . . 0.0 110.732 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.804 ' HZ ' ' HE3' ' A' ' 45' ' ' LYS . 24.9 p90 -138.76 136.86 36.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.867 0.841 . . . . 0.0 112.679 -176.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.711 ' HG2' HG22 ' A' ' 9' ' ' VAL . 54.1 mttp -126.07 130.9 52.02 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.207 171.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -139.06 157.94 28.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.391 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 29.5 m-20 -103.74 113.4 26.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -159.4 158.68 32.61 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.947 -172.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.439 ' HG3' ' HA ' ' A' ' 5' ' ' SER . 45.3 mt-10 -106.73 138.64 42.53 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.206 174.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.665 ' HA ' HD23 ' A' ' 31' ' ' LEU . 15.2 t80 -71.88 124.35 24.67 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.197 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -105.94 -43.21 7.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.102 -177.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.9 150.84 13.7 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.505 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.47 ' HB2' ' HE2' ' A' ' 21' ' ' PHE . 6.3 t -115.1 136.88 52.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.93 119.97 12.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.606 0.241 . . . . 0.0 110.913 -173.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 26' ' ' LYS . 17.9 tptm 55.75 41.17 30.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.314 174.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 65' ' ' PHE . . . 89.92 -4.84 83.45 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.309 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -109.71 159.93 16.74 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 122.453 -0.439 . . . . 0.0 110.765 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.522 HG23 ' HD2' ' A' ' 21' ' ' PHE . 76.1 mt -122.33 124.82 71.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.979 -174.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 92.2 m-70 -87.6 126.42 34.93 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 21' ' ' PHE . 87.4 mt -125.14 136.76 53.93 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.522 -178.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -102.1 100.38 10.62 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -63.32 159.57 17.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.136 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.28 -15.29 56.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.232 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.14 -25.22 37.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.523 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.9 -6.55 27.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.198 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.97 137.64 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.674 0.273 . . . . 0.0 110.577 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 36.5 ttmt -102.57 124.74 48.67 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 31.8 pt -123.43 153.68 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -176.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.29 103.43 8.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.129 175.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 m -99.03 153.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.487 ' HB1' ' OD1' ' A' ' 44' ' ' ASP . . . -82.33 122.22 27.69 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.009 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.93 -20.03 63.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.476 0.655 . . . . 0.0 110.923 -176.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.661 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 6.6 p-10 -77.02 -12.13 59.9 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.164 -175.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.804 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -117.43 10.32 13.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.931 0.872 . . . . 0.0 109.012 173.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 10' ' ' ASP . 14.1 tp -89.82 162.79 15.32 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.646 -177.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.572 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 27.0 m -68.28 142.75 55.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.588 0.709 . . . . 0.0 110.68 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -65.41 -27.85 68.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.267 -173.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -64.72 -48.9 72.95 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.603 0.716 . . . . 0.0 109.598 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.572 ' OD1' ' HB2' ' A' ' 47' ' ' SER . 1.6 m-20 -59.86 -36.29 76.57 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.219 175.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.686 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -65.47 -47.37 76.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.576 178.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -62.36 -27.57 69.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.789 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.428 ' O ' HG12 ' A' ' 57' ' ' ILE . 48.8 t80 -71.91 -47.88 49.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.628 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' A' ' 62' ' ' LEU . 61.5 t -62.68 -33.55 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.695 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.632 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 38.2 mt-10 -52.19 -34.77 46.85 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.21 0.529 . . . . 0.0 110.483 173.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 1.033 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.6 mmpt? -82.51 -37.01 25.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.894 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.44 HG21 ' CD1' ' A' ' 21' ' ' PHE . 20.7 mm -69.81 -28.35 36.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.008 0.432 . . . . 0.0 111.202 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.656 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 43.7 p -104.83 -45.38 4.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -173.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.4 4.34 46.84 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -172.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.656 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 96.7 m-85 -102.94 -175.88 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.2 t -125.4 121.75 34.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.102 0.477 . . . . 0.0 110.748 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 51' ' ' LEU . 25.4 mt -95.94 22.83 6.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.647 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.14 -41.14 74.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.402 0.62 . . . . 0.0 110.458 176.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HE3' ' CE2' ' A' ' 65' ' ' PHE . 48.6 pttt -62.53 -14.17 38.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.673 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.661 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 32.7 m-85 -104.38 -8.86 18.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.908 0.385 . . . . 0.0 111.031 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 95.0 mttt . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 121.101 0.477 . . . . 0.0 109.714 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.582 ' CA ' ' HB2' ' A' ' 20' ' ' GLU . 46.1 t . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 121.866 0.841 . . . . 0.0 112.154 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 14.2 ptp180 -149.42 -179.08 6.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.168 -171.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.6 tm? -86.43 107.87 18.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.772 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.456 ' CE3' ' HB3' ' A' ' 50' ' ' ASP . 46.4 m95 -92.38 149.09 21.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.098 176.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 15.6 t -130.58 154.33 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.831 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -101.65 -179.05 3.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.815 0.341 . . . . 0.0 111.217 -178.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -60.41 -52.83 63.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.054 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 m -81.8 -7.29 59.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.184 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.0 28.54 45.26 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.527 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.1 m -99.7 -37.28 9.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.521 0.677 . . . . 0.0 109.468 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.831 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 4.8 m-85 -87.01 125.82 34.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.739 -176.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.457 ' HB3' HD11 ' A' ' 7' ' ' LEU . 50.5 mttp -131.63 129.56 41.01 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 158.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.87 133.59 6.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.455 0.645 . . . . 0.0 112.119 -177.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 7.3 p-10 -87.73 116.2 25.71 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.732 176.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -168.49 167.64 11.57 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.102 -174.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' CA ' ' A' ' 5' ' ' SER . 9.6 tp10 -126.97 136.56 52.43 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.137 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.779 ' HA ' HD23 ' A' ' 31' ' ' LEU . 7.1 t80 -65.53 126.6 28.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.723 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -105.54 -50.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.818 179.281 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.11 148.07 15.97 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.583 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 t -108.9 129.12 55.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.18 133.02 15.02 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.138 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm 63.69 23.72 13.61 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.328 175.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.92 4.59 88.52 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.956 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 33.1 mmtp -103.23 154.51 19.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.008 0.433 . . . . 0.0 110.166 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.647 HG23 ' HD1' ' A' ' 21' ' ' PHE . 40.3 mm -108.71 114.07 45.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.347 174.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.448 ' O ' HG13 ' A' ' 22' ' ' ILE . 65.0 m170 -76.21 125.59 29.44 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 175.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.779 HD23 ' HA ' ' A' ' 21' ' ' PHE . 86.3 mt -129.04 136.69 50.62 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.695 -174.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -106.74 107.94 19.21 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.574 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 4.8 mtpm? -67.63 166.14 15.64 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.15 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.64 -14.38 60.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.297 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -93.42 1.96 56.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.904 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.33 -18.08 58.11 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.185 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.1 t -63.67 139.35 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.518 0.199 . . . . 0.0 110.869 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -107.81 121.68 45.22 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 pt -124.42 158.51 31.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.726 -173.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.48 103.39 8.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.152 0.501 . . . . 0.0 110.049 174.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.28 119.97 55.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -58.79 124.95 21.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.436 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -64.96 -26.91 68.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.982 177.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.7 -34.24 71.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.58 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -110.46 18.38 19.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.034 0.445 . . . . 0.0 110.789 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.684 ' HB3' HD21 ' A' ' 51' ' ' LEU . 10.1 tp -95.18 170.12 9.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.149 -176.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.608 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 35.3 t -83.66 139.48 32.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.033 0.92 . . . . 0.0 110.751 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -51.52 -35.04 38.85 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.272 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.22 -50.54 71.35 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 121.412 0.625 . . . . 0.0 109.99 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.608 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 5.8 m-20 -60.99 -36.41 79.4 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.606 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.772 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 26.4 mt -69.82 -43.21 72.49 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -59.41 -28.88 67.32 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.514 0.673 . . . . 0.0 109.869 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.547 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 29.3 t80 -73.7 -50.34 21.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.146 176.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.0 p -70.28 -29.66 40.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.891 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.772 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 42.8 mt-10 -54.63 -37.12 65.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.465 168.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -39.44 66.6 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.547 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 53.3 mt -64.19 -47.23 90.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.084 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.9 p -80.62 -46.46 15.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.363 -174.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.04 -4.55 41.62 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -173.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -100.35 179.36 4.48 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.52 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 6.4 t -118.98 134.51 55.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.805 0.336 . . . . 0.0 110.479 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.531 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 21.8 mt -97.84 35.75 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.123 0.487 . . . . 0.0 110.845 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.44 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 5.8 mm-40 -44.61 -58.41 3.05 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.506 1.122 . . . . 0.0 113.365 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -69.11 -10.54 58.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.644 0.259 . . . . 0.0 111.693 -173.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -105.04 -8.97 18.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.286 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.666 ' HA ' HD12 ' A' ' 51' ' ' LEU . 64.2 mttm . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 121.246 0.546 . . . . 0.0 111.867 -173.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 8.2 ptp180 -115.44 178.16 4.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.879 -171.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 7' ' ' LEU . 6.1 mt -84.45 114.32 21.84 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.214 0.531 . . . . 0.0 111.546 -173.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.581 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 43.9 m95 -98.63 140.66 32.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.595 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 10' ' ' ASP . 43.8 t -124.62 144.84 33.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.915 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.532 ' HA ' HD12 ' A' ' 46' ' ' LEU . 7.4 p-10 -84.89 170.55 12.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.0 109.887 173.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -75.47 -14.52 60.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.631 -172.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -98.13 -16.48 19.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.907 0.384 . . . . 0.0 111.184 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.5 36.85 25.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.661 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -98.87 -37.69 9.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.189 -0.505 . . . . 0.0 110.724 -175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 37.8 p90 -137.0 135.15 37.37 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.725 0.774 . . . . 0.0 112.434 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 47.8 mttp -128.92 130.61 47.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.369 173.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.559 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -145.1 146.1 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.987 0.422 . . . . 0.0 112.102 -176.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 6.3 m-20 -82.12 120.39 25.25 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.513 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.674 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -163.16 162.89 25.77 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.74 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.6 138.53 54.53 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 174.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.8 ' HD1' HG23 ' A' ' 29' ' ' ILE . 6.8 t80 -70.91 122.72 20.48 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.508 0.67 . . . . 0.0 110.507 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -100.81 -51.16 9.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.383 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.84 154.35 25.34 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.485 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.412 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 22.6 t -120.82 138.58 53.97 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -177.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.1 131.07 15.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.045 -175.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 56.62 27.1 11.98 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.729 0.643 . . . . 0.0 112.311 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.41 -1.53 69.61 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.711 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 57.0 mttp -103.99 158.93 16.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.011 0.434 . . . . 0.0 110.799 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.8 HG23 ' HD1' ' A' ' 21' ' ' PHE . 94.3 mt -116.38 122.8 70.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.117 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.435 ' O ' HG13 ' A' ' 22' ' ' ILE . 39.7 m170 -84.5 126.94 33.73 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 21' ' ' PHE . 81.8 mt -124.14 135.69 53.69 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.833 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -95.7 103.97 15.87 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.696 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.866 ' HD3' HD13 ' A' ' 39' ' ' ILE . 11.8 mmmm -64.82 158.75 24.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.218 -174.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.8 -20.72 66.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.802 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -66.48 -32.49 73.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.686 173.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.83 -17.26 27.73 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.295 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.4 t -72.59 147.4 10.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.368 -0.416 . . . . 0.0 110.654 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -100.62 128.77 46.56 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.866 HD13 ' HD3' ' A' ' 33' ' ' LYS . 18.1 pt -120.04 159.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.259 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.82 103.55 8.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.069 0.461 . . . . 0.0 110.096 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.1 t -107.29 129.56 60.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -68.18 131.56 45.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.78 0.324 . . . . 0.0 110.191 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -69.07 -6.55 28.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.881 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 2.8 p30 -81.76 -33.81 30.77 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -172.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.588 ' HD3' ' H ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -107.78 19.98 19.4 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.094 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.532 HD12 ' HA ' ' A' ' 10' ' ' ASP . 11.6 tp -93.34 169.69 10.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.799 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.515 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.3 t -74.15 139.47 44.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.561 0.696 . . . . 0.0 110.676 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -63.21 -30.55 71.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.419 -173.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -62.03 -46.98 86.78 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.594 0.712 . . . . 0.0 109.789 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.573 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.3 m-20 -65.54 -34.69 78.85 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.565 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.779 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -69.32 -47.21 65.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.11 177.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.576 ' O ' ' HD2' ' A' ' 56' ' ' LYS . . . -60.94 -30.85 70.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.575 0.702 . . . . 0.0 109.991 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.442 ' CE1' HD11 ' A' ' 57' ' ' ILE . 35.2 t80 -69.22 -52.12 30.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.099 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.768 ' HA ' HG12 ' A' ' 57' ' ' ILE . 3.0 p -69.06 -27.22 34.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.868 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.779 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 71.2 mt-10 -51.09 -49.29 60.99 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.106 0.479 . . . . 0.0 109.894 167.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -72.24 -26.62 62.09 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.57 -175.169 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.768 HG12 ' HA ' ' A' ' 54' ' ' VAL . 10.8 mm -67.3 -43.18 88.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.561 174.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 17.8 p -97.19 -47.25 5.82 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.14 -6.9 19.18 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.486 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 90.8 m-85 -92.71 167.89 11.58 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -117.13 134.46 54.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 27.4 mt -105.3 25.17 10.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.685 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 5.5 tp10 -54.5 -41.59 69.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.3 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -60.27 -19.95 56.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.204 177.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.484 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 57.6 m-85 -101.04 -14.16 17.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.31 0.576 . . . . 0.0 110.081 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.685 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 49.6 mtpt . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.282 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.462 ' HD3' HG23 ' A' ' 57' ' ' ILE . 63.9 pttt . . . . . 0 C--O 1.237 0.407 0 CA-C-O 121.286 0.565 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.52 ' C ' ' HG2' ' A' ' 20' ' ' GLU . 15.8 mttt -169.63 154.67 5.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.077 -177.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 1.2 p -56.99 112.63 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.3 0.572 . . . . 0.0 111.157 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 12.1 ptp180 -136.97 -177.09 4.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.054 -171.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.714 HD11 ' HE2' ' A' ' 16' ' ' LYS . 2.2 tm? -91.24 106.68 18.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.41 -174.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.525 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 35.3 m95 -92.12 149.32 21.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.738 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.1 t -135.75 139.96 45.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.844 ' HA ' HD12 ' A' ' 46' ' ' LEU . 1.2 p-10 -80.8 175.14 10.94 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.619 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.528 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 3.7 tpm_? -54.21 -51.21 65.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.836 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -80.21 -14.85 58.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.616 -172.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.68 47.31 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.466 -0.653 . . . . 0.0 111.466 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.2 m -86.62 -36.88 18.56 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.735 0.302 . . . . 0.0 110.189 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.487 ' CE2' ' HE2' ' A' ' 45' ' ' LYS . 39.3 p90 -129.99 141.42 50.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.812 0.815 . . . . 0.0 111.985 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.714 ' HE2' HD11 ' A' ' 7' ' ' LEU . 9.5 ptmm? -128.93 131.81 47.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.895 174.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -134.9 140.92 44.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -172.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.563 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 8.6 p-10 -81.22 122.4 27.35 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 169.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -162.01 155.89 21.51 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.594 -175.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.537 ' HG2' ' N ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -116.33 145.93 42.83 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.415 171.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 62.7 t80 -80.91 129.55 34.59 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.148 0.499 . . . . 0.0 110.395 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -108.75 -49.55 7.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.091 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.42 140.87 6.43 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.901 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.595 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 30.8 t -111.1 130.41 55.62 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.41 137.98 18.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.613 0.244 . . . . 0.0 110.713 -174.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 61.6 24.62 14.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.481 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.6 2.68 75.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.789 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -115.03 161.83 17.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.549 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' A' ' 43' ' ' ALA . 69.6 mt -114.36 120.66 64.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.361 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.416 ' O ' HG13 ' A' ' 22' ' ' ILE . 23.0 m-70 -80.48 123.53 28.15 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.646 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 97.7 mt -126.34 139.67 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.152 -174.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -112.66 103.13 11.17 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.205 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.8 mtpt -59.65 152.64 21.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.32 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 5' ' ' SER . . . -72.23 -15.17 61.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.217 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.36 -13.29 60.72 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.437 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.27 9.46 51.1 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.154 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.99 142.77 16.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.759 0.279 . . . . 0.0 110.43 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -105.33 125.21 50.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 pt -127.29 172.44 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.888 0.375 . . . . 0.0 111.123 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.9 110.0 11.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.2 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.15 127.03 71.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.875 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 128.4 36.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.708 0.289 . . . . 0.0 110.486 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.541 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -70.78 -10.16 58.92 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.536 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 11.7 p-10 -96.23 -19.76 19.07 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -172.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.487 ' HE2' ' CE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -104.84 19.56 20.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.428 0.632 . . . . 0.0 109.953 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.844 HD12 ' HA ' ' A' ' 10' ' ' ASP . 8.1 tp -101.5 176.44 5.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.076 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.669 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 22.2 t -88.38 147.52 24.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.065 0.936 . . . . 0.0 111.005 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.737 HD22 ' HB3' ' A' ' 66' ' ' LYS . 1.1 m120 -56.87 -35.38 68.84 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.455 -172.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.07 -45.55 73.51 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.095 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.669 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 2.2 m-20 -59.21 -40.8 86.95 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.989 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.797 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -68.05 -42.94 79.75 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.288 178.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' A' ' 56' ' ' LYS . . . -58.81 -35.19 72.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.253 0.549 . . . . 0.0 110.051 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.438 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 43.6 t80 -68.79 -50.26 51.77 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.151 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.4 p -68.89 -31.41 50.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.614 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.797 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.0 mt-10 -51.91 -40.95 61.54 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.604 168.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.672 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -75.54 -33.97 60.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 110.574 -174.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.462 HG23 ' HD3' ' A' ' 3' ' ' LYS . 52.2 mt -66.26 -39.65 84.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.971 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 p -92.13 -46.32 7.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -171.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.51 -5.5 35.38 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -89.75 -178.48 5.52 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.531 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 13.8 t -124.25 125.41 44.35 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.166 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 21.3 mt -104.19 24.16 11.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.771 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -53.83 -46.53 71.21 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.897 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -59.43 -24.79 63.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.504 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.536 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 90.9 m-85 -89.17 -14.07 36.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 0.0 110.739 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.737 ' HB3' HD22 ' A' ' 48' ' ' ASN . 93.4 mttt -81.29 129.79 34.76 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.79 -21.73 24.93 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.864 -173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 C--N 1.311 -1.094 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.368 -177.014 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.613 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 2.5 ttpm? . . . . . 0 C--O 1.236 0.38 0 CA-C-O 121.082 0.467 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 68.5 mmtt -79.96 80.58 6.35 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.542 0.687 . . . . 0.0 110.37 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -58.47 120.19 8.36 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.385 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 2.8 ptp180 -110.13 174.83 5.68 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.689 -173.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 16' ' ' LYS . 1.7 tm? -94.2 104.72 16.72 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.155 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.776 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 69.3 m95 -91.56 142.73 27.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.825 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 10' ' ' ASP . 82.4 t -132.82 142.45 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 O-C-N 123.488 0.492 . . . . 0.0 110.926 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.97 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -90.63 161.2 15.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -68.5 -23.03 64.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.074 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -75.88 -23.37 55.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.132 0.492 . . . . 0.0 110.377 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.11 12.32 60.28 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.941 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -87.66 -48.11 8.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.525 0.679 . . . . 0.0 109.868 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.97 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 2.4 m-85 -79.67 134.33 36.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.034 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.776 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 7.2 ptpp? -159.97 128.96 5.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.493 165.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.45 151.67 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 120.129 -0.629 . . . . 0.0 111.955 -173.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 8.0 p-10 -84.05 125.48 32.14 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.691 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.441 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -167.93 156.83 9.41 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.183 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.613 ' HG3' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -109.71 149.16 30.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.538 177.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.717 ' HA ' HD12 ' A' ' 31' ' ' LEU . 58.2 t80 -87.39 131.36 34.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.491 -173.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -107.85 -44.98 7.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.823 0.344 . . . . 0.0 110.58 179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.33 161.81 31.07 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 121.129 -0.557 . . . . 0.0 111.836 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 t -141.78 132.58 25.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.286 0.543 . . . . 0.0 110.96 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.09 149.33 26.0 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.12 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.58 21.43 10.02 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.095 0.558 . . . . 0.0 111.937 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.17 23.06 50.1 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.336 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.67 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 47.1 mmtm -125.59 146.51 49.66 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 120.872 0.367 . . . . 0.0 110.982 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.556 ' CG2' HD13 ' A' ' 31' ' ' LEU . 1.9 mp -106.92 123.95 62.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.354 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 22' ' ' ILE . 36.6 m170 -89.83 120.32 30.97 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.717 HD12 ' HA ' ' A' ' 21' ' ' PHE . 3.0 tp -121.63 153.35 38.22 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.342 -173.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -128.53 107.2 9.52 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.352 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.512 ' HD3' HD13 ' A' ' 39' ' ' ILE . 12.6 mmmm -58.59 161.35 4.69 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.242 -175.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.62 -25.63 68.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.773 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -79.16 -19.61 50.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.081 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.7 26.92 6.23 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.691 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.51 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 47.3 t -102.42 143.01 15.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -105.52 131.12 53.32 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.079 0.466 . . . . 0.0 110.963 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.512 HD13 ' HD3' ' A' ' 33' ' ' LYS . 24.5 pt -135.36 160.27 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.605 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.81 117.87 29.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.039 0.447 . . . . 0.0 110.135 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.2 t -112.11 134.98 52.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.775 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.67 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . . . -69.8 127.03 31.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.724 0.297 . . . . 0.0 110.907 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.11 -14.15 61.28 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.418 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.436 ' OD1' ' HB1' ' A' ' 42' ' ' ALA . 7.1 p-10 -92.88 -14.72 27.29 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 19.4 ptmt -97.51 -2.1 42.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.474 0.654 . . . . 0.0 110.124 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 46' ' ' LEU . 2.6 tp -84.86 159.63 20.34 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.504 -170.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.589 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 48.1 t -71.65 153.34 42.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.4 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.472 ' HA ' HD22 ' A' ' 51' ' ' LEU . 12.6 m-80 -64.12 -28.65 69.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.211 -176.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -66.11 -47.82 72.93 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.865 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.589 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 4.1 m-20 -62.63 -32.14 73.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.486 177.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.724 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -65.98 -51.6 57.02 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.112 177.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -63.71 -27.2 69.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.123 0.487 . . . . 0.0 111.06 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.475 ' CE1' HD11 ' A' ' 57' ' ' ILE . 22.9 t80 -70.0 -48.3 58.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.866 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 50' ' ' ASP . 78.8 t -62.8 -34.3 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.777 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.691 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 44.0 mt-10 -54.84 -32.77 60.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.022 0.439 . . . . 0.0 110.512 174.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.566 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -80.18 -47.15 15.13 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.053 -178.008 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.475 HD11 ' CE1' ' A' ' 53' ' ' TYR . 25.0 mt -62.47 -36.63 75.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 111.727 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 55.8 p -103.12 -46.48 4.62 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.22 -8.01 30.87 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -173.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 92.8 m-85 -90.99 135.42 33.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.11 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.1 m -82.11 130.59 35.13 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.766 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.724 HD12 ' HA ' ' A' ' 51' ' ' LEU . 48.6 mt -104.63 30.2 5.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.179 0.514 . . . . 0.0 109.875 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -53.95 -47.48 71.24 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.349 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -67.11 -13.55 62.05 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.8 -14.97 27.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.922 0.391 . . . . 0.0 110.235 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 92.2 mttt -86.07 171.05 11.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.599 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.89 72.92 0.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.86 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.163 -178.046 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt . . . . . 0 C--O 1.234 0.27 0 CA-C-O 121.271 0.558 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.648 ' HB2' HH21 ' A' ' 6' ' ' ARG . 31.4 mmmt -122.32 120.9 35.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.879 -174.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 t -61.16 124.56 20.89 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.648 HH21 ' HB2' ' A' ' 4' ' ' LYS . 9.3 ptp180 -143.39 -179.29 6.32 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.81 -167.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 16' ' ' LYS . 2.1 tm? -95.24 105.27 17.2 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.856 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.604 ' CE3' ' HB3' ' A' ' 50' ' ' ASP . 37.0 m95 -91.57 139.16 30.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 10' ' ' ASP . 47.6 t -119.31 137.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.846 0.355 . . . . 0.0 110.858 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.6 ' HB3' ' H ' ' A' ' 14' ' ' THR . 9.8 t70 -63.46 158.82 19.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.552 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 44.5 ttp180 -74.11 -35.03 64.12 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.712 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -95.87 11.97 31.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.137 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.71 28.58 73.5 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.897 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.6 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 6.7 m -67.5 -37.07 82.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.745 -0.228 . . . . 0.0 111.111 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -158.39 157.54 32.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.261 0.553 . . . . 0.0 111.407 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.71 ' HB3' HD11 ' A' ' 7' ' ' LEU . 9.1 mtmp? -125.13 132.29 53.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.514 171.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.448 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -135.27 141.39 42.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 112.548 0.574 . . . . 0.0 112.548 -175.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.7 OUTLIER -95.29 115.11 26.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.312 176.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.875 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . . . -170.24 167.19 8.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.16 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.464 ' HG2' ' C ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -117.3 140.33 49.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.912 ' HA ' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -65.72 134.54 53.41 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.993 0.425 . . . . 0.0 109.876 177.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.983 HD12 ' HE3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -110.29 -47.64 6.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.111 177.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.54 139.41 5.78 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.293 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.616 ' HG ' ' HE2' ' A' ' 21' ' ' PHE . 78.2 m -98.69 126.36 44.27 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.58 136.5 22.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.6 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 tptt 63.8 27.64 14.63 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.643 0.735 . . . . 0.0 110.118 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.56 3.57 88.92 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.211 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.873 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 42.1 mttm -109.95 171.91 7.17 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.66 HG23 ' HD2' ' A' ' 21' ' ' PHE . 57.9 mt -124.67 116.72 48.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.384 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.418 ' O ' HG13 ' A' ' 22' ' ' ILE . 57.3 m-70 -75.88 128.2 34.61 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.912 HD23 ' HA ' ' A' ' 21' ' ' PHE . 77.1 mt -126.82 136.92 53.02 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.363 -172.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.571 ' HB2' HD11 ' A' ' 22' ' ' ILE . 15.1 t-160 -102.31 102.59 12.97 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.345 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.875 ' HD2' ' HB2' ' A' ' 19' ' ' ALA . 1.6 mmmp? -65.13 163.99 13.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.073 -176.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.3 -13.48 62.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.101 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -87.29 -10.49 52.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.592 176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.91 -18.4 52.47 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.922 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.6 p -72.65 147.98 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.945 0.402 . . . . 0.0 110.823 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.983 ' HE3' HD12 ' A' ' 22' ' ' ILE . 84.6 tttt -111.16 132.96 53.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.613 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 pt -126.95 174.69 10.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.484 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.89 103.19 5.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.245 0.545 . . . . 0.0 110.056 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.563 HG13 ' HE3' ' A' ' 45' ' ' LYS . 73.2 t -106.84 118.63 54.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.668 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.873 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -57.85 139.14 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.375 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.14 -9.33 58.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.693 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -84.05 -31.27 25.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.122 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.563 ' HE3' HG13 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -99.24 27.34 5.21 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.362 175.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.546 HD12 HD12 ' A' ' 29' ' ' ILE . 13.9 mt -102.26 163.67 12.11 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 122.338 1.066 . . . . 0.0 112.241 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.567 ' O ' HD22 ' A' ' 51' ' ' LEU . 30.2 t -71.05 135.65 47.87 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.104 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.472 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 3.0 m-20 -48.44 -38.91 21.04 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.842 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.74 -47.07 83.5 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.564 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.604 ' HB3' ' CE3' ' A' ' 8' ' ' TRP . 43.6 m-20 -67.49 -34.97 78.24 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.238 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.789 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -70.95 -41.71 70.76 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.505 176.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.513 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -60.69 -29.44 69.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.515 0.674 . . . . 0.0 110.135 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 51.1 t80 -71.51 -51.59 22.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.935 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.802 ' HA ' HG12 ' A' ' 57' ' ' ILE . 2.7 p -71.23 -27.66 30.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.607 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.789 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 42.6 mt-10 -51.67 -38.53 55.36 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.165 0.507 . . . . 0.0 109.796 168.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -76.4 -41.11 48.97 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.783 -178.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.802 HG12 ' HA ' ' A' ' 54' ' ' VAL . 7.5 mm -61.69 -36.29 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.8 p -101.88 -49.17 4.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.34 -34.22 4.37 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.989 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -87.98 140.74 29.19 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 117.14 0.47 . . . . 0.0 110.451 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.7 t -79.51 135.73 36.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.424 -171.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 23.8 mt -104.68 22.28 15.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.115 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.589 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 2.2 tp10 -50.69 -38.63 47.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.4 0.619 . . . . 0.0 110.362 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 18.3 ptmt -67.48 -5.92 17.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.843 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -115.94 -12.48 11.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.229 0.537 . . . . 0.0 110.103 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 45.1 mtpt -90.08 140.37 29.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.831 -174.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.552 ' HB2' ' HD2' ' A' ' 11' ' ' ARG . . . -96.77 54.43 1.3 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.442 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.243 0.746 0 CA-C-O 118.887 -0.577 . . . . 0.0 110.228 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.7 tptm . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 121.339 0.59 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.586 ' HE3' ' HG3' ' A' ' 20' ' ' GLU . 29.7 mtpp -106.71 172.94 6.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.504 -175.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 1.084 ' H ' ' HG2' ' A' ' 20' ' ' GLU . 60.9 p 54.41 105.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.479 -176.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 11.6 ptp180 -118.96 176.52 5.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.798 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.6 tm? -95.66 105.68 17.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.975 0.417 . . . . 0.0 110.769 -173.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.701 ' HB2' HG23 ' A' ' 17' ' ' VAL . 48.7 m95 -92.4 152.64 19.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.299 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 16' ' ' LYS . 47.6 t -135.76 142.94 37.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.673 ' HA ' HD12 ' A' ' 46' ' ' LEU . 3.5 p-10 -85.41 178.31 7.49 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.084 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.534 ' HG3' ' HB1' ' A' ' 67' ' ' ALA . 48.2 ttp180 -59.52 -40.48 87.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.83 0.348 . . . . 0.0 111.552 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.8 m -84.5 -18.65 35.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.5 13.93 74.89 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.708 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 m -79.87 -37.02 35.75 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.683 -0.258 . . . . 0.0 111.182 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 47.0 p90 -123.4 125.15 44.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.009 0.909 . . . . 0.0 112.175 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.611 ' HB3' HD11 ' A' ' 7' ' ' LEU . 52.2 mttp -116.61 131.17 57.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.452 174.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -131.91 136.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.1 p-10 -90.02 106.11 18.26 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.181 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -161.44 161.79 30.3 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.767 -171.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 1.084 ' HG2' ' H ' ' A' ' 5' ' ' SER . 1.1 mm-40 -107.92 142.79 37.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.563 174.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.645 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 69.4 t80 -73.85 130.32 39.68 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.975 174.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -115.8 -47.62 4.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.408 178.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.83 148.51 14.86 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.86 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.645 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 30.8 t -124.18 126.89 46.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.859 0.329 . . . . 0.0 110.126 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.33 116.69 16.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.112 -173.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.5 tptt 55.2 44.5 27.6 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.201 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.28 2.82 85.19 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.46 175.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 46.7 mmtm -107.06 151.74 24.94 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 117.118 0.459 . . . . 0.0 110.079 174.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.672 HG13 ' HB2' ' A' ' 43' ' ' ALA . 91.0 mt -119.87 123.76 71.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.286 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.502 ' O ' HG13 ' A' ' 22' ' ' ILE . 34.6 m170 -84.96 124.08 31.27 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 21' ' ' PHE . 96.5 mt -125.63 138.45 53.92 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.83 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -107.37 101.14 10.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.175 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HE3' HG12 ' A' ' 17' ' ' VAL . 38.1 mtpt -64.96 159.06 23.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.471 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.9 -15.68 63.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.54 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.77 -20.07 61.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.566 174.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.57 -20.5 27.37 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.963 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.7 p -79.2 142.12 14.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.293 0.568 . . . . 0.0 111.19 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -99.65 127.8 45.76 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.928 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.1 pt -122.87 162.62 22.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.958 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.91 122.66 38.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.842 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.59 163.55 15.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . . . -92.42 119.71 32.22 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.411 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.672 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -64.24 -21.92 66.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.735 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.61 -22.41 63.5 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.764 -174.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HE2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -127.22 28.62 5.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.431 0.634 . . . . 0.0 110.377 179.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 10' ' ' ASP . 10.7 tp -95.03 170.58 9.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.592 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.649 ' O ' HD22 ' A' ' 51' ' ' LEU . 33.4 t -72.74 139.73 47.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.422 0.63 . . . . 0.0 110.1 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.466 ' CB ' ' HB3' ' A' ' 66' ' ' LYS . 11.2 p30 -66.06 -24.51 66.74 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.983 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -63.87 -47.77 79.36 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.637 0.732 . . . . 0.0 109.192 174.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.629 ' O ' HG12 ' A' ' 54' ' ' VAL . 3.3 m-20 -58.62 -43.8 89.78 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.712 176.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.797 HD23 ' HA ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -67.57 -42.39 82.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.819 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -61.5 -29.64 70.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.401 0.62 . . . . 0.0 110.134 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.744 ' CE2' HD11 ' A' ' 57' ' ' ILE . 40.9 t80 -74.61 -49.13 22.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.763 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.2 p -69.48 -27.65 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.119 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.764 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 50.6 mt-10 -51.24 -40.91 59.85 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 167.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 52' ' ' ALA . 9.3 mmpt? -74.14 -38.61 63.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.389 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.744 HD11 ' CE2' ' A' ' 53' ' ' TYR . 31.9 mt -62.84 -39.8 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.976 0.417 . . . . 0.0 111.253 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 40.3 p -95.22 -43.91 7.85 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -168.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.2 7.46 43.4 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.494 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.593 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 98.1 m-85 -103.7 177.06 4.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -123.69 124.66 43.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.959 0.409 . . . . 0.0 110.034 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 65' ' ' PHE . 62.1 mt -102.89 41.19 1.27 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.45 0.643 . . . . 0.0 110.189 -175.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.73 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 8.5 tp10 -50.62 -59.65 3.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.479 -176.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -70.35 -10.47 59.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.339 0.59 . . . . 0.0 109.917 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.677 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 60.3 m-85 -91.88 -14.2 30.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.566 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.797 ' HA ' HD23 ' A' ' 51' ' ' LEU . 50.8 mtmt -72.34 136.32 46.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.476 -175.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.534 ' HB1' ' HG3' ' A' ' 11' ' ' ARG . . . -65.27 116.42 6.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.319 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.074 177.715 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.6 tptm . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.421 0.153 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 57.9 tttm 64.11 18.55 11.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 122.113 0.958 . . . . 0.0 111.111 173.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.6 p -78.58 144.26 35.71 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.754 -170.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 2.8 ptp180 -136.54 -179.17 5.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.052 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -93.18 115.14 27.77 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.497 -172.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.719 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 62.4 m95 -104.6 149.15 25.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.156 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 59.5 t -136.75 149.92 26.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 123.543 0.527 . . . . 0.0 109.829 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.993 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -96.67 174.09 7.0 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.214 178.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.896 ' HG3' ' HB3' ' A' ' 67' ' ' ALA . 1.6 tmm_? -66.82 -34.29 77.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.705 0.288 . . . . 0.0 110.857 -174.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -75.68 -23.36 56.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.21 2.17 66.3 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.666 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -80.8 -40.48 24.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.349 0.595 . . . . 0.0 109.834 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.993 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 5.7 m-85 -85.93 127.12 34.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.829 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.719 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 8.6 ptmt -153.35 128.57 9.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.917 166.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.422 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -158.36 156.36 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.785 -173.367 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -92.81 118.67 31.35 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.899 174.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -163.86 164.62 23.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.621 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -115.97 138.32 51.3 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.818 ' HD2' HG23 ' A' ' 29' ' ' ILE . 6.6 t80 -74.41 117.91 16.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.324 0.583 . . . . 0.0 109.504 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -96.07 -45.37 13.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.136 -177.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.93 143.21 7.55 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.766 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.598 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 22.1 p -100.82 133.93 44.55 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.74 126.91 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.576 -173.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.3 OUTLIER 61.44 34.2 18.27 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.811 176.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.29 7.42 88.48 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.254 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -104.7 165.91 10.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.028 0.442 . . . . 0.0 110.442 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.818 HG23 ' HD2' ' A' ' 21' ' ' PHE . 84.6 mt -125.51 116.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.52 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.492 ' O ' HG13 ' A' ' 22' ' ' ILE . 11.2 m170 -83.61 126.94 33.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.725 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.7 mt -124.72 138.89 54.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.284 0.564 . . . . 0.0 111.021 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -104.72 105.55 15.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.468 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HD3' HD13 ' A' ' 39' ' ' ILE . 13.5 mmmm -61.14 162.89 6.75 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.527 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.14 -12.47 60.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.265 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -89.26 -13.46 38.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.195 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.82 2.56 56.19 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.468 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.17 148.14 5.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.554 0.216 . . . . 0.0 110.46 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -100.04 126.41 46.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.041 0.448 . . . . 0.0 110.857 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.624 HD13 ' HD3' ' A' ' 33' ' ' LYS . 24.8 pt -124.86 168.45 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.949 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.88 124.36 18.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.258 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 m -114.05 164.71 9.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.522 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . . . -85.86 127.85 34.68 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.183 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -63.97 -5.8 5.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.372 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -110.71 -15.72 13.77 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.522 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -96.26 0.88 51.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 6.6 tp -86.27 169.23 13.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.058 -175.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.634 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.5 t -78.9 138.29 38.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.776 0.798 . . . . 0.0 109.923 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.45 ' ND2' ' HB3' ' A' ' 66' ' ' LYS . 1.2 m-20 -53.53 -32.79 52.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.329 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -62.91 -48.13 80.28 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.046 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.668 ' O ' HG12 ' A' ' 54' ' ' VAL . 2.6 m-20 -59.67 -39.26 83.88 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.555 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.736 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -70.21 -38.89 75.39 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.158 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -60.33 -30.44 69.51 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.566 0.698 . . . . 0.0 110.197 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.663 ' CE2' HD11 ' A' ' 57' ' ' ILE . 80.2 t80 -74.36 -48.41 28.21 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.507 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -65.17 -26.98 41.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.415 -0.803 . . . . 0.0 110.853 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.736 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 37.8 mt-10 -51.47 -43.53 62.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.26 166.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.599 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 1.6 ppmt? -72.87 -31.58 64.82 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.992 0.425 . . . . 0.0 109.983 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.663 HD11 ' CE2' ' A' ' 53' ' ' TYR . 37.7 mt -66.94 -42.84 89.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.735 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.4 p -104.52 -46.38 4.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -171.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.13 -14.57 23.51 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -79.74 137.64 37.08 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.432 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 20.9 t -89.45 112.04 23.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.938 0.399 . . . . 0.0 110.238 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 30.1 mt -91.51 24.86 2.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.638 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -53.48 -47.37 69.85 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.677 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -73.33 -5.35 39.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.502 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -97.41 -16.13 20.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.102 0.477 . . . . 0.0 110.14 176.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 97.9 mttt -72.94 147.98 44.75 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.877 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.896 ' HB3' ' HG3' ' A' ' 11' ' ' ARG . . . -109.36 166.93 10.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.191 -170.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 . . . . . 0 C--O 1.251 1.164 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.958 -179.868 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.236 0.39 0 CA-C-O 121.264 0.554 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 5' ' ' SER . 66.6 mttm -113.64 134.19 54.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.624 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 25.1 t 69.75 160.12 0.19 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.722 0.639 . . . . 0.0 111.101 -175.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -148.59 -179.82 7.26 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 110.737 178.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.461 HD11 ' HB3' ' A' ' 16' ' ' LYS . 2.6 tm? -103.72 108.18 19.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.507 -175.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.6 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 43.1 m95 -93.22 145.46 24.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.046 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.24 148.5 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -86.66 177.32 7.39 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.187 176.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.839 ' HG2' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -55.11 -44.87 75.35 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.637 ' N ' ' HD3' ' A' ' 11' ' ' ARG . 64.6 p -85.4 -28.97 24.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.017 0.437 . . . . 0.0 111.436 -173.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.11 20.3 30.92 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.467 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.6 m -78.24 -37.48 45.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.783 0.325 . . . . 0.0 110.297 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.42 ' HZ ' ' HD3' ' A' ' 45' ' ' LYS . 42.0 p90 -132.87 133.56 43.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.84 0.828 . . . . 0.0 112.376 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HB3' HD11 ' A' ' 7' ' ' LEU . 21.7 mtmm -123.11 143.89 49.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.608 175.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.639 HG12 ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -137.66 135.85 46.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.674 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 10.3 p-10 -85.89 105.36 16.32 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.486 173.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.792 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -156.21 162.43 40.18 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.329 -171.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.624 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -119.1 139.47 51.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.857 172.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.805 ' HD2' HG23 ' A' ' 29' ' ' ILE . 33.6 t80 -68.56 132.22 46.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -113.76 -48.89 5.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.19 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.08 157.59 29.15 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.0 p -116.87 140.87 48.94 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 28' ' ' LYS . . . -135.02 105.59 6.43 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.172 -174.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? 59.12 41.86 19.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.923 0.868 . . . . 0.0 109.573 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.71 -19.18 52.87 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.978 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 42' ' ' ALA . 3.6 ptpp? -89.18 163.72 15.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.406 0.603 . . . . 0.0 110.423 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.805 HG23 ' HD2' ' A' ' 21' ' ' PHE . 57.8 mt -115.39 126.8 73.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.12 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.459 ' O ' HG13 ' A' ' 22' ' ' ILE . 91.4 m-70 -86.16 127.27 34.69 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 169.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.792 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 95.8 mt -125.63 137.8 53.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.91 -176.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -106.3 110.05 22.17 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.271 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.674 ' HE2' ' O ' ' A' ' 18' ' ' ASP . 11.8 mmmm -58.05 151.81 17.91 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 123.696 0.623 . . . . 0.0 109.901 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.65 -16.06 63.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.623 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -89.82 -7.13 55.03 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.153 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.45 -23.41 12.33 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.718 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 t -67.44 145.78 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 117.001 0.4 . . . . 0.0 110.88 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -112.37 130.27 56.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.821 0.343 . . . . 0.0 110.196 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.429 HD13 ' HD3' ' A' ' 33' ' ' LYS . 20.8 pt -126.1 165.68 23.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.385 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.58 124.46 40.0 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.59 HG13 ' HE3' ' A' ' 45' ' ' LYS . 70.4 t -130.4 120.58 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.402 -175.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . . . -66.06 129.27 39.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.2 -18.27 63.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.626 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.726 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 2.9 p30 -72.72 -25.64 61.3 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.094 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.59 ' HE3' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.43 29.03 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.751 0.786 . . . . 0.0 110.051 176.413 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.5 tp -108.77 174.5 5.84 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.197 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.559 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 47.6 t -80.21 138.01 36.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.925 0.869 . . . . 0.0 110.766 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -51.2 -41.23 60.1 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.756 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.7 -45.27 87.32 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.132 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.6 ' OD2' ' HA ' ' A' ' 8' ' ' TRP . 3.9 m-20 -60.24 -36.83 78.63 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.166 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.784 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -67.18 -42.72 83.74 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 120.597 -0.441 . . . . 0.0 109.918 176.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -60.97 -29.65 69.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.486 0.66 . . . . 0.0 110.237 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -73.85 -51.32 16.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.169 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.833 ' HA ' HG12 ' A' ' 57' ' ' ILE . 3.6 p -69.63 -25.7 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.143 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.784 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.0 mt-10 -50.34 -44.38 54.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.101 0.476 . . . . 0.0 109.733 167.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 52' ' ' ALA . 1.1 mpmm? -72.76 -34.55 67.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.492 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.833 HG12 ' HA ' ' A' ' 54' ' ' VAL . 4.9 mm -68.78 -34.15 63.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.067 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.732 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 37.6 p -99.31 -48.1 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -171.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.56 -0.76 34.5 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -171.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.732 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 87.3 m-85 -102.04 141.13 35.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.439 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 17.7 t -88.2 111.7 21.92 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.695 HD12 HG13 ' A' ' 54' ' ' VAL . 50.9 mt -90.3 24.44 2.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.174 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -57.78 -40.97 81.06 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.002 0.43 . . . . 0.0 110.504 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' NZ ' ' HB2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -71.35 -5.79 35.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.254 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.726 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 96.4 m-85 -108.68 -4.33 17.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.307 177.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.641 ' HG2' HD23 ' A' ' 51' ' ' LEU . 98.8 mttt -86.01 143.31 28.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.038 -176.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 67.0 86.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 O-C-N 124.221 0.951 . . . . 0.0 111.558 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.839 ' HB3' ' HG2' ' A' ' 11' ' ' ARG . 27.7 t-20 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.354 -0.832 . . . . 0.0 109.517 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.622 ' HE3' ' O ' ' A' ' 5' ' ' SER . 51.6 tptt . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 121.243 0.545 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 4' ' ' LYS . 22.1 mtpp -81.42 153.84 26.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 169.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.837 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 12.1 t 67.91 156.54 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.848 0.717 . . . . 0.0 109.701 -170.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -152.72 174.14 14.39 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.82 -0.55 . . . . 0.0 111.555 -177.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.8 tm? -94.75 104.58 16.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.182 -174.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.603 ' HA ' ' OD2' ' A' ' 50' ' ' ASP . 63.2 m95 -92.88 143.94 25.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.086 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.496 HG22 ' HG2' ' A' ' 16' ' ' LYS . 45.3 t -128.73 143.35 41.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HA ' HD12 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -89.31 160.13 17.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 8.1 tmm_? -70.64 -20.76 62.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.586 -170.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 t -82.28 -12.78 57.81 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.245 0.545 . . . . 0.0 109.781 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.4 30.8 61.91 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.915 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.6 m -93.9 -44.4 8.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.413 0.149 . . . . 0.0 110.975 -176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 10' ' ' ASP . 34.8 p90 -127.17 131.74 50.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.912 0.863 . . . . 0.0 112.932 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.718 ' HB3' HD11 ' A' ' 7' ' ' LEU . 86.9 mttt -116.48 130.73 56.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.674 170.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.45 144.66 27.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.623 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 17.9 t70 -94.46 115.07 27.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.196 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.656 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -161.07 162.56 31.67 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.914 -172.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.837 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 5.5 mm-40 -107.94 137.97 45.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.246 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.887 ' HD1' HG23 ' A' ' 29' ' ' ILE . 4.4 t80 -78.95 120.09 23.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.83 HD12 ' HE3' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -105.41 -42.01 6.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.711 -174.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.73 142.15 7.56 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.848 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.526 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 27.5 p -104.73 125.53 50.9 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.24 115.54 20.56 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.117 -172.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 65.67 -76.29 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.112 0.883 . . . . 0.0 111.085 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.49 18.32 1.49 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.949 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -125.77 166.52 16.66 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.472 0.653 . . . . 0.0 111.503 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.887 HG23 ' HD1' ' A' ' 21' ' ' PHE . 67.4 mt -117.24 126.49 74.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.828 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.467 ' O ' HG13 ' A' ' 22' ' ' ILE . 25.2 m170 -91.29 127.42 36.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.656 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.5 mm? -121.0 140.64 51.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.481 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -104.29 101.33 11.05 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 169.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.604 ' HD2' HD13 ' A' ' 39' ' ' ILE . 44.0 mtpt -68.21 154.67 41.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.165 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.73 -14.05 57.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.551 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.641 ' OD1' HG12 ' A' ' 37' ' ' VAL . 43.2 p30 -80.84 -18.93 45.8 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.935 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.65 -21.11 9.22 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.521 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.641 HG12 ' OD1' ' A' ' 35' ' ' ASN . 9.9 p -85.16 150.75 3.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.276 0.56 . . . . 0.0 111.238 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.83 ' HE3' HD12 ' A' ' 22' ' ' ILE . 85.4 tttt -107.24 125.92 51.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.557 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.604 HD13 ' HD2' ' A' ' 33' ' ' LYS . 16.4 pt -122.07 169.99 12.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.279 -173.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.03 103.68 6.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.607 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.517 HG11 HD13 ' A' ' 46' ' ' LEU . 67.8 t -101.82 122.81 54.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB1' ' OD1' ' A' ' 44' ' ' ASP . . . -60.45 129.57 42.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.259 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -72.4 -6.38 43.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.01 0.433 . . . . 0.0 111.835 -172.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.44 ' OD1' ' HB1' ' A' ' 42' ' ' ALA . 8.6 p-10 -98.14 -20.23 17.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.823 -173.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HE2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -102.82 6.03 39.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.782 0.801 . . . . 0.0 109.78 176.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 10' ' ' ASP . 13.1 tp -91.62 170.39 9.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.299 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.626 ' O ' HD22 ' A' ' 51' ' ' LEU . 40.7 t -75.65 135.35 40.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.694 0.759 . . . . 0.0 110.444 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.444 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 19.3 m-20 -60.03 -32.15 70.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.949 -174.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.89 -43.78 97.88 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.664 0.745 . . . . 0.0 109.845 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.615 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.0 m-20 -64.75 -37.92 89.23 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.444 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.767 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -67.73 -39.8 84.25 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.667 177.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.654 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -60.25 -32.13 70.86 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.458 0.647 . . . . 0.0 109.978 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.746 ' CE2' HD11 ' A' ' 57' ' ' ILE . 80.6 t80 -72.21 -48.41 43.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.523 176.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -68.94 -26.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 121.757 -0.589 . . . . 0.0 111.241 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.767 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 48.2 mt-10 -51.3 -38.33 52.33 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.139 0.495 . . . . 0.0 109.764 166.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.559 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -73.56 -43.65 59.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.042 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.746 HD11 ' CE2' ' A' ' 53' ' ' TYR . 35.9 mt -57.58 -37.96 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.023 0.44 . . . . 0.0 111.193 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 35.1 p -98.66 -47.1 5.46 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -170.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.76 -3.77 39.2 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -171.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -92.09 172.84 8.17 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.7 t -117.94 128.01 54.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.172 0.51 . . . . 0.0 109.918 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 33.3 mt -106.22 19.76 20.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.941 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -53.17 -42.71 66.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.189 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -59.14 -23.62 62.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.5 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.408 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 79.2 m-85 -97.25 -12.78 22.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.668 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 97.3 mttt -76.71 140.15 40.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.428 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.71 108.28 19.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.908 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.438 177.323 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm . . . . . 0 C--O 1.234 0.277 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.621 ' HE3' ' HG3' ' A' ' 20' ' ' GLU . 31.9 mmmt 69.46 158.42 0.17 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.89 0.744 . . . . 0.0 111.077 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.926 ' H ' ' HG2' ' A' ' 20' ' ' GLU . 40.1 t 63.13 112.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 122.052 0.929 . . . . 0.0 110.958 -174.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 13.8 ptp180 -126.12 177.36 6.42 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.447 -171.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.709 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.9 tm? -89.39 119.11 29.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.882 0.372 . . . . 0.0 111.325 -171.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.568 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 41.9 m95 -108.5 148.04 30.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.953 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.534 ' CG1' ' HA2' ' A' ' 13' ' ' GLY . 39.2 t -129.88 143.41 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 123.026 0.204 . . . . 0.0 110.456 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.66 ' HA ' HD12 ' A' ' 46' ' ' LEU . 1.7 p-10 -86.05 -179.47 6.77 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.9 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -52.94 -44.87 67.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.603 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 m -88.1 -20.53 25.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.039 0.447 . . . . 0.0 111.069 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.534 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . 86.81 14.58 64.83 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.629 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 m -74.49 -38.68 62.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.774 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 49.2 p90 -120.21 121.54 38.97 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 122.062 0.934 . . . . 0.0 111.846 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.709 ' HB3' HD11 ' A' ' 7' ' ' LEU . 49.5 mttp -112.41 130.95 55.8 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.005 -1.452 . . . . 0.0 107.611 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.5 146.09 28.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.183 0.516 . . . . 0.0 112.142 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.3 p30 -86.14 124.05 32.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.001 172.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -169.52 156.81 6.87 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.632 -175.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.926 ' HG2' ' H ' ' A' ' 5' ' ' SER . 0.4 OUTLIER -112.05 139.9 47.18 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.538 172.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.739 ' HE2' ' HB3' ' A' ' 24' ' ' CYS . 28.7 t80 -68.49 133.67 48.95 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.273 176.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -120.94 -48.93 3.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.462 178.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 30' ' ' HIS . . . -148.25 144.41 12.28 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 30.8 p -123.16 115.18 21.36 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.506 -0.408 . . . . 0.0 109.974 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.78 146.02 22.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 58.24 34.48 24.14 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.625 0.578 . . . . 0.0 111.26 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.89 17.01 64.74 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.401 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 39.4 mmtm -114.74 153.69 29.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.913 0.387 . . . . 0.0 110.039 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.555 HG23 ' HD2' ' A' ' 21' ' ' PHE . 79.0 mt -114.1 113.06 42.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.035 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.528 ' O ' HG13 ' A' ' 22' ' ' ILE . 15.2 m-70 -75.48 119.87 20.14 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.021 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.64 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 91.3 mt -124.57 140.25 53.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.171 0.51 . . . . 0.0 111.498 -172.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.5 ' NE2' ' HA2' ' A' ' 36' ' ' GLY . 17.7 t-80 -108.94 98.58 8.04 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.36 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.597 ' HD2' ' HB2' ' A' ' 19' ' ' ALA . 1.7 mmmp? -57.69 167.09 1.17 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.852 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.19 -28.16 69.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.498 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -86.06 10.35 14.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.5 ' HA2' ' NE2' ' A' ' 32' ' ' HIS . . . 73.89 27.44 66.78 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.465 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.45 137.95 25.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 66.8 mttt -99.47 124.39 44.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.074 0.464 . . . . 0.0 111.383 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.1 pt -126.97 146.4 32.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.126 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.09 103.29 14.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.4 ' CG1' HD13 ' A' ' 46' ' ' LEU . 71.1 t -103.22 110.99 31.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -56.99 127.48 32.12 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.576 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.36 -8.0 29.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.069 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' OD2' ' HB1' ' A' ' 42' ' ' ALA . 2.8 p30 -95.59 -10.38 29.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.55 ' HD2' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -120.61 17.58 12.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.012 0.911 . . . . 0.0 108.806 171.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.66 HD12 ' HA ' ' A' ' 10' ' ' ASP . 13.7 tp -97.6 166.68 11.39 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.177 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.602 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 47.3 t -74.33 137.31 42.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.636 0.732 . . . . 0.0 110.693 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -58.07 -29.41 65.4 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.744 -177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.49 -50.68 72.6 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.7 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.602 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 3.8 m-20 -61.67 -36.82 81.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.83 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.773 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -68.79 -41.15 79.15 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.55 177.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.557 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -64.65 -28.63 69.74 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.544 0.688 . . . . 0.0 109.611 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.777 ' CE2' HD11 ' A' ' 57' ' ' ILE . 16.7 t80 -73.28 -48.02 38.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.49 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.654 HG13 HD23 ' A' ' 62' ' ' LEU . 3.0 p -68.48 -26.68 34.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 121.761 -0.587 . . . . 0.0 110.949 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.773 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.2 mt-10 -52.03 -35.25 46.37 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.11 0.481 . . . . 0.0 110.059 167.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 1.7 tptt -73.2 -50.29 23.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.161 176.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.777 HD11 ' CE2' ' A' ' 53' ' ' TYR . 51.1 mt -49.98 -46.34 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.126 0.489 . . . . 0.0 111.811 -177.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.406 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 34.2 p -105.08 -46.83 4.16 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -170.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.87 -6.7 27.55 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 90.3 m-85 -83.17 141.24 32.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.0 t -90.36 108.74 19.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.043 0.449 . . . . 0.0 110.037 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.737 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 2.6 mm? -87.1 19.41 3.12 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.403 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -53.82 -43.74 69.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.387 0.675 . . . . 0.0 110.756 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -67.44 -12.62 60.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.806 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 44' ' ' ASP . 72.1 m-85 -108.99 -0.99 19.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.723 0.297 . . . . 0.0 110.776 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 98.9 mttt -76.83 142.09 40.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.81 54.19 2.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -166.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.66 174.01 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.5 tttm . . . . . 0 C--O 1.235 0.334 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -144.48 139.66 28.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.808 -171.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.8 t -54.7 118.88 4.59 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.007 0.817 . . . . 0.0 110.128 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 18.6 ptp180 -137.0 -179.13 5.52 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.66 -173.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.91 110.82 21.41 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.139 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.524 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 41.1 m95 -91.93 138.07 31.85 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.7 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 10' ' ' ASP . 58.9 t -129.41 142.54 43.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -74.48 159.43 32.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.616 0.722 . . . . 0.0 110.699 172.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.429 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -64.22 -21.36 66.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.403 -172.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.4 m -113.72 6.72 16.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.969 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.38 24.51 72.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.468 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 m -68.82 -40.11 79.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.615 0.245 . . . . 0.0 111.572 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.484 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 5.6 p90 -137.29 142.81 41.93 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.163 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 45.4 mttp -137.56 131.03 31.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.475 HG11 ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -148.51 146.31 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-O 120.912 0.386 . . . . 0.0 111.431 177.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.5 m-20 -83.32 121.51 27.22 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.16 171.94 17.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.237 0.542 . . . . 0.0 111.71 -173.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.93 142.59 51.21 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.62 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.617 ' HA ' HD12 ' A' ' 31' ' ' LEU . 64.6 t80 -77.67 132.23 38.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.104 0.478 . . . . 0.0 110.354 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -112.02 -51.1 5.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.52 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.11 145.94 11.14 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.217 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.569 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 27.0 t -123.8 130.8 53.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.828 0.347 . . . . 0.0 110.493 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.15 143.79 21.63 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 -177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 60.02 29.13 18.72 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.783 0.677 . . . . 0.0 111.601 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.06 1.16 89.82 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.498 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -106.73 161.0 15.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.964 0.412 . . . . 0.0 110.47 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.606 HG22 HD13 ' A' ' 31' ' ' LEU . 94.1 mt -123.11 123.49 68.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.531 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.409 ' O ' HG13 ' A' ' 22' ' ' ILE . 90.0 m-70 -87.76 128.09 35.32 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.617 HD12 ' HA ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -124.03 148.42 47.04 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.665 -176.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -110.91 100.14 8.92 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.208 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.764 ' HD2' HD13 ' A' ' 39' ' ' ILE . 59.5 mtpt -71.94 152.0 42.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.784 -173.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.25 -12.0 46.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.99 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.42 -20.6 62.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.087 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.14 0.99 44.77 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.122 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.45 141.46 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.831 0.348 . . . . 0.0 111.207 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -98.26 128.03 44.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.967 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.764 HD13 ' HD2' ' A' ' 33' ' ' LYS . 49.0 pt -127.4 169.28 19.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.111 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.3 109.32 8.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.951 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.628 ' HB ' ' HE3' ' A' ' 45' ' ' LYS . 32.8 m -110.19 147.45 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.9 129.12 37.43 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.78 -16.17 47.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.466 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 4.7 p-10 -74.27 -23.2 59.09 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -173.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.628 ' HE3' ' HB ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.54 38.37 1.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.903 0.858 . . . . 0.0 110.163 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.485 HD22 HD12 ' A' ' 29' ' ' ILE . 6.0 mp -115.76 161.63 18.45 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.121 176.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.595 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 43.8 t -74.29 140.46 44.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.754 0.788 . . . . 0.0 110.047 176.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -49.86 -34.32 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.267 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -59.22 -51.33 70.44 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.599 0.714 . . . . 0.0 109.981 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.634 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.1 m-20 -60.37 -38.24 83.26 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.422 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.802 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.5 OUTLIER -70.3 -43.85 69.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.363 179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.63 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -58.96 -30.27 67.79 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.551 0.691 . . . . 0.0 110.375 -178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.401 ' O ' HG12 ' A' ' 57' ' ' ILE . 51.6 t80 -73.75 -50.64 19.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.325 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.762 ' HA ' HG12 ' A' ' 57' ' ' ILE . 2.2 p -69.94 -29.1 39.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.401 -176.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.802 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 47.4 mt-10 -51.61 -40.05 59.14 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.193 0.521 . . . . 0.0 109.914 169.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.893 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -78.38 -31.65 48.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.873 -176.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.762 HG12 ' HA ' ' A' ' 54' ' ' VAL . 10.9 mm -66.3 -35.82 75.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.031 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.4 p -107.88 -47.35 3.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -170.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.47 -31.85 4.28 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.389 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.467 ' HZ ' ' HB3' ' A' ' 24' ' ' CYS . 14.9 p90 -87.28 152.64 22.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.177 0.488 . . . . 0.0 110.842 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.451 ' OG ' ' HG2' ' A' ' 63' ' ' GLU . 7.7 t -92.37 140.97 29.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.708 -172.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 35.3 mt -115.94 31.42 6.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.86 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.451 ' HG2' ' OG ' ' A' ' 61' ' ' SER . 18.5 mm-40 -53.13 -40.69 64.42 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.666 174.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -62.78 -15.2 52.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.971 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.466 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 36.9 m-85 -106.96 -7.32 17.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.245 0.545 . . . . 0.0 110.545 -177.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.56 149.8 24.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.221 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -106.63 113.75 27.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.672 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 t30 . . . . . 0 C--O 1.251 1.146 0 O-C-N 123.78 0.675 . . . . 0.0 111.054 177.537 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.609 ' HA ' ' NH2' ' A' ' 6' ' ' ARG . 62.4 tttm . . . . . 0 C--O 1.23 0.065 0 CA-C-O 121.768 0.794 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 16.7 ptpt -97.79 179.88 4.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.668 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.7 t -63.07 125.46 24.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.164 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 12.0 ptp180 -131.44 -179.9 5.64 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.107 -170.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -95.06 106.22 18.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.814 -171.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -92.18 141.77 28.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.474 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 10' ' ' ASP . 96.5 t -132.88 136.84 55.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.989 0.423 . . . . 0.0 111.442 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.14 153.42 41.66 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.601 0.715 . . . . 0.0 110.379 171.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 6.3 tmm_? -63.66 -28.66 70.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.853 -169.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -93.39 -6.74 46.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.115 0.483 . . . . 0.0 110.687 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.08 20.85 60.07 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.933 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.5 m -69.03 -45.37 70.63 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.569 0.347 . . . . 0.0 111.662 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -137.92 143.85 41.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.182 0.515 . . . . 0.0 110.832 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.832 ' HB3' HD11 ' A' ' 7' ' ' LEU . 54.4 mttm -133.4 130.88 39.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.601 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.66 152.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.258 0.551 . . . . 0.0 111.88 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.619 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.1 p30 -90.36 130.46 36.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.295 173.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.96 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -171.38 157.39 4.9 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.18 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -117.49 140.41 49.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.734 ' HD1' HG23 ' A' ' 29' ' ' ILE . 42.7 t80 -72.01 130.69 41.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.378 0.609 . . . . 0.0 110.721 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -112.53 -49.73 5.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.237 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.29 148.7 14.44 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.59 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 27.9 t -118.41 134.41 55.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.954 0.377 . . . . 0.0 110.172 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.98 140.33 29.56 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.775 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 62.68 -78.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.099 0.874 . . . . 0.0 111.282 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -155.63 12.45 0.4 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.75 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 47.6 mttm -115.51 160.29 20.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.101 0.476 . . . . 0.0 110.925 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.734 HG23 ' HD1' ' A' ' 21' ' ' PHE . 2.2 mp -112.8 124.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.614 174.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.444 ' O ' HG13 ' A' ' 22' ' ' ILE . 79.0 m-70 -80.32 130.86 35.48 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.96 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 97.6 mt -130.16 140.51 50.76 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.686 -174.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -111.93 110.54 20.92 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.555 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 5.1 mtpm? -69.76 170.5 10.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.042 -174.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.42 -20.5 60.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.815 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.482 ' HB2' HG23 ' A' ' 37' ' ' VAL . 7.8 m120 -79.87 -7.72 58.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.137 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.92 0.27 75.04 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.92 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 35' ' ' ASN . 43.0 t -75.29 136.65 24.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -100.41 117.21 34.12 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.535 HG13 ' HB2' ' A' ' 31' ' ' LEU . 40.4 pt -119.63 172.1 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.0 110.64 4.02 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 m -112.13 129.39 67.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.879 0.371 . . . . 0.0 110.509 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.75 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -61.51 130.61 46.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.068 0.461 . . . . 0.0 110.181 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . . . -54.88 -26.17 33.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.165 -173.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.46 -10.64 59.76 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.554 ' HD3' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -101.19 17.72 21.77 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.697 178.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 88.8 mt -115.05 -174.8 2.56 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.246 1.022 . . . . 0.0 111.813 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.601 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 34.9 t -97.25 143.71 27.76 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.285 -1.78 . . . . 0.0 108.942 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -60.05 -24.18 64.34 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.918 -174.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -62.76 -47.32 84.04 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.964 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.601 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 3.8 m-20 -64.19 -38.52 91.35 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.441 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.659 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.8 OUTLIER -70.66 -38.33 73.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.952 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.485 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -68.03 -27.23 66.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.303 0.573 . . . . 0.0 109.968 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.593 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 32.5 t80 -74.04 -49.95 21.91 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.198 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 50' ' ' ASP . 3.4 p -70.55 -32.04 48.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.018 0.437 . . . . 0.0 111.085 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.917 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 1.7 pt-20 -68.45 -23.51 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.302 0.572 . . . . 0.0 110.031 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 1.1 ttpp -72.79 -40.44 65.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.593 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 54.2 mt -63.08 -44.69 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.013 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.2 p -78.37 -43.99 26.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.289 -172.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.94 2.05 28.51 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.485 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 64.0 m-85 -104.83 -166.19 1.21 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 t -130.99 132.43 45.01 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.917 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 9.7 mt -103.68 29.7 5.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.387 0.613 . . . . 0.0 109.381 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.482 ' OE2' ' HD2' ' A' ' 66' ' ' LYS . 6.2 tp10 -45.0 -48.84 11.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.033 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -65.34 -17.53 64.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -100.8 -4.83 27.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.496 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.482 ' HD2' ' OE2' ' A' ' 63' ' ' GLU . 97.8 mttt -77.47 104.82 8.22 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.697 0.761 . . . . 0.0 110.836 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.09 107.95 16.03 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.26 175.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.528 -176.552 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HB3' ' HE2' ' A' ' 3' ' ' LYS . 51.3 mtpt . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.737 0.303 . . . . 0.0 111.371 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 167.77 12.5 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 171.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.683 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 33.0 p 51.51 97.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 122.356 1.074 . . . . 0.0 111.45 -176.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 10.9 ptp180 -107.98 179.13 4.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.588 -166.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.769 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.9 tm? -88.9 108.95 19.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.852 -173.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.514 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 37.7 m95 -97.54 153.72 17.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.18 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.431 HG13 ' HG2' ' A' ' 16' ' ' LYS . 23.5 t -133.68 146.79 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.59 ' HA ' HD12 ' A' ' 46' ' ' LEU . 7.8 p-10 -84.24 178.82 7.64 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.143 172.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.509 ' HD2' ' O ' ' A' ' 11' ' ' ARG . 2.1 tmm_? -81.32 -23.58 37.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 110.947 -174.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.9 t -89.91 -29.31 18.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.875 0.369 . . . . 0.0 110.679 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.89 21.18 19.21 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -76.79 -40.97 46.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.346 -0.427 . . . . 0.0 110.966 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.582 ' HZ ' ' HE3' ' A' ' 45' ' ' LYS . 33.0 p90 -142.2 131.01 22.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.908 0.861 . . . . 0.0 113.157 -174.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.769 ' HB3' HD11 ' A' ' 7' ' ' LEU . 36.0 mtmm -118.86 130.45 55.75 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.252 169.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.38 153.18 21.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.41 0.624 . . . . 0.0 112.371 -173.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.4 p30 -90.36 129.03 36.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.61 174.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -178.7 159.54 1.11 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.946 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.683 ' HG2' ' HA ' ' A' ' 5' ' ' SER . 3.8 mm-40 -110.61 144.26 39.77 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 121.251 0.548 . . . . 0.0 110.017 169.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.906 ' HD1' HG23 ' A' ' 29' ' ' ILE . 3.7 t80 -74.9 120.67 20.75 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.339 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.83 -52.77 8.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.079 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.3 141.87 7.76 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.759 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 24.6 p -101.0 144.04 30.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.39 109.16 4.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.186 -0.206 . . . . 0.0 111.159 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? 53.43 52.28 13.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.103 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.81 -7.01 71.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.124 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -101.44 161.06 13.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.26 0.53 . . . . 0.0 111.283 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.906 HG23 ' HD1' ' A' ' 21' ' ' PHE . 78.0 mt -123.03 120.79 61.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.248 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -87.82 131.7 34.44 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.794 HD23 ' HA ' ' A' ' 21' ' ' PHE . 85.7 mt -129.31 138.99 51.91 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.27 0.557 . . . . 0.0 111.284 -170.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -105.81 104.41 14.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.185 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.621 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 6.3 mtpm? -66.09 169.03 7.46 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.55 -18.66 62.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.301 -176.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -103.86 14.75 30.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.611 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.9 -16.43 59.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.633 171.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.434 ' HB ' ' HD3' ' A' ' 33' ' ' LYS . 60.7 t -65.43 139.18 21.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.708 0.289 . . . . 0.0 110.654 -178.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -104.31 124.19 48.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.521 HG13 ' HB2' ' A' ' 31' ' ' LEU . 39.1 pt -125.68 160.34 32.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.795 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.49 121.61 23.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.159 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -119.3 148.33 22.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.482 ' HB1' ' OD2' ' A' ' 44' ' ' ASP . . . -78.85 123.73 27.51 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.82 -19.66 65.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.566 0.698 . . . . 0.0 111.123 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.816 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 3.7 p30 -74.53 -14.28 60.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.274 -176.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.582 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -117.12 18.31 14.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.997 0.903 . . . . 0.0 109.201 174.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.59 HD12 ' HA ' ' A' ' 10' ' ' ASP . 12.8 tp -100.21 167.79 10.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.434 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.8 t -67.11 137.83 56.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.426 0.632 . . . . 0.0 111.054 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.485 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 53.1 m-20 -58.66 -36.72 74.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.81 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -65.29 -46.04 82.0 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.658 0.742 . . . . 0.0 109.713 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.547 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.5 m-20 -61.78 -36.46 81.11 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.91 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.757 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -66.32 -45.72 79.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.852 176.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.578 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -61.86 -29.24 70.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.46 0.648 . . . . 0.0 110.449 -176.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.638 ' CE2' HD11 ' A' ' 57' ' ' ILE . 29.2 t80 -74.01 -49.93 22.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.232 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 50' ' ' ASP . 4.1 p -70.51 -26.58 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.894 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.757 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 41.9 mt-10 -51.45 -40.16 58.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.189 0.519 . . . . 0.0 109.872 167.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.623 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -75.78 -36.25 59.86 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.113 -176.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.638 HD11 ' CE2' ' A' ' 53' ' ' TYR . 29.8 mt -64.45 -40.23 88.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.992 175.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.698 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 36.6 p -91.02 -47.43 7.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -169.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.3 -4.73 51.74 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 -170.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.698 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 79.9 m-85 -95.58 162.24 13.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.9 t -110.79 117.08 32.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.219 0.533 . . . . 0.0 110.762 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.613 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 29.5 mt -91.67 17.53 8.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.58 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.813 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -56.61 -41.02 76.34 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.213 178.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -60.25 -20.33 58.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.812 178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.816 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 53.4 m-85 -99.17 -16.72 18.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.843 0.354 . . . . 0.0 110.341 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.813 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 9.4 mtpm? -75.63 143.96 41.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.705 -176.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -94.25 7.59 44.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.548 0.69 . . . . 0.0 110.752 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.513 ' C ' HD22 ' A' ' 68' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.923 0 CA-C-N 114.766 -1.107 . . . . 0.0 108.598 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.445 0.641 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.65 150.61 39.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.303 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 1.063 ' H ' ' HG2' ' A' ' 20' ' ' GLU . 38.1 t 59.58 99.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 122.204 1.002 . . . . 0.0 110.987 -176.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 9.7 ptp180 -118.25 175.15 5.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.321 -1.308 . . . . 0.0 110.816 -170.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.706 HD11 ' HB2' ' A' ' 16' ' ' LYS . 1.3 tm? -83.62 117.12 22.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.943 -174.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.602 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 69.1 m95 -108.9 145.0 36.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.139 175.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 16' ' ' LYS . 88.8 t -131.59 138.43 52.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.22 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.705 ' HA ' HD12 ' A' ' 46' ' ' LEU . 6.4 p-10 -84.92 168.86 14.63 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.598 175.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.647 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 4.6 tpm_? -67.08 -35.22 79.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.514 0.197 . . . . 0.0 111.417 -174.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 m -79.16 -12.26 59.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.97 0.414 . . . . 0.0 111.209 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.5 17.63 75.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.506 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -66.69 -47.73 71.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.994 -0.603 . . . . 0.0 110.656 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 10' ' ' ASP . 16.4 p90 -138.57 132.64 31.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.7 0.762 . . . . 0.0 112.627 -174.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.706 ' HB2' HD11 ' A' ' 7' ' ' LEU . 20.6 ptmt -120.83 129.67 53.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.225 166.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.808 ' HB ' ' HE2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -148.9 159.12 6.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.225 0.536 . . . . 0.0 112.016 -172.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.59 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.5 OUTLIER -93.54 122.83 36.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.478 177.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.716 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -162.07 156.36 21.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.589 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 1.063 ' HG2' ' H ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -109.34 138.89 45.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.014 174.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.64 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 50.7 t80 -67.93 133.15 48.62 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.026 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -116.25 -50.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.158 179.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.16 153.7 24.78 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.465 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.64 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 29.2 t -129.09 130.05 46.0 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.43 134.44 21.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.486 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 63.11 15.53 8.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.236 0.541 . . . . 0.0 111.196 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.23 2.08 71.41 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.272 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 61.4 mttp -93.89 146.79 23.65 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.536 -0.39 . . . . 0.0 110.365 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.556 HD11 ' HB2' ' A' ' 43' ' ' ALA . 17.5 mm -105.09 119.42 54.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.539 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.457 ' O ' HG13 ' A' ' 22' ' ' ILE . 24.1 m170 -89.7 125.53 35.3 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.716 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 92.5 mt -128.74 139.15 52.35 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.23 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -102.18 106.64 17.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.56 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.808 ' HE2' ' HB ' ' A' ' 17' ' ' VAL . 2.5 mmmp? -64.36 152.09 42.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.174 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.12 -13.78 62.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.429 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 6.9 p-10 -98.01 12.63 33.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.894 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.06 -30.8 9.37 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.861 -0.685 . . . . 0.0 114.198 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.94 139.44 21.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.899 0.381 . . . . 0.0 111.795 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.97 122.68 45.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.0 161.75 19.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.928 -176.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.29 106.06 6.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.677 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.7 m -108.38 146.16 14.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -76.1 122.62 24.55 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.608 176.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.703 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -64.45 -21.47 66.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.581 0.705 . . . . 0.0 109.836 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 12.9 t70 -50.63 -32.95 20.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.341 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 26.54 9.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.238 0.542 . . . . 0.0 110.93 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.705 HD12 ' HA ' ' A' ' 10' ' ' ASP . 8.6 tp -100.1 173.53 6.59 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.319 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.644 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 19.8 m -79.98 133.85 36.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.613 0.721 . . . . 0.0 110.475 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -55.04 -35.15 64.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.917 -172.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.4 -44.38 83.17 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.338 0.589 . . . . 0.0 109.733 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.644 ' OD1' ' HB2' ' A' ' 47' ' ' SER . 1.4 m-20 -57.77 -40.62 80.2 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.764 175.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.82 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -68.94 -39.54 79.52 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.408 178.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.684 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -59.31 -32.49 70.12 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.434 0.635 . . . . 0.0 109.885 -177.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.75 ' CE2' HD11 ' A' ' 57' ' ' ILE . 49.5 t80 -74.2 -49.61 22.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.551 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 50' ' ' ASP . 1.7 p -68.81 -28.07 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.205 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.82 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 46.9 mt-10 -52.18 -39.85 60.67 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.071 0.462 . . . . 0.0 110.061 167.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.622 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 9.4 mmpt? -78.08 -28.36 48.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.75 HD11 ' CE2' ' A' ' 53' ' ' TYR . 40.9 mt -67.88 -42.97 86.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.145 0.498 . . . . 0.0 110.712 173.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.5 p -90.84 -47.53 7.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.493 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.87 -19.7 15.47 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.893 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -107.04 151.24 25.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.954 0.407 . . . . 0.0 110.203 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -82.86 136.85 34.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.704 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.622 HD12 HG13 ' A' ' 54' ' ' VAL . 23.4 mt -107.0 20.16 19.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.847 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.408 ' OE2' ' HD2' ' A' ' 66' ' ' LYS . 4.0 tp10 -55.33 -44.38 75.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.967 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -14.45 61.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.238 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' ASP . 62.6 m-85 -105.13 -0.43 26.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.621 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 99.2 mttt -87.38 -175.78 5.38 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.375 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.44 99.91 0.33 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.884 0.373 . . . . 0.0 110.866 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.251 -0.881 . . . . 0.0 109.653 179.342 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' NZ ' ' HB2' ' A' ' 3' ' ' LYS . 8.6 mtmp? . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.545 0.212 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 66.35 107.63 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.652 0.739 . . . . 0.0 112.105 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.28 123.2 12.15 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.579 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 16.3 ptp180 -126.64 -178.66 4.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.975 -171.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.709 HD11 ' HB3' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -88.76 105.59 17.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.378 -168.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.481 ' HH2' ' HB ' ' A' ' 54' ' ' VAL . 47.2 m95 -94.46 139.71 30.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.72 176.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 10' ' ' ASP . 72.9 t -129.78 141.99 45.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.974 0.416 . . . . 0.0 111.71 -175.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.639 ' O ' HG12 ' A' ' 9' ' ' VAL . 9.8 t70 -70.58 157.47 37.86 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.856 ' HG2' ' HB3' ' A' ' 67' ' ' ALA . 7.0 tpm_? -79.41 -25.86 42.01 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -174.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 p -99.68 7.22 45.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.046 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.77 68.34 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.72 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.598 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 31.8 m -68.27 -40.14 81.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.69 0.281 . . . . 0.0 111.257 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -150.81 150.21 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.144 0.497 . . . . 0.0 111.703 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.709 ' HB3' HD11 ' A' ' 7' ' ' LEU . 94.2 mttt -132.45 132.25 42.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.768 171.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.08 145.51 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.0 0.429 . . . . 0.0 111.807 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 5.9 p-10 -93.6 112.11 23.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.884 0.849 . . . . 0.0 110.133 174.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.433 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . . . -160.28 168.87 24.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.093 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.04 139.91 53.03 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.781 ' HA ' HD23 ' A' ' 31' ' ' LEU . 3.4 t80 -71.6 128.0 34.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.697 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -107.0 -46.91 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.608 -178.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 30' ' ' HIS . . . -153.79 153.54 24.9 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.598 -177.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.2 p -112.89 134.12 54.55 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.08 97.41 5.09 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.593 -173.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 57.56 23.71 9.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.231 173.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.59 -7.55 24.28 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.363 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 61.4 mttp -94.0 160.23 14.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.016 0.436 . . . . 0.0 110.925 175.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.929 HD11 ' HB2' ' A' ' 43' ' ' ALA . 10.7 mm -113.79 115.79 50.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.72 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -87.52 117.85 26.59 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.781 HD23 ' HA ' ' A' ' 21' ' ' PHE . 96.4 mt -119.99 139.69 52.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.451 0.643 . . . . 0.0 112.213 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -99.21 109.97 22.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.003 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HD3' HD13 ' A' ' 39' ' ' ILE . 13.7 mmmm -66.05 155.1 37.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.876 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.41 -15.42 36.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.882 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -105.32 21.77 16.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.43 0.633 . . . . 0.0 110.424 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.87 -16.23 48.02 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.464 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -66.74 154.78 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 35.5 ttmt -122.94 125.62 45.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.953 0.406 . . . . 0.0 110.4 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.506 HD13 ' HD3' ' A' ' 33' ' ' LYS . 33.6 pt -122.5 176.92 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.754 -176.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.13 116.72 6.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.665 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 m -118.13 165.39 13.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -97.51 134.45 40.72 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.929 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -67.37 -8.0 29.31 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -72.05 -28.52 63.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HD3' ' H ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -107.63 15.21 24.92 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.657 177.02 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 46' ' ' LEU . 8.2 tp -84.73 159.79 20.42 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.266 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.579 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 50.1 m -71.32 133.96 46.4 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.59 0.71 . . . . 0.0 109.89 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -57.53 -30.42 65.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.783 -171.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -65.83 -46.26 79.19 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.648 0.737 . . . . 0.0 109.349 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.587 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -59.54 -37.89 79.6 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.929 176.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.711 ' HB3' ' HB2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -68.37 -44.95 74.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.899 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.429 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -61.18 -28.43 69.13 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.297 0.57 . . . . 0.0 109.871 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.567 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 32.6 t80 -73.97 -51.79 14.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.335 175.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.5 p -70.86 -33.53 52.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.971 -0.455 . . . . 0.0 111.226 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 1.074 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 3.7 pt-20 -67.29 -24.93 65.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.03 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -46.27 64.58 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.567 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 56.9 mt -56.13 -43.72 76.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.035 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 7.0 p -80.35 -44.9 18.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.352 -175.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.72 -13.98 22.38 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -174.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.458 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 80.2 m-85 -80.21 -167.7 1.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.059 -0.571 . . . . 0.0 109.813 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.42 ' HA ' ' CD ' ' A' ' 55' ' ' GLU . 8.8 t -135.82 130.33 33.81 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 171.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.074 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 12.2 mt -104.87 23.61 13.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.409 0.623 . . . . 0.0 109.617 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.482 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 22.3 tt0 -53.35 -39.61 64.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.373 174.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -70.24 -6.08 32.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.772 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -109.05 -2.16 18.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.349 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' A' ' 63' ' ' GLU . 96.7 mttt -74.73 126.35 30.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.481 0.658 . . . . 0.0 109.687 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.856 ' HB3' ' HG2' ' A' ' 11' ' ' ARG . . . -97.37 113.56 25.23 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.577 -171.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.5 t30 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.681 176.621 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.7 mttt . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.01 131.31 36.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.546 -168.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.6 m -65.98 120.74 13.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 15.3 ptp180 -142.07 -178.81 5.88 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.509 -168.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.835 HD11 ' HB2' ' A' ' 16' ' ' LYS . 2.0 tm? -86.72 103.14 14.89 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.898 -175.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 33.5 m95 -91.61 144.68 25.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.548 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 10' ' ' ASP . 64.8 t -129.93 145.87 35.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -89.74 159.79 16.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 173.335 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -17.42 64.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -171.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 t -86.39 -12.39 49.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.321 0.581 . . . . 0.0 109.866 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.34 37.69 70.56 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.005 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 m -102.12 -42.1 6.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.47 0.176 . . . . 0.0 111.05 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.644 ' CZ ' ' HE3' ' A' ' 45' ' ' LYS . 34.7 p90 -125.1 138.07 54.18 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.821 0.82 . . . . 0.0 112.581 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.835 ' HB2' HD11 ' A' ' 7' ' ' LEU . 8.6 ptpp? -134.89 132.14 38.16 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 113.959 -1.473 . . . . 0.0 108.989 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.458 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -148.51 154.81 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.627 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 12.0 m-20 -92.87 123.79 36.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.235 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -164.54 157.07 16.69 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.201 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.75 146.76 33.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.509 ' HA ' HD23 ' A' ' 31' ' ' LEU . 78.1 t80 -76.64 132.56 39.48 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.089 0.471 . . . . 0.0 110.013 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -111.6 -46.83 5.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.443 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -166.63 148.34 13.29 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.938 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.491 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 6.9 t -122.75 126.81 48.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.793 0.33 . . . . 0.0 110.25 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.52 141.85 20.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.578 -176.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt 56.7 32.04 20.42 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.621 0.575 . . . . 0.0 111.55 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.69 9.36 87.13 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.624 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 72.3 mmtt -109.56 146.05 35.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.027 0.442 . . . . 0.0 110.76 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' A' ' 43' ' ' ALA . 42.0 mm -105.14 113.27 41.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.485 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.503 ' O ' HG13 ' A' ' 22' ' ' ILE . 17.9 m170 -82.57 120.78 25.95 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.8 mt -122.45 140.4 52.76 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 -175.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -100.05 103.82 15.37 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.911 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.922 ' HD3' HD13 ' A' ' 39' ' ' ILE . 12.5 mmmm -61.28 153.62 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.632 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.82 66.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.388 0.613 . . . . 0.0 109.359 172.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.42 HD22 ' C ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -63.07 -32.69 74.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.766 172.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.47 -2.59 27.88 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.295 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -91.94 150.28 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.634 0.255 . . . . 0.0 110.593 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 38' ' ' LYS . 4.4 tmmm? -101.73 125.49 48.41 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.922 HD13 ' HD3' ' A' ' 33' ' ' LYS . 16.1 pt -121.33 163.91 18.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.836 -177.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.79 103.84 7.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.272 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.1 t -110.54 127.04 67.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.515 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . . . -56.18 124.69 18.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.989 0.423 . . . . 0.0 111.665 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -61.72 -30.1 70.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.908 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.476 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 3.6 p30 -68.73 -32.67 72.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.566 -173.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.644 ' HE3' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -103.44 15.28 29.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.328 0.585 . . . . 0.0 110.11 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.5 tp -95.44 166.82 11.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.287 -177.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.552 ' O ' HD22 ' A' ' 51' ' ' LEU . 44.0 t -71.38 132.53 44.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.901 0.857 . . . . 0.0 111.001 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.647 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 1.6 m-20 -50.94 -38.1 48.37 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.187 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.82 -49.64 72.7 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.086 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.67 ' O ' HG12 ' A' ' 54' ' ' VAL . 74.0 m-20 -67.3 -32.72 73.89 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.784 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.786 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -69.9 -40.05 75.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.944 177.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.5 -32.39 72.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.372 0.606 . . . . 0.0 109.767 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.52 ' CE1' HD11 ' A' ' 57' ' ' ILE . 50.8 t80 -67.95 -50.64 54.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.332 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.736 ' HA ' HG12 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -68.32 -32.47 55.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 120.72 0.295 . . . . 0.0 111.253 -177.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.786 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 45.5 mt-10 -52.56 -35.66 54.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.52 170.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 1.05 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.55 -30.38 33.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.676 -179.369 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.736 HG12 ' HA ' ' A' ' 54' ' ' VAL . 21.7 mm -64.24 -38.71 83.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.6 p -116.56 -46.99 2.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -170.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.41 1.94 24.63 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.578 -173.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -78.88 153.68 30.35 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 t -97.48 101.48 13.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.038 0.447 . . . . 0.0 110.22 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.654 ' HA ' ' HD2' ' A' ' 65' ' ' PHE . 21.3 mt -98.44 19.67 14.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -63.83 -39.71 94.87 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.972 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -69.04 -9.57 53.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.456 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.654 ' HD2' ' HA ' ' A' ' 62' ' ' LEU . 91.4 m-85 -101.37 -4.84 26.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.948 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.647 ' HD3' ' HB3' ' A' ' 48' ' ' ASN . 52.0 mttp -82.53 138.95 34.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.359 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.73 90.9 6.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.972 176.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.005 -179.57 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.76 ' HG2' ' H ' ' A' ' 5' ' ' SER . 33.7 ttpt -172.73 -176.07 1.41 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.76 ' H ' ' HG2' ' A' ' 4' ' ' LYS . 19.9 p -50.83 148.44 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.088 0.471 . . . . 0.0 111.728 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 11.3 ptp180 -158.64 -177.85 6.83 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.093 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.421 ' CD2' ' HB2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -89.4 107.08 18.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.264 -175.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.649 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 30.1 m95 -90.89 140.21 30.03 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 90.8 t -130.1 158.32 42.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.963 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -91.66 162.21 14.59 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.4 -0.187 . . . . 0.0 110.503 176.304 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.431 ' HE ' ' HB3' ' A' ' 11' ' ' ARG . 1.7 tmm_? -57.57 -37.88 73.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.642 0.258 . . . . 0.0 111.144 -176.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 t -83.44 -15.44 49.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.734 0.302 . . . . 0.0 111.373 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.78 16.28 56.72 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.302 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 m -83.5 -37.12 23.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.458 0.647 . . . . 0.0 110.071 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.963 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 5.8 m-85 -95.14 137.95 33.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.023 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 19.0 ptpt -152.21 130.1 11.73 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.529 162.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.08 136.22 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.689 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 4.3 p-10 -75.99 109.15 9.39 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.218 173.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -148.13 167.39 25.14 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.508 -170.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 5' ' ' SER . 26.5 tt0 -133.71 124.35 26.54 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.294 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.654 ' HD1' HG23 ' A' ' 29' ' ' ILE . 67.1 t80 -65.39 130.29 42.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.345 0.593 . . . . 0.0 110.367 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.91 -54.28 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.874 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.06 142.02 7.67 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.467 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.468 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 16.4 p -103.28 142.81 33.55 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -178.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.21 126.81 9.45 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.956 -0.297 . . . . 0.0 111.225 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 55.61 41.4 30.62 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.768 0.667 . . . . 0.0 111.206 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.55 -0.74 80.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.642 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -104.28 166.77 10.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 0.0 110.813 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.654 HG23 ' HD1' ' A' ' 21' ' ' PHE . 85.1 mt -124.09 121.65 62.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.085 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -88.48 129.02 35.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.912 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 90.4 mt -124.49 136.76 54.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.845 0.831 . . . . 0.0 111.873 -172.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 14.3 t-80 -98.43 99.59 10.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.994 176.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 36.2 mtpt -61.83 156.96 19.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.817 0.341 . . . . 0.0 110.167 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.77 -12.45 60.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.627 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -90.91 1.82 56.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.394 177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.02 -24.4 31.43 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.707 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -65.3 145.09 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.599 0.238 . . . . 0.0 110.833 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -114.24 131.62 56.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.1 0.476 . . . . 0.0 110.503 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.8 pt -129.52 166.82 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.989 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.45 118.78 19.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.649 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 m -116.78 156.98 17.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.22 128.04 33.78 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.746 -0.382 . . . . 0.0 109.976 175.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.423 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -64.68 -15.23 61.04 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -174.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.665 ' HB3' ' HD1' ' A' ' 65' ' ' PHE . 8.1 p-10 -91.56 -13.93 31.17 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -173.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.05 19.94 19.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.711 0.767 . . . . 0.0 109.523 176.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 8.5 tp -103.48 169.21 8.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.276 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.482 ' O ' HD22 ' A' ' 51' ' ' LEU . 25.2 t -73.61 141.68 46.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.582 0.706 . . . . 0.0 109.367 176.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.581 ' ND2' ' HA ' ' A' ' 66' ' ' LYS . 7.6 m120 -73.89 -18.73 60.87 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.607 -171.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -43.34 81.23 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.563 ' O ' HG12 ' A' ' 54' ' ' VAL . 35.6 m-20 -63.67 -38.01 89.49 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.196 176.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.822 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -66.42 -45.18 80.79 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.134 177.358 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.68 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . . . -59.39 -32.34 70.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.475 0.655 . . . . 0.0 110.241 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.607 ' CE2' HD11 ' A' ' 57' ' ' ILE . 43.9 t80 -72.32 -50.48 26.56 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.379 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 50' ' ' ASP . 3.2 p -68.42 -28.9 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 O-C-N 122.089 -0.382 . . . . 0.0 110.77 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.822 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 44.4 mt-10 -52.5 -41.43 63.42 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 120.647 0.26 . . . . 0.0 110.471 169.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.502 ' N ' ' HE3' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -73.79 -33.02 64.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.806 -178.239 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.607 HD11 ' CE2' ' A' ' 53' ' ' TYR . 29.9 mt -67.65 -37.37 78.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.281 175.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.471 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 32.4 p -97.78 -45.17 6.44 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -170.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.97 -7.27 37.94 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -172.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.471 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 65.0 m-85 -80.32 175.88 10.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 110.784 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -121.1 114.77 21.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.432 176.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 35.8 mt -103.58 27.28 7.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.571 -176.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -56.59 -42.1 78.12 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.665 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -72.55 -6.45 44.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.341 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.665 ' HD1' ' HB3' ' A' ' 44' ' ' ASP . 97.3 m-85 -102.99 0.3 31.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.418 0.628 . . . . 0.0 109.52 176.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.581 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 98.5 mttt -96.54 148.2 23.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.778 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.14 -177.45 5.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.873 0.368 . . . . 0.0 111.57 -171.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.9 m120 . . . . . 0 C--O 1.247 0.952 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.597 -179.203 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.9 mttm . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.8 0.333 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -94.94 167.69 11.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.269 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 t -53.48 142.77 21.27 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.098 173.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.581 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 6.6 ptp180 -140.66 -178.83 5.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.245 -173.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.35 105.41 16.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.04 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.688 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 52.4 m95 -91.92 145.05 24.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.828 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 10' ' ' ASP . 61.5 t -135.6 146.0 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.443 0.465 . . . . 0.0 110.379 -176.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.976 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -90.42 174.1 7.74 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.778 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 2.4 tpm_? -61.68 -43.36 99.01 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 122.389 -0.194 . . . . 0.0 111.393 -177.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -67.74 -29.74 69.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.236 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.96 12.71 51.99 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.33 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -91.47 -39.37 11.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.507 0.67 . . . . 0.0 109.506 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.976 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 3.7 m-85 -82.46 130.7 35.16 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.417 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 8.6 ptpt -157.42 128.68 6.77 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.9 169.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.51 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -154.91 145.79 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.032 -173.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.581 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 2.5 p-10 -88.24 117.51 27.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.062 174.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.775 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . . . -164.84 163.66 21.11 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.13 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.42 140.34 52.28 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.742 ' HA ' HD23 ' A' ' 31' ' ' LEU . 48.2 t80 -69.3 132.61 46.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.468 0.651 . . . . 0.0 110.372 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.03 -52.51 5.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.043 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.87 143.38 8.55 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.141 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.553 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 20.0 p -105.61 142.13 35.88 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.98 112.43 8.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 111.439 -173.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.6 tptt 52.68 53.55 12.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.791 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.57 -3.73 77.09 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.118 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 84.9 mttt -110.96 170.48 8.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.068 0.461 . . . . 0.0 110.533 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.531 HG23 ' HD1' ' A' ' 21' ' ' PHE . 59.2 mt -129.0 128.04 66.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.882 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -91.31 127.95 36.95 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' ' 21' ' ' PHE . 95.9 mt -127.3 137.39 52.82 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.583 -174.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -98.13 100.92 12.26 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.351 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.829 ' HD3' HD13 ' A' ' 39' ' ' ILE . 12.1 mmmm -61.77 160.54 11.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.34 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.29 -14.94 63.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.721 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -84.45 -6.81 59.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.959 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.64 7.52 58.95 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.738 174.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.5 155.04 6.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 117.059 0.429 . . . . 0.0 110.377 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -97.9 144.27 27.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 0.0 110.863 177.077 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.829 HD13 ' HD3' ' A' ' 33' ' ' LYS . 37.2 pt -127.53 156.27 39.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.15 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.13 103.73 11.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.243 0.545 . . . . 0.0 110.159 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.8 t -109.4 125.16 66.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.276 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -79.51 130.63 35.58 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.44 -5.81 12.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.458 -174.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.85 -42.74 57.37 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -172.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -99.13 12.13 37.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 0.0 110.319 -176.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 11.9 tp -83.88 169.35 15.19 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.678 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.569 ' O ' HD22 ' A' ' 51' ' ' LEU . 47.8 t -73.12 138.0 45.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.025 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -47.03 -50.03 20.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.854 0.835 . . . . 0.0 111.248 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.2 -30.36 68.53 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.795 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.609 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -65.65 -38.03 88.21 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.8 177.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.736 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.7 OUTLIER -70.17 -44.21 69.22 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.81 176.211 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.41 65.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.423 0.63 . . . . 0.0 110.224 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.655 ' CE2' HD11 ' A' ' 57' ' ' ILE . 66.5 t80 -73.79 -49.66 24.24 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.421 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.777 HG13 HD12 ' A' ' 62' ' ' LEU . 2.2 p -70.03 -28.25 35.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 O-C-N 122.006 -0.434 . . . . 0.0 110.823 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.736 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 39.3 mt-10 -56.09 -31.47 63.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.724 168.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.859 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 6.6 mmpt? -80.84 -32.25 35.19 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.77 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.655 HD11 ' CE2' ' A' ' 53' ' ' TYR . 39.6 mt -63.32 -41.38 92.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 174.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.563 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 27.4 p -107.41 -46.79 3.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -171.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.31 -5.74 35.97 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.563 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 66.9 m-85 -85.77 136.95 33.13 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.992 0.425 . . . . 0.0 110.29 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 m -75.7 100.94 4.83 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.623 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.777 HD12 HG13 ' A' ' 54' ' ' VAL . 34.3 mt -94.97 18.74 11.42 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.67 0.748 . . . . 0.0 109.389 172.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 1.07 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 24.7 tt0 -73.83 -29.38 62.1 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.894 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -14.88 58.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.954 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.432 ' HD2' ' HA ' ' A' ' 62' ' ' LEU . 96.0 m-85 -105.57 -7.19 18.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.253 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.07 ' HG3' ' HA ' ' A' ' 63' ' ' GLU . 43.1 mttp -60.33 126.86 29.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.521 0.677 . . . . 0.0 110.881 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.23 124.78 51.44 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.31 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.494 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 2.7 m-20 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.991 -177.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.1 tptt . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 120.8 0.333 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -89.67 -143.64 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.659 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.869 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 20.1 p -53.17 134.09 39.01 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.515 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 17.5 ptp180 -148.47 -178.25 6.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.451 -173.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.833 HD11 ' HB3' ' A' ' 16' ' ' LYS . 2.6 tm? -81.44 106.63 13.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.699 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.583 ' HH2' ' HB ' ' A' ' 54' ' ' VAL . 32.2 m95 -92.8 151.29 20.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.165 174.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 36.9 t -123.07 145.32 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.644 0.259 . . . . 0.0 110.72 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -83.16 160.29 21.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.403 175.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -51.57 -46.1 63.34 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.536 0.523 . . . . 0.0 111.921 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 m -94.91 9.81 37.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.819 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.7 23.98 69.37 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.12 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -71.55 -34.36 69.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.176 0.512 . . . . 0.0 110.359 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 10' ' ' ASP . 33.0 p90 -143.21 132.61 23.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.386 0.613 . . . . 0.0 111.186 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.833 ' HB3' HD11 ' A' ' 7' ' ' LEU . 88.3 mttt -109.37 129.98 55.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 167.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.11 135.9 42.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.598 0.713 . . . . 0.0 112.887 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 1.1 p30 -78.27 119.94 22.34 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.757 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.811 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -157.43 158.4 35.75 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.505 0.669 . . . . 0.0 111.892 -172.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.869 ' HB2' ' HB3' ' A' ' 5' ' ' SER . 30.9 tt0 -122.59 124.67 44.03 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.786 176.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.755 ' HD1' HG23 ' A' ' 29' ' ' ILE . 4.5 t80 -70.14 123.35 21.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.153 0.502 . . . . 0.0 110.321 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -105.9 -44.07 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.647 -178.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.36 139.93 6.18 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.103 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.43 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 51.9 t -110.04 118.44 36.43 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.93 140.39 29.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.628 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? 65.06 11.7 7.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.131 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.56 -2.79 60.84 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.127 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.734 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 86.6 mttt -102.83 164.45 11.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.0 110.755 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.755 HG23 ' HD1' ' A' ' 21' ' ' PHE . 75.5 mt -114.98 121.22 66.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.015 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.443 ' O ' HG13 ' A' ' 22' ' ' ILE . 20.5 m170 -82.91 124.31 30.23 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.811 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 71.0 mt -124.6 137.49 54.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.432 0.634 . . . . 0.0 111.415 -174.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -107.36 106.18 16.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.577 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 4.1 mtpm? -67.07 166.68 13.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.14 0.495 . . . . 0.0 111.711 -172.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.97 -12.84 60.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.099 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.94 -23.48 38.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.813 173.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.49 -15.08 29.94 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -173.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.2 t -65.86 142.72 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.725 -0.238 . . . . 0.0 110.485 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -108.86 130.21 55.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.157 0.503 . . . . 0.0 110.459 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.457 HG12 ' HB2' ' A' ' 31' ' ' LEU . 12.3 pt -127.39 166.54 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.351 -177.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.1 103.21 5.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.088 0.47 . . . . 0.0 109.994 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 46' ' ' LEU . 74.4 t -116.08 126.36 73.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.934 -176.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -59.35 135.32 57.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.687 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.11 -6.13 12.19 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.374 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -90.15 -41.17 11.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.069 0.462 . . . . 0.0 111.215 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -87.53 22.19 2.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.824 -175.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.514 HD13 HG11 ' A' ' 41' ' ' VAL . 9.1 tp -111.91 167.23 10.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.651 -174.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.564 ' O ' HD22 ' A' ' 51' ' ' LEU . 29.6 t -65.0 129.22 38.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.36 0.6 . . . . 0.0 109.649 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.429 ' HA ' HD23 ' A' ' 51' ' ' LEU . 8.1 m120 -67.2 -21.71 65.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.631 -172.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -60.68 -48.34 82.21 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.695 0.759 . . . . 0.0 109.294 171.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.598 ' O ' HG12 ' A' ' 54' ' ' VAL . 16.2 m-20 -67.59 -31.77 72.05 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.827 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -69.31 -40.79 77.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.395 176.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . . . -65.24 -27.92 68.99 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.382 0.61 . . . . 0.0 109.541 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.595 ' CE2' HD11 ' A' ' 57' ' ' ILE . 31.1 t80 -73.61 -50.77 19.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.594 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.4 p -70.5 -33.29 52.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 120.885 0.374 . . . . 0.0 111.255 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.926 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 1.6 pt-20 -65.58 -24.63 67.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.11 0.481 . . . . 0.0 109.923 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 1.035 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 5.3 mmpt? -81.31 -27.27 35.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.585 175.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.595 HD11 ' CE2' ' A' ' 53' ' ' TYR . 54.3 mt -64.33 -41.58 92.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.163 0.506 . . . . 0.0 109.728 172.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.474 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 6.4 p -86.34 -47.43 9.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.775 -173.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.7 -9.91 19.01 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -173.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.551 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 66.6 m-85 -89.25 -172.7 3.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 55' ' ' GLU . 17.1 t -131.53 128.28 38.98 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.573 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.926 ' HG ' ' HB3' ' A' ' 55' ' ' GLU . 10.2 mt -95.73 25.94 4.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.034 0.445 . . . . 0.0 110.031 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.429 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 1.2 tp10 -44.36 -51.1 8.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.81 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -71.03 -9.9 58.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.066 -176.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -100.42 0.53 39.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 0.0 110.012 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 87.3 mttt -96.16 143.59 27.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.808 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -92.14 24.44 3.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.732 0.777 . . . . 0.0 109.549 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.2 t30 . . . . . 0 C--O 1.247 0.943 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.629 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 121.459 0.647 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -92.29 -162.12 0.9 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.8 177.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.439 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 2.0 p -63.06 119.96 10.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.488 173.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 3.6 ptp180 -112.48 173.42 6.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.213 -167.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -85.72 114.73 22.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.507 -172.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.544 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 81.1 m95 -105.58 146.17 30.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.2 176.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.711 HG22 ' HG2' ' A' ' 16' ' ' LYS . 66.0 t -136.37 138.26 47.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.187 0.304 . . . . 0.0 110.707 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.584 ' HA ' HD12 ' A' ' 46' ' ' LEU . 6.6 p-10 -84.89 159.74 20.29 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -76.76 -1.98 30.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.029 0.443 . . . . 0.0 111.997 -169.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 t -105.34 -3.51 22.62 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.448 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.5 31.02 70.86 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.418 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.4 m -84.76 -43.06 14.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.848 0.356 . . . . 0.0 110.732 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.804 ' HZ ' ' HE3' ' A' ' 45' ' ' LYS . 24.9 p90 -138.76 136.86 36.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.867 0.841 . . . . 0.0 112.679 -176.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.711 ' HG2' HG22 ' A' ' 9' ' ' VAL . 54.1 mttp -126.07 130.9 52.02 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.207 171.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -139.06 157.94 28.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.391 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 29.5 m-20 -103.74 113.4 26.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -159.4 158.68 32.61 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.947 -172.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.439 ' HG3' ' HA ' ' A' ' 5' ' ' SER . 45.3 mt-10 -106.73 138.64 42.53 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.206 174.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.665 ' HA ' HD23 ' A' ' 31' ' ' LEU . 15.2 t80 -71.88 124.35 24.67 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.197 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -105.94 -43.21 7.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.102 -177.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.9 150.84 13.7 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.505 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.47 ' HB2' ' HE2' ' A' ' 21' ' ' PHE . 6.3 t -115.1 136.88 52.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.93 119.97 12.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.606 0.241 . . . . 0.0 110.913 -173.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 26' ' ' LYS . 17.9 tptm 55.75 41.17 30.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.314 174.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 65' ' ' PHE . . . 89.92 -4.84 83.45 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.309 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -109.71 159.93 16.74 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 122.453 -0.439 . . . . 0.0 110.765 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.522 HG23 ' HD2' ' A' ' 21' ' ' PHE . 76.1 mt -122.33 124.82 71.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.979 -174.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 92.2 m-70 -87.6 126.42 34.93 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 21' ' ' PHE . 87.4 mt -125.14 136.76 53.93 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.522 -178.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -102.1 100.38 10.62 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -63.32 159.57 17.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.136 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.28 -15.29 56.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.232 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.14 -25.22 37.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.523 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.9 -6.55 27.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.198 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.97 137.64 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.674 0.273 . . . . 0.0 110.577 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 36.5 ttmt -102.57 124.74 48.67 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 31.8 pt -123.43 153.68 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -176.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.29 103.43 8.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.129 175.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 m -99.03 153.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.487 ' HB1' ' OD1' ' A' ' 44' ' ' ASP . . . -82.33 122.22 27.69 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.009 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.93 -20.03 63.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.476 0.655 . . . . 0.0 110.923 -176.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.661 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 6.6 p-10 -77.02 -12.13 59.9 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.164 -175.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.804 ' HE3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -117.43 10.32 13.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.931 0.872 . . . . 0.0 109.012 173.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 10' ' ' ASP . 14.1 tp -89.82 162.79 15.32 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.646 -177.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.572 ' HB2' ' OD1' ' A' ' 50' ' ' ASP . 27.0 m -68.28 142.75 55.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.588 0.709 . . . . 0.0 110.68 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -65.41 -27.85 68.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.267 -173.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -64.72 -48.9 72.95 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.603 0.716 . . . . 0.0 109.598 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.572 ' OD1' ' HB2' ' A' ' 47' ' ' SER . 1.6 m-20 -59.86 -36.29 76.57 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.219 175.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.686 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -65.47 -47.37 76.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.576 178.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -62.36 -27.57 69.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.789 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.428 ' O ' HG12 ' A' ' 57' ' ' ILE . 48.8 t80 -71.91 -47.88 49.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.628 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' A' ' 62' ' ' LEU . 61.5 t -62.68 -33.55 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.695 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.632 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 38.2 mt-10 -52.19 -34.77 46.85 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.21 0.529 . . . . 0.0 110.483 173.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 1.033 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 4.6 mmpt? -82.51 -37.01 25.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.894 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.44 HG21 ' CD1' ' A' ' 21' ' ' PHE . 20.7 mm -69.81 -28.35 36.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.008 0.432 . . . . 0.0 111.202 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.656 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 43.7 p -104.83 -45.38 4.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -173.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.4 4.34 46.84 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -172.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.656 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 96.7 m-85 -102.94 -175.88 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.2 t -125.4 121.75 34.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.102 0.477 . . . . 0.0 110.748 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 51' ' ' LEU . 25.4 mt -95.94 22.83 6.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.647 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.14 -41.14 74.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.402 0.62 . . . . 0.0 110.458 176.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HE3' ' CE2' ' A' ' 65' ' ' PHE . 48.6 pttt -62.53 -14.17 38.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.673 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.661 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 32.7 m-85 -104.38 -8.86 18.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.908 0.385 . . . . 0.0 111.031 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 62' ' ' LEU . 95.0 mttt -84.77 126.17 33.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.101 0.477 . . . . 0.0 109.714 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.77 -84.59 0.07 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.988 -177.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 . . . . . 0 C--N 1.301 -1.509 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.094 175.851 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp . . . . . 0 C--O 1.234 0.251 0 CA-C-O 121.135 0.493 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.773 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -108.31 154.98 21.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.515 -178.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.582 ' CA ' ' HB2' ' A' ' 20' ' ' GLU . 46.1 t 71.8 125.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.866 0.841 . . . . 0.0 112.154 177.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 14.2 ptp180 -149.42 -179.08 6.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.168 -171.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.6 tm? -86.43 107.87 18.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.772 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.456 ' CE3' ' HB3' ' A' ' 50' ' ' ASP . 46.4 m95 -92.38 149.09 21.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.098 176.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 15.6 t -130.58 154.33 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.831 ' HB3' ' HB2' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -101.65 -179.05 3.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.815 0.341 . . . . 0.0 111.217 -178.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.432 ' HG2' ' CB ' ' A' ' 67' ' ' ALA . 1.9 tmm_? -60.41 -52.83 63.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.054 -177.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 m -81.8 -7.29 59.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.184 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.0 28.54 45.26 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.527 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.1 m -99.7 -37.28 9.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.521 0.677 . . . . 0.0 109.468 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.831 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 4.8 m-85 -87.01 125.82 34.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.739 -176.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.457 ' HB3' HD11 ' A' ' 7' ' ' LEU . 50.5 mttp -131.63 129.56 41.01 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 158.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.87 133.59 6.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.455 0.645 . . . . 0.0 112.119 -177.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 7.3 p-10 -87.73 116.2 25.71 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.732 176.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -168.49 167.64 11.57 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.102 -174.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' CA ' ' A' ' 5' ' ' SER . 9.6 tp10 -126.97 136.56 52.43 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.137 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.779 ' HA ' HD23 ' A' ' 31' ' ' LEU . 7.1 t80 -65.53 126.6 28.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.723 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -105.54 -50.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.818 179.281 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.11 148.07 15.97 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.583 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 t -108.9 129.12 55.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.18 133.02 15.02 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.138 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm 63.69 23.72 13.61 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.328 175.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.92 4.59 88.52 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.956 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 33.1 mmtp -103.23 154.51 19.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.008 0.433 . . . . 0.0 110.166 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.647 HG23 ' HD1' ' A' ' 21' ' ' PHE . 40.3 mm -108.71 114.07 45.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.347 174.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.448 ' O ' HG13 ' A' ' 22' ' ' ILE . 65.0 m170 -76.21 125.59 29.44 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 175.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.779 HD23 ' HA ' ' A' ' 21' ' ' PHE . 86.3 mt -129.04 136.69 50.62 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.695 -174.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -106.74 107.94 19.21 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.574 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 4.8 mtpm? -67.63 166.14 15.64 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.15 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.64 -14.38 60.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.297 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -93.42 1.96 56.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.904 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.33 -18.08 58.11 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.185 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.1 t -63.67 139.35 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.518 0.199 . . . . 0.0 110.869 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -107.81 121.68 45.22 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 pt -124.42 158.51 31.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.726 -173.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.48 103.39 8.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.152 0.501 . . . . 0.0 110.049 174.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.28 119.97 55.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -58.79 124.95 21.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.436 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -64.96 -26.91 68.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.982 177.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.7 -34.24 71.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.58 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -110.46 18.38 19.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.034 0.445 . . . . 0.0 110.789 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.684 ' HB3' HD21 ' A' ' 51' ' ' LEU . 10.1 tp -95.18 170.12 9.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.149 -176.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.608 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 35.3 t -83.66 139.48 32.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.033 0.92 . . . . 0.0 110.751 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -51.52 -35.04 38.85 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.272 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.22 -50.54 71.35 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 121.412 0.625 . . . . 0.0 109.99 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.608 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 5.8 m-20 -60.99 -36.41 79.4 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.606 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.772 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 26.4 mt -69.82 -43.21 72.49 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . . . -59.41 -28.88 67.32 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.514 0.673 . . . . 0.0 109.869 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.547 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 29.3 t80 -73.7 -50.34 21.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.146 176.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 50' ' ' ASP . 2.0 p -70.28 -29.66 40.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.891 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.772 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 42.8 mt-10 -54.63 -37.12 65.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.465 168.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -39.44 66.6 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.547 HD11 ' CZ ' ' A' ' 53' ' ' TYR . 53.3 mt -64.19 -47.23 90.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.084 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.9 p -80.62 -46.46 15.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.363 -174.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.04 -4.55 41.62 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -173.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -100.35 179.36 4.48 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.52 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 6.4 t -118.98 134.51 55.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.805 0.336 . . . . 0.0 110.479 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.531 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 21.8 mt -97.84 35.75 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.123 0.487 . . . . 0.0 110.845 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.44 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 5.8 mm-40 -44.61 -58.41 3.05 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.506 1.122 . . . . 0.0 113.365 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -69.11 -10.54 58.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.644 0.259 . . . . 0.0 111.693 -173.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -105.04 -8.97 18.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.286 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.666 ' HA ' HD12 ' A' ' 51' ' ' LEU . 64.2 mttm -62.99 147.43 50.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.246 0.546 . . . . 0.0 111.867 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.432 ' CB ' ' HG2' ' A' ' 11' ' ' ARG . . . -71.45 68.06 0.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.803 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 C--O 1.246 0.918 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.942 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.685 ' HG3' ' H ' ' A' ' 4' ' ' LYS . 15.0 ptmt . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.685 ' H ' ' HG3' ' A' ' 3' ' ' LYS . 27.7 mttp 51.78 55.51 9.21 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 122.158 0.98 . . . . 0.0 111.158 -173.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 p -70.25 125.93 28.21 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.696 -1.593 . . . . 0.0 109.944 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 18' ' ' ASP . 8.2 ptp180 -115.44 178.16 4.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.879 -171.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 7' ' ' LEU . 6.1 mt -84.45 114.32 21.84 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.214 0.531 . . . . 0.0 111.546 -173.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.581 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 43.9 m95 -98.63 140.66 32.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.595 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 10' ' ' ASP . 43.8 t -124.62 144.84 33.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.915 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.532 ' HA ' HD12 ' A' ' 46' ' ' LEU . 7.4 p-10 -84.89 170.55 12.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.0 109.887 173.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.443 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 36.4 ttp180 -75.47 -14.52 60.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.631 -172.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -98.13 -16.48 19.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.907 0.384 . . . . 0.0 111.184 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.5 36.85 25.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.661 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -98.87 -37.69 9.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.189 -0.505 . . . . 0.0 110.724 -175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 10' ' ' ASP . 37.8 p90 -137.0 135.15 37.37 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.725 0.774 . . . . 0.0 112.434 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 8' ' ' TRP . 47.8 mttp -128.92 130.61 47.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.369 173.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.559 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -145.1 146.1 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.987 0.422 . . . . 0.0 112.102 -176.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 6.3 m-20 -82.12 120.39 25.25 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.513 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.674 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -163.16 162.89 25.77 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.74 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -123.6 138.53 54.53 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 174.304 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.8 ' HD1' HG23 ' A' ' 29' ' ' ILE . 6.8 t80 -70.91 122.72 20.48 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.508 0.67 . . . . 0.0 110.507 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -100.81 -51.16 9.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.383 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.84 154.35 25.34 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.485 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.412 ' HB2' ' HE1' ' A' ' 21' ' ' PHE . 22.6 t -120.82 138.58 53.97 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -177.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.1 131.07 15.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.045 -175.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 56.62 27.1 11.98 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.729 0.643 . . . . 0.0 112.311 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.41 -1.53 69.61 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.711 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 57.0 mttp -103.99 158.93 16.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.011 0.434 . . . . 0.0 110.799 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.8 HG23 ' HD1' ' A' ' 21' ' ' PHE . 94.3 mt -116.38 122.8 70.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.117 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.435 ' O ' HG13 ' A' ' 22' ' ' ILE . 39.7 m170 -84.5 126.94 33.73 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 21' ' ' PHE . 81.8 mt -124.14 135.69 53.69 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.833 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -95.7 103.97 15.87 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.696 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.866 ' HD3' HD13 ' A' ' 39' ' ' ILE . 11.8 mmmm -64.82 158.75 24.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.218 -174.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.8 -20.72 66.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.802 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -66.48 -32.49 73.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.686 173.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.83 -17.26 27.73 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.295 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.4 t -72.59 147.4 10.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.368 -0.416 . . . . 0.0 110.654 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -100.62 128.77 46.56 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.866 HD13 ' HD3' ' A' ' 33' ' ' LYS . 18.1 pt -120.04 159.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.259 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.82 103.55 8.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.069 0.461 . . . . 0.0 110.096 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.1 t -107.29 129.56 60.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -68.18 131.56 45.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.78 0.324 . . . . 0.0 110.191 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' A' ' 29' ' ' ILE . . . -69.07 -6.55 28.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.881 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 65' ' ' PHE . 2.8 p30 -81.76 -33.81 30.77 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -172.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.588 ' HD3' ' H ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -107.78 19.98 19.4 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.094 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.532 HD12 ' HA ' ' A' ' 10' ' ' ASP . 11.6 tp -93.34 169.69 10.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.799 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.515 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.3 t -74.15 139.47 44.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.561 0.696 . . . . 0.0 110.676 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -63.21 -30.55 71.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.419 -173.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -62.03 -46.98 86.78 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.594 0.712 . . . . 0.0 109.789 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.573 ' O ' HG12 ' A' ' 54' ' ' VAL . 4.3 m-20 -65.54 -34.69 78.85 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.565 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.779 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -69.32 -47.21 65.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.11 177.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.576 ' O ' ' HD2' ' A' ' 56' ' ' LYS . . . -60.94 -30.85 70.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.575 0.702 . . . . 0.0 109.991 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.442 ' CE1' HD11 ' A' ' 57' ' ' ILE . 35.2 t80 -69.22 -52.12 30.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.099 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.768 ' HA ' HG12 ' A' ' 57' ' ' ILE . 3.0 p -69.06 -27.22 34.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.868 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.779 ' HG3' ' O ' ' A' ' 51' ' ' LEU . 71.2 mt-10 -51.09 -49.29 60.99 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.106 0.479 . . . . 0.0 109.894 167.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -72.24 -26.62 62.09 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.57 -175.169 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.768 HG12 ' HA ' ' A' ' 54' ' ' VAL . 10.8 mm -67.3 -43.18 88.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.561 174.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 60' ' ' PHE . 17.8 p -97.19 -47.25 5.82 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.14 -6.9 19.18 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.486 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 90.8 m-85 -92.71 167.89 11.58 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -117.13 134.46 54.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 27.4 mt -105.3 25.17 10.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.685 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 5.5 tp10 -54.5 -41.59 69.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.3 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -60.27 -19.95 56.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.204 177.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.484 ' HB3' ' HA ' ' A' ' 44' ' ' ASP . 57.6 m-85 -101.04 -14.16 17.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.31 0.576 . . . . 0.0 110.081 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.685 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 49.6 mtpt -81.43 140.05 34.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.282 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.443 ' HB3' ' HD2' ' A' ' 11' ' ' ARG . . . -116.89 121.24 40.91 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.905 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.636 -178.992 . . . . . . . . 0 0 . 1 stop_ save_